UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report: June 22, 2015
(Date of earliest event reported)
SEQUENTIAL BRANDS GROUP, INC.
(Exact name of registrant as specified
in its charter)
|
|
|
|
|
Delaware |
|
001-36082 |
|
86-0449546 |
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
5 Bryant Park, 30th Floor,
New York, NY 10018
(Address of Principal Executive Offices/Zip
Code)
(646) 564-2577
(Registrant’s telephone number,
including area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
x |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01 Entry
into a Material Definitive Agreement
On June 22, 2015, Sequential Brands
Group, Inc., a Delaware corporation (the “Company”), Martha Stewart Living Omnimedia, Inc., a Delaware corporation
(“MSLO”), Madeline Merger Sub., Inc., a Delaware corporation and wholly owned subsidiary of TopCo (“Madeline
Merger Sub”), Singer Merger Sub., Inc., a Delaware corporation and wholly owned subsidiary of TopCo (“Singer Merger
Sub” and, together with the Madeline Merger Sub, the “Merger Subs”), and Singer Madeline Holdings, Inc., a Delaware
corporation (“TopCo”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to
which the Company will acquire MSLO.
Pursuant to the Merger Agreement, at the
closing (the date on which the closing occurs, the “Closing Date”), Madeline Merger Sub will merge with and into MSLO
(the “MSLO Merger”), with MSLO continuing as the surviving corporation of the MSLO Merger and a wholly owned subsidiary
of TopCo, upon the terms and subject to the conditions set forth in the Merger Agreement. In connection therewith, each issued
and outstanding share of MSLO’s Class A common stock, par value $.01 per share, and Class B Common stock, par value $.01
per share (collectively, the “MSLO Common Stock”), will be converted into the right to receive either $6.15 in cash
(the “MSLO Cash Consideration”) or a number of fully-paid and nonassessable shares of TopCo’s common stock, par
value $0.01 per share (the “TopCo Common Stock”), together with cash, in lieu of fractional shares of TopCo Common
Stock, equal to the MSLO Cash Consideration divided by the volume weighted average price per share of the Company’s common
stock, par value $.001 per share (“Sequential Common Stock”), on the Nasdaq Stock Market for the consecutive period
over the five trading days ending on the trading day immediately preceding the Closing Date, as calculated by Bloomberg Financial
LP under the function “VWAP.”
Substantially concurrently with the MSLO
Merger, Singer Merger Sub will merge with and into the Company (the “Sequential Merger” and together with the MSLO
Merger, the “Mergers”), with the Company continuing as the surviving corporation of the Sequential Merger, upon the
terms and subject to the conditions set forth in the Merger Agreement. In connection with the Sequential Merger, each issued and
outstanding share of Sequential Common Stock will be converted into the right to receive one fully-paid and nonassessable share
of TopCo Common Stock (“the Sequential Merger Consideration”).
The stockholders of MSLO will be asked
to vote on the adoption of the Merger Agreement at a special stockholders meeting that will be held on a date to be announced.
Consummation of the Mergers is contingent upon obtaining the approval of both MSLO stockholders holding at least a majority in
combined voting power of the outstanding MSLO common stock and holders of at least fifty percent (50%) in combined voting power
of the outstanding MSLO common stock not owned, directly or indirectly, by Martha Stewart and her affiliates (the “MSLO Stockholder
Approval”).
The Company and MSLO will prepare, and
the Company will cause TopCo to file with the Securities and Exchange Commission (“SEC”), a registration statement
on Form S-4 in connection with the issuance of shares of TopCo Common Stock in the Mergers (the “Form S-4”), which
will include a prospectus with respect to the shares to be issued in the MSLO Merger, a preliminary and definitive proxy statement
with respect to the required vote of the stockholders of MSLO in connection with the MSLO Merger, and a preliminary and definitive
information statement for the Company’s stockholders (the “Combined Statement”).
After the closing, TopCo will be renamed
Sequential Brands Group, Inc., TopCo Common Stock will be listed on Nasdaq, the Company’s current board will become the board
of directors of TopCo and Martha Stewart will join the TopCo Board.
The Merger Agreement generally contains
reciprocal representations and warranties of each of MSLO and the Company that are typical for a public company merger, and are
qualified by information contained in each party’s respective SEC filings.
In addition to the MSLO Stockholder Approval,
consummation of the Mergers is subject to customary conditions, including without limitation (i) the expiration or termination
of any waiting period applicable to the consummation of the Mergers under the Hart-Scott-Rodino Antitrust Improvements Act of 1976,
as amended, (ii) obtaining Company stockholder approval, which approval was obtained by written consent on June 22, 2015 following
execution and delivery of the Merger Agreement, (iii) the receipt of certain tax opinions, (iv) the effectiveness of the Form S-4,
(v) obtaining authorization for TopCo shares to be listed on Nasdaq, and (vi) the absence of any law or order prohibiting
the Mergers. Moreover, each party’s obligation to consummate the Mergers is subject to certain other conditions, including
without limitation (x) the accuracy of the other party’s representations and warranties (subject to customary materiality
qualifiers) and (y) the other party’s compliance with its covenants and agreements contained in the Merger Agreement (subject
to customary materiality qualifiers).
During the period beginning on June 22,
2015 and continuing until 11:59 p.m. on July 22, 2015 (the “No Shop Period Start Date”), MSLO and its representatives
may initiate, solicit and encourage any alternative acquisition proposals from third parties and participate in discussions and
negotiate with third parties with respect to alternative acquisition proposals. Notwithstanding the No Shop Period Start Date,
MSLO and its representatives may continue to engage in such activities until August 6, 2015 with any person or group of persons
that submits a bona fide written acquisition proposal prior to the No Shop Period Start Date (each, an “Excluded Party”)
that the Board of Directors of MSLO (the “MSLO Board”) determines in good faith constitutes or would reasonably be
expected to result in a superior proposal, (provided such date and time shall be extended to the extent and during such period
thereafter as MSLO is in active discussions with an Excluded Party). From and after the No Shop Period Start Date, MSLO will become
subject to customary “no-shop” restrictions on its ability to solicit, initiate, endorse, knowingly encourage or knowingly
facilitate, and, subject to certain exceptions, not to participate in any discussions or negotiations, or cooperate in any way
with respect to, any inquiries or the making of, any proposal of an alternative transaction, except as described above with regard
to the Excluded Parties, or to withdraw the support of its Board of Directors for the MSLO Merger.
The Merger Agreement also contains mutual
customary pre-closing covenants of the Company and MSLO, including covenants, among others, (i) each to operate its businesses
in the ordinary course consistent with past practice and to refrain from taking certain actions without the other party’s
consent and (ii) each to use their respective reasonable best efforts to obtain governmental, regulatory and third party approvals.
In addition, the Merger Agreement contains covenants that require MSLO to call and hold a special stockholder meeting and, subject
to certain exceptions, require the MSLO Board to recommend that the MSLO stockholders approve the Mergers and the Merger Agreement.
In connection with the financing of the
transactions contemplated by the Merger Agreement, the Company has entered into a commitment letter (the “Commitment Letter”)
with GSO Capital Partners LP (“GSO Capital”), dated as of June 22, 2015, pursuant to which GSO Capital has committed
(the “Debt Commitment”) to make available to the Company two senior secured term loans facilities (the “Term
Loans Facilities”) under which the Company (and following the Closing Date, TopCo) may borrow (i) on the Closing Date, up
to $300 million, plus (ii) on or after the Closing Date, up to an additional $60 million. In addition, GSO Capital has committed
(the “Equity Commitment” and, together with the Debt Commitment, the “Financing Commitments”) under the
Commitment Letter to purchase $10 million of TopCo Common Stock at a price of $13.50 per share. The proceeds of the Financing Commitments
will be used to fund the MSLO Merger pursuant to the terms of the Merger Agreement, to repay existing debt of the Company, to pay
fees and expenses in connection with the foregoing, for working capital, capital expenditures and other general corporate purposes
of the Company and its subsidiaries (and following the Closing Date, of TopCo and its subsidiaries). The Financing Commitments
are subject to various conditions, including the negotiation and execution of definitive financing agreements prior to December
22, 2015 and the consummation of the Mergers in accordance with the terms and conditions set forth in the Merger Agreement.
The Merger Agreement contains certain provisions
giving each of the Company and MSLO rights to terminate the Merger Agreement, including in the event that: (i) the Mergers are
not consummated on or before December 22, 2015, not as the result of a breach by either party, (ii) the approval of the MSLO stockholders
is not obtained, (iii) the Company’s written consent is not delivered to MSLO within 24 hours after execution of the Merger
Agreement, (iv) the MSLO Board withdraws its recommendation or declaration of advisability of the Merger Agreement and transactions
contemplated therein, or fails to publicly reaffirm its recommendation of the Mergers or (v) MSLO enters into a binding agreement
providing for a superior alternative transaction before obtaining stockholder approval, subject to certain conditions.
The Merger Agreement further provides,
that in the event that the Merger Agreement is terminated due to either a failure of MSLO to obtain the MSLO Stockholder Approval
or a breach by MSLO of any covenants or agreements of the Merger Agreement (and such breach led to MSLO’s failure to consummate
the transactions contemplated by the Merger Agreement), then MSLO will reimburse the Company for all expenses incurred in connection
with the Merger Agreement in an amount not to exceed $2.5 million. Additionally, upon termination in the event of certain circumstances,
including the MSLO Board withdrawing its recommendation or declaration of the advisability of the Merger Agreement or MSLO entering
into a binding agreement with another party providing for a superior alternative transaction, then MSLO will pay the Company a
termination fee. If the termination fee becomes payable as a result of the Company entering into an alternative acquisition agreement
prior to the No Shop Period Start Date or with an Excluded Party prior to August 6, 2015, the amount of the termination fee is
$7.5 million. If the termination fee becomes payable under any other circumstances, the amount of the termination fee is $12.8
million.
Additional Information
The foregoing description of the Merger
Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement,
which is filed as Exhibit 2.1 and is incorporated by reference into this report.
The Merger Agreement has been included
to provide investors and security holders with information regarding its terms. It is not intended to provide any other factual
information about the Company, Singer Merger Sub, MSLO, Madeline Merger Sub, TopCo or any of their respective subsidiaries or affiliates.
The representations, warranties and covenants contained in the Merger Agreement (a) were made by the parties thereto only for purposes
of that agreement and as of specific dates; (b) were made solely for the benefit of the parties to the Merger Agreement; (c) may
be subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosures exchanged
between the parties in connection with the execution of the Merger Agreement (such disclosures include information that has been
included in public disclosures, as well as additional non-public information); (d) may have been made for the purposes of allocating
contractual risk between the parties to the Merger Agreement instead of establishing these matters as facts; and (e) may be subject
to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Accordingly,
the Merger Agreement is included with this filing only to provide investors with information regarding the terms of the Merger
Agreement, and not to provide investors with any other factual information regarding the Company, Singer Merger Sub, MSLO, Madeline
Merger Sub, TopCo or their respective businesses. Investors should not rely on the representations, warranties and covenants or
any descriptions thereof as characterizations of the actual state of facts or condition of the Company, Singer Merger Sub, MSLO,
Madeline Merger Sub, TopCo or any of their respective subsidiaries or affiliates. Additionally, the representations, warranties,
covenants, conditions and other terms of the Merger Agreement may be subject to subsequent waiver or modification. Moreover, information
concerning the subject matter of the representations, warranties and covenants may change after the date of the Merger Agreement,
which subsequent information may or may not be fully reflected in the Company’s public disclosures. The Merger Agreement
should not be read alone, but should instead be read in conjunction with the other information regarding the Company that is or
will be contained in, or incorporated by reference into, the Forms 10-K, Forms 10-Q and other documents that are filed
with the Securities and Exchange Commission.
Voting Agreement
In connection with the execution of the
Merger Agreement, MSLO’s Founder and Chief Creative Officer, Martha Stewart and the Martha Stewart Family Limited Partnership
(the “MS Stockholders”) entered into a Voting and Support Agreement (the “Voting Agreement”). Under the
Voting Agreement the MS Stockholders agreed to vote or cause to be voted, in person or proxy, their shares of Class A Common Stock
and Class B Common Stock (i) in favor of the MSLO Merger, (ii) against any action or agreement submitted for the vote or written
consent of stockholders that is in opposition to the MSLO Merger and (iii) against any alternative acquisition proposal. The Voting
Agreement terminates on the earliest of (i) the date the Merger Agreement is terminated in accordance with its terms, (ii) the
closing of the Merger, (iii) the MSLO Board withdrawing or modifying the recommendation of advisability of the Merger or recommending
or declaring advisable the approval by MSLO stockholders of an alternative proposal, (iv) the date the MSLO Stockholder Approval
has been obtained, (v) the delivery of notice by the Company of the termination of the Voting Agreement and (vi) the delivery of
notice by the MS Stockholders to Company of the termination of the Voting Agreement in the event of certain fundamental amendments
to the Merger Agreement without the prior consent of the MS Stockholders. The foregoing description of the Voting Agreement and
the transactions contemplated thereby does not purport to be complete and is subject to, and qualified in its entirety by, the
full text of the Voting Agreement, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.
Agreements with Martha Stewart
Employment Agreement.
In connection with the transactions contemplated
by the Merger Agreement, TopCo entered into an agreement with Martha Stewart with respect to her employment, as described below.
These arrangements will replace at the closing, and are based on, the employment agreement currently in existence between Ms. Stewart
and MSLO.
During the term of her new employment agreement
with TopCo, Ms. Stewart will, among other things, serve as Founder and Chief Creative Officer of TopCo and will be entitled to
receive, among other things, (i) an annual base salary of $500,000 per year, (ii) a guaranteed annual payment of $1.3 million (the
“Guaranteed Payment”), (iii) annually, 10% of the gross licensing revenues, in excess of a specified threshold (the
“Incentive Payment”), (iv) the opportunity to earn an annual bonus, and (v) payment of certain of Ms. Stewart’s
expenses, up to an annual maximum amount.
In addition, and regardless of whether
Ms. Stewart remains employed with TopCo, beginning in 2026 and ending on the later of December 31, 2030 or the date of her death,
TopCo will pay to Ms. Stewart 3.5% of the annual gross licensing revenues for each such year.
The initial term of the new employment
agreement runs through December 31, 2020, and will be automatically extended for an additional five years if gross licensing revenues
exceed specified thresholds. In the event that the new employment agreement is not renewed after its initial term because the extension
threshold is not met, Ms. Stewart instead will consult for TopCo through December 31, 2025, and for these services will receive
an annual consulting fee ranging from $1.5 million to $4.5 million, determined annually based on gross licensing revenues.
Upon certain qualifying terminations of
employment, Ms. Stewart will be entitled to, among other things, continued payments of (a) her base salary, the Guaranteed Payment,
the Incentive Payment and reimbursement of expenses, all as if Ms. Stewart had remained employed through the end of the then-current
term, and (b) continuation of certain benefits and perquisites for a specified period of time post-termination. If such termination
occurs upon or prior to the end of the initial term of the employment agreement, and if the term (i) would have been extended under
the terms of the agreement, the payments in clause (a) above will continue through December 31, 2025, the end of what would have
been the extended term; and (ii) would not have been extended under the terms of the agreement, then Ms. Stewart will receive the
consulting fee as described above.
The foregoing description of Employment
Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Employment
Agreement, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference.
Other Agreements.
In connection with the transactions contemplated
by the Merger Agreement, MSLO entered into an Amended and Restated Asset License Agreement (“Intangible Asset Agreement”)
and Amended and Restated Intellectual Property License and Preservation Agreement (“IP License Agreement” and, together
with the Intangible Asset Agreement, the “IP Agreements”) pursuant to which Ms. Stewart licensed certain intellectual
property to MSLO. Further descriptions of the IP Agreements can be found in MSLO’s filings with the SEC. In addition,
TopCo and Martha Stewart and certain of her affiliates have entered into a Registration Rights Agreement, which grants Ms. Stewart
and such affiliates customary registration rights with respect to certain shares of TopCo Common Stock issued to them in the MSLO
Merger.
Item 5.03 Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On June 21, 2015, the board of directors
of the Company approved and adopted the amendment and restatement of the bylaws of the Company (the “Amended and Restated
Bylaws”). Article VIII, Section 5 of the Amended and Restated Bylaws provides that unless the Corporation consents in writing
to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not
have jurisdiction, the federal district court for the District of Delaware) shall be the sole and exclusive forum for certain actions
brought on behalf of or against the Company.
The foregoing is a summary and does not
contain all information that may be important to you. This summary is qualified in its entirety by reference to the Company’s
Amended and Restated Bylaws, which are attached as Exhibit 3.2 hereto and incorporated herein by reference.
Item 5.07 Submission
of Matters to a Vote of Security Holders.
The transactions contemplated by the Merger
Agreement and certain related matters were submitted to the stockholders of the Company, and such matters were approved on June
22, 2015 by written consent executed by stockholders holding approximately 50.8% of the issued and outstanding shares of Sequential
Common Stock.
Forward-Looking Statements
Certain statements in this communication
are forward-looking statements ("forward-looking statements") within the meaning of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements are made as of the date hereof and are based on current expectations,
estimates, forecasts and projections as well as the beliefs and assumptions of management. The Company's and TopCo’s
actual results could differ materially from those stated or implied in forward-looking statements. Forward-looking statements
include statements concerning guidance, plans, objectives, goals, strategies, expectations, intentions, projections, developments,
future events, performance or products, underlying assumptions and other statements that are not historical in nature, including
those that include the words "subject to," "believes," "anticipates," "plans," "expects,"
"intends," "estimates," "forecasts," "projects," "aims," "targets,"
"may," "will," "should," "can," the negatives thereof, variations thereon and similar expressions.
Such forward-looking statements reflect the Company's current views with respect to future events, based on what the Company
believes are reasonable assumptions. Whether actual results will conform to expectations and predictions is subject to known
and unknown risks and uncertainties, including: (i) risks and uncertainties discussed in the reports that the Company and MSLO
have filed with the Securities and Exchange Commission (“SEC”); (ii) general economic, market, or business conditions;
(iii) risks associated with the ability to consummate the transaction and the timing of the closing of the transaction; (iv) the
ability to successfully integrate the Company’s and MSLO’s operations and employees; (v) the ability to realize anticipated
benefits and synergies of the transaction; (vi) the potential impact of announcement of the transaction or consummation of the
transaction on relationships, including with employees, licensees, customers and competitors; and (vii) other circumstances beyond
the Company's, MSLO’s and TopCo’s control. Refer to section entitled "Risk Factors" set forth each of in
the Company's and MSLO’s Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q for a discussion of important risks,
uncertainties and other factors that may affect our business, results of operations and financial condition. The Company's and
MSLO’s stockholders are urged to consider such risks, uncertainties and factors carefully in evaluating the forward-looking
statements and are cautioned not to place undue reliance on such forward-looking statements. Forward-looking statements are
not, and should not be relied upon as, a guarantee of future performance or results, nor will they necessarily prove to be accurate
indications of the times at or by which any such performance or results will be achieved. As a result, actual outcomes and results
may differ materially from those expressed in forward-looking statements. Neither the Company nor MSLO is under any obligation
to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new
information, future events or otherwise.
No Offer or Solicitation
The information in this communication is
for informational purposes only and is neither an offer to purchase, nor a solicitation of an offer to sell, subscribe for or buy
any securities or the solicitation of any vote or approval in any jurisdiction pursuant to or in connection with the proposed transactions
or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable
law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities
Act of 1933, as amended, and otherwise in accordance with applicable law.
Additional Information about the Proposed Transaction
and Where to Find It
The proposed transaction involving Sequential
and MSLO will be submitted to the stockholders of MSLO for their consideration. In connection with the proposed transaction,
Sequential and MSLO will cause TopCo to file with the SEC a registration statement on Form S-4 (the “Registration Statement”),
which will include a prospectus with respect to the shares to be issued in the proposed transaction, and a preliminary and definitive
proxy statement for the stockholders of MSLO and a preliminary and definitive information statement for the stockholders of Sequential
(the “Combined Statement”) and each of MSLO and Sequential will mail the Combined Statement to their respective stockholders
and file other documents regarding the proposed transaction with the SEC. The definitive Registration Statement and the Combined
Statement will contain important information about the proposed transaction and related matters. SECURITY HOLDERS ARE URGED
AND ADVISED TO READ THE REGISTRATION STATEMENT AND THE COMBINED STATEMENT CAREFULLY WHEN THEY BECOME AVAILABLE, AS WELL AS ANY
OTHER RELEVANT DOCUMENTS FILED WITH THE SEC AND ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT
INFORMATION. The Registration Statement, the Combined Statement and other relevant materials (when they become available)
and any other documents filed or furnished by MSLO, Sequential or TopCo with the SEC may be obtained free of charge at the SEC's
website at www.sec.gov. In addition, security holders will be able to obtain free copies of the Registration Statement and
the Combined Statement from Sequential by going to its investor relations page on its corporate website at ir.sequentialbrandsgroup.com
and from MSLO on its investor relations page on its corporate website at www.marthastewart.com/ir.
Participants in the Solicitation
MLSO, Sequential, their respective directors
and certain of their executive officers and employees may be deemed to be participants in the solicitation of proxies in connection
with the proposed transaction. Information about Sequential’s directors and executive officers is set forth in its definitive
proxy statement for its 2015 Annual Meeting of Stockholders, which was filed with the SEC on April 16, 2015, and information about
MSLO's directors and executive officers is set forth in its amendment to its Annual Report on Form 10-K/A for the calendar year
ended December 31, 2014, which was filed with the SEC on April 27, 2015. These documents are available free of charge from
the sources indicated above, from Sequential by going to its investor relations page on its corporate website at ir.sequentialbrandsgroup.com
and from MSLO on its investor relations page on its corporate website at www.marthastewart.com/ir.
Additional information regarding the interests
of participants in the solicitation of proxies in connection with the proposed transaction will be included in the Registration
Statement, the Combined Statement and other relevant materials Sequential, MLSO and TopCo intend to file with the SEC.
Item 9.01 |
Financial Statements and Exhibits. |
Exhibit No. |
|
Exhibit Description |
|
|
|
2.1 |
|
Agreement and Plan of Merger, dated as of June 22, 2015, by and among Martha Stewart Living Omnimedia, Inc., Madeline Merger Sub, Inc., Sequential Brands Group, Inc., Singer Merger Sub., Inc. and Singer Madeline Holdings, Inc. |
|
|
|
3.2 |
|
Sequential Brands Group, Inc. Amended and Restated Bylaws, effective as of June 21, 2015. |
|
|
|
10.1 |
|
Voting and Support Agreement, dated as of June 22, 2015, by and among Sequential Brands Group, Inc., Singer Madeline Holdings, Inc., Martha Stewart and the Martha Stewart Family Limited Partnership. |
|
|
|
99.1 |
|
Employment Agreement, dated as of June 22, 2015, between Singer Madeline Holdings, Inc. and Martha Stewart. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
SEQUENTIAL BRANDS GROUP, INC. |
|
|
Date: June 23, 2015 |
|
|
|
|
/s/ Gary Klein |
|
Chief Financial Officer |
|
Chief Financial Officer |
EXHIBIT INDEX
Exhibit No. |
|
Exhibit Description |
|
|
|
2.1 |
|
Agreement and Plan of Merger, dated as of June 22, 2015, by and among Martha Stewart Living Omnimedia, Inc., Madeline Merger Sub, Inc., Sequential Brands Group, Inc., Singer Merger Sub., Inc. and Singer Madeline Holdings, Inc. |
|
|
|
3.2 |
|
Sequential Brands Group, Inc. Amended and Restated Bylaws, effective as of June 21, 2015. |
|
|
|
10.1 |
|
Voting and Support Agreement, dated as of June 22, 2015, by and among Sequential Brands Group, Inc., Singer Madeline Holdings, Inc., Martha Stewart and the Martha Stewart Family Limited Partnership. |
|
|
|
99.1 |
|
Employment Agreement, dated as of June 22, 2015, between Singer Madeline Holdings, Inc. and Martha Stewart. |
Exhibit 2.1
EXECUTION VERSION
AGREEMENT AND PLAN OF MERGER
by and among
MARTHA STEWART LIVING OMNIMEDIA, INC.,
MADELINE MERGER SUB, INC.,
SEQUENTIAL BRANDS GROUP, INC.,
SINGER MERGER SUB, INC.,
and
SINGER MADELINE HOLDINGS, INC.
DATED AS OF JUNE 22, 2015
Table
of Contents
|
|
Page |
|
|
ARTICLE I THE MERGERS |
2 |
|
|
|
1.1 |
The Mergers. |
2 |
1.2 |
Closing. |
3 |
1.3 |
Effective Time. |
3 |
1.4 |
Effects. |
3 |
1.5 |
Organizational Documents. |
3 |
1.6 |
Directors and Officers. |
4 |
1.7 |
Reservation of Right to Change Structure. |
4 |
|
|
|
ARTICLE II EFFECT ON CAPITAL STOCK AND EQUITY AWARDS; PAYMENT PROCEDURES |
5 |
|
|
2.1 |
Effect on Capital Stock and Equity Awards of MSLO and Sequential. |
5 |
2.2 |
Exchange of Shares and Certificates. |
10 |
2.3 |
Election Procedures |
14 |
2.4 |
Proration. |
16 |
2.5 |
Certain Adjustments. |
18 |
2.6 |
Further Assurances. |
18 |
|
|
|
ARTICLE III REPRESENTATIONS AND WARRANTIES OF MSLO |
18 |
|
|
3.1 |
Corporate Organization. |
18 |
3.2 |
Capitalization. |
19 |
3.3 |
Corporate Authorization. |
21 |
3.4 |
Governmental Authorization. |
21 |
3.5 |
Non-Contravention. |
22 |
3.6 |
MSLO SEC Filings. |
22 |
3.7 |
Form S-4. |
24 |
3.8 |
Absence of Certain Changes or Events. |
25 |
3.9 |
Compliance with Laws; Permits. |
25 |
3.10 |
Litigation. |
26 |
3.11 |
Title to Properties; Absence of Liens. |
26 |
3.12 |
Taxes. |
26 |
3.13 |
Employee Benefit Plans. |
28 |
3.14 |
Employees, Labor Matters. |
29 |
3.15 |
Environmental Matters. |
29 |
3.16 |
Intellectual Property. |
30 |
3.17 |
MSLO Material Contracts. |
32 |
3.18 |
Licensees. |
32 |
3.19 |
Affiliate Transactions. |
33 |
3.20 |
Insurance. |
33 |
3.21 |
Brokers’ and Finders’ Fees. |
34 |
|
|
Page |
|
|
|
3.22 |
No Other Representations or Warranties. |
34 |
|
|
|
ARTICLE IV REPRESENTATIONS AND WARRANTIES OF SEQUENTIAL |
34 |
|
|
4.1 |
Corporate Organization. |
34 |
4.2 |
Capitalization. |
35 |
4.3 |
Corporate Authorization. |
36 |
4.4 |
Governmental Authorization. |
37 |
4.5 |
Non-Contravention. |
37 |
4.6 |
Sequential SEC Filings. |
37 |
4.7 |
Form S-4. |
40 |
4.8 |
Absence of Certain Changes or Events. |
40 |
4.9 |
Compliance with Laws; Permits. |
41 |
4.10 |
Litigation. |
41 |
4.11 |
Title to Properties; Absence of Liens. |
41 |
4.12 |
Taxes. |
42 |
4.13 |
Employee Benefit Plans. |
43 |
4.14 |
Employees, Labor Matters. |
44 |
4.15 |
Environmental Matters. |
45 |
4.16 |
Intellectual Property. |
45 |
4.17 |
Sequential Material Contracts. |
47 |
4.18 |
Financing. |
48 |
4.19 |
Licensees. |
49 |
4.20 |
Affiliate Transactions. |
49 |
4.21 |
Insurance. |
49 |
4.22 |
Brokers’ and Finders’ Fees. |
50 |
4.23 |
TopCo and Merger Subs. |
50 |
4.24 |
No Other Representations or Warranties. |
51 |
|
|
|
ARTICLE V COVENANTS RELATING TO CONDUCT OF BUSINESS |
51 |
|
|
5.1 |
Conduct of Businesses Prior to the Effective Time. |
51 |
5.2 |
MSLO Forbearances. |
51 |
5.3 |
Sequential Forbearances. |
54 |
5.4 |
Control of Other Party’s Business. |
56 |
5.5 |
No Solicitation; Recommendation of the Merger. |
56 |
5.6 |
Directors. |
61 |
5.7 |
Financing |
61 |
5.8 |
Termination of Certain Agreements. |
63 |
|
|
|
ARTICLE VI ADDITIONAL AGREEMENTS |
63 |
|
|
6.1 |
Preparation of the Form S-4 and the Proxy Statement; MSLO Stockholders Meeting. |
63 |
6.2 |
Access to Information; Confidentiality. |
65 |
6.3 |
Required Actions. |
65 |
|
|
Page |
|
|
|
6.4 |
Indemnification and Insurance. |
66 |
6.5 |
Sequential Stockholder Approval. |
67 |
6.6 |
Public Announcements. |
68 |
6.7 |
Takeover Laws. |
68 |
6.8 |
Section 16 Matters. |
68 |
6.9 |
Stockholder Litigation. |
68 |
6.10 |
Nasdaq Listing. |
69 |
6.11 |
Employees and Employee Benefits. |
69 |
|
|
|
ARTICLE VII CONDITIONS PRECEDENT |
70 |
|
|
7.1 |
Conditions to Each Party’s Obligation to Effect the Mergers. |
70 |
7.2 |
Conditions to Obligations of MSLO. |
71 |
7.3 |
Conditions to Obligations of Sequential. |
72 |
|
|
|
ARTICLE VIII TERMINATION AND AMENDMENT |
73 |
|
|
8.1 |
Termination. |
73 |
8.2 |
Effect of Termination. |
74 |
8.3 |
Amendment. |
76 |
8.4 |
Extension; Waiver. |
76 |
|
|
|
ARTICLE IX GENERAL PROVISIONS |
76 |
|
|
9.1 |
Nonsurvival of Representations and Warranties. |
76 |
9.2 |
Fees and Expenses. |
76 |
9.3 |
Notices. |
76 |
9.4 |
Definitions. |
77 |
9.5 |
Interpretation. |
81 |
9.6 |
Severability. |
82 |
9.7 |
Counterparts. |
82 |
9.8 |
Entire Agreement; No Third-Party Beneficiaries. |
82 |
9.9 |
Governing Law. |
82 |
9.10 |
Assignment; Successors. |
82 |
9.11 |
Specific Enforcement. |
83
|
9.12 |
Submission to Jurisdiction. |
83 |
9.13 |
Waiver of Jury Trial. |
84 |
9.14 |
No Presumption Against Drafting Party. |
84 |
|
|
|
Annex A |
Defined Terms |
A-1 |
|
|
|
Exhibit A |
Form of MSLO Support Agreement |
|
Exhibit B |
Form of Sequential Written Consent |
|
Exhibit C |
Certificate of Incorporation of MSLO Surviving Corporation |
|
Exhibit D |
Bylaws of MSLO Surviving Corporation |
|
Exhibit E |
Certificate of Incorporation of Sequential Surviving Corporation |
|
Exhibit F |
Bylaws of Sequential Surviving Corporation |
|
AGREEMENT AND PLAN OF MERGER
This AGREEMENT AND PLAN OF MERGER (this
“Agreement”), dated as of June 22, 2015, is by and among Martha Stewart Living Omnimedia, Inc., a Delaware corporation
(“MSLO”), Madeline Merger Sub, Inc., a Delaware corporation and wholly owned Subsidiary of TopCo (“Madeline
Merger Sub”), Sequential Brands Group, Inc., a Delaware corporation (“Sequential”), Singer Merger
Sub, Inc., a Delaware corporation and wholly owned Subsidiary of TopCo (“Singer Merger Sub” and, together with
Madeline Merger Sub, Inc., the “Merger Subs”), and Singer Madeline Holdings, Inc., a Delaware corporation (“TopCo”).
WITNESSETH:
WHEREAS, the respective Boards of Directors
of MSLO and Sequential deem it advisable and in the best interests of each corporation and its respective stockholders that MSLO
and Sequential engage in a business combination upon the terms and subject to the conditions set forth in this Agreement;
WHEREAS, the Board of Directors of MSLO,
acting upon the recommendation of a special committee comprised solely of independent directors (the “Special Committee”)
has approved entry into this Agreement and the merger of Madeline Merger Sub with and into MSLO (the “MSLO Merger”),
with MSLO continuing as the surviving corporation and a wholly owned subsidiary of TopCo (the “MSLO Surviving Corporation”),
pursuant to which each share of Class A common stock, par value $.01 per share, of MSLO (the “MSLO Class A Common Stock”),
and Class B common stock, par value $.01 per share, of MSLO (the “MSLO Class B Common Stock” and collectively
with the MSLO Class A Common Stock, the “MSLO Common Stock”) shall be converted into the right to receive shares
of common stock, par value $0.01 per share of TopCo (the “TopCo Common Stock”) and/or cash, in each case upon
the terms and subject to the conditions set forth in this Agreement, and has directed that this Agreement be submitted to stockholders
and recommended to holders of MSLO Common Stock that they adopt and approve this Agreement in accordance with the DGCL on the terms
and conditions set forth herein;
WHEREAS, the Board of Directors of Sequential
has approved this Agreement and the merger of Singer Merger Sub with and into Sequential (the “Sequential Merger”
and, together with the MSLO Merger, the “Mergers”), with Sequential continuing as the surviving corporation
and a wholly owned subsidiary of TopCo (the “Sequential Surviving Corporation”), pursuant to which each share
of common stock, par value $.001 per share, of Sequential (the “Sequential Common Stock”) shall be converted
into the right to receive shares of TopCo Common Stock, upon the terms and subject to the conditions set forth in this Agreement;
WHEREAS, Sequential and MSLO desire to make
certain representations, warranties, covenants and agreements in connection with the Mergers and also to prescribe various conditions
to the Mergers;
WHEREAS, for U.S. federal income tax purposes,
it is intended that the Mergers will qualify as a transaction described in Section 351 of the Internal Revenue Code of 1986, as
amended (the “Code”);
WHEREAS, concurrently with the execution
and delivery of this Agreement, and as a condition to the willingness of Sequential to enter into this Agreement, certain stockholders
of MSLO (the “MSLO Supporting Stockholders”) are entering into a voting and support agreement with Sequential
substantially in the form attached hereto as Exhibit A (the “MSLO Support Agreement”), pursuant to which,
among other things, the MSLO Supporting Stockholders have irrevocably agreed, subject to the terms of the MSLO Support Agreement,
to vote all shares of MSLO Common Stock owned by such stockholders in favor of the MSLO Merger; and
WHEREAS, immediately following the execution
and delivery of this Agreement, certain stockholders of Sequential will be executing and delivering to MSLO a written consent pursuant
to which such holders shall adopt and approve this Agreement in accordance with Section 228 and Section 251(c) of the DGCL (as
defined below), substantially in the form attached hereto as Exhibit B.
NOW, THEREFORE, in consideration of the
foregoing and intending to be legally bound hereby, the parties hereto agree as follows:
ARTICLE
I
THE MERGERS
1.1 The
Mergers.
(a) On
the terms and subject to the conditions set forth in this Agreement, and in accordance with the General Corporation Law of the
State of Delaware (the “DGCL” ), Madeline Merger Sub shall be merged with and into MSLO at the MSLO Effective
Time. Following the MSLO Effective Time, the separate corporate existence of Madeline Merger Sub shall cease, and MSLO shall continue
as the surviving corporation in the MSLO Merger and shall succeed to and assume all the rights, privileges, immunities, properties,
powers and franchises of Madeline Merger Sub in accordance with the DGCL.
(b) On
the terms and subject to the conditions set forth in this Agreement, and in accordance with the DGCL, Singer Merger Sub shall be
merged with and into Sequential at the Sequential Effective Time. Following the Sequential Effective Time, the separate corporate
existence of Singer Merger Sub shall cease, and Sequential shall continue as the surviving corporation in the Sequential Merger
and shall succeed to and assume all the rights, privileges, immunities, properties, powers and franchises of Singer Merger Sub
in accordance with the DGCL.
(c) In
connection with the Mergers, TopCo shall take such actions as may be necessary to reserve, prior to the Mergers, a sufficient number
of shares of TopCo Common Stock to permit the issuance of shares of TopCo Common Stock to the holders of shares of MSLO Common
Stock and Sequential Common Stock as of the Effective Time in accordance with the terms of this Agreement.
1.2 Closing.
The closing (the “Closing”) of the Mergers shall take place at 10:00 a.m., Eastern time, on the second
business day after satisfaction or waiver of all of the conditions set forth in ARTICLE VII (other than those conditions
that by their nature are to be fulfilled at the Closing, but subject to the fulfillment or waiver of such conditions), at the offices
of Gibson, Dunn & Crutcher LLP, 200 Park Avenue, New York, New York 10166, unless another time, date or place is agreed to
in writing by the parties hereto (the date on which the Closing actually occurs shall be referred to as the “Closing Date”).
1.3 Effective
Time. Subject to the provisions of this Agreement, as soon as practicable on the Closing Date, the parties shall cause the
Mergers to be consummated substantially concurrently with each other by filing with the Secretary of State of the State of Delaware
(a) a Certificate of Merger (the “Sequential Certificate of Merger”) with respect to the Sequential Merger,
and (b) a Certificate of Merger (the “MSLO Certificate of Merger”) with respect to the MSLO Merger, each
duly executed and completed in accordance with the relevant provisions of the DGCL, and shall make all other filings or recordings
required under the DGCL. The Sequential Merger shall become effective at such time on the Closing Date as the Sequential Certificate
of Merger is duly filed with the Delaware Secretary of State or at such other time as MSLO and Sequential shall agree and specify
in the Sequential Certificate of Merger (such time as the Sequential Merger becomes effective being the “Sequential Effective
Time”). The MSLO Merger shall become effective at such time as the MSLO Certificate of Merger is duly filed with the
Delaware Secretary of State or at such other time as MSLO and Sequential shall agree and specify in the MSLO Certificate of Merger,
provided that the MSLO Merger shall not become effective until the Sequential Effective Time (such time as the MSLO Merger becomes
effective being the “MSLO Effective Time”, and such time as the Mergers become effective being the “Effective
Time”).
1.4 Effects.
The Mergers shall have the effects set forth in this Agreement and the applicable provisions of the DGCL. Without limiting
the generality of the foregoing, and subject thereto, (i) upon the consummation of the MSLO Merger, all the property, rights, privileges,
powers and franchises of Madeline Merger Sub shall vest in MSLO, and all debts, liabilities and duties of Madeline Merger Sub shall
become the debts, liabilities and duties of MSLO and (ii) upon the consummation of the Sequential Merger, all the property, rights,
privileges, powers and franchises of Singer Merger Sub shall vest in Sequential, and all debts, liabilities and duties of Singer
Merger Sub shall become the debts, liabilities and duties of Sequential.
1.5 Organizational
Documents.
(a) MSLO
Certificate of Incorporation and Bylaws. Upon the consummation of the MSLO Merger, (i) the certificate of incorporation of
the MSLO Surviving Corporation shall be amended and restated to read in its entirety as set forth in Exhibit C, and as so
amended and restated, will be the certificate of incorporation of the MSLO Surviving Corporation and (ii) the bylaws of the MSLO
Surviving Corporation shall be amended and restated to read in its entirety as set forth in Exhibit D, and as so amended
and restated, will be the bylaws of the MSLO Surviving Corporation.
(b) Sequential
Certificate of Incorporation and Bylaws. Upon the consummation of the Sequential Merger, (i) the certificate of incorporation
of the Sequential Surviving Corporation shall be amended and restated to read in its entirety as set forth in Exhibit E,
and as so amended and restated, will be the certificate of incorporation of the Sequential Surviving Corporation and (ii) the
bylaws of the Sequential Surviving Corporation shall be amended and restated to read in its entirety as set forth in Exhibit
F, and as so amended and restated, will be the bylaws of the Sequential Surviving Corporation.
(c) TopCo
Certificate of Incorporation and Bylaws; Name. As of the Closing, the certificate of incorporation and bylaws of TopCo shall
remain the certificate of incorporation and bylaws of TopCo, until thereafter amended as provided therein or by applicable Law,
except that TopCo’s name shall be changed to “Sequential Brands Group, Inc.”
1.6 Directors
and Officers.
(a) MSLO
Surviving Corporation Directors and Officers. The directors and officers of Madeline Merger Sub immediately prior to the consummation
of the MSLO Merger shall be the directors and officers of the MSLO Surviving Corporation until the earlier of their resignation
or removal or until their respective successors are duly elected and qualified.
(b) Sequential
Surviving Corporation Directors and Officers. The directors and officers of Singer Merger Sub immediately prior to the consummation
of the Sequential Merger shall be the directors and officers of the Sequential Surviving Corporation until the earlier of their
resignation or removal or until their respective successors are duly elected and qualified.
(c) TopCo
Directors and Officers. As of the Closing, the directors and officers of TopCo shall be the individuals listed in Section 1.6(c)
of the Sequential Disclosure Schedule, until the earlier of their resignation or removal or until their respective successors are
duly elected and qualified.
1.7 Reservation
of Right to Change Structure. Notwithstanding anything to the contrary contained in this Agreement, before the Effective
Time, Sequential and MSLO may, with the prior written consent of the other party in its sole discretion, and to the extent permitted
by applicable Law, at any time change the method of effecting the business combination contemplated by this Agreement if and to
the extent that they deem such a change to be desirable; provided, that (A) any such change shall not affect the U.S. federal
income tax consequences of the MSLO Merger to holders of MSLO Common Stock and (B) no such change shall (i) alter or change the
amount or kind of the consideration to be issued to holders of MSLO Common Stock or Sequential Common Stock as Merger Consideration,
(ii) adversely affect the rights of the holders of MSLO Equity Awards, or (iii) materially impede or delay consummation of the
transactions contemplated by this Agreement. In the event Sequential and MSLO elect to make such a change pursuant to this Section
1.7, the parties agree to execute appropriate documents to reflect such change.
ARTICLE
II
EFFECT ON CAPITAL STOCK AND EQUITY AWARDS;
PAYMENT PROCEDURES
2.1 Effect
on Capital Stock and Equity Awards of MSLO and Sequential.
(a) Conversion
of MSLO Common Stock and Madeline Merger Sub Common Stock. As of the MSLO Effective Time, by virtue of the MSLO Merger and
without any action on the part of MSLO, TopCo, Madeline Merger Sub or the holders of any shares of MSLO Common Stock (or options
thereon) or TopCo Common Stock:
(i) Each
issued and outstanding share of MSLO Common Stock (other than any shares of MSLO Common Stock to be canceled pursuant to Section
2.1(c) and subject to Section 2.1(f)) shall be converted into the right to receive (A) in the case of a share of MSLO
Common Stock with respect to which an election to receive cash (a “Cash Election”) has been properly made and
not revoked or lost pursuant to Section 2.3 (each, a “Cash Election Share”), $6.15 in cash, without interest
(the “MSLO Cash Consideration”), (B) in the case of a share of MSLO Common Stock with respect to which an election
to receive stock (a “Stock Election”) has been properly made and not revoked or lost pursuant to Section
2.3 (each, a “Stock Election Share”), a number of fully paid and nonassessable shares of TopCo Common Stock,
together with cash in lieu of fractional shares of TopCo Common Stock as specified below, without interest, equal to the quotient
determined by dividing (x) the MSLO Cash Consideration by (y) the Sequential Trading Price (the “MSLO Stock Consideration”
and, together with the MSLO Cash Consideration, the “MSLO Merger Consideration”) or (C) in the case of a share
of MSLO Common Stock with respect to which neither a Cash Election nor a Stock Election has been properly made and not revoked
or lost pursuant to Section 2.3 (each, a “Non-Election Share”), the MSLO Cash Consideration or the MSLO
Stock Consideration or a combination of both, subject in each case to Section 2.4. As of the MSLO Effective Time, all such
shares of MSLO Common Stock shall no longer be outstanding and shall automatically be canceled and retired and shall cease to exist.
As of the MSLO Effective Time, each holder of a certificate or book-entry share representing any shares of MSLO Common Stock shall
cease to have any rights with respect thereto, except the right to receive, upon the surrender thereof, subject to Section 2.1(f),
the MSLO Merger Consideration in accordance with Section 2.2.
(ii) Each
share of common stock of Madeline Merger Sub issued and outstanding immediately prior to the MSLO Effective Time shall be converted
into one fully paid and nonassessable share of the common stock of the MSLO Surviving Corporation.
(iii) The
“Sequential Trading Price” shall mean the volume weighted average price per share of Sequential Common Stock
on the NASDAQ Stock Market (“Nasdaq”) for the consecutive period over the five trading days ending on the trading
day immediately preceding the Closing Date, as calculated by Bloomberg Financial LP under the function “VWAP”.
(iv) The
aggregate MSLO Cash Consideration received by each MSLO Holder will be rounded to the nearest whole cent.
(b) Conversion
of Sequential Common Stock and Singer Merger Sub Common Stock. As of the Sequential Effective Time, by virtue of the Sequential
Merger and without any action on the part of Sequential, TopCo, Singer Merger Sub or the holders of any shares of Sequential Common
Stock (or options thereon) or TopCo Common Stock:
(i) Each
issued and outstanding share of Sequential Common Stock (other than any shares of Sequential Common Stock to be canceled pursuant
to Section 2.1(c)) shall be converted into the right to receive one fully paid and nonassessable share of TopCo Common Stock
(the “Sequential Merger Consideration” and, together with the MSLO Merger Consideration, the “Merger
Consideration”). Such exchange ratio shall be referred to herein as the “Sequential Exchange Ratio”.
As of the Sequential Effective Time, all such shares of Sequential Common Stock shall no longer be outstanding and shall automatically
be canceled and retired and shall cease to exist. As of the Sequential Effective Time, each holder of a certificate or book-entry
share representing any shares of Sequential Common Stock shall cease to have any rights with respect thereto, except the right
to receive, upon the surrender thereof, the Sequential Merger Consideration in accordance with Section 2.2.
(ii) Each
share of common stock of Singer Merger Sub issued and outstanding immediately prior to the Sequential Effective Time shall be converted
into one fully paid and nonassessable share of the common stock of the Sequential Surviving Corporation.
(c) Cancellation
of Treasury Shares. Each share of MSLO Common Stock held in the treasury of MSLO immediately prior to the MSLO Effective Time,
and each share of Sequential Common Stock held in the treasury of Sequential immediately prior to the Sequential Effective Time,
shall automatically be canceled and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor.
(d) Treatment
of MSLO Equity Awards.
(i) Each
outstanding option to acquire shares of MSLO Common Stock that is subject solely to a time-based condition (a “MSLO Stock
Option”), whether vested or unvested, that is outstanding immediately prior to the MSLO Effective Time shall, as of the
MSLO Effective Time, automatically and without any action on the part of the holder thereof, be cancelled and, in exchange therefor,
the holder will be entitled to receive a cash payment equal to the product of (A) the number of shares of MSLO Common Stock for
which such MSLO Stock Option is exercisable and (B) the excess of the MSLO Cash Consideration over the per share exercise price
of such MSLO Stock Option. In addition to the foregoing amounts, to the extent that any such MSLO Stock Option that was granted
pursuant to an employment agreement requirement and is identified on Section 2.1(d)(i) of the MSLO Disclosure Schedule as having
also been subject to a performance vesting condition that has been satisfied and having included a minimum post-termination exercise
period of 18 months, the holder of such MSLO Stock Option shall receive the further consideration (which shall be payable in the
form) specified in such section of the MSLO Disclosure Schedule. The amounts described in this Section 2.1(d)(i) shall be
deemed to have been paid in full satisfaction of all rights pertaining to such MSLO Stock Options; provided, that if the
exercise price per share of any such MSLO Stock Option is equal to or greater than the MSLO Cash Consideration, such MSLO Stock
Option shall be cancelled without any payments being made or other consideration being delivered in respect thereof.
(ii) Each
outstanding option to acquire shares of MSLO Common Stock that is subject to performance-based vesting conditions (a “MSLO
Performance Stock Option”) and that is outstanding immediately prior to the Effective Time and vested as of the Effective
Time (taking into account the next-following sentence) shall, as of the Effective Time, automatically and without any action on
the part of the holder thereof, be cancelled and, in exchange therefor, the holder will be entitled to receive a cash payment equal
to the product of (A) the number of shares of MSLO Common Stock for which such MSLO Performance Stock Option is exercisable and
(B) the excess of the MSLO Cash Consideration over the per share exercise price of such MSLO Performance Stock Option. Each unvested
MSLO Performance Stock Option shall vest at the Effective Time, unless and to the extent that the specified stock price condition(s)
at which such MSLO Performance Stock Option would have become vested in the ordinary course, as specified in the applicable award
agreement, are higher than the MSLO Cash Consideration. MSLO Performance Stock Options that remain unvested at the Effective Time
pursuant to the preceding sentence shall, as of the Effective Time, automatically and without any action on the part of the holder
thereof, be cancelled and in exchange thereof, all such MSLO Performance Stock Options held by any single holder shall collectively
be converted into and thereafter evidence the right to receive a cash payment in the amount set forth on Section 2.1(d)(ii) of
the MSLO Disclosure Schedule next to such holder’s name. The amounts described in this Section 2.1(d)(ii) shall be
deemed to have been paid in full satisfaction of all rights pertaining to such MSLO Performance Stock Options.
(iii) Each
award of restricted stock units corresponding to shares of MSLO Common Stock that is subject solely to a time-based vesting condition
(a “MSLO RSU Award”) and that is outstanding immediately prior to the MSLO Effective Time shall, as of the MSLO
Effective Time, automatically and without any action on the part of the holder thereof, be cancelled and converted into the right
to receive a cash payment equal to the MSLO Cash Consideration for each share of MSLO Common Stock subject to such MSLO RSU Award.
(iv) Each
award of restricted stock units corresponding to shares of MSLO Common Stock that is subject to performance-based vesting conditions
(a “MSLO Performance RSU Award”) and that is outstanding immediately prior to the MSLO Effective Time and becomes
vested pursuant to the next-following sentence shall, as of the Effective Time, automatically and without any action on the part
of the holder thereof, be cancelled and converted into the right to receive a cash payment equal to the MSLO Cash Consideration
for each share of MSLO Common Stock subject to such MSLO Performance RSU Award. Each unvested MSLO Performance RSU Award shall
vest at the MSLO Effective Time, unless and to the extent that the specified stock price condition(s) at which such MSLO Performance
RSU Award would have become vested in the ordinary course, as specified in the applicable award agreement, are higher than the
MSLO Cash Consideration. MSLO Performance RSU Awards that remain unvested at the MSLO Effective Time pursuant to the preceding
sentence shall, as of the Effective Time, automatically and without any action on the part of the holder thereof, be cancelled
and in exchange thereof, all such MSLO Performance RSU Awards held by any single holder shall collectively be converted into and
thereafter evidence the right to receive a cash payment in the amount set forth on Section 2.1(d)(iv) of the MSLO Disclosure Schedule
next to such holder’s name. The amounts described in this Section 2.1(d)(iv) that are payable in respect to MSLO Performance
RSU Awards shall be deemed to have been paid in full satisfaction of all rights pertaining to such MSLO Performance RSU Awards.
(v) Prior
to the MSLO Effective Time, the Board of Directors of MSLO or the appropriate committee thereof shall adopt resolutions providing
for the treatment of the MSLO Stock Options, MSLO Performance Stock Options, MSLO RSU Awards and MSLO Performance RSU Awards (collectively,
the “MSLO Equity Awards”) as contemplated by this Section 2.1(d). TopCo, MSLO and Sequential shall cooperate
to provide any required notices to the holders of MSLO Equity Awards required in connection with the consummation of the Mergers.
(vi) The
aggregate cash payment made to each holder of MSLO Stock Options, MSLO Performance Stock Options, MSLO RSU Awards and/or MSLO Performance
RSU Awards contemplated by this Section 2.1(d) will be rounded to the nearest whole cent. Any payments made with respect
to the MSLO Equity Awards shall be made by the MSLO Surviving Corporation through payroll promptly after the Effective Time.
(e) Treatment
of Sequential Equity Awards and Warrants.
(i) Each
outstanding option to acquire shares of Sequential Common Stock (a “Sequential Stock Option”), whether vested
or unvested, that is outstanding immediately prior to the Sequential Effective Time shall, as of the Sequential Effective Time,
automatically and without any action on the part of the holder thereof, be converted into an option to purchase, on the terms and
conditions (including applicable vesting requirements) under the applicable plan and award agreement in effect immediately prior
to the Sequential Effective Time, (A) that number of shares of TopCo Common Stock, rounded down to the nearest whole share, equal
to the product determined by multiplying (x) the total number of shares of Sequential Common Stock subject to such Sequential
Stock Option immediately prior to the Sequential Effective Time by (y) the Sequential Exchange Ratio, (B) at a per-share exercise
price, rounded up to the nearest whole cent, equal to the quotient determined by dividing (x) the exercise price per share of Sequential
Common Stock at which such Sequential Stock Option was exercisable immediately prior to the Sequential Effective Time by (y) the
Sequential Exchange Ratio.
(ii) Each
award of restricted stock units corresponding to shares of Sequential Common Stock (a “Sequential RSU Award”),
whether vested or unvested, that is outstanding immediately prior to the Sequential Effective Time shall, as of the Sequential
Effective Time, automatically and without any action on the part of the holder thereof, be converted into a TopCo restricted stock
unit award on the terms and conditions (including applicable vesting requirements) under the applicable plan and award agreement
in effect immediately prior to the Sequential Effective Time, with respect to a number of shares of TopCo Common Stock, rounded
up to the nearest whole share, determined by multiplying the number of shares of Sequential Common Stock subject to such Sequential
RSU Award immediately prior to the Sequential Effective Time by the Sequential Exchange Ratio. To the extent that the Sequential
RSU Awards vest in whole or in part based on the achievement of performance goals, the compensation committee of the Sequential
Board shall appropriately adjust such performance goals to reflect the effect of the transactions contemplated by this Agreement.
(iii) Each
unvested award of restricted Sequential Common Stock (a “Sequential Restricted Stock Award”) that is outstanding
immediately prior to the Sequential Effective Time shall, as of the Sequential Effective Time, automatically and without any action
on the part of the holder thereof, be converted into a TopCo restricted stock award on the terms and conditions (including applicable
vesting requirements) under the applicable plan and award agreement in effect immediately prior to the Sequential Effective Time,
with respect to a number of shares of TopCo Common Stock, rounded up to the nearest whole share, determined by multiplying the
number of shares of Sequential Common Stock subject to such Sequential Restricted Stock Award immediately prior to the Sequential
Effective Time by the Sequential Exchange Ratio. To the extent that the Sequential Restricted Stock Awards vest in whole or in
part based on the achievement of performance goals, the compensation committee of the Sequential Board shall appropriately adjust
such performance goals to reflect the effect of the transactions contemplated by this Agreement.
(iv) Each
warrant to purchase any shares of Sequential Common Stock or other equity interests (a “Sequential Warrant”),
whether vested or unvested, that is outstanding immediately prior to the Effective Time shall, as of the Effective Time, automatically
and without any action on the part of the holder thereof, be converted into a warrant to purchase shares of TopCo Common Stock
on the terms and conditions (including applicable strike price and vesting requirements) under the applicable plan and award agreement
in effect immediately prior to the Effective Time, with respect to a number of shares of TopCo Common Stock, rounded up to the
nearest whole share, determined by multiplying the number of shares of Sequential Common Stock subject to such Sequential Warrant
immediately prior to the Effective Time by the Sequential Exchange Ratio. TopCo and Sequential shall cooperate to provide any required
notices to the holders of Sequential Equity Awards and Sequential Warrants required in connection with the consummation of the
Mergers.
(v) Prior
to the Sequential Effective Time, the Sequential Board or the appropriate committee thereof shall adopt resolutions providing for
the treatment of (i) the Sequential Stock Options, Sequential RSU Awards and Sequential Restricted Stock Awards (collectively,
the “Sequential Equity Awards”) and (ii) the Sequential Warrants, each as contemplated by this Section 2.1(e).
As soon as practicable after the Sequential Effective Time, TopCo shall prepare and file with the SEC a Form S-8 (or file such
other appropriate form) registering a number of shares of TopCo Common Stock necessary to fulfill TopCo’s obligations under
this Section 2.1(e). TopCo shall take all corporate action necessary to reserve for issuance a sufficient number of shares
of TopCo Common Stock for delivery with respect to the Sequential Equity Awards and Sequential Warrants assumed by it in accordance
with this Section 2.1(e). TopCo and Sequential shall cooperate to provide any required notices to the holders of Sequential
Equity Awards and Sequential Warrants required in connection with the consummation of the Mergers.
(f) Dissenting
Shares. Notwithstanding anything in this Agreement to the contrary, shares of MSLO Common Stock issued and outstanding immediately
prior to the MSLO Effective Time that are held by any holder who has not voted in favor of the MSLO Merger and who is entitled
to demand and properly demands appraisal of such shares pursuant to Section 262 of the DGCL (“Dissenting Shares”)
shall not be converted into the right to receive the MSLO Merger Consideration, unless and until such holder shall have failed
to perfect, or shall have effectively withdrawn or lost, such holder’s right to appraisal under the DGCL. Dissenting Shares
shall be treated in accordance with Section 262 of the DGCL. If any such holder fails to perfect or withdraws or loses any such
right to appraisal, each such share of MSLO Common Stock of such holder shall thereupon be converted into and become exchangeable
only for the right to receive, as of the later of the MSLO Effective Time and the time that such right to appraisal has been irrevocably
lost, withdrawn or expired, the MSLO Merger Consideration in accordance with Section 2.1(a). Notwithstanding anything
to the contrary in this Section 2.1(f), if this Agreement is terminated prior to the Effective Time, then the right of any
stockholder to be paid the fair value of such stockholder’s Dissenting Shares pursuant to Section 262 of the DGCL will cease.
MSLO shall serve prompt notice to Sequential of any demands for appraisal of any shares of MSLO Common Stock, attempted withdrawals
of such notices or demands and any other instruments received by MSLO relating to rights to appraisal, and Sequential shall have
the right to participate in and direct all negotiations and proceedings with respect to such demands. MSLO shall not, without the
prior written consent of Sequential, make any payment with respect to, settle or offer to settle any such demands, and prior to
the Effective Time, Sequential shall not, without the prior written consent of MSLO (such consent not to be unreasonably withheld,
conditioned or delayed), make any payment with respect to, settle or offer to settle, any such demands.
2.2 Exchange
of Shares and Certificates.
(a) Exchange
Agent. No later than five Business Days prior to the mailing of the Proxy Statement/Prospectus, Sequential shall designate
a bank, trust company or nationally recognized shareholder services provider reasonably acceptable to MSLO (the “Exchange
Agent”), for the purpose of receiving Elections and exchanging, in accordance with this ARTICLE II, Certificates
and Book-Entry Shares for the Merger Consideration. Prior to the Effective Time, TopCo shall deposit, or cause to be deposited,
with the Exchange Agent, as needed, the Merger Consideration to be delivered in respect of the number of shares of TopCo Common
Stock issuable pursuant to Section 2.1 in exchange for outstanding shares of MSLO Common Stock and shares of Sequential
Common Stock. In addition, at or prior to the MSLO Effective Time, Sequential shall deposit, or cause to be deposited, with the
Exchange Agent for the benefit of the holders of shares of MSLO Common Stock at the MSLO Effective Time, for exchange in accordance
with this ARTICLE II, immediately available funds equal to the aggregate MSLO Cash Consideration (other than in respect
of any Dissenting Shares), including any additional amounts necessary to fund the adjustment set forth in Section 2.1(a)(iv).
In addition, Sequential shall deposit with the Exchange Agent, as necessary from time to time after the Effective Time, cash in
lieu of any fractional shares payable pursuant to Section 2.2(e). All shares of TopCo Common Stock and cash deposited with
the Exchange Agent pursuant to this Section 2.2 shall be referred to herein as the “Exchange Fund”. Sequential
shall instruct the Exchange Agent to timely pay the Merger Consideration in accordance with this Agreement.
(b) Exchange
Procedures. As soon as reasonably practicable after the Effective Time, the Exchange Agent shall mail (1) to each holder of
record of a certificate (a “Sequential Certificate”) that immediately prior to the Sequential Effective Time
represented outstanding shares of Sequential Common Stock and (2) to each holder of record of a certificate (a “MSLO Certificate”
and, together with a Sequential Certificate, a “Certificate”) that immediately prior to the MSLO Effective Time
represented outstanding shares of MSLO Common Stock, in each case whose shares were converted into the right to receive the applicable
Merger Consideration, (i) a letter of transmittal (which shall specify that delivery shall be effected, and risk of loss and title
to the Certificates shall pass, only upon delivery of the Certificates (or affidavits of loss in lieu of the Certificates as provided
in Section 2.2(j)) to the Exchange Agent, and which shall be in such form and have such other provisions as agreed among
the parties hereto) and (ii) instructions for use in effecting the surrender of the Certificates or affidavits of loss in
exchange for the applicable Merger Consideration. Upon surrender of a Certificate for cancellation or affidavit of loss to the
Exchange Agent, together with such letter of transmittal, duly executed, and such other documents as may reasonably be required
by the Exchange Agent, the holder of such Certificate or affidavit of loss shall be entitled to receive in exchange therefor that
number of whole shares of TopCo Common Stock and/or cash, as applicable, that such holder has the right to receive pursuant to
the provisions of this ARTICLE II, and the Certificate or affidavit of loss so surrendered shall forthwith be canceled.
Promptly after the Effective Time and in any event not later than the third Business Day thereafter, Sequential shall cause the
Exchange Agent to issue and deliver to each holder of uncertificated shares of Sequential Common Stock represented by book-entry
(the “Sequential Book-Entry Shares”) and uncertificated shares of MSLO Common Stock represented by book-entry
(the “MSLO Book-Entry Shares” and, together with the Sequential Book-Entry Shares, the “Book-Entry
Shares”) the applicable Merger Consideration that such holder is entitled to pursuant to the provisions of this ARTICLE
II in respect of such Book-Entry Shares, without such holder being required to deliver a Certificate or an executed letter
of transmittal to the Exchange Agent, and such Book-Entry Shares shall then be cancelled. No interest shall be paid or shall accrue
for the benefit of holders of Certificates or Book-Entry Shares on the applicable Merger Consideration payable. If any portion
of the applicable Merger Consideration is to be registered in the name of a person other than the person in whose name the applicable
surrendered Certificate is registered, it shall be a condition to the registration of such Merger Consideration that the surrendered
Certificate shall be properly endorsed or otherwise be in proper form for transfer and the person requesting such delivery of the
applicable Merger Consideration shall pay to the Exchange Agent any transfer or other taxes required by reason of such registration
in the name of a person other than the registered holder of such Certificate or establish to the reasonable satisfaction of the
Exchange Agent that such tax has been paid or is not applicable. Until surrendered as contemplated by this Section 2.2(b),
each Certificate shall be deemed at any time after the Effective Time to represent only the right to receive upon such surrender
the applicable Merger Consideration.
(c) Distributions
with Respect to Unexchanged Shares. All TopCo Common Stock to be paid as a portion of the Merger Consideration shall be deemed
issued and outstanding as of the Effective Time. No dividends or other distributions declared or made with respect to TopCo Common
Stock with a record date after the Effective Time shall be paid to the holder of any unsurrendered Certificate or Book-Entry Share
with respect to any shares of TopCo Common Stock represented thereby, and no cash payment in lieu of fractional shares shall be
paid to any such holder pursuant to Section 2.2(e), in each case until the surrender of such Certificate or Book-Entry Share
in accordance with this ARTICLE II. Subject to the effect of applicable Law, following surrender of any such Certificate
or Book-Entry Share, there shall be paid to the holder of shares of TopCo Common Stock issued in exchange therefor, without interest,
(i) at the time of such surrender, the amount of any cash payable in lieu of a fractional share of TopCo Common Stock to which
such holder is entitled pursuant to Section 2.2(e) and the amount of dividends or other distributions with a record date
after the Effective Time theretofore paid with respect to such shares of TopCo Common Stock, and (ii) at the appropriate payment
date, the amount of dividends or other distributions with a record date after the Effective Time but prior to such surrender and
a payment date subsequent to such surrender payable with respect to such shares of TopCo Common Stock.
(d) No
Further Ownership Rights in Sequential Common Stock and MSLO Common Stock. All shares of TopCo Common Stock issued and cash
paid upon the surrender for exchange of Certificates or Book-Entry Shares in accordance with the terms of this ARTICLE II
(including any cash paid pursuant to Section 2.2(e)) shall be deemed to have been issued and paid in full satisfaction of
all rights pertaining to the shares of Sequential Common Stock or MSLO Common Stock, as applicable, theretofore represented by
such Certificates or Book-Entry Shares, subject, however, to the obligation of TopCo to pay any dividends or make any other distributions
with a record date prior to the Effective Time that may have been declared or made by Sequential or MSLO, as applicable, on such
shares of Sequential Common Stock or MSLO Common Stock in accordance with the terms of this Agreement and that remain unpaid at
the Effective Time, and there shall be no further registration of transfers on the stock transfer books of the Sequential Surviving
Corporation of the shares of Sequential Common Stock, or the MSLO Surviving Corporation of the shares of MSLO Common Stock, that
were outstanding immediately prior to the Effective Time. If, after the Effective Time, Certificates or Book-Entry Shares are presented
to TopCo or the Exchange Agent for any reason, they shall be canceled and exchanged as provided in this ARTICLE II, except
as otherwise provided by Law.
(e) Fractional
Shares.
(i) No
certificates representing fractional shares of TopCo Common Stock shall be issued upon the surrender for exchange of Certificates
or Book-Entry Shares, and such fractional share interests shall not entitle the owner thereof to vote or to any other rights of
a stockholder of TopCo.
(ii) Notwithstanding
any other provision of this Agreement, each holder of shares of MSLO Common Stock converted pursuant to the MSLO Merger who would
otherwise have been entitled to receive a fraction of a share of TopCo Common Stock (after taking into account all Certificates
and Book-Entry Shares delivered by such holder) shall receive, in lieu thereof, cash (without interest) in an amount equal to such
fraction as determined below. As promptly as practicable following the Effective Time, the Exchange Agent shall determine the excess
of (i) the number of full shares of TopCo Common Stock delivered to the Exchange Agent by TopCo for issuance to holders of Certificates
or Book-Entry Shares over (ii) the aggregate number of full shares of TopCo Common Stock to be distributed to holders of Certificates
or Book-Entry Shares (such excess being herein referred to as the “Excess Shares”). As soon as practicable after
the Effective Time, the Exchange Agent, as agent for such holders of Certificates or Book-Entry Shares, shall sell the Excess Shares
at then prevailing prices on Nasdaq all in the manner provided herein.
(iii) The
sale of the Excess Shares by the Exchange Agent shall be executed on Nasdaq and shall be executed in round lots to the extent practicable.
Until the proceeds of any such sale or sales have been distributed to the holders of Certificates or Book-Entry Shares, the Exchange
Agent shall hold such proceeds in trust for such holders. The Exchange Agent shall determine the portion of such proceeds to which
each holder of Certificates or Book-Entry Shares shall be entitled, if any, by multiplying the amount of the aggregate proceeds
by a fraction, the numerator of which is the amount of the fractional share interest to which such holder of Certificates or Book-Entry
Shares is entitled (after taking into account all Certificates and Book-Entry Shares then held by such holder) and the denominator
of which is the aggregate amount of fractional share interests to which all holders of Certificates or Book-Entry Shares are entitled.
As soon as practicable after the determination of the amount of cash, if any, to be paid to holders of Certificates or Book-Entry
Shares with respect to any fractional share interests, the Exchange Agent shall promptly pay such amounts to such holders subject
to and in accordance with this Section 2.2(e).
(f) Return
of Merger Consideration. Any portion of the Merger Consideration made available to the Exchange Agent pursuant to Section
2.2(a) (including any interest or other amounts received with respect thereto) that remains undistributed to the holders of
the Certificates or Book-Entry Shares for nine months after the Effective Time shall be delivered to TopCo, upon demand, and any
holders of the Certificates or Book-Entry Shares who have not theretofore complied with this ARTICLE II shall thereafter
be entitled to look only to TopCo for payment of their claim for any shares of TopCo Common Stock, any MSLO Cash Consideration,
any cash in lieu of fractional shares of TopCo Common Stock and any dividends or distributions with respect to TopCo Common Stock,
as applicable.
(g) No
Liability. None of Sequential, MSLO, TopCo, Singer Merger Sub, the Sequential Surviving Corporation, Madeline Merger Sub, the
MSLO Surviving Corporation or the Exchange Agent shall be liable to any person in respect of any portion of the Merger Consideration
delivered to a public official pursuant to any applicable abandoned property, escheat or similar law. If any Certificate or Book-Entry
Share has not been surrendered prior to seven years after the Effective Time, or immediately prior to such earlier date on which
any cash, any shares of TopCo Common Stock, any cash in lieu of fractional shares, as applicable, of TopCo Common Stock or any
dividends or distributions with respect to TopCo Common Stock in respect of such Certificate or Book-Entry Share would otherwise
escheat to or become the property of any Governmental Entity, any such shares, cash, dividends or distributions in respect of such
Certificate or Book-Entry Share shall, to the extent permitted by applicable Law, become the property of TopCo, free and clear
of all claims or interests of any person previously entitled thereto.
(h) Investment
of Exchange Fund. The Exchange Agent shall invest any cash included in the Exchange Fund as directed by Sequential, provided,
that no losses on such investments shall affect the cash payable to former holders of shares of MSLO Common Stock pursuant to this
ARTICLE II. TopCo shall replace, as necessary, any cash deposited with the Exchange Agent lost through any investment made
pursuant to this Section 2.2(h). Any interest and other income resulting from such investments shall be paid to TopCo.
(i) Withholding
Rights. Each of TopCo, Sequential, MSLO, Singer Merger Sub, the Sequential Surviving Corporation, Madeline Merger Sub, the
MSLO Surviving Corporation and the Exchange Agent shall be entitled to deduct and withhold from any amounts otherwise payable to
any Person pursuant to this Agreement such amounts as may be required to be deducted and withheld with respect to the making of
such payment under applicable Tax Law. Any amounts so deducted and withheld shall be treated for all purposes of this Agreement
as having been paid to the Person in respect of which such deduction or withholding was made. Notwithstanding any other provision
of this Agreement, TopCo shall make all payments of stock (other than payments treated as compensation for U.S. federal income
tax purposes) under this Agreement free and clear of all deductions and withholdings in respect of Taxes other than “backup
withholding” if required under Section 3406 of the Code.
(j) Lost
Certificates. If any Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by
the Person claiming such Certificate to be lost, stolen or destroyed and, if required by TopCo or the Exchange Agent, the posting
by such Person of a bond in such amount as TopCo or the Exchange Agent, as applicable, may determine is reasonably necessary as
indemnity against any claim that may be made against it, the Exchange Agent shall deliver in exchange for such lost, stolen or
destroyed Certificate, the applicable Merger Consideration with respect to the shares of Sequential Common Stock or shares of MSLO
Common Stock, as the case may be, formerly represented thereby, any cash in lieu of fractional shares of TopCo Common Stock, and
unpaid dividends and distributions on shares of TopCo Common Stock deliverable in respect thereof, pursuant to this Agreement.
2.3 Election
Procedures. Each holder of record of shares of MSLO Common Stock issued and outstanding immediately prior to the Election
Deadline (a “MSLO Holder”) shall have the right, subject to the limitations set forth in this ARTICLE II,
to submit an election on or prior to the Election Deadline in accordance with the following procedures.
(a) Each
MSLO Holder may specify in a request made in accordance with the provisions of this Section 2.3 (an “Election”)
(i) the number of shares of MSLO Common Stock owned by such MSLO Holder with respect to which such MSLO Holder desires to make
a Stock Election, (ii) the number of shares of MSLO Common Stock owned by such MSLO Holder with respect to which such MSLO Holder
desires to make a Cash Election and (iii) the particular shares for which the MSLO Holder desires to make either such election,
and the order in which either such election is to apply to any such shares if the election is subject to proration under Section 2.4.
Any MSLO Holder who wishes to make an Election shall be required to waive all dissenters’ rights in connection with making
such Election.
(b) TopCo
shall prepare a form reasonably acceptable to MSLO and Sequential (the “Form of Election”), which shall be mailed
by TopCo to record holders of MSLO Common Stock so as to permit those MSLO Holders to exercise their right to make an Election
prior to the Election Deadline.
(c) TopCo
shall mail or cause to be mailed or delivered, as applicable, the Form of Election to record holders of MSLO Common Stock as of
the record date for the MSLO Stockholders Meeting not less than 20 Business Days prior to the anticipated Election Deadline. TopCo
shall make available one or more Forms of Election as may reasonably be requested from time to time by all persons who become holders
of record of MSLO Common Stock during the period following the record date for the MSLO Stockholders Meeting and prior to the Election
Deadline.
(d) Any
Election shall have been made properly only if the Exchange Agent shall have received, prior to the Election Deadline, a Form of
Election properly completed and signed and accompanied by MSLO Certificates (or affidavits of loss in lieu of the MSLO Certificates,
subject to Section 2.2(j)) to which such Form of Election relates, duly endorsed in blank or otherwise in form acceptable
for transfer on the books of MSLO or by an appropriate customary guarantee of delivery of such MSLO Certificates, as set forth
in such Form of Election, from a firm that is an eligible guarantor institution (as defined in Rule 17Ad-15 under the Exchange
Act); provided, that such MSLO Certificates are in fact delivered to the Exchange Agent by the time required in such guarantee
of delivery, and, in the case of MSLO Book-Entry Shares, any additional documents specified in the procedures set forth in the
Form of Election. Failure to deliver shares of MSLO Common Stock covered by such a guarantee of delivery within the time set forth
on such guarantee shall be deemed to invalidate any otherwise properly made Election, unless otherwise determined by Sequential,
in its sole and absolute discretion. As used herein, unless otherwise jointly agreed in advance by Sequential and MSLO, “Election
Deadline” means 5:00 p.m. local time (in the city in which the principal office of the Exchange Agent is located) on
the later of (i) the date immediately prior to the MSLO Stockholders Meeting and (ii) if on the date immediately prior to the MSLO
Stockholders Meeting, the condition set forth in Section 7.1(d) has not been satisfied, three Business Days prior to the
Closing Date. MSLO and Sequential shall issue a joint press release reasonably satisfactory to each of them announcing the anticipated
date of the Election Deadline not more than 15 Business Days before, and at least five Business Days prior to, the anticipated
date of the Election Deadline. If the Closing is delayed to a subsequent date, the Election Deadline shall be similarly delayed
to a subsequent date (which shall be three Business Days prior to the Closing Date) and MSLO and Sequential shall cooperate to
promptly publicly announce such rescheduled Election Deadline.
(e) Any
MSLO Holder may, at any time prior to the Election Deadline, change or revoke such MSLO Holder’s Election by written notice
received by the Exchange Agent prior to the Election Deadline accompanied by a properly completed and signed revised Form of Election
or by withdrawal prior to the Election Deadline of such MSLO Holder’s MSLO Certificates, or of the guarantee of delivery
of such MSLO Certificates, or any documents in respect of MSLO Book-Entry Shares, previously deposited with the Exchange Agent.
After an Election is validly made with respect to any shares of MSLO Common Stock, any subsequent transfer of such shares of MSLO
Common Stock shall automatically revoke such Election. Notwithstanding anything to the contrary in this Agreement, all Elections
shall be automatically deemed revoked upon receipt by the Exchange Agent of written notification from MSLO or Sequential that this
Agreement has been terminated in accordance with ARTICLE VIII. The Exchange Agent shall have reasonable discretion to determine
if any Election is not properly made with respect to any shares of MSLO Common Stock (none of Sequential, MSLO, TopCo, Singer Merger
Sub, Madeline Merger Sub or the Exchange Agent being under any duty to notify any stockholder of any such defect). In the event
the Exchange Agent makes such a determination, such Election shall be deemed to be not in effect, and the shares of MSLO Common
Stock covered by such Election shall, for purposes hereof, be deemed to be Non-Election Shares, unless a proper Election is thereafter
timely made with respect to such shares.
(f) Sequential
and MSLO, in the exercise of their reasonable discretion, shall have the joint right to make all determinations, not inconsistent
with the terms of this Agreement, governing the manner and extent to which Elections are to be taken into account in making the
determinations prescribed by Section 2.4.
2.4 Proration.
(a) Notwithstanding
any other provision contained in this Agreement, the total number of shares of MSLO Common Stock to be converted into the MSLO
Cash Consideration pursuant to Section 2.1(a)(i) (which, for this purpose, shall be deemed to include the Dissenting Shares
determined as of the MSLO Effective Time) (the “Cash Conversion Number”) shall be equal to the quotient obtained
by dividing (x) $176,681,757.15 by (y) the MSLO Cash Consideration. All other shares of MSLO Common Stock (other than cancelled
shares and Dissenting Shares) shall be converted into MSLO Stock Consideration.
(b) Within
three Business Days after the MSLO Effective Time, Sequential shall cause the Exchange Agent to effect the allocation among the
holders of shares of MSLO Common Stock of the rights to receive the MSLO Cash Consideration and the MSLO Stock Consideration as
follows:
(i) first,
with respect to each MSLO Holder who has made a Cash Election with respect to one-half of the number of shares of such MSLO Holder’s
MSLO Common Stock and a Stock Election with respect to one-half of the number of shares of such MSLO Holder’s MSLO Common
Stock, all of such MSLO Holder’s Cash Election Shares will be converted into the MSLO Cash Consideration and all of such
MSLO Holder’s Stock Election Shares will be converted into the MSLO Stock Consideration; and
(ii) then,
if the aggregate remaining number of shares of MSLO Common Stock with respect to which Cash Elections shall have been made (which,
for this purpose, shall be deemed to include the Dissenting Shares determined as of the MSLO Effective Time but exclude the shares
of MSLO Common Stock converted into the right to receive the MSLO Cash Consideration pursuant to Section 2.4(b)(i)) (the
“Total Cash Election Number”) exceeds the Adjusted Cash Conversion Number, then (A) all Stock Election Shares
and all Non-Election Shares shall be converted into the right to receive the MSLO Stock Consideration and (B) Cash Election Shares
of each holder thereof will be converted into the right to receive the MSLO Cash Consideration in respect of that number of Cash
Election Shares equal to the product obtained by multiplying (x) the number of Cash Election Shares held by such holder by (y)
a fraction, the numerator of which is the Cash Conversion Number and the denominator of which is the Total Cash Election Number
(with the Exchange Agent to determine, consistent with Section 2.4(a), whether fractions of Cash Election Shares shall be
rounded up or down), with the remaining number of such holder’s Cash Election Shares being converted into the right to receive
the MSLO Stock Consideration; or
(iii) if
the Total Cash Election Number is less than the Adjusted Cash Conversion Number (the amount by which the Adjusted Cash Conversion
Number exceeds the Total Cash Election Number being referred to herein as the “Shortfall Number”), then all
remaining Cash Election Shares shall be converted into the right to receive the MSLO Cash Consideration, and the Stock Election
Shares and Non-Election Shares shall be treated in the following manner:
(A) if
the Shortfall Number is less than or equal to the number of Non-Election Shares, then all Stock Election Shares shall be converted
into the right to receive the MSLO Stock Consideration, and the Non-Election Shares of each holder thereof shall convert into the
right to receive the MSLO Cash Consideration in respect of that number of Non-Election Shares equal to the product obtained by
multiplying (1) the number of Non-Election Shares held by such holder by (2) a fraction, the numerator of which is the Shortfall
Number and the denominator of which is the total number of Non-Election Shares (with the Exchange Agent to determine, consistent
with Section 2.4(a), whether fractions of Non-Election Shares shall be rounded up or down), with the remaining number of
such holder’s Non-Election Shares being converted into the right to receive the MSLO Stock Consideration; or
(B) if
the Shortfall Number exceeds the number of Non-Election Shares, then (1) all Non-Election Shares shall be converted into the right
to receive the MSLO Cash Consideration and (2) the Stock Election Shares of each holder thereof shall convert into the right to
receive the MSLO Cash Consideration in respect of that number of Stock Election Shares equal to the product obtained by multiplying
(A) the number of Stock Election Shares held by such holder by (B) a fraction, the numerator of which is the amount by which (1)
the Shortfall Number exceeds (2) the total number of Non-Election Shares, and the denominator of which is the total number of Stock
Election Shares (with the Exchange Agent to determine, consistent with Section 2.4(a), whether fractions of Stock Election
Shares shall be rounded up or down), with the remaining number of such holder’s Stock Election Shares being converted into
the right to receive the MSLO Stock Consideration.
2.5 Certain
Adjustments. If between the date hereof and the Effective Time, the outstanding shares of Sequential Common Stock or
MSLO Common Stock are changed into a different number of shares by reason of any reclassification, recapitalization, split-up,
combination, exchange of shares, dividend payable in stock or other securities or other similar transaction, the Sequential Merger
Consideration and related provisions or the MSLO Merger Consideration and related provisions, as applicable, shall be appropriately
adjusted to provide to the holders of Sequential Common Stock and MSLO Common Stock or Sequential Equity Awards and MSLO Equity
Awards the same economic effect as contemplated by this Agreement prior to such reclassification, recapitalization, split-up, combination,
exchange, dividend or other similar transaction. Nothing in this Section 2.5 shall be construed to permit Sequential or
MSLO to take any action that is otherwise prohibited or restricted by any other provision of this Agreement.
2.6 Further
Assurances. If, at any time MSLO or Sequential reasonably believes or is advised that any further instruments, deeds,
assignments or assurances are reasonably necessary or desirable to consummate the Mergers or to carry out the purposes and intent
of this Agreement at the Effective Time, then MSLO, Sequential, TopCo, the MSLO Surviving Corporation and the Sequential Surviving
Corporation and their respective officers and directors shall execute and deliver all such proper instruments, deeds, assignments
or assurances and do all other things reasonably necessary or desirable to consummate the Mergers and to carry out the purposes
and intent of this Agreement.
ARTICLE
III
REPRESENTATIONS AND WARRANTIES OF MSLO
Except as (x) disclosed in the MSLO
SEC Documents filed with or furnished to the SEC (excluding disclosure contained in the “risk factors” section or constituting
“forward-looking statements,” in each case, to the extent such disclosure is cautionary, predictive or speculative
in nature) or (y) set forth in the disclosure letter delivered by MSLO to Sequential on or prior to the date of this Agreement
(the “MSLO Disclosure Schedule”), MSLO represents and warrants to Sequential as set forth in this ARTICLE
III. For purposes of the representations and warranties of MSLO contained herein, disclosure in any section of the MSLO Disclosure
Schedule of any facts or circumstances shall be deemed to be disclosure of such facts or circumstances with respect to all representations
or warranties by MSLO to which the relevance of such disclosure to the applicable representation and warranty is readily apparent
on the face thereof. The inclusion of any information in the MSLO Disclosure Schedule or other document delivered by MSLO pursuant
to this Agreement shall not be deemed to be an admission or evidence of the materiality of such item, nor shall it establish a
standard of materiality for any purpose whatsoever.
3.1 Corporate
Organization.
(a) Each
of MSLO and its Subsidiaries (i) is an entity duly organized, validly existing and in good standing under the Laws of the jurisdiction
of its organization, (ii) has all requisite corporate or similar power and authority to own, lease and operate its properties
and to carry on its business as now being conducted and (iii) is duly qualified or licensed to do business and is in good standing
in each jurisdiction in which the nature of its business or the ownership, leasing or operation of its properties makes such qualification
or licensing necessary, except in the case of clause (iii) as, individually or in the aggregate, has not had and would not reasonably
be expected to have a MSLO Material Adverse Effect.
(b) True
and complete copies of the certificate of incorporation of MSLO, as amended through, and as in effect as of, the date of this Agreement
and the bylaws, as in effect as of, the date of this Agreement and the certificate of incorporation and bylaws (or comparable organizational
documents of each of its Subsidiaries, in each case as amended to the date of this Agreement) have previously been made available
to Sequential.
3.2 Capitalization.
(a) Authorized
and Issued Shares.
(i) As
of the date of this Agreement, the authorized capital stock of MSLO consists solely of (A) 350,000,000 shares of MSLO Class A Common
Stock; (B) 150,000,000 shares of MSLO Class B Common Stock and (C) 150,000,000 shares of preferred stock, par value $.01 per share
(the “MSLO Preferred Stock”). As of June 15, 2015 (the “Measurement Date”), (i) 32,472,857
shares of MSLO Class A Common Stock; 24,984,625 shares of MSLO Class B Common Stock and no shares of MSLO Preferred Stock were
issued and outstanding, (ii) 59,400 shares of MSLO Common Stock were held in treasury, (iii) 6,447,172 shares of MSLO
Common Stock were reserved for issuance pursuant to MSLO Equity Awards, (iv) 3,079,325 shares of MSLO Common Stock were subject
to outstanding MSLO Stock Options with a weighted average exercise price of $3.45 (of which MSLO Stock Options to purchase an aggregate
of 2,525,090 shares of MSLO Common Stock were exercisable with a weighted average exercise price of $2.71), (v) 185,000 shares
of MSLO Common Stock were subject to outstanding MSLO Performance Stock Options with a weighted average exercise price of $8.39
(of which MSLO Performance Stock Options to purchase an aggregate of 10,000 shares of MSLO Common Stock were exercisable with a
weighted average exercise price of $5.00), (vi) 489,127 shares of MSLO Common Stock were subject to outstanding MSLO RSU Awards
and (vii) 808,333 shares of MSLO Common Stock were subject to outstanding MSLO Performance RSU Awards. Section 3.2 of the MSLO
Disclosure Schedule contains a complete and correct list, as of the Measurement Date, of each outstanding MSLO Stock Option, each
outstanding MSLO Performance Stock Option, each outstanding MSLO RSU Award, each outstanding MSLO Performance RSU Award including,
as applicable, the holder, date of grant, exercise price (to the extent applicable), vesting schedule, performance targets and
number of shares of MSLO Common Stock subject thereto.
(ii) Except
as described in Section 3.2(a)(i) and except for changes since the close of business on the Measurement Date resulting from
the exercise of MSLO Equity Awards, there is no, and neither MSLO nor any of its Subsidiaries has issued or agreed to issue any:
(a) share of capital stock or other equity or ownership interest; (b) option, warrant or interest convertible into or
exchangeable or exercisable for the purchase of shares of capital stock or other equity or ownership interests; (c) stock
appreciation right, phantom stock, interest in the ownership or earnings of MSLO or any of its Subsidiaries or other equity equivalent
or equity-based award or right; or (d) bond, debenture or other indebtedness having the right to vote or convertible or exchangeable
for securities having the right to vote. Each outstanding share of capital stock or other equity or ownership interest of MSLO
and each of the MSLO Subsidiaries is duly authorized, validly issued, fully paid and nonassessable, and in the case of its Subsidiaries,
each such share or other equity or ownership interest is owned by MSLO or another Subsidiary of MSLO, free and clear of any Lien.
All of the aforesaid shares or other equity or ownership interests have been offered, sold and delivered by MSLO or a MSLO Subsidiary
in compliance with all applicable federal and state securities Laws. Except for rights granted to Sequential and TopCo under this
Agreement, there are no outstanding obligations of MSLO or any MSLO Subsidiary to issue, sell or transfer or repurchase, redeem
or otherwise acquire, or that relate to the holding, voting or disposition of, or that restrict the transfer of, the issued or
unissued capital stock or other equity or ownership interests of MSLO or any of its Subsidiaries. No shares of capital stock or
other equity or ownership interests of MSLO or any of the MSLO Subsidiaries are subject to or have been issued in violation of
any rights, agreements, arrangements or commitments under any provision of applicable Law, the certificate of incorporation or
bylaws or equivalent organizational documents of MSLO or any of the MSLO Subsidiaries or any Contract to which MSLO or any of the
MSLO Subsidiaries is a party or by which MSLO or any of the MSLO Subsidiaries is bound. There are no declared or accrued but unpaid
dividends with respect to any shares of MSLO Common Stock.
(b) Except
as set forth in Section 3.2(b) of the MSLO Disclosure Schedule, there are no agreements to which MSLO or any of its Subsidiaries
is a party, or to which any shares of MSLO Common Stock are subject, relating to the voting of shares of MSLO Common Stock or otherwise
granting, limiting or affecting the rights pertaining to shares of MSLO Common Stock.
(c) Section
3.2(c) of the MSLO Disclosure Schedule sets forth a true and complete list of each MSLO Subsidiary, including its jurisdiction
of organization and authorized and outstanding equity securities. All of the issued and outstanding shares of capital stock or
other equity ownership interests of each Subsidiary of MSLO are owned by MSLO, directly or indirectly, free and clear of any material
Liens other than Permitted Liens, and free of any restriction on the right to vote, sell or otherwise dispose of such capital stock
or other equity ownership interest (other than restrictions under applicable securities Laws), and all of such shares or equity
ownership interests are duly authorized and validly issued and are fully paid, nonassessable and free of preemptive rights. Except
for the capital stock or other MSLO ownership interests of the MSLO Subsidiaries, as of the date of this Agreement, MSLO does not
beneficially own, directly or indirectly, any capital stock, membership interest, partnership interest, joint venture interest
or other equity interest in any Person.
3.3 Corporate
Authorization. MSLO has full corporate power and authority to execute and deliver this Agreement and, subject to the
approval and adoption of this Agreement by the affirmative vote at the MSLO Stockholders Meeting, or any adjournment or postponement
thereof, of (i) holders of at least a majority in combined voting power of the outstanding MSLO Class A Common Stock and MSLO Class
B Common Stock and (ii) holders of at least fifty percent (50%) in combined voting power of the outstanding MSLO Class A Common
Stock and MSLO Class B Common Stock not owned directly or indirectly, by Martha Stewart and her Affiliates (the “MSLO
Stockholder Approval”), to perform its obligations hereunder and to consummate the transactions contemplated hereby.
The execution, delivery and performance by MSLO of this Agreement and the consummation by MSLO of the transactions to which it
is a party contemplated hereby have been duly and validly authorized and approved by the board of directors of MSLO (the “MSLO
Board”). The MSLO Board, acting upon the recommendation of the Special Committee, has, by resolutions duly adopted by
a vote of all members of the MSLO Board other than Martha Stewart (who recused herself), (i) determined that this Agreement and
the transactions contemplated hereby, including the MSLO Merger, are fair to, and in the best interests of, MSLO and its stockholders,
(ii) approved and adopted this Agreement, including the MSLO Merger, (iii) approved and declared advisable the execution,
delivery and performance by MSLO of this Agreement and the consummation of the transactions contemplated hereby, and (iv) recommended
that the stockholders of MSLO adopt this Agreement and approve the transactions contemplated by this Agreement. Other than the
MSLO Stockholder Approval, no other corporate proceedings on the part of MSLO or any other vote by the holders of any class or
series of capital stock of MSLO are necessary to authorize the execution, delivery or performance of this Agreement or to consummate
the transactions contemplated hereby. The MSLO Stockholder Approval is the only vote of the holders of any securities of MSLO or
any of the MSLO Subsidiaries necessary to approve and adopt this Agreement, the MSLO Merger and the other transactions contemplated
hereby. This Agreement has been duly executed and delivered by MSLO and, assuming due execution and delivery by each of the other
parties hereto, this Agreement constitutes the legal, valid and binding obligation of MSLO, enforceable against MSLO in accordance
with its terms, except as enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar
laws affecting creditors’ rights generally and by general principles of equity (regardless of whether considered in a proceeding
in equity or at law).
3.4 Governmental
Authorization. The execution, delivery and performance by MSLO of this Agreement and the consummation by MSLO of the
transactions contemplated hereby require at or prior to the Closing no consent or approval by, or filing with, or notification
to any Governmental Entity, other than (a) the filing of the MSLO Certificate of Merger and the Sequential Certificate of
Merger with the Secretary of State of the State of Delaware, (b) compliance with any applicable requirements of the Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended (the “HSR Act”), (c) compliance with any applicable requirements
of the Securities Act, the Exchange Act, any other applicable U.S. federal or state securities Laws or “blue sky” Laws,
including the filing with the SEC and effectiveness of the registration statement on Form S-4 to be filed by TopCo in connection
with the issuance of shares of TopCo Common Stock in the Mergers (the “Form S-4”) which shall include (x) a
proxy statement relating to the MSLO Stockholders Meeting as a prospectus (such proxy statement/prospectus, as amended or supplemented
from time to time, the “Proxy Statement/Prospectus”) and (y) an information statement with respect to the Sequential
Stockholder Approval (as amended or supplemented from time to time, the “Information Statement”), (d) compliance
with any applicable requirements of the New York Stock Exchange (the “NYSE” ), (e) those consents, approvals
or filings required pursuant to Section 4.4 and (f) any other consents, approvals or filings the failure of which to be
obtained or made would not, individually or in the aggregate, reasonably be expected to have a MSLO Material Adverse Effect or
prevent or materially delay the consummation of the transactions contemplated by this Agreement.
3.5 Non-Contravention.
The execution, delivery and performance by MSLO of this Agreement do not, and the consummation of the transactions contemplated
hereby will not, (a) violate or conflict with or result in any breach of any provision of MSLO’s certificate of incorporation,
bylaws or comparable organizational documents of MSLO or any of its Subsidiaries; (b) assuming receipt of the MSLO Stockholder
Approval and compliance with the matters referred to in Section 3.4 and Section 4.4, violate or conflict
with any provision of any applicable Law; (c) violate or conflict with or result in any breach or constitute a default, or
an event that, with or without notice or lapse of time or both, would constitute a default under, or cause the termination, cancellation,
acceleration or other change of any right or obligation or the loss of any benefit to which MSLO or any of its Subsidiaries is
entitled, or require consent by any Person under, any loan or credit agreement, note, mortgage, indenture, lease, MSLO Benefit
Plan, or MSLO Material Contract; or (d) result in the creation or imposition of any Lien (other than Permitted Liens) on any asset
of MSLO or any of its Subsidiaries, except, in the case of clauses (b), (c) and (d), as would not, individually or in the aggregate,
reasonably be expected to have a MSLO Material Adverse Effect or prevent or materially delay the consummation of the transactions
contemplated by this Agreement.
3.6 MSLO
SEC Filings.
(a) MSLO
has timely filed all reports, schedules, forms, registration statements and other documents required to be filed by MSLO with the
Securities and Exchange Commission (the “SEC”) since December 31, 2013 (together with any documents furnished
during such period by MSLO to the SEC on a voluntary basis on Current Reports on Form 8-K and any reports, schedules, forms,
registration statements and other documents filed with the SEC subsequent to the date hereof, collectively, the “MSLO
SEC Documents”). As of their respective filing dates (or, if amended or superseded by a filing prior to the date of this
Agreement, then on the date of such filing), the MSLO SEC Documents complied or, if not yet filed, will comply, in all material
respects with the applicable requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley
Act”), as the case may be, including, in each case, the rules and regulations promulgated thereunder, and none of the
MSLO SEC Documents contained or, if not yet filed, will contain, any untrue statement of a material fact or omitted or, if not
yet filed, will omit a material fact required to be stated therein or necessary in order to make the statements therein, in light
of the circumstances under which they were made, not misleading.
(b) The
financial statements (including the related notes and schedules thereto) included (or incorporated by reference) in the MSLO SEC
Documents (i) have been prepared or, if not yet filed, will be prepared, in a manner consistent with the books and records of MSLO
and its Subsidiaries, (ii) have been prepared or, if not yet filed, will be prepared, in accordance with GAAP (except, in
the case of unaudited statements, as permitted by Form 10 Q of the SEC) applied on a consistent basis during the periods involved
(except as may be indicated in the notes thereto), (iii) comply or, if not yet filed, will comply, as to form in all material respects
with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto and (iv) fairly
present or, if not yet filed, will fairly present, in all material respects the consolidated financial position of MSLO and its
Subsidiaries as of the dates thereof and their respective consolidated results of operations and cash flows for the periods then
ended (subject, in the case of unaudited statements, to normal year-end audit adjustments that were not, or are not expected to
be, material in amount), all in accordance with GAAP and the applicable rules and regulations promulgated by the SEC. Since January
1, 2014, MSLO has not made any change in the accounting practices or policies applied in the preparation of its financial statements,
except as required by GAAP, SEC rule or policy or applicable Law. The books and records of MSLO and its Subsidiaries have been,
and are being, maintained in all material respects in accordance with GAAP (to the extent applicable) and any other applicable
legal and accounting requirements and reflect only actual transactions.
(c) MSLO
has established and maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange
Act). Such disclosure controls and procedures are designed to ensure that information relating to MSLO, including its consolidated
Subsidiaries, required to be disclosed in MSLO’s periodic and current reports under the Exchange Act, is made known to MSLO’s
chief executive officer and its chief financial officer by others within those entities to allow timely decisions regarding required
disclosures as required under the Exchange Act. The chief executive officer and chief financial officer of MSLO have evaluated
the effectiveness of MSLO’s disclosure controls and procedures and, to the extent required by applicable Law, presented in
any applicable MSLO SEC Document that is a report on Form 10-K or Form 10-Q, or any amendment thereto, its conclusions about the
effectiveness of the disclosure controls and procedures as of the end of the period covered by such report or amendment based on
such evaluation.
(d) MSLO
and its Subsidiaries have established and maintain a system of internal control over financial reporting (as defined in Rules 13a-15(f)
and 15d-15(f) under the Exchange Act) which is effective in providing reasonable assurance regarding the reliability of MSLO’s
financial reporting and the preparation of MSLO’s financial statements for external purposes in accordance with GAAP. MSLO
has disclosed, based on its most recent evaluation of MSLO’s internal control over financial reporting prior to the date
hereof, to MSLO’s auditors and audit committee (i) any significant deficiencies and material weaknesses in the design or
operation of MSLO’s internal control over financial reporting which are reasonably likely to adversely affect MSLO’s
ability to record, process, summarize and report financial information and (ii) any fraud, whether or not material, that involves
management or other employees who have a significant role in MSLO’s internal control over financial reporting. A true, correct
and complete summary of any such disclosures made by management to MSLO’s auditors and audit committee is set forth as Section
3.6(d) of the MSLO Disclosure Schedule.
(e) Since
December 31, 2012, (i) neither MSLO nor any of its Subsidiaries nor, to the knowledge of MSLO, any director, officer, employee,
auditor, accountant or representative of MSLO or any of its Subsidiaries has received or otherwise had or obtained knowledge of
any material complaint, allegation, assertion or claim, whether written or oral, regarding the accounting or auditing practices,
procedures, methodologies or methods of MSLO or any of its Subsidiaries or their respective internal accounting controls, including
any material complaint, allegation, assertion or claim that MSLO or any of its Subsidiaries has engaged in questionable accounting
or auditing practices and (ii) no attorney representing MSLO or any of its Subsidiaries, whether or not employed by MSLO or any
of its Subsidiaries, has reported evidence of a material violation of securities Laws, breach of fiduciary duty or similar violation
by MSLO or any of its Subsidiaries or any of their respective officers, directors, employees or agents to the MSLO Board or any
committee thereof or to any director or officer of MSLO or any of its Subsidiaries.
(f) MSLO
has made available to Sequential true, correct and complete copies of all written correspondence between the SEC, on the one hand,
and MSLO and any of its Subsidiaries, on the other hand, occurring since December 31, 2012.
(g) Neither
MSLO nor any of its Subsidiaries is a party to, or has any commitment to become a party to, any joint venture, off balance sheet
partnership or any similar Contract (including any Contract or arrangement relating to any transaction or relationship between
or among MSLO and any of its Subsidiaries, on the one hand, and any unconsolidated Affiliate, including any structured finance,
special purpose or limited purpose entity or Person, on the other hand, or any “off balance sheet arrangements” (as
defined in Item 303(a) of Regulation S-K under the Exchange Act)), where the result, purpose or intended effect of such Contract
is to avoid disclosure of any material transaction involving, or material liabilities of, MSLO or any of its Subsidiaries in MSLO’s
or such Subsidiary’s published financial statements or other MSLO SEC Documents.
(h) MSLO
is in compliance in all material respects with (i) the provisions of the Sarbanes-Oxley Act and (ii) the rules and regulations
of the NYSE, in each case, that are applicable to MSLO.
(i) No
Subsidiary of MSLO is required to file any form, report, schedule, statement or other document with the SEC.
(j) Except
as and to the extent adequately accrued or reserved against in the audited consolidated balance sheet of MSLO and its Subsidiaries
as at December 31, 2014 (such balance sheet, the “MSLO Balance Sheet”), neither MSLO nor any of its Subsidiaries
has any liability or obligation of any nature, whether accrued, absolute, contingent or otherwise, whether known or unknown and
whether or not required by GAAP to be reflected in a consolidated balance sheet of MSLO and its Subsidiaries or disclosed in the
notes thereto, except for liabilities and obligations, incurred in the ordinary course of business consistent with past practice
since the date of the MSLO Balance Sheet, that would not, individually or in the aggregate, reasonably be expected to have a MSLO
Material Adverse Effect.
3.7 Form S-4.
The information supplied or to be supplied by MSLO for inclusion in the Form S-4, including the Proxy Statement/Prospectus
and Information Statement, will not, at the time that the Form S-4 is declared effective by the SEC, contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading, except that no representation or warranty is
made by MSLO with respect to statements made therein based on information supplied by or on behalf of Sequential, Madeline Merger
Sub, Singer Merger Sub, TopCo or any of their Affiliates specifically for inclusion or incorporation by reference in the Form S-4.
The Proxy Statement/Prospectus will not, at the date the Proxy Statement/Prospectus is first mailed to the stockholders of MSLO,
contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances under which they were made, not misleading, except that, in
each case, no representation or warranty is made by MSLO with respect to statements made therein based on information supplied
by or on behalf of Sequential, Madeline Merger Sub, Singer Merger Sub, TopCo or any of their Affiliates specifically for inclusion
or incorporation by reference in the Proxy Statement/Prospectus. The Information Statement will not, at the date the Information
Statement is first mailed to the stockholders of Sequential, contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading, except that, in each case, no representation or warranty is made by MSLO with respect
to statements made therein based on information supplied by or on behalf of Sequential, Madeline Merger Sub, Singer Merger Sub,
TopCo or any of their Affiliates specifically for inclusion or incorporation by reference in the Information Statement.
3.8 Absence
of Certain Changes or Events.
(a) Since
the date of the MSLO Balance Sheet and through the date of this Agreement, no event or events or development or developments have
occurred that have had or would reasonably be expected to have, individually or in the aggregate, a MSLO Material Adverse Effect.
(b) Except
in connection with the execution and delivery of this Agreement and the transactions contemplated by this Agreement, from December
31, 2014 through the date of this Agreement, MSLO and the MSLO Subsidiaries have carried on their respective businesses in all
material respects in the ordinary course of business consistent with past practice.
3.9 Compliance
with Laws; Permits.
(a) Since
December 31, 2013, (i) each of MSLO and its Subsidiaries is and has been in compliance in all material respects with all Laws applicable
to it and (ii) MSLO has complied with the applicable listing and corporate governance rules and regulations of the NYSE except,
in each case, where the failure to so conduct such business and operations or comply with such rules and regulations would not,
individually or in the aggregate, reasonably be expected to have a MSLO Material Adverse Effect. Since December 31, 2012, none
of MSLO, any of the MSLO Subsidiaries or any of its or their executive officers has received, nor is there any basis for, any written
notice, order, complaint or other communication from any Governmental Entity or any other Person that MSLO or any of its Subsidiaries
is not in compliance in any material respect with any Law applicable to it.
(b) Section
3.9(b) of the MSLO Disclosure Schedule sets forth a true and complete list of all material permits, licenses, franchises, approvals,
certificates, consents, waivers, concessions, exemptions, orders, registrations, notices or other authorizations of any Governmental
Entity necessary for each of MSLO and its Subsidiaries to own, lease and operate its properties and to carry on its business in
all material respects as currently conducted (the “Permits”). Each of MSLO and its Subsidiaries is and has been
in compliance in all material respects with all such material Permits. No suspension, cancellation, modification, revocation or
nonrenewal of any material Permit is pending or, to the knowledge of MSLO, threatened in writing. MSLO and its Subsidiaries will
continue to have the use and benefit of all material Permits following consummation of the transactions contemplated hereby. No
material Permit is held in the name of any employee, officer, director, stockholder, agent or otherwise on behalf of MSLO or any
of its Subsidiaries.
3.10 Litigation. As
of the date hereof, there is no action pending or, to the knowledge of MSLO, threatened by or against MSLO, any of the MSLO Subsidiaries,
any of their respective properties or assets, or any officer or director of MSLO or any of its Subsidiaries that, individually
or in the aggregate, would reasonably be expected to have a MSLO Material Adverse Effect. As of the date hereof, none of MSLO or
any of its Subsidiaries, or any of their respective properties or assets is subject to any outstanding Order of any Governmental
Entity that, individually or in the aggregate, has had or would reasonably be expected to have a MSLO Material Adverse Effect.
3.11 Title
to Properties; Absence of Liens. Section 3.11 of the MSLO Disclosure Schedule sets forth a true and complete description
(including address, and for each lease, sublease and license, and all amendments, extensions, renewals, guaranties, modifications,
supplements or other agreements, if any, with respect thereto) of all real property leased, subleased or licensed by MSLO or any
of its Subsidiaries (collectively, the “MSLO Leased Real Properties”; and the leases, subleases and licenses
with respect thereto, collectively, the “MSLO Real Property Leases”). MSLO has made available to Sequential
true, correct and complete copies of the MSLO Real Property Leases, together with all amendments, extensions, renewals, guaranties,
modifications, supplements or other agreements, if any, with respect thereto. Each of the MSLO Real Property Leases is in full
force and effect. MSLO or one of its Subsidiaries has a valid, binding and enforceable leasehold or subleasehold interest (or license,
as applicable) in each MSLO Leased Real Property, in each case as to such leasehold or subleasehold interest (or license, as applicable),
free and clear of all Liens (other than Permitted Liens). Neither MSLO nor any of its Subsidiaries owns, or has owned in the past
10 years, any real property or any interests in real property.
3.12 Taxes.
(a) All
material Tax Returns required by applicable Law to be filed with any Governmental Entity by, or on behalf of, MSLO or any of its
Subsidiaries have been duly filed when due (including extensions) in accordance with all applicable Laws, and all such Tax Returns
are true, correct and complete in all material respects.
(b) MSLO
and each of its Subsidiaries has duly and timely paid or has duly and timely withheld and remitted to the appropriate Governmental
Entity all material Taxes due and payable, or, where payment is not yet due, has established in accordance with GAAP an adequate
accrual for all material Taxes in the financial statements included in the MSLO SEC Documents.
(c) There
is no claim, audit, action, suit, proceeding or investigation pending or threatened in writing against or with respect to MSLO
or any of its Subsidiaries in respect of any Tax or Tax Return which if determined adversely would, individually or in the aggregate,
be expected to result in a material Tax deficiency. Neither MSLO nor any of its Subsidiaries has received or applied for a Tax
ruling that would be binding on MSLO or any of its Subsidiaries after the Closing Date.
(d) MSLO
and each of its Subsidiaries has withheld or provided an accrual for all material amounts required to have been withheld by it
in connection with amounts paid or owed to any employee, independent contractor, creditor, stockholder or any other third party;
such amounts were either duly paid to the appropriate Governmental Entity or set aside in accounts for such purpose in accordance
with applicable Law. MSLO and each of its Subsidiaries has reported such withheld amounts to the appropriate Governmental Entity
and to each such employee, independent contractor, creditor, stockholder or any other third party, as required under applicable
Law.
(e) Neither
MSLO nor any of its Subsidiaries is liable for any Taxes of any Person (other than MSLO and its Subsidiaries) as a result of (i)
being a transferee or successor of such Person, (ii) the application of Treasury Regulation Section 1.1502-6 or any similar provision
of state, local or foreign law or (iii) a tax sharing, tax indemnity or tax allocation agreement or any similar agreement to indemnify
such Person.
(f) Neither
MSLO nor any of its Subsidiaries shall be required to include any item of income in, or exclude any item of deduction from, taxable
income for any period (or portion thereof) ending after the Closing Date, as a result of (1) any elective change in method of accounting
for a taxable period ending on or prior to the Closing Date under Section 481 of the Code (or any corresponding provision of state,
local or foreign Law), (2) “closing agreement” as described in Section 7121 of the Code (or any corresponding or similar
provision of state, local or foreign Tax Law) executed on or prior to the Closing Date, (3) intercompany transaction or excess
loss account described in Treasury Regulations under Section 1502 of the Code (or any corresponding or similar provision of state,
local or foreign Tax Law), (4) installment sale or open transaction made on or prior to the Closing Date, or (5) prepaid amount
received on or prior to the Closing Date.
(g) Neither
MSLO nor any of its Subsidiaries has participated or engaged in any “listed transaction” within the meaning of Treasury
Regulations Section 1.6011-4.
(h) Neither
MSLO nor any of its Subsidiaries has been informed in writing by any Governmental Entity in any jurisdiction in which it does not
file a Tax Return that it may be required to file a Tax Return in such jurisdiction.
(i) Neither
MSLO nor any of its Subsidiaries has distributed stock of another corporation, or has had its stock distributed by another corporation,
in a transaction that was governed, or purported or intended to be governed or described, in whole or in part, by Section 355 or
Section 368(a)(1)(D) of the Code.
(j) Neither
MSLO nor any of its Subsidiaries has taken or agreed to take any action or is aware of any fact or circumstance that would prevent
or impede, or could reasonably be expected to prevent or impede, the Mergers from qualifying as a transaction described in Section
351 of the Code.
3.13 Employee
Benefit Plans.
(a) Section 3.13(a)
of the MSLO Disclosure Schedule sets forth as of the date of this Agreement a true and complete list of each “employee benefit
plan” (within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”)),
and all stock purchase, stock option, severance, employment, change-in-control, fringe benefit, bonus, incentive, deferred compensation
and all other employee benefit plans, agreements, programs, policies or other arrangements, whether or not subject to ERISA (including
any funding mechanism therefor now in effect or required in the future as a result of the transactions contemplated by this Agreement
or otherwise), whether formal or informal, written, legally binding or not, under which any employee or former employee of MSLO
or its Subsidiaries has any present or future right to benefits or MSLO or its Subsidiaries has any direct or contingent liability
(each, a “MSLO Benefit Plan”). With respect to each such MSLO Benefit Plan, MSLO has made available to Sequential
a true and complete copy of such MSLO Benefit Plan, if written, or a description of the material terms of such MSLO Benefit Plan
if not written, and to the extent applicable: (i) all trust agreements, or other funding arrangements; (ii) the most
recent actuarial and trust reports for both ERISA funding and financial statement purposes; (iii) the two most recent Form 5500
with all attachments required to have been filed with the Internal Revenue Service (the “IRS”) or the Department
of Labor or any similar reports filed with any comparable Governmental Entity in any non-U.S. jurisdiction having jurisdiction
over any MSLO Benefit Plan and all schedules thereto; (iv) the most recent IRS determination or opinion letter; and (v) all
current summary plan descriptions.
(b) Each
MSLO Benefit Plan has been maintained in all material respects in accordance with its terms and the requirements of applicable
Law. Each of MSLO and its Subsidiaries has performed all material obligations required to be performed by it under any MSLO Benefit
Plan and, to the knowledge of MSLO, is not in any material respect in default under or in violation of any MSLO Benefit Plan. No
material action (other than claims for benefits in the ordinary course) is pending or, to the knowledge of MSLO, threatened with
respect to any MSLO Benefit Plan.
(c) Each
MSLO Benefit Plan that is intended to be qualified under Section 401(a) of the Code has received a determination or opinion
letter from the IRS that it is so qualified and each related trust that is intended to be exempt from federal income taxation under
Section 501(a) of the Code has received a determination or opinion letter from the IRS that it is so exempt and, to the knowledge
of MSLO, no fact or event has occurred since the date of such letter or letters from the IRS that could reasonably be expected
to adversely affect the qualified status of any such MSLO Benefit Plan or the exempt status of any such trust.
(d) No
MSLO Benefit Plan is subject to Title IV of ERISA, is a multiemployer plan (within the meaning of Section 3(37) of ERISA) or provides
post-employment welfare benefits except to the extent required by Section 4980B of the Code.
(e) Any
arrangement of MSLO or any of its Subsidiaries that is subject to Section 409A of the Code has complied in form and operation
with the requirements of Section 409A of the Code as in effect from time to time. Neither MSLO nor any of its Subsidiaries
has any obligation to provide any gross-up payment to any individual with respect to any income Tax, additional Tax, excise Tax
or interest charge imposed pursuant to Section 409A or 4999 of the Code.
(f) Except
as set forth in Section 3.13(f) of the MSLO Disclosure Schedule, the consummation of the transactions contemplated hereby
will not, either alone or in combination with another event, (i) entitle any current or former director, officer or employee
of MSLO or of any of its Subsidiaries to severance pay, unemployment compensation or any other payment; (ii) result in any
payment becoming due, accelerate the time of payment or vesting, or increase the amount of compensation due to any such director,
officer or employee; (iii) result in any forgiveness of indebtedness, trigger any funding obligation under any MSLO Benefit
Plan or impose any restrictions or limitations on MSLO rights to administer, amend or terminate any MSLO Benefit Plan; or (iv) result
in any payment (whether in cash or property or the vesting of property) to any “disqualified individual” (as such term
is defined in Treasury Regulations Section 1.280G-1) that could reasonably be expected, individually or in combination with any
other such payment, to constitute an “excess parachute payment” (as defined in Section 280G(b)(1) of the Code).
3.14 Employees,
Labor Matters.
(a) Neither
MSLO nor any of its Subsidiaries is a party to or bound by any collective bargaining agreement, and there are no, and during the
last three years have been no, labor unions or other organizations representing, purporting to represent or, to the knowledge of
MSLO, attempting to represent any employees of MSLO or any of its Subsidiaries.
(b) Since
January 1, 2011, there has not occurred or, to the knowledge of MSLO, been threatened any strike, slowdown, work stoppage, concerted
refusal to work overtime or other similar labor activity or union organizing campaign with respect to any employees of MSLO or
any of its Subsidiaries. There are no labor disputes subject to any formal grievance procedure, arbitration or litigation and there
is no representation petition pending or, to the knowledge of MSLO, threatened with respect to any employee of MSLO or any of its
Subsidiaries.
(c) MSLO
and its Subsidiaries have complied in all material respects with all applicable Laws relating to employment of labor, including
all applicable Laws relating to wages, hours, collective bargaining, employment discrimination, civil rights, safety and health,
workers’ compensation, pay equity, classification of employees, immigration, and the collection and payment of withholding
and/or social security Taxes.
3.15 Environmental
Matters.
(a) Except
as would not, individually or in the aggregate, have a MSLO Material Adverse Effect: (i) MSLO and each of its Subsidiaries are
in compliance with all applicable Environmental Laws, and possess and are in compliance with all applicable Environmental Permits
necessary to operate the business as presently operated; (ii) to the knowledge of MSLO, there have been no releases of Hazardous
Materials at or on any property owned or operated by MSLO or any of its Subsidiaries, except under circumstances that are not reasonably
likely to result in liability of MSLO or any of its Subsidiaries under any applicable Environmental Law; (iii) neither MSLO nor
any of its Subsidiaries has received from a Governmental Entity a request for information pursuant to Section 104(e) of the Comprehensive
Environmental Response, Compensation and Liability Act of 1980 or similar state statute, or any written notification alleging that
it is liable for any release or threatened release of Hazardous Materials at any location, except with respect to any such notification
or request for information concerning any such release or threatened release, to the extent such matter has been resolved with
the appropriate foreign, federal, state or local regulatory authority or otherwise; and (iv) neither MSLO nor any of its Subsidiaries
has received any written claim or complaint, or is presently subject to any lawsuit, proceeding or action, relating to noncompliance
with Environmental Laws or any other liabilities pursuant to Environmental Laws, and to the knowledge of MSLO, no such matter has
been threatened in writing.
(b) For
purposes of this Agreement, the following terms shall have the meanings assigned below:
(i) “Environmental
Laws” shall mean all foreign, federal, state, or local statutes, regulations, ordinances, codes, or decrees protecting
the quality of the ambient air, soil, surface water or groundwater.
(ii) “Environmental
Permits” shall mean all permits, licenses, registrations, approvals, and other authorizations required under applicable
Environmental Laws.
(iii) “Hazardous
Materials” shall mean any substance or waste defined and regulated as hazardous, acutely hazardous, or toxic under applicable
Environmental Laws.
3.16 Intellectual
Property.
(a) Section
3.16 of the MSLO Disclosure Schedule sets forth a true and complete list of all Registered Intellectual Property (each identified
as a Mark, Patent, Copyright or domain name) owned (in whole or in part) by MSLO or any of its Subsidiaries as of the date of this
Agreement, identifying for each whether it is owned by MSLO or the relevant Subsidiary (together with all Trade Secrets owned by
MSLO or any of its Subsidiaries, collectively, the “MSLO Owned IP”).
(b) Since
January 1, 2013, no MSLO Owned IP has been or is now involved in any opposition, cancellation, reissue, reexamination, inter-partes
review, public protest, interference, arbitration, mediation, domain name dispute resolution or other proceeding and, to the knowledge
of MSLO, no such proceeding is or has been threatened or asserted with respect to any MSLO Owned IP, which, in each case, if determined
or resolved adversely against MSLO or any of its Subsidiaries, would reasonably be expected to have a MSLO Material Adverse Effect
(c) MSLO
or its Subsidiaries own or otherwise have a valid right to use, free and clear of any and all Liens (other than Permitted Liens),
all Intellectual Property used in the operation of MSLO and its Subsidiaries’ businesses as currently conducted and neither
MSLO nor any of its Subsidiaries has received any written notice or claim challenging the ownership, validity or enforceability
of, or asserting the misuse of, any of the Intellectual Property used in the operation of MSLO’s or any of its Subsidiaries’
businesses, nor to the knowledge of MSLO is there a reasonable basis for any such notice or claim.
(d) Except
as would not reasonably be expected to have a MSLO Material Adverse Effect, (i) each of MSLO and its Subsidiaries: (A) has taken
reasonable steps in accordance with standard industry practices to protect its and their rights in the Intellectual Property used
in the operation of MSLO’s and its Subsidiaries’ businesses; and (B) has maintained the confidentiality, secrecy and
value of all Trade Secrets used in the operation of MSLO’s or any of its Subsidiaries’ businesses, and (ii) to the
knowledge of MSLO, no unauthorized disclosure of such Trade Secrets has occurred.
(e) All
material MSLO Registered Intellectual Property is subsisting and, to the knowledge of MSLO, valid and enforceable. Except as would
not reasonably be expected to have a MSLO Material Adverse Effect, neither MSLO nor any of its Subsidiaries has taken any action
or failed to take any action that could reasonably be expected to result in the abandonment, cancellation, forfeiture, relinquishment,
invalidation or unenforceability of any of the MSLO Registered Intellectual Property (including the failure to pay any filing,
examination, issuance, post registration and maintenance fees, or annuities, and the failure to disclose any known material prior
art in connection with the prosecution of patent applications).
(f) Since
January 1, 2013, to the knowledge of MSLO, (i) the development, manufacture, sale, distribution or other commercial exploitation
of products, and the provision of any services, by or on behalf of MSLO or any of its Subsidiaries, and all of the other activities
or operations of MSLO or any of its Subsidiaries, have not infringed upon, misappropriated, violated, diluted or constituted the
unauthorized use of, any Intellectual Property of any Person, and (ii) neither MSLO nor any of its Subsidiaries has received any
notice or claim, including invitations to license, asserting or suggesting that any such infringement, misappropriation, violation,
dilution or unauthorized use is or may be occurring or has or may have occurred, which, in each case, under either (i) or (ii),
if determined or resolved adversely against MSLO or any of its Subsidiaries, would reasonably be expected to have a MSLO Material
Adverse Effect. To the knowledge of MSLO, no Person is misappropriating, infringing, diluting or violating the Intellectual Property
owned by MSLO or any of its Subsidiaries, which infringement would reasonably be expected to have a MSLO Material Adverse Effect.
(g) Section
3.16(g) of the MSLO Disclosure Schedule sets forth a list of all Contracts pursuant to which MSLO or any of its Subsidiaries has
granted any exclusive license with respect to any MSLO Owned IP.
(h) Except
as would not reasonably be expected to have a MSLO Material Adverse Effect, MSLO or its Subsidiaries, as the case may be,
owns or has rights to access and use all electronic data processing, information, record keeping, communications, telecommunications,
account management, inventory management and other computer systems (including all computer programs, software, databases, firmware,
hardware and related documentation) (collectively, “IT Systems”) used to process, store, maintain and operate
data, information and functions used in connection with MSLO’s and its Subsidiaries’ businesses or otherwise necessary
for the conduct of MSLO’s and its Subsidiaries’ businesses, including systems to operate payroll, accounting, billing
and receivables, payables, inventory, asset tracking, customer service and human resources functions. MSLO and its Subsidiaries
have taken reasonable steps in accordance with industry standards to secure the IT Systems from unauthorized access or use by any
Person, and to ensure the continued, uninterrupted and error-free operation of the IT Systems.
(i) The
IT Systems are adequate in all material respects for their intended use and for the operation of MSLO’s and its Subsidiaries’
businesses as currently conducted, and are in good working condition (normal wear and tear excepted), and, to the knowledge of
MSLO, are free of all viruses, worms, Trojan horses and other known contaminants and do not contain any bugs, errors or problems
of a nature that would materially disrupt their operation or have a material adverse impact on the operation of the IT Systems.
There has not been any malfunction with respect to any of the IT Systems since January 1, 2013 that has not been remedied or replaced
in all material respects.
(j) MSLO
is in material compliance with its privacy policies and applicable Laws relating to the use, collection and receipt of personal
information and sensitive non-personally identifiable information.
3.17 MSLO
Material Contracts.
(a) MSLO
has made available to Sequential a true and complete copy of each Contract to which MSLO or any of its Subsidiaries is a party
as of the date of this Agreement or by which MSLO, any of its Subsidiaries or any of its respective properties or assets is bound
as of the date of this Agreement, which: (i) is a “material contract” within the meaning of Item 601(b)(10) of
Regulation S-K promulgated by the SEC; (ii) contains covenants of MSLO or any of its Subsidiaries not to compete or engage
in any line of business or compete with any Person in any geographic area, including any exclusive licensing arrangements with
respect to Intellectual Property; (iii) pursuant to which MSLO or any of its Subsidiaries has entered into a partnership or
joint venture with any other Person (other than MSLO or any of its Subsidiaries); or (iv) relates to or evidences indebtedness
for borrowed money or any guarantee of indebtedness for borrowed money by MSLO or any of its Subsidiaries in excess of $100,000
(each, a “MSLO Material Contract”).
(b) MSLO
has delivered or made available to MSLO true and complete copies of all MSLO Material Contracts, including any amendments thereto.
Each MSLO Material Contract is a legal, valid, binding and enforceable agreement of MSLO or its applicable Subsidiary and, to the
knowledge of MSLO, any other party thereto, and is in full force and effect. None of MSLO or any of its Subsidiaries or, to the
knowledge of MSLO, any other party is in breach or violation of, or (with or without notice or lapse of time or both) default under,
any MSLO Material Contract, nor has MSLO or any of its Subsidiaries received any claim of any such breach, violation or default,
except for such breaches and defaults which would not, individually or in the aggregate, reasonably be expected to have a MSLO
Material Adverse Effect.
3.18 Licensees. Section
3.18 of the MSLO Disclosure Schedule sets forth a true and complete list of the top 10 licensees by revenue of MSLO and the MSLO
Subsidiaries, taken as a whole, for each of (a) calendar year 2014 and (b) the first three months of calendar year 2015. Except
as set forth in Section 3.18 of the MSLO Disclosure Schedule, since the date of the MSLO Balance Sheet, no such licensee has (i)
canceled or otherwise terminated, or, to the knowledge of MSLO, threatened to cancel or otherwise terminate its relationship with
MSLO or the MSLO Subsidiary, (ii) decreased, or to the knowledge of MSLO, threatened to decrease, amounts payable, including royalty
payments, to MSLO or the MSLO Subsidiary, or (iii) increased or decreased, as applicable, or to the knowledge of MSLO, threatened
to increase or decrease, as applicable, pricing terms with respect to amounts payable, including royalty payments, to MSLO or the
MSLO Subsidiaries.
3.19 Affiliate
Transactions.
(a) Since
January 1, 2013, no Related Party of MSLO or any of its Subsidiaries: (i) owns or has owned, directly or indirectly, any equity
or other financial or voting interest in any competitor, supplier, licensor, lessor, distributor, independent contractor or customer
of MSLO or any of its Subsidiaries or their business; (ii) owns or has owned, directly or indirectly, or has or has had any interest
in any property (real or personal, tangible or intangible) that MSLO or any of its Subsidiaries uses or has used in or pertaining
to the business of MSLO or any of its Subsidiaries; (iii) has or has had any business dealings or a financial interest in any transaction
with MSLO or any of its Subsidiaries or involving any assets or property of MSLO or any of its Subsidiaries, other than business
dealings or transactions conducted in the ordinary course of business at prevailing market prices and on prevailing market terms;
or (iv) is or has been employed by MSLO or any of its Subsidiaries.
(b) There
are no Contracts by and between MSLO or any of its Subsidiaries, on the one hand, and any Related Party of MSLO or any its Subsidiaries,
on the other hand, pursuant to which such Related Party provides or receives any information, assets, properties, support or other
services to or from MSLO or any of its Subsidiaries (including Contracts relating to billing, financial, tax, accounting, data
processing, human resources, administration, legal services, information technology and other corporate overhead matters).
(c) There
are no outstanding notes payable to, accounts receivable from or advances by MSLO or any of its Subsidiaries to, and neither MSLO
nor any of its Subsidiaries is otherwise a debtor or creditor of, or has any liability or other obligation of any nature to, any
Related Party of MSLO or any of its Subsidiaries. Since the date of the MSLO Balance Sheet, neither MSLO nor any of its Subsidiaries
has incurred any obligation or liability to, or entered into or agreed to enter into any transaction with or for the benefit of,
any Related Party.
3.20 Insurance.
Section 3.20 of the MSLO Disclosure Schedule sets forth a true and complete list of all casualty, directors and officers
liability, general liability, product liability and all other types of material insurance policies maintained with respect to MSLO
or any of its Subsidiaries, together with the carriers and liability limits for each such policy. All such policies are in full
force and effect and no application therefor included a material misstatement or omission. All premiums with respect thereto have
been paid to the extent due. MSLO has not received notice of, nor to the knowledge of MSLO is there threatened in writing, any
cancellation, termination, reduction of coverage or material premium increases with respect to any such policy. All material insurable
risks in respect of the business and assets of MSLO and its Subsidiaries are covered by such insurance policies and the types and
amounts of coverage provided therein are usual and customary in the context of the business and operations in which MSLO and its
Subsidiaries are engaged. The activities and operations of MSLO and its Subsidiaries have been conducted in a manner so as to conform
in all material respects to all applicable provisions of such insurance policies. The consummation of the transactions contemplated
by this Agreement will not cause a cancellation or reduction in the coverage of such policies.
3.21 Brokers’
and Finders’ Fees. Except for Moelis & Company, the fees and expenses of which will be paid by MSLO, there
is no investment banker, broker, finder or other intermediary that has been retained by or is authorized to act on behalf of MSLO
or any of the MSLO Subsidiaries who is entitled to any fee or commission from MSLO or any of the MSLO Subsidiaries in connection
with the transactions to which MSLO is a party contemplated hereby. MSLO has furnished to Sequential a true and complete copy of
any Contract between MSLO and Moelis & Company pursuant to which Moelis & Company could be entitled to any payment from
MSLO relating to the transactions contemplated hereby.
3.22 No
Other Representations or Warranties. Except for the representations and warranties contained in this ARTICLE III,
neither MSLO nor any other Person makes any other express or implied representation or warranty on behalf of MSLO or any of its
Affiliates.
ARTICLE
IV
REPRESENTATIONS AND WARRANTIES OF SEQUENTIAL
Except as (x) disclosed in the Sequential
SEC Documents filed with or furnished to the SEC (excluding disclosure contained in the “risk factors” section or constituting
“forward-looking statements,” in each case, to the extent such disclosure is cautionary, predictive or speculative
in nature) or (y) set forth in the disclosure letter delivered by Sequential to MSLO on or prior to the date of this Agreement
(the “Sequential Disclosure Schedule”), Sequential represents and warrants to MSLO as set forth in this ARTICLE
IV. For purposes of the representations and warranties of Sequential contained herein, disclosure in any section of the Sequential
Disclosure Schedule of any facts or circumstances shall be deemed to be disclosure of such facts or circumstances with respect
to all representations or warranties by Sequential to which the relevance of such disclosure to the applicable representation and
warranty is readily apparent on the face thereof. The inclusion of any information in the Sequential Disclosure Schedule or other
document delivered by Sequential pursuant to this Agreement shall not be deemed to be an admission or evidence of the materiality
of such item, nor shall it establish a standard of materiality for any purpose whatsoever.
4.1 Corporate
Organization.
(a) Each
of Sequential and its Subsidiaries (i) is an entity, duly organized, validly existing and in good standing under the Laws of the
jurisdiction of its organization, (ii) has all requisite corporate or similar power and authority to own, lease and operate
its properties and to carry on its business as now being conducted and (iii) is duly qualified or licensed to do business and is
in good standing in each jurisdiction in which the nature of its business or the ownership, leasing or operation of its properties
makes such qualification or licensing necessary, except in the case of clause (iii) as, individually or in the aggregate, has not
had and would not reasonably be expected to have a Sequential Material Adverse Effect.
(b) True
and complete copies of the certificate of incorporation of Sequential, as amended through, and as in effect as of, the date of
this Agreement and the bylaws, as in effect as of, the date of this Agreement and the certificate of incorporation and bylaws (or
comparable organizational documents of each of its Subsidiaries, in each case as amended to the date of this Agreement) have previously
been made available to MSLO.
4.2 Capitalization.
(a) Authorized
and Issued Shares.
(i) As
of the date of this Agreement, the authorized capital stock of Sequential consists solely of 150,000,000 shares of Sequential Common
Stock and 10,000,000 shares of preferred stock, par value $0.001 per share, of Sequential (the “Sequential Preferred Stock”).
As of the Measurement Date, (i) 39,448,320 shares of Sequential Common Stock and no shares of Sequential Preferred Stock were
issued and outstanding, (ii) 267,200 shares of Sequential Common Stock were held in treasury, (iii) 354,766 shares of Sequential
Common Stock were subject to outstanding Sequential Stock Options with a weighted average exercise price of $5.213 (of which Sequential
Stock Options to purchase an aggregate of 311,766 shares of Sequential Common Stock were exercisable with a weighted average exercise
price of $4.391), (iv) 1,314,499 shares of Sequential Common Stock were subject to outstanding Sequential RSU Awards, (v) 524,335
shares of Sequential Common Stock were subject to Sequential Restricted Stock Awards and (vi) 630,160 shares of Sequential
Common Stock were subject to outstanding Sequential Warrants.
(ii) Except
as described in Section 4.2(a)(i), and except for changes since the close of business on the Measurement Date resulting
from the exercise of Sequential Equity Awards, there is no, and neither Sequential nor any of its Subsidiaries has issued or agreed
to issue any: (a) share of capital stock or other equity or ownership interest; (b) option, warrant or interest convertible
into or exchangeable or exercisable for the purchase of shares of capital stock or other equity or ownership interests; (c) stock
appreciation right, phantom stock, interest in the ownership or earnings of Sequential or any of its Subsidiaries or other equity
equivalent or equity-based award or right; or (d) bond, debenture or other indebtedness having the right to vote or convertible
or exchangeable for securities having the right to vote. Each outstanding share of capital stock or other equity or ownership interest
of Sequential and each of the Sequential Subsidiaries is duly authorized, validly issued, fully paid and nonassessable, and in
the case of its Subsidiaries, each such share or other equity or ownership interest is owned by Sequential or another Subsidiary
of Sequential, free and clear of any Lien. All of the aforesaid shares or other equity or ownership interests have been offered,
sold and delivered by Sequential or a Sequential Subsidiary in compliance with all applicable federal and state securities Laws.
Except for rights granted to MSLO and TopCo under this Agreement, there are no outstanding obligations of Sequential or any Sequential
Subsidiary to issue, sell or transfer or repurchase, redeem or otherwise acquire, or that relate to the holding, voting or disposition
of, or that restrict the transfer of, the issued or unissued capital stock or other equity or ownership interests of Sequential
or any of its Subsidiaries. No shares of capital stock or other equity or ownership interests of Sequential or any of the Sequential
Subsidiaries are subject to or have been issued in violation of any rights, agreements, arrangements or commitments under any provision
of applicable Law, the certificate of incorporation or bylaws or equivalent organizational documents of Sequential or any of the
Sequential Subsidiaries or any Contract to which Sequential or any of the Sequential Subsidiaries is a party or by which Sequential
or any of the Sequential Subsidiaries is bound. There are no declared or accrued but unpaid dividends with respect to any shares
of Sequential Common Stock.
(b) Except
as set forth in Section 4.2(b) of the Sequential Disclosure Schedule, there are no agreements to which Sequential or any of its
Subsidiaries is a party, or to which any shares of Sequential Common Stock are subject, relating to the voting of shares of Sequential
Common Stock or otherwise granting, limiting or affecting the rights pertaining to shares of Sequential Common Stock.
(c) Section
4.2(c) of the Sequential Disclosure Schedule sets forth a true and complete list of each Sequential Subsidiary, including its jurisdiction
of organization. All of the issued and outstanding shares of capital stock or other equity ownership interests of each “significant
subsidiary” (as such term is defined under Regulation S-X promulgated by the SEC) of Sequential are owned by Sequential,
directly or indirectly, free and clear of any material Liens other than Permitted Liens, and free of any restriction on the right
to vote, sell or otherwise dispose of such capital stock or other equity ownership interest (other than restrictions under applicable
securities Laws), and all of such shares or equity ownership interests are duly authorized and validly issued and are fully paid,
nonassessable and free of preemptive rights. Except for the capital stock or other equity ownership interests of the Sequential
Subsidiaries, as of the date of this Agreement, Sequential does not beneficially own, directly or indirectly, any capital stock,
membership interest, partnership interest, joint venture interest or other equity interest in any Person.
4.3 Corporate
Authorization. Sequential has full corporate power and authority to execute and deliver this Agreement, to perform its
obligations hereunder and to consummate the transactions contemplated hereby subject to obtaining the Sequential Stockholder Approval.
The execution, delivery and performance by Sequential of this Agreement and the consummation by Sequential of the transactions
to which it is a party contemplated hereby have been duly and validly authorized and approved by the board of directors of Sequential
(the “Sequential Board”). The Sequential Board has, by resolutions duly adopted, unanimously (i) determined
that this Agreement and the transactions contemplated hereby, including the Sequential Merger, are fair to, and in the best interests
of Sequential and its stockholders, (ii) approved and adopted this Agreement, including the Sequential Merger, (iii) approved
and declared advisable the execution, delivery and performance by Sequential of this Agreement and the consummation of the transactions
contemplated hereby, and (iv) recommended approval by the stockholders of Sequential of the transactions contemplated by this
Agreement. Except for the approval by the written consent of the holders of a majority of the outstanding shares of Sequential
Common Stock (the “Sequential Stockholder Approval”), which approval is subject to Section 6.5, no other
corporate proceedings on the part of Sequential or any other vote by the holders of any class or series of capital stock of Sequential
are necessary to approve or adopt this Agreement or to consummate the transactions contemplated hereby. This Agreement has been
duly executed and delivered by Sequential and, assuming due execution and delivery by each of the other parties hereto, this Agreement
constitutes the legal, valid and binding obligation of Sequential, enforceable against Sequential in accordance with its terms,
except as enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting
creditors’ rights generally and by general principles of equity (regardless of whether considered in a proceeding in equity
or at law).
4.4 Governmental
Authorization. The execution, delivery and performance by Sequential of this Agreement and the consummation by Sequential
of the transactions contemplated hereby require at or prior to the Closing no consent or approval by, or filing with, or notification
to any Governmental Entity, other than (a) the filing of the MSLO Certificate of Merger and the Sequential Certificate of
Merger with the Secretary of State of the State of Delaware, (b) compliance with any applicable requirements of the HSR Act,
(c) compliance with any applicable requirements of the Securities Act, the Exchange Act, any other applicable U.S. federal
or state securities Laws or “blue sky” Laws, including the filing with the SEC and effectiveness of the Form S-4 including
(x) the Proxy Statement/Prospectus and (y) the Information Statement, (d) compliance with any applicable requirements of Nasdaq,
(e) those consents, approvals or filings set forth in Section 3.4, and (f) any other consents, approvals or filings
the failure of which to be obtained or made would not, individually or in the aggregate, reasonably be expected to have a Sequential
Material Adverse Effect or prevent or materially delay the consummation of the transactions contemplated by this Agreement.
4.5 Non-Contravention.
The execution, delivery and performance by Sequential of this Agreement do not, and the consummation of the transactions
contemplated hereby will not, (a) violate or conflict with or result in any breach of any provision of Sequential’s
certificate of incorporation, bylaws or comparable organizational documents of Sequential or any of its Subsidiaries; (b) assuming
receipt of the Sequential Stockholder Approval and compliance with the matters referred to in Section 3.4 and Section 4.4,
violate or conflict with any provision of any applicable Law; (c) violate or conflict with or result in any breach or constitute
a default, or an event that, with or without notice or lapse of time or both, would constitute a default under, or cause the termination,
cancellation, acceleration or other change of any right or obligation or the loss of any benefit to which Sequential or any of
its Subsidiaries is entitled, or require consent by any Person under, any loan or credit agreement, note, mortgage, indenture,
lease, Sequential Benefit Plan, or Sequential Material Contract; or (d) result in the creation or imposition of any Lien (other
than Permitted Liens) on any asset of Sequential or any of its Subsidiaries, except in the case of clauses (b), (c) and (d), as
would not, individually or in the aggregate, reasonably be expected to have a Sequential Material Adverse Effect or prevent or
materially delay the consummation of the transactions contemplated by this Agreement.
4.6 Sequential
SEC Filings.
(a) Sequential
has timely filed all reports, schedules, forms, registration statements and other documents required to be filed by Sequential
with the SEC since December 31, 2012 (together with any documents furnished during such period by Sequential to the SEC on a voluntary
basis on Current Reports on Form 8-K and any reports, schedules, forms, registration statements and other documents filed
with the SEC subsequent to the date hereof, collectively, the “Sequential SEC Documents”). As of their respective
filing dates (or, if amended or superseded by a filing prior to the date of this Agreement, then on the date of such filing), the
Sequential SEC Documents complied or, if not yet filed, will comply, in all material respects with the applicable requirements
of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act, as the case may be, including, in each case, the rules and
regulations promulgated thereunder, and none of the Sequential SEC Documents contained or, if not yet filed, will contain, any
untrue statement of a material fact or omitted or, if not yet filed, will omit a material fact required to be stated therein or
necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
(b) The
financial statements (including the related notes and schedules thereto) included (or incorporated by reference) in the Sequential
SEC Documents (i) have been prepared or, if not yet filed, will be prepared, in a manner consistent with the books and records
of Sequential and its Subsidiaries, (ii) have been prepared or, if not yet filed, will be prepared, in accordance with GAAP
(except, in the case of unaudited statements, as permitted by Form 10-Q of the SEC) applied on a consistent basis during the periods
involved (except as may be indicated in the notes thereto), (iii) comply or, if not yet filed, will comply, as to form in all material
respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto and (iv)
fairly present or, if not yet filed, will fairly present, in all material respects the consolidated financial position of Sequential
and its Subsidiaries as of the dates thereof and their respective consolidated results of operations and cash flows for the periods
then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments that were not, or are not expected
to be, material in amount), all in accordance with GAAP and the applicable rules and regulations promulgated by the SEC. Since
January 1, 2014, Sequential has not made any change in the accounting practices or policies applied in the preparation of its financial
statements, except as required by GAAP, SEC rule or policy or applicable Law. The books and records of Sequential and its Subsidiaries
have been, and are being, maintained in all material respects in accordance with GAAP (to the extent applicable) and any other
applicable legal and accounting requirements and reflect only actual transactions.
(c) Sequential
has established and maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange
Act). Such disclosure controls and procedures are designed to ensure that information relating to Sequential, including its consolidated
Subsidiaries, required to be disclosed in Sequential’s periodic and current reports under the Exchange Act, is made known
to Sequential’s chief executive officer and its chief financial officer by others within those entities to allow timely decisions
regarding required disclosures as required under the Exchange Act. The chief executive officer and chief financial officer of Sequential
have evaluated the effectiveness of Sequential’s disclosure controls and procedures and, to the extent required by applicable
Law, presented in any applicable Sequential SEC Document that is a report on Form 10-K or Form 10-Q, or any amendment thereto,
its conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by such report
or amendment based on such evaluation.
(d) Sequential
and its Subsidiaries have established and maintain a system of internal control over financial reporting (as defined in Rules 13a-15(f)
and 15d-15(f) under the Exchange Act) which is effective in providing reasonable assurance regarding the reliability of Sequential’s
financial reporting and the preparation of Sequential’s financial statements for external purposes in accordance with GAAP.
Sequential has disclosed, based on its most recent evaluation of Sequential’s internal control over financial reporting prior
to the date hereof, to Sequential’s auditors and audit committee (i) any significant deficiencies and material weaknesses
in the design or operation of Sequential’s internal control over financial reporting which are reasonably likely to adversely
affect Sequential’s ability to record, process, summarize and report financial information and (ii) any fraud, whether or
not material, that involves management or other employees who have a significant role in Sequential’s internal control over
financial reporting. A true, correct and complete summary of any such disclosures made by management to Sequential’s auditors
and audit committee is set forth as Section 4.6(d) of the Sequential Disclosure Schedule.
(e) Since
December 31, 2012, (i) neither Sequential nor any of its Subsidiaries nor, to the knowledge of Sequential, any director, officer,
employee, auditor, accountant or representative of Sequential or any of its Subsidiaries has received or otherwise had or obtained
knowledge of any material complaint, allegation, assertion or claim, whether written or oral, regarding the accounting or auditing
practices, procedures, methodologies or methods of Sequential or any of its Subsidiaries or their respective internal accounting
controls, including any material complaint, allegation, assertion or claim that Sequential or any of its Subsidiaries has engaged
in questionable accounting or auditing practices and (ii) no attorney representing Sequential or any of its Subsidiaries, whether
or not employed by Sequential or any of its Subsidiaries, has reported evidence of a material violation of securities Laws, breach
of fiduciary duty or similar violation by Sequential or any of its Subsidiaries or any of their respective officers, directors,
employees or agents to the Sequential Board or any committee thereof or to any director or officer of Sequential or any of its
Subsidiaries.
(f) Sequential
has made available to MSLO true, correct and complete copies of all written correspondence between the SEC, on the one hand, and
Sequential and any of its Subsidiaries, on the other hand, occurring since December 31, 2012.
(g) Neither
Sequential nor any of its Subsidiaries is a party to, or has any commitment to become a party to, any joint venture, off balance
sheet partnership or any similar Contract (including any Contract or arrangement relating to any transaction or relationship between
or among Sequential and any of its Subsidiaries, on the one hand, and any unconsolidated Affiliate, including any structured finance,
special purpose or limited purpose entity or Person, on the other hand, or any “off balance sheet arrangements” (as
defined in Item 303(a) of Regulation S-K under the Exchange Act)), where the result, purpose or intended effect of such Contract
is to avoid disclosure of any material transaction involving, or material liabilities of, Sequential or any of its Subsidiaries
in Sequential’s or such Subsidiary’s published financial statements or other Sequential SEC Documents.
(h) Sequential
is in compliance in all material respects with (i) the provisions of the Sarbanes-Oxley Act and (ii) the rules and regulations
of Nasdaq, in each case, that are applicable to Sequential.
(i) No
Subsidiary of Sequential is required to file any form, report, schedule, statement or other document with the SEC.
(j) Except
as and to the extent adequately accrued or reserved against in the audited consolidated balance sheet of Sequential and its Subsidiaries
as at December 31, 2014 (such balance sheet, the “Sequential Balance Sheet”), neither Sequential nor any of
its Subsidiaries has any liability or obligation of any nature, whether accrued, absolute, contingent or otherwise, whether known
or unknown and whether or not required by GAAP to be reflected in a consolidated balance sheet of Sequential and its Subsidiaries
or disclosed in the notes thereto, except for liabilities and obligations, incurred in the ordinary course of business consistent
with past practice since the date of the Sequential Balance Sheet, that would not, individually or in the aggregate, reasonably
be expected to have a Sequential Material Adverse Effect .
4.7 Form S-4.
The information supplied or to be supplied by Sequential for inclusion in the Form S-4, including the related Proxy
Statement/Prospectus and Information Statement, will not, at the time that the Form S-4 is declared effective by the SEC,
contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances under which they were made, not misleading, except that no
representation or warranty is made by Sequential with respect to statements made therein based on information supplied by or on
behalf of MSLO or any of its Affiliates specifically for inclusion or incorporation by reference in the Form S-4. The Proxy
Statement/Prospectus will not, at the date the Proxy Statement/Prospectus is first mailed to the stockholders of MSLO, contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order
to make the statements therein, in light of the circumstances under which they were made, not misleading, except that, in each
case, no representation or warranty is made by Sequential with respect to statements made therein based on information supplied
by or on behalf of MSLO specifically for inclusion or incorporation by reference in the Proxy Statement/Prospectus. The Information
Statement will not, at the date the Information Statement is first mailed to the stockholders of Sequential, contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made, not misleading, except that, in each case, no representation
or warranty is made by Sequential with respect to statements made therein based on information supplied by or on behalf of MSLO
or any of its Affiliates specifically for inclusion or incorporation by reference in the Information Statement.
4.8 Absence
of Certain Changes or Events.
(a) Since
the date of the Sequential Balance Sheet and through the date of this Agreement, no event or events or development or developments
have occurred that have had or would reasonably be expected to have, individually or in the aggregate, a Sequential Material Adverse
Effect.
(b) Except
in connection with the execution and delivery of this Agreement and the transactions contemplated by this Agreement, from December
31, 2014 through the date of this Agreement, Sequential and the Sequential Subsidiaries have carried on their respective businesses
in all material respects in the ordinary course of business consistent with past practice.
4.9 Compliance
with Laws; Permits.
(a) Since
December 31, 2012, (i) each of Sequential and its Subsidiaries is and has been in compliance in all material respects with all
Laws applicable to it and (ii) Sequential has complied with the applicable listing and corporate governance rules and regulations
of Nasdaq except, in each case, where the failure to so conduct such business and operations or comply with such rules and regulations
would not, individually or in the aggregate, reasonably be expected to have a Sequential Material Adverse Effect. Since December
31, 2012, none of Sequential, any of the Sequential Subsidiaries or any of its or their executive officers has received, nor is
there any basis for, any written notice, order, complaint or other communication from any Governmental Entity or any other Person
that Sequential or any of its Subsidiaries is not in compliance in any material respect with any Law applicable to it.
(b) Section
4.9(b) of the Sequential Disclosure Schedule sets forth a true and complete list of all material Permits. Each of Sequential and
its Subsidiaries is and has been in compliance in all material respects with all such material Permits. No suspension, cancellation,
modification, revocation or nonrenewal of any material Permit is pending or, to the knowledge of Sequential, threatened in writing.
Sequential and its Subsidiaries will continue to have the use and benefit of all material Permits following consummation of the
transactions contemplated hereby. No material Permit is held in the name of any employee, officer, director, stockholder, agent
or otherwise on behalf of Sequential or any of its Subsidiaries.
4.10 Litigation.
As of the date hereof, there is no action pending or, to the knowledge of Sequential, threatened by or against Sequential,
any of the Sequential Subsidiaries, any of their respective properties or assets, or any officer or director of Sequential or any
of its Subsidiaries that, individually or in the aggregate, would reasonably be expected to have a Sequential Material Adverse
Effect. As of the date hereof, none of Sequential or any of its Subsidiaries, or any of their respective properties or assets is
subject to any outstanding Order of any Governmental Entity that, individually or in the aggregate, has had or would reasonably
be expected to have a Sequential Material Adverse Effect.
4.11 Title
to Properties; Absence of Liens. Section 4.11 of the Sequential Disclosure Schedule sets forth a true and complete description
(including address, and for each lease, sublease and license, and all amendments, extensions, renewals, guaranties, modifications,
supplements or other agreements, if any, with respect thereto) of all real property leased, subleased or licensed by Sequential
or any of its Subsidiaries (collectively, the “Sequential Leased Real Properties”; and the leases, subleases
and licenses with respect thereto, collectively, the “Sequential Real Property Leases”). Sequential has made
available to MSLO true, correct and complete copies of the Sequential Real Property Leases, together with all amendments, extensions,
renewals, guaranties, modifications, supplements or other agreements, if any, with respect thereto. Each of the Sequential Real
Property Leases is in full force and effect. Sequential or one of its Subsidiaries has a valid, binding and enforceable leasehold
or subleasehold interest (or license, as applicable) in each Sequential Leased Real Property, in each case as to such leasehold
or subleasehold interest (or license, as applicable), free and clear of all Liens (other than Permitted Liens). Neither Sequential
nor any of its Subsidiaries owns, or has owned in the past 10 years, any real property or any interests in real property.
4.12 Taxes.
(a) All
material Tax Returns required by applicable Law to be filed with any Governmental Entity by, or on behalf of, Sequential or any
of its Subsidiaries have been duly filed when due (including extensions) in accordance with all applicable Laws, and all such Tax
Returns are true, correct and complete in all material respects.
(b) Sequential
and each of its Subsidiaries has duly and timely paid or has duly and timely withheld and remitted to the appropriate Governmental
Entity all material Taxes due and payable, or, where payment is not yet due, has established in accordance with GAAP an adequate
accrual for all material Taxes on the financial statements set forth in the Sequential SEC Documents.
(c) There
is no claim, audit, action, suit, proceeding or investigation pending or threatened in writing against or with respect to Sequential
or any of its Subsidiaries in respect of any Tax or Tax Return which if determined adversely would, individually or in the aggregate,
be expected to result in a material Tax deficiency. Neither Sequential nor any of its Subsidiaries has received or applied for
a Tax ruling that would be binding on Sequential or any of its Subsidiaries after the Closing Date.
(d) Sequential
and each of its Subsidiaries has withheld all material amounts required to have been withheld by it in connection with amounts
paid or owed to any employee, independent contractor, creditor, stockholder or any other third party; such withheld amounts were
either duly paid to the appropriate Governmental Entity or set aside in accounts for such purpose in accordance with applicable
Law. Sequential and each of its Subsidiaries has reported such withheld amounts to the appropriate Governmental Entity and to each
such employee, independent contractor, creditor, stockholder or any other third party, as required under applicable Law.
(e) Neither
Sequential nor any of its Subsidiaries is liable for any Taxes of any Person (other than Sequential and its Subsidiaries) as a
result of (i) being a transferee or successor of such Person, (ii) the application of Treasury Regulation Section 1.1502-6 or any
similar provision of state, local or foreign law or (iii) a party to a tax sharing, tax indemnity or tax allocation agreement or
any similar agreement to indemnify such Person.
(f) Neither
Sequential nor any of its Subsidiaries shall be required to include any item of income in, or exclude any item of deduction from,
taxable income for any period (or portion thereof) ending after the Closing Date, as a result of (1) any elective change in method
of accounting for a taxable period ending on or prior to the Closing Date under Section 481 of the Code (or any corresponding provision
of state, local or foreign Law), (2) “closing agreement” as described in Section 7121 of the Code (or any corresponding
or similar provision of state, local or foreign Tax Law) executed on or prior to the Closing Date, (3) intercompany transaction
or excess loss account described in Treasury Regulations under Section 1502 of the Code (or any corresponding or similar provision
of state, local or foreign Tax Law), (4) installment sale or open transaction made on or prior to the Closing Date, or (5) prepaid
amount received on or prior to the Closing Date.
(g) Neither
Sequential nor any of its Subsidiaries has participated or engaged in any “listed transaction” within the meaning of
Treasury Regulations Section 1.6011-4.
(h) Neither
Sequential nor any of its Subsidiaries has been informed in writing by any Governmental Entity in any jurisdiction in which it
does not file a Tax Return that it may be required to file a Tax Return in such jurisdiction.
(i) Neither
Sequential nor any of its Subsidiaries has distributed stock of another corporation, or has had its stock distributed by another
corporation, in a transaction that was governed, or purported or intended to be governed or described, in whole or in part, by
Section 355 or Section 368(a)(1)(D) of the Code.
(j) Neither
Sequential nor any of its Subsidiaries has taken or agreed to take any action or is aware of any fact or circumstance that would
prevent or impede, or could reasonably be expected to prevent or impede, the Mergers from qualifying as a transaction described
in Section 351 of the Code.
4.13 Employee
Benefit Plans.
(a) Section
4.13(a) of the Sequential Disclosure Schedule sets forth as of the date of this Agreement a true and complete list of each material
“employee benefit plan” (within the meaning of Section 3(3) of ERISA), and all material stock purchase, stock
option, severance, employment, change-in-control, fringe benefit, bonus, incentive, deferred compensation and all other material
employee benefit plans, agreements, programs, policies or other arrangements, whether or not subject to ERISA (including any funding
mechanism therefor now in effect or required in the future as a result of the transactions contemplated by this Agreement or otherwise),
whether formal or informal, written, legally binding or not, under which any employee or former employee of Sequential or its Subsidiaries
has any present or future right to benefits or Sequential or its Subsidiaries has direct or contingent liability (each, a “Sequential
Benefit Plan”). With respect to each such Sequential Benefit Plan, Sequential has made available to MSLO a true and complete
copy of such Sequential Benefit Plan, if written, or a description of the material terms of such Sequential Benefit Plan if not
written, and to the extent applicable: (i) all trust agreements, insurance contracts or other funding arrangements; (ii) the
most recent actuarial and trust reports for both ERISA funding and financial statement purposes; (iii) the most recent Form 5500
with all attachments required to have been filed with the IRS or the Department of Labor or any similar reports filed with any
comparable Governmental Entity in any non-U.S. jurisdiction having jurisdiction over any Sequential Benefit Plan and all schedules
thereto; (iv) the most recent IRS determination or opinion letter; and (v) all current summary plan descriptions.
(b) Each
Sequential Benefit Plan has been maintained in all material respects in accordance with its terms and the requirements of applicable
Law. Each of Sequential and its Subsidiaries has performed all material obligations required to be performed by it under any Sequential
Benefit Plan and, to the knowledge of Sequential, is not in any material respect in default under or in violation of any Sequential
Benefit Plan. No action (other than claims for benefits in the ordinary course) is pending or, to the knowledge of Sequential,
threatened with respect to any Sequential Benefit Plan.
(c) Each
Sequential Benefit Plan that is intended to be qualified under Section 401(a) of the Code has received a determination or
opinion letter from the IRS that it is so qualified and each related trust that is intended to be exempt from federal income taxation
under Section 501(a) of the Code has received a determination or opinion letter from the IRS that it is so exempt and, to
the knowledge of Sequential, no fact or event has occurred since the date of such letter or letters from the IRS that could reasonably
be expected to adversely affect the qualified status of any such Sequential Benefit Plan or the exempt status of any such trust.
(d) No
Sequential Benefit Plan is subject to Title IV of ERISA, is a multiemployer plan (within the meaning of Section 3(37) of ERISA)
or provides post-employment welfare benefits except to the extent required by Section 4980B of the Code.
(e) Any
arrangement of Sequential or any of its Subsidiaries that is subject to Section 409A of the Code has complied in form and
operation with the requirements of Section 409A of the Code as in effect from time to time. Neither Sequential nor any of its Subsidiaries
has any obligation to provide any gross-up payment to any individual with respect to any income Tax, additional Tax, excise Tax
or interest charge imposed pursuant to Section 409A or 4999 of the Code.
(f) Except
as set forth in Section 4.13(f) of the Sequential Disclosure Schedule, the consummation of the transactions contemplated hereby
will not, either alone or in combination with another event; (i) entitle any current or former director, officer or employee
of Sequential or of any of its Subsidiaries to severance pay, unemployment compensation or any other payment; (ii) result
in any payment becoming due, accelerate the time of payment or vesting, or increase the amount of compensation due to any such
director, officer or employee; (iii) result in any forgiveness of indebtedness, trigger any funding obligation under any Sequential
Benefit Plan or impose any restrictions or limitations on Sequential rights to administer, amend or terminate any Sequential Benefit
Plan; or (iv) result in any payment (whether in cash or property or the vesting of property) to any “disqualified individual”
(as such term is defined in Treasury Regulations Section 1.280G-1) that could reasonably be expected, individually or in combination
with any other such payment, to constitute an “excess parachute payment” (as defined in Section 280G(b)(1) of the Code).
4.14 Employees,
Labor Matters.
(a) Neither
Sequential nor any of its Subsidiaries is a party to or bound by any collective bargaining agreement, and there are no, and during
the last three years have been no, labor unions or other organizations representing, purporting to represent or, to the knowledge
of Sequential, attempting to represent any employees of Sequential or any of its Subsidiaries.
(b) Since
January 1, 2011, there has not occurred or, to the knowledge of Sequential, been threatened any strike, slowdown, work stoppage,
concerted refusal to work overtime or other similar labor activity or union organizing campaign with respect to any employees of
Sequential or any of its Subsidiaries. There are no labor disputes subject to any formal grievance procedure, arbitration or litigation
and there is no representation petition pending or, to the knowledge of Sequential, threatened with respect to any employee of
Sequential or any of its Subsidiaries.
(c) Sequential
and its Subsidiaries have complied in all material respects with all applicable Laws relating to employment of labor, including
all applicable Laws relating to wages, hours, collective bargaining, employment discrimination, civil rights, safety and health,
workers’ compensation, pay equity, classification of employees, immigration, and the collection and payment of withholding
and/or social security Taxes.
4.15 Environmental
Matters. Except as would not, individually or in the aggregate, have a Sequential Material Adverse Effect: (i) Sequential
and each of its Subsidiaries are in compliance with all applicable Environmental Laws, and possess and are in compliance with all
applicable Environmental Permits necessary to operate the business as presently operated; (ii) to the knowledge of Sequential,
there have been no releases of Hazardous Materials at or on any property owned or operated by Sequential or any of its Subsidiaries,
except under circumstances that are not reasonably likely to result in liability of Sequential or any of its Subsidiaries under
any applicable Environmental Law; (iii) neither Sequential nor any of its Subsidiaries has received from a Governmental Entity
a request for information pursuant to Section 104(e) of the Comprehensive Environmental Response, Compensation and Liability Act
of 1980 or similar state statute, or any written notification alleging that it is liable for any release or threatened release
of Hazardous Materials at any location, except with respect to any such notification or request for information concerning any
such release or threatened release, to the extent such matter has been resolved with the appropriate foreign, federal, state or
local regulatory authority or otherwise; and (iv) neither Sequential nor any of its Subsidiaries has received any written
claim or complaint, or is presently subject to any lawsuit, proceeding or action, relating to noncompliance with Environmental
Laws or any other liabilities pursuant to Environmental Laws, and to the knowledge of Sequential, no such matter has been threatened
in writing.
4.16 Intellectual
Property.
(a) Section 4.16
of the Sequential Disclosure Schedule sets forth a true and complete list of all Registered Intellectual Property (each identified
as a Mark, Patent, Copyright or domain name) owned (in whole or in part) by Sequential or any of its Subsidiaries as of the date
of this Agreement, identifying for each whether it is owned by Sequential or the relevant Subsidiary (together with all Trade Secrets
owned by Sequential or any of its Subsidiaries, collectively, the “Sequential Owned IP”).
(b) Since
January 1, 2013, no Sequential Owned IP has been or is now involved in any opposition, cancellation, reissue, reexamination, inter-partes
review, public protest, interference, arbitration, mediation, domain name dispute resolution or other proceeding and, to the knowledge
of Sequential, no such proceeding is or has been threatened or asserted with respect to any Sequential Owned IP, which, in each
case, if determined or resolved adversely against Sequential or any of its Subsidiaries, would reasonably be expected to have a
Sequential Material Adverse Effect.
(c) Sequential
or its Subsidiaries own or otherwise have a valid right to use, free and clear of any and all Liens (other than Permitted Liens),
all Intellectual Property used in the operation of Sequential and its Subsidiaries’ businesses as currently conducted and
neither Sequential nor any of its Subsidiaries has received any written notice or claim challenging the ownership, validity or
enforceability of, or asserting the misuse of, any of the Intellectual Property used in the operation of Sequential’s or
any of its Subsidiaries’ businesses, nor to the knowledge of Sequential is there a reasonable basis for any such notice or
claim.
(d) Except
as would not reasonably be expected to have a Sequential Material Adverse Effect, (i) each of Sequential and its Subsidiaries:
(A) has taken reasonable steps in accordance with standard industry practices to protect its and their rights in the Intellectual
Property used in the operation of Sequential’s and its Subsidiaries’ businesses; and (B) has maintained the confidentiality,
secrecy and value of all Trade Secrets used in the operation of Sequential or any of its Subsidiaries’ businesses and (ii)
to the knowledge of Sequential, no unauthorized disclosure of such Trade Secrets has occurred.
(e) All
Sequential Registered Intellectual Property is subsisting and, to the knowledge of Sequential, valid and enforceable. Except as
would not reasonably be expected to have a Sequential Material Adverse Effect, neither Sequential nor any of its Subsidiaries
has taken any action or failed to take any action that could reasonably be expected to result in the abandonment, cancellation,
forfeiture, relinquishment, invalidation or unenforceability of any of the Sequential Registered Intellectual Property (including
the failure to pay any filing, examination, issuance, post registration and maintenance fees, or annuities, and the failure to
disclose any known material prior art in connection with the prosecution of patent applications).
(f) Since
January 1, 2013, (i) the development, manufacture, sale, distribution or other commercial exploitation of products, and the provision
of any services, by or on behalf of Sequential or any of its Subsidiaries, and all of the other activities or operations of Sequential
or any of its Subsidiaries, have not infringed upon, misappropriated, violated, diluted or constituted the unauthorized use of,
any Intellectual Property of any Person, and (ii) neither Sequential nor any of its Subsidiaries has received any notice or claim,
including invitations to license, asserting or suggesting that any such infringement, misappropriation, violation, dilution or
unauthorized use is or may be occurring or has or may have occurred, which, in each case under either (i) or (ii), if determined
or resolved adversely against Sequential or any of its Subsidiaries, would reasonably be expected to have a Sequential Material
Adverse Effect. To the knowledge of Sequential, no Person is misappropriating, infringing, diluting or violating the Intellectual
Property owned by Sequential or any of its Subsidiaries, which infringement would reasonably be expected to have a Sequential
Material Adverse Effect.
(g) Except
as would not reasonably be expected to have a Sequential Material Adverse Effect, Sequential or its Subsidiaries, as the
case may be, owns or has rights to access and use IT Systems used to process, store, maintain and operate data, information and
functions used in connection with Sequential’s and its Subsidiaries’ businesses or otherwise necessary for the conduct
of Sequential’s and its Subsidiaries’ businesses, including systems to operate payroll, accounting, billing and receivables,
payables, inventory, asset tracking, customer service and human resources functions. Sequential and its Subsidiaries have taken
reasonable steps in accordance with industry standards to secure the IT Systems from unauthorized access or use by any Person,
and to ensure the continued, uninterrupted and error-free operation of the IT Systems.
(h) The
IT Systems (i) are adequate in all material respects for their intended use and for the operation of Sequential’s and its
Subsidiaries’ businesses as currently conducted, (ii) are in good working condition (normal wear and tear excepted), (iii)
are free of all viruses, worms, Trojan horses and other known contaminants and (iv) do not contain any bugs, errors or problems
of a nature that would materially disrupt their operation or have a material adverse impact on the operation of the IT Systems.
There has not been any malfunction with respect to any of the IT Systems since January 1, 2013 that has not been remedied or replaced
in all material respects.
(i) Sequential
is in material compliance with its privacy policies and applicable Laws relating to the use, collection and receipt of personal
information and sensitive non-personally identifiable information.
4.17 Sequential
Material Contracts.
(a) Sequential
has made available to MSLO a true and complete copy of each Contract to which Sequential or any of its Subsidiaries is a party
as of the date of this Agreement or by which Sequential, any of its Subsidiaries or any of its respective properties or assets
is bound as of the date of this Agreement, which: (i) is a “material contract” within the meaning of Item 601(b)(10)
of Regulation S-K promulgated by the SEC; (ii) contains covenants of Sequential or any of its Subsidiaries not to compete
or engage in any line of business or compete with any Person in any geographic area; (iii) pursuant to which Sequential or
any of its Subsidiaries has entered into a partnership or joint venture with any other Person (other than Sequential or any of
its Subsidiaries); or (iv) relates to or evidences indebtedness for borrowed money or any guarantee of indebtedness for borrowed
money by Sequential or any of its Subsidiaries in excess of $1,000,000 (each, a “Sequential Material Contract”).
(b) Sequential
has delivered or made available to MSLO true and complete copies of all Sequential Material Contracts, including any amendments
thereto. Each Sequential Material Contract is a legal, valid, binding and enforceable agreement of Sequential or its applicable
Subsidiary and, to the knowledge of Sequential, any other party thereto, and is in full force and effect. None of Sequential or
any of its Subsidiaries or, to the knowledge of Sequential, any other party is in breach or violation of, or (with or without
notice or lapse of time or both) default under, any Sequential Material Contract, nor has Sequential or any of its Subsidiaries
received any claim of any such breach, violation or default, except for such breaches and defaults which would not, individually
or in the aggregate, reasonably be expected to have a Sequential Material Adverse Effect.
4.18 Financing.
(a) Sequential
has delivered to MSLO a true, complete and correct copy of the executed debt commitment letter, dated as of the date hereof between
Sequential and GSO Capital Partners, LP (such commitment letter and all fee letters associated therewith, in each case as amended
or otherwise modified only to the extent permitted by this Agreement, collectively, “Financing Commitments”),
pursuant to which the lenders party thereto have committed, subject to the terms and conditions set forth therein, to lend the
aggregate principal amounts set forth therein for the purposes of financing the transactions contemplated by this Agreement and
related fees and expenses (the “Financing”). As of the date hereof, (a) the Financing Commitments have not
been amended, restated or otherwise modified, (b) no amendment, restatement or other modification to the Financing Commitments
is contemplated and (c) the respective commitments contained in the Financing Commitments have not been reduced, withdrawn, terminated
or rescinded in any respect and, to Sequential’s knowledge, no reduction, withdrawal, termination or rescission is contemplated.
Except for the fee letter referenced in the Financing Commitments (a true, complete and correct copy of which has been provided
to MSLO, with only fee amounts and certain economic terms of the market flex agreed to by the parties redacted, none of which
redacted provisions will adversely affect the availability of, or impose conditions on the availability of, the full amount of
the Financing at Closing), there are no side letters or other agreements, Contracts or arrangements related to the funding of
the Financing other than as expressly set forth in the Financing Commitments delivered to MSLO on or prior to the date hereof.
As of the date hereof, the Financing Commitments are in full force and effect and constitute the legal, valid and binding obligation
of Sequential, and to the knowledge of Sequential, the other parties thereto, enforceable in accordance with their terms, except
as enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’
rights generally and by general principles of equity (regardless of whether considered in a proceeding in equity or at law). There
are no conditions precedent or other contingencies (including pursuant to any “market flex” provisions in the related
fee letter or otherwise) related to the funding of the full amount of the Financing, other than as expressly set forth in the
Financing Commitments. As of the date hereof, (i) Sequential is not in default or breach under the terms and conditions of the
Financing Commitments and no event has occurred which, with or without notice, lapse of time or both, would constitute a default
or breach on the part of Sequential or, to the knowledge of Sequential, any other party thereto, under the terms and conditions
of the Financing Commitments and (ii) Sequential has not received any written notice of such default or event. All commitment
and other fees required to be paid on or prior to the date hereof under the Financing Commitments have been paid and, assuming
the satisfaction of the conditions precedent to Sequential’s obligations in Section 7.1 and 7.3 hereunder,
Sequential does not have any reason to believe that it will not be able to satisfy any term or condition of closing of the Financing
that is required to be satisfied as a condition to availability of the Financing or that the full amount of the Financing will
not be made available to Sequential on the Closing Date and, as of the date hereof, Sequential is not aware of the existence of
any facts or events that would reasonably be expected to cause such conditions to the Financing not to be satisfied or the full
amount of the Financing not to be available. The aggregate proceeds contemplated to be provided under the Financing Commitments,
together with Sequential’s existing resources, in the aggregate, will be sufficient to make all required payments in connection
with the MSLO Merger and the other transactions contemplated hereby, including payment of the MSLO Cash Consideration, any debt
required to be repaid, redeemed, retired, cancelled, terminated or otherwise satisfied or discharged in connection with the Mergers
(including all indebtedness of MSLO and its Subsidiaries required to be repaid, redeemed, retired, cancelled, terminated or otherwise
satisfied or discharged in connection therewith) and all other amounts to be paid pursuant to this Agreement and associated fees,
costs and expenses of the Mergers and the other transactions contemplated hereby, including the Financing, on the Closing Date.
Sequential affirms that it is not a condition to the Closing or any of its other obligations under this Agreement that it obtain
financing for, or related to, any of the transactions contemplated by this Agreement.
4.19 Licensees. Section
4.19 of the Sequential Disclosure Schedule sets forth a true and complete list of the top 10 licensees by revenue of Sequential
and the Sequential Subsidiaries, taken as a whole, for each of (a) calendar year 2014 and (b) the first three months of calendar
year 2015. Except as set forth in Section 4.19 of the Sequential Disclosure Schedule, since the date of the Sequential Balance
Sheet, no such licensee has (i) canceled or otherwise terminated, or, to the knowledge of Sequential, threatened to cancel or
otherwise terminate its relationship with Sequential or the Sequential Subsidiary, (ii) decreased, or to the knowledge of Sequential,
threatened to decrease, amounts payable, including royalty payments, to Sequential or the Sequential Subsidiary, or (iii) increased
or decreased, as applicable, or, to the knowledge of Sequential, threatened to increase or decrease, as applicable, pricing terms
with respect to amounts payable, including royalty payments, to Sequential or the Sequential Subsidiaries.
4.20 Affiliate
Transactions.
(a) Since
January 1, 2013, no Related Party of Sequential or any of its Subsidiaries: (i) owns or has owned, directly or indirectly, any
equity or other financial or voting interest in any competitor, supplier, licensor, lessor, distributor, independent contractor
or customer of Sequential or any of its Subsidiaries or their business; (ii) owns or has owned, directly or indirectly, or has
or has had any interest in any property (real or personal, tangible or intangible) that Sequential or any of its Subsidiaries
uses or has used in or pertaining to the business of Sequential or any of its Subsidiaries; (iii) has or has had any business
dealings or a financial interest in any transaction with Sequential or any of its Subsidiaries or involving any assets or property
of Sequential or any of its Subsidiaries, other than business dealings or transactions conducted in the ordinary course of business
at prevailing market prices and on prevailing market terms; or (iv) is or has been employed by Sequential or any of its Subsidiaries.
(b) There
are no Contracts by and between Sequential or any of its Subsidiaries, on the one hand, and any Related Party of Sequential or
any its Subsidiaries, on the other hand, pursuant to which such Related Party provides or receives any information, assets, properties,
support or other services to or from Sequential or any of its Subsidiaries (including Contracts relating to billing, financial,
tax, accounting, data processing, human resources, administration, legal services, information technology and other corporate
overhead matters).
(c) There
are no outstanding notes payable to, accounts receivable from or advances by Sequential or any of its Subsidiaries to, and neither
Sequential nor any of its Subsidiaries is otherwise a debtor or creditor of, or has any liability or other obligation of any nature
to, any Related Party of Sequential or any of its Subsidiaries. Since the date of the Sequential Balance Sheet, neither Sequential
nor any of its Subsidiaries has incurred any obligation or liability to, or entered into or agreed to enter into any transaction
with or for the benefit of, any Related Party.
4.21 Insurance.
Section 4.21 of the Sequential Disclosure Schedule sets forth a true and complete list of all casualty, directors and officers
liability, general liability, product liability and all other types of material insurance policies maintained with respect to
Sequential or any of its Subsidiaries, together with the carriers and liability limits for each such policy. All such policies
are in full force and effect and no application therefor included a material misstatement or omission. All premiums with respect
thereto have been paid to the extent due. Sequential has not received notice of, nor to the knowledge of Sequential is there threatened
in writing, any cancellation, termination, reduction of coverage or material premium increases with respect to any such policy.
All material insurable risks in respect of the business and assets of Sequential and its Subsidiaries are covered by such insurance
policies and the types and amounts of coverage provided therein are usual and customary in the context of the business and operations
in which Sequential and its Subsidiaries are engaged. The activities and operations of Sequential and its Subsidiaries have been
conducted in a manner so as to conform in all material respects to all applicable provisions of such insurance policies. The consummation
of the transactions contemplated by this Agreement will not cause a cancellation or reduction in the coverage of such policies.
4.22 Brokers’
and Finders’ Fees. There is no investment banker, broker, finder or other intermediary that has been retained by or
is authorized to act on behalf of Sequential or any of its Subsidiaries who is entitled to any fee or commission from Sequential
or any of its Subsidiaries in connection with the transactions contemplated hereby.
4.23 TopCo
and Merger Subs.
(a) Each
of TopCo, Singer Merger Sub and Madeline Merger Sub is a corporation duly organized, validly existing and in good standing under
the laws of the State of Delaware and has the requisite corporate power and authority to carry on its business as now being conducted.
Sequential has delivered to or made available to MSLO certified copies of the certificate of incorporation and bylaws for each
of TopCo, Singer Merger Sub and Madeline Merger Sub (the “New Entity Organizational Documents”).
(b) Each
of TopCo, Singer Merger Sub and Madeline Merger Sub (A) was formed solely for the purpose of entering into the transactions contemplated
by this Agreement and (B) since the date of its formation, has not carried on any business, conducted any operations or incurred
any liabilities or obligations other than the execution of an amendment to this Agreement, the performance of its obligations
hereunder and matters ancillary thereto.
(c) Each
of TopCo, Singer Merger Sub and Madeline Merger Sub has all requisite corporate power and authority to enter into this Agreement
and to consummate the transactions contemplated hereby and the execution and delivery of this Agreement by TopCo, Singer Merger
Sub or Madeline Merger Sub, as applicable, and the consummation by TopCo, Singer Merger Sub or Madeline Merger Sub, as applicable,
of the transactions contemplated hereby have been duly authorized by all necessary corporate action on the part thereof.
(d) The
execution and delivery of this Agreement by each of TopCo, Singer Merger Sub and Madeline Merger Sub does not, and the consummation
of the transactions contemplated hereby and compliance with the provisions of this Agreement by each of TopCo, Singer Merger Sub
and Madeline Merger Sub shall not, conflict with, or result in any violation of, or default (with or without notice or lapse of
time, or both) under, or give rise to a right of termination, cancellation or acceleration of any obligation or loss of a benefit
under, or result in the creation of any Lien upon any of the properties or assets of TopCo, Singer Merger Sub or Madeline Merger
Sub, as applicable, under the applicable New Entity Organizational Documents.
(e) As
of the date of this Agreement and as of immediately prior to the Sequential Effective Time, TopCo shall have no shares of capital
stock issued and outstanding.
(f) All
outstanding shares of capital stock of each of Madeline Merger Sub and Singer Merger Sub are, and all shares of capital stock
of each of Madeline Merger Sub and Singer Merger Sub that may be issued as permitted by this Agreement or otherwise shall be,
when issued, duly authorized, validly issued, fully paid and nonassessable and not subject to preemptive rights, and all outstanding
shares are owned, directly or indirectly, by TopCo, free and clear of any Lien.
4.24 No
Other Representations or Warranties. Except for the representations and warranties contained in this ARTICLE IV,
neither Sequential nor any other Person makes any other express or implied representation or warranty on behalf of Sequential
or any of its Affiliates.
ARTICLE
V
COVENANTS RELATING TO CONDUCT OF BUSINESS
5.1 Conduct
of Businesses Prior to the Effective Time. During the period from the date of this Agreement until the Effective Time, except
as expressly contemplated or permitted by this Agreement (including by Section 5.2 or Section 5.3 below,
as applicable), except as specifically set forth in Section 5.2 of the MSLO Disclosure Schedule or Section 5.3 of the Sequential
Disclosure Schedule, as applicable, or except with the prior written consent of the other party (which shall not be unreasonably
withheld, conditioned or delayed), each of MSLO and Sequential shall, and shall cause each of its respective Subsidiaries to (i) conduct
its business in the ordinary course consistent with past practice in all material respects, (ii) use reasonable best efforts
to maintain and preserve intact its business organization and advantageous business relationships and retain the services of its
officers and key employees, and (iii) take no action that would prohibit or materially impair or delay the ability of either
MSLO or Sequential to obtain any necessary approvals of any regulatory agency or other Governmental Entity required for the transactions
contemplated hereby or to consummate the transactions contemplated hereby. Notwithstanding the foregoing provisions of this Section 5.1,
(i) neither party will take any action prohibited by Section 5.2 or Section 5.3, as applicable, in
order to satisfy such party’s obligations under this Section 5.1 and (ii) each party shall be deemed not
to have failed to satisfy its obligations under this Section 5.1 to the extent such failure resulted, directly or
indirectly, from such party’s failure to take any action prohibited by Section 5.2 or Section 5.3,
as applicable.
5.2 MSLO
Forbearances. During the period from the date of this Agreement until the Effective Time, except as set forth in Section 5.2
of the MSLO Disclosure Schedule, except as required by Law or the rules and regulations of the SEC or the NYSE or as expressly
contemplated by this Agreement, MSLO will not, and will not permit any of the MSLO Subsidiaries to, without the prior written
consent of Sequential:
(a) amend
its certificate of incorporation, bylaws or comparable organizational documents (whether by merger, consolidation or otherwise);
(b) (i) split,
combine or reclassify any shares of its capital stock, or propose to split, combine or reclassify, any of its share capital, or
issue or authorize or propose the issuance or authorization of any other securities in respect of, or in lieu of or in substitution
for, shares of its share capital, (ii) declare, set aside or pay any dividend or other distribution (whether in cash, stock
or property or any combination thereof) in respect of its capital stock, except dividends paid by a direct or indirect wholly
owned Subsidiary of MSLO to MSLO or to any of MSLO’s other direct or indirect wholly owned Subsidiaries or (iii) redeem,
repurchase or otherwise acquire or offer to redeem, repurchase, or otherwise acquire any shares of MSLO’s (or any of its
Subsidiaries’) share capital or any securities convertible into or exercisable for any shares of MSLO’s (or any of
its Subsidiaries’) share capital, other than repurchases, redemptions or acquisitions by MSLO or any wholly owned Subsidiary
of MSLO of share capital or such other securities, as the case may be, of any other wholly owned Subsidiary of MSLO;
(c) (i) issue,
deliver, pledge or sell, or authorize the issuance, delivery or sale of, any shares of MSLO Common Stock, equity equivalents or
shares of capital stock of MSLO or any MSLO Subsidiary or capital stock of any MSLO Subsidiary, other than the issuance of (A) any
shares of MSLO Common Stock upon the exercise of MSLO Stock Options in accordance with the terms of the applicable MSLO Benefit
Plan; (B) any capital stock of any MSLO Subsidiary to MSLO or any other Subsidiary of MSLO; or (C) any shares of MSLO Common
Stock in connection with any acquisition permitted by Section 5.2(e); or (ii) amend any term of any shares of MSLO
Common Stock or equity equivalent (in each case, whether by merger, consolidation or otherwise) in any fashion that may have a
materially adverse impact on Sequential;
(d) incur
any capital expenditures or any obligations or liabilities in respect thereof, except for (i) those contemplated by the capital
expenditure budget set forth in Section 5.2(d) of the MSLO Disclosure Schedule or (ii) any unbudgeted capital expenditures
not to exceed $50,000 individually or $500,000 in the aggregate;
(e) acquire
(by merger, consolidation, acquisition of stock or assets or otherwise), directly or indirectly, any assets, securities, properties,
interests or businesses, other than any acquisitions with consideration (comprised of cash, shares of MSLO Common Stock or other
property) not in excess of $250,000 individually or $500,000 in the aggregate;
(f) sell,
lease, sublease, exchange or otherwise transfer, or create or incur any Lien, other than a Permitted Lien, on, any of MSLO’s
or any of its Subsidiaries’ assets, securities, properties, interests or businesses, or grant any option with respect to
any of the foregoing;
(g) make
any loans, advances or capital contributions to, or investments in, any other Person, other than in the ordinary course of business
consistent with past practice or loans, advances or capital contributions to, or investments in, wholly owned Subsidiaries of
MSLO;
(h) create,
incur, assume, suffer to exist or otherwise be liable with respect to any indebtedness for borrowed money or guarantees thereof
(including reimbursement obligations with respect to letters of credit);
(i) (i)
grant or increase any severance or termination pay to (or amend any existing severance pay or termination arrangement) or enter
into any employment, deferred compensation or other similar agreement (or amend any such existing agreement) with respect to any
employee, officer or director, (ii) increase benefits payable under any existing severance or termination pay policies, (iii)
establish, adopt or amend any collective bargaining, bonus, profit-sharing, thrift, pension, retirement, deferred compensation,
stock option, restricted stock or other benefit plan or arrangement, or (iv) increase compensation, bonus or other benefits payable
to any employee or hire any new employee (other than any non-executive employee hired to fill a pre-existing vacancy or to replace
any non-executive employee that terminates prior to the Effective Time, in each case, with the same salary for such position as
of the date hereof), except for (x) increases in salary for non-executive employees or (y) increases to the pre-established salary
level for any employee hired to fill a pre-existing non-executive vacancy or replace any non-executive employee that terminates
prior to the Effective Time in an amount not to exceed $250,000 in the aggregate with respect to all such increases and hires;
(j) change
MSLO’s methods of accounting, except as required by concurrent changes in GAAP, as agreed to by its independent public accountants;
(k) settle,
or offer or propose to settle, any litigation, investigation, arbitration, proceeding or other claim involving or against MSLO
or any of its Subsidiaries controlled or directed by MSLO or any of its Subsidiaries;
(l) (i) make
or change any material Tax election, (ii) change any annual tax accounting period, (iii) adopt or change any elective
method of tax accounting, (iv) materially amend any Tax Returns, (v) enter into any material closing agreement, (vi) settle
any material Tax claim, audit or assessment or (vii) surrender any right to claim a material Tax refund, offset or other
reduction in Tax liability;
(m) except
in the ordinary course of business consistent with past practice, amend, modify or terminate (excluding terminations upon expiration
of the term thereof in accordance with their terms) any MSLO Material Contract or waive, release or assign any material rights,
claims or benefits of it or its Subsidiaries under any MSLO Material Contract, or enter into any Contract or agreement that would
have been a MSLO Material Contract had it been entered into prior to this Agreement or which grants any third party the right
to receive payments with respect to any Intellectual Property, including any royalty payments or similar;
(n) adopt
a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization
of MSLO or any material MSLO Subsidiary (other than the Mergers);
(o) cancel
any indebtedness or waive any claims or rights of substantial value, in each case other than in the ordinary course of business
consistent with past practice;
(p) take
any action, or knowingly fail to take any action, which action or failure to act prevents or impedes, or could reasonably be expected
to impede, the Mergers from qualifying as a transaction described in Section 351 of the Code; or
(q) agree,
resolve or commit to (i) do any action restricted by this Section 5.2 or (ii) accept any restriction that
would prevent MSLO or any of its Subsidiaries from taking any action required by this Section 5.2.
5.3 Sequential
Forbearances. During the period from the date of this Agreement until the Effective Time, except as set forth in Section 5.3
of the Sequential Disclosure Schedule and except as required by Law or the rules and regulations of the SEC or Nasdaq or as contemplated
or permitted by this Agreement, Sequential will not, and will not permit any of the Sequential Subsidiaries to, without the prior
written consent of MSLO (which shall not be unreasonably withheld, conditioned or delayed):
(a) amend
its certificate of incorporation, bylaws or comparable organizational documents (whether by merger, consolidation or otherwise);
(b) (i) split,
combine or reclassify any shares of its capital stock, or propose to split, combine or reclassify, any of its share capital, or
issue or authorize or propose the issuance or authorization of any other securities in respect of, or in lieu of or in substitution
for, shares of its share capital, (ii) declare, set aside or pay any dividend or other distribution (whether in cash, stock
or property or any combination thereof) in respect of its capital stock, except dividends paid by a direct or indirect wholly
owned Subsidiary of Sequential to Sequential or to any of Sequential’s other direct or indirect wholly owned Subsidiaries
or (iii) redeem, repurchase or otherwise acquire or offer to redeem, repurchase, or otherwise acquire any shares of Sequential’s
(or any of its Subsidiaries’) share capital or any securities convertible into or exercisable for any shares of Sequential’s
(or any of its Subsidiaries’) share capital, other than repurchases, redemptions or acquisitions by Sequential or any wholly
owned Subsidiary of Sequential of share capital or such other securities, as the case may be, of any other wholly owned Subsidiary
of Sequential;
(c) (i) issue,
deliver, pledge or sell, or authorize the issuance, delivery or sale of, any shares of Sequential Common Stock or Sequential Preferred
Stock or capital stock of any Sequential Subsidiary, other than the issuance of (A) any shares of Sequential Common Stock
upon the exercise of Sequential Stock Options in accordance with the terms of the applicable Sequential Benefit Plan; (B) any
capital stock of any Sequential Subsidiary to Sequential or any other Subsidiary of Sequential; or (C) any shares of Sequential
Common Stock in connection with any acquisition permitted by Section 5.3(e); or (ii) amend any term of the shares
of Sequential Common Stock (in each case, whether by merger, consolidation or otherwise) in any fashion that may have a materially
adverse impact on MSLO;
(d) incur
any capital expenditures or any obligations or liabilities in respect thereof, other than capital expenditures not to exceed $1,500,000
in the aggregate;
(e) acquire
(by merger, consolidation, acquisition of stock or assets or otherwise), directly or indirectly, any material assets, securities,
properties, interests or businesses, other than any acquisitions with consideration (comprised of cash, shares of Sequential Common
Stock or other property) not in excess of $15,000,000 in the aggregate;
(f) sell,
lease, sublease, exchange or otherwise transfer, or create or incur any Lien, other than a Permitted Lien, on, any of Sequential’s
or any of its Subsidiaries’ assets, securities, properties, interests or businesses, or grant any option with respect to
any of the foregoing;
(g) make
any loans, advances or capital contributions to, or investments in, any other Person, other than in the ordinary course of business
consistent with past practice or loans, advances or capital contributions to, or investments in, wholly owned Subsidiaries of
Sequential;
(h) create,
incur, assume, suffer to exist or otherwise be liable with respect to any indebtedness for borrowed money or guarantees thereof
(including reimbursement obligations with respect to letters of credit);
(i) other
than with respect to non-executive employees, (i) grant or increase any severance or termination pay to (or amend any existing
severance pay or termination arrangement) or enter into any employment, deferred compensation or other similar agreement (or amend
any such existing agreement) with respect to any employee, officer or director, (ii) increase benefits payable under any existing
severance or termination pay policies, (iii) establish, adopt or amend any collective bargaining, bonus, profit-sharing, thrift,
pension, retirement, deferred compensation, stock option, restricted stock or other benefit plan or arrangement, or (iv) increase
compensation, bonus or other benefits payable to any employee or hire any executive officer if Sequential does not provide notice
to MSLO at least two Business Days prior to the hiring of any executive officer;
(j) change
Sequential’s methods of accounting, except as required by concurrent changes in GAAP, as agreed to by its independent public
accountants;
(k) settle,
or offer or propose to settle, any litigation, investigation, arbitration, proceeding or other claim involving or against Sequential
or any of its Subsidiaries controlled or directed by Sequential or any of its Subsidiaries;
(l) (i)
make or change any material Tax election, (ii) change any annual tax accounting period, (iii) adopt or change any elective method
of tax accounting, (iv) materially amend any Tax Returns, (v) enter into any material closing agreement, (vi) settle any material
Tax claim, audit or assessment or (vii) surrender any right to claim a material Tax refund, offset or other reduction in Tax liability;
(m) except
in the ordinary course of business consistent with past practice, amend, modify or terminate (excluding terminations upon expiration
of the term thereof in accordance with their terms) any Sequential Material Contract or waive, release or assign any material
rights, claims or benefits of it or its Subsidiaries under any Sequential Material Contract, or enter into any Contract or agreement
that would have been a Sequential Material Contract had it been entered into prior to this Agreement or which grants any third
party the right to receive payments with respect to any Intellectual Property, including any royalty payments or similar;
(n) adopt
a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization
of Sequential or any material Sequential Subsidiary (other than the Mergers);
(o) cancel
any indebtedness or waive any claims or rights of substantial value, in each case other than in the ordinary course of business
consistent with past practice;
(p) take
any action, or knowingly fail to take any action, which action or failure to act prevents or impedes, or could reasonably be expected
to impede, the Mergers from qualifying as a transaction described in Section 351 of the Code; or
(q) agree,
resolve or commit to (i) do any action restricted by this Section 5.3 or (ii) accept any restriction that
would prevent Sequential or any of its Subsidiaries from taking any action required by this Section 5.3.
5.4 Control
of Other Party’s Business. Nothing contained in this Agreement will give MSLO, directly or indirectly, the right to
control Sequential or any of the Sequential Subsidiaries or direct the business or operations of Sequential or any of the Sequential
Subsidiaries. Nothing contained in this Agreement will give Sequential, directly or indirectly, the right to control MSLO or any
of the MSLO Subsidiaries or direct the business or operations of MSLO or any of the MSLO Subsidiaries prior to the Effective Time.
Prior to the Effective Time, each of MSLO and Sequential will exercise, consistent with the terms and conditions of this Agreement,
complete control and supervision over its respective operations and the operations of its respective Subsidiaries. Nothing in
this Agreement, including any of the actions, rights or restrictions set forth herein, will be interpreted in such a way as to
place Sequential or MSLO in violation of any applicable Law.
5.5 No
Solicitation; Recommendation of the Merger.
(a) Notwithstanding
anything to the contrary set forth in this Agreement, during the period beginning on the date of this Agreement and continuing
until 11:59 p.m. (New York City time) on the 30th calendar day after the date of this Agreement (the “No Shop Period
Start Date”), MSLO and its Subsidiaries and their respective directors, officers, employees, investment bankers, financial
advisors, attorneys, accountants or other advisors, agents or representatives (collectively, “Representatives”)
shall have the right to (i) initiate, solicit and encourage any inquiry or the making of any proposal or offer that constitutes
an Acquisition Proposal, including by providing information (including non-public information and data) regarding, and affording
access to the business, properties, assets, books, records and personnel of, MSLO and its Subsidiaries to any Person pursuant
to an Acceptable Confidentiality Agreement; provided that MSLO shall promptly (and in any event within 48 hours) make available
to Sequential any non-public information provided to any such Person or Persons or Representatives (other than immaterial information)
that was not previously provided to Sequential, and (ii) engage in, enter into, continue or otherwise participate in any discussions
or negotiations with any Persons or groups of Persons with respect to any Acquisitions Proposals and cooperate with or assist
or participate in, or facilitate any such inquiries, proposals, discussions or negotiations or any effort or attempt to make any
Acquisition Proposals. No later than 48 hours after the No Shop Period Start Date, MSLO shall notify Sequential in writing of
the identity of any Person that submitted any Acquisition Proposal prior to the No Shop Period Start Date, and shall provide to
Sequential a copy of such Acquisition Proposal.
(b) Except
as expressly permitted in this Section 5.5(b), from and after the No Shop Period Start Date until the Effective Time or,
if earlier, the valid termination of this Agreement in accordance with ARTICLE VIII, MSLO shall not, and shall not permit
or authorize any of its Subsidiaries or any Representative of MSLO or any of its Subsidiaries, directly or indirectly, to (i) solicit,
initiate, endorse, knowingly encourage or knowingly facilitate any inquiry, proposal or offer with respect to, or the making or
completion of, any Acquisition Proposal, or any inquiry, proposal or offer that is reasonably likely to lead to any Acquisition
Proposal, (ii) enter into, continue or otherwise participate in any discussions or negotiations regarding, or furnish to
any Person any information or data with respect to, or otherwise cooperate in any way with, any Acquisition Proposal or (iii) resolve,
agree or propose to do any of the foregoing. Except as expressly permitted in this Section 5.5(b) (including with respect
to any Excluded Party as provided in the last sentence hereof), as of the No Shop Period Start Date, MSLO shall, and shall cause
each of its Subsidiaries and the Representatives of MSLO and its Subsidiaries to, (A) immediately cease and cause to be terminated
all existing discussions and negotiations with any Person conducted theretofore with respect to any Acquisition Proposal or potential
Acquisition Proposal and (B) request the prompt return or destruction of all confidential information previously furnished
with respect to any Acquisition Proposal or potential Acquisition Proposal. Notwithstanding the foregoing, if at any time following
the No Shop Period Start Date and prior to the time the MSLO Stockholder Approval is obtained, (1) MSLO receives a written
Acquisition Proposal from any Person that the MSLO Board believes in good faith to be bona fide, (2) such Acquisition Proposal
did not result from a breach of this Section 5.5, (3) the MSLO Board determines in good faith (after consultation
with outside counsel and its financial advisor) that such Acquisition Proposal constitutes or is reasonably likely to lead to
a Superior Proposal, and (4) the MSLO Board determines in good faith (after consultation with outside counsel) that the failure
to take the actions referred to in clause (x) or (y) below would reasonably be expected to result in a breach of its fiduciary
duties to the stockholders of MSLO under applicable Law, then MSLO may (x) furnish information regarding, and afford access
to the business, properties, assets, books, records and personnel of, MSLO and its Subsidiaries to the Person or Persons making
such Acquisition Proposal and to the Representatives of such Person or Persons pursuant to a customary confidentiality agreement
containing terms no less favorable to MSLO than those set forth in the Confidentiality Agreement (any such confidentiality agreement,
an “Acceptable Confidentiality Agreement”); provided, that any non-public information provided to any
such Person or Persons or Representatives (other than immaterial information) that was not previously provided to Sequential shall
be promptly provided to Sequential and (y) participate in discussions or negotiations with the Person or Persons making such
Acquisition Proposal regarding such Acquisition Proposal. Notwithstanding the passage of the No Shop Period Start Date, until
11:59 p.m. (New York City time) on the 45th calendar day after the date of this Agreement (provided such date and time shall be
extended to the extent and during such period thereafter as MSLO is in active discussions with an Excluded Party), MSLO may continue
to engage in the activities described in Section 5.5(a) with respect to any Excluded Party, including with respect to any
amended or modified Acquisition Proposal submitted by any Excluded Party following the No Shop Period Start Date, and the restrictions
in this Section 5.5(b) shall not apply with respect thereto.
(c) Except
as set forth in Section 5.5(d), neither the MSLO Board nor any committee thereof shall:
(i) (A) withdraw
(or modify or qualify in any manner adverse to Sequential) the recommendation or declaration of advisability by the MSLO Board
or any such committee of this Agreement, the MSLO Merger or any of the other transactions contemplated hereby, (B) recommend
or otherwise declare advisable the approval by MSLO stockholders of any Acquisition Proposal, or (C) resolve, agree or propose
to take any such actions (each such action set forth in this Section 5.5(c)(i) being referred to herein as an “Adverse
Recommendation Change”); or
(ii) authorize,
adopt or approve an Acquisition Proposal or cause or permit MSLO or any of its Subsidiaries to enter into any letter of intent,
memorandum of understanding, agreement in principle, acquisition agreement, merger agreement, option agreement, joint venture
agreement, partnership agreement or other Contract (each, an “Alternative Acquisition Agreement”) constituting
or related to, or which is intended to or is reasonably likely to lead to, any Acquisition Proposal (other than an Acceptable
Confidentiality Agreement), or resolve, agree or propose to take any such actions.
(d) Notwithstanding
anything in this Agreement to the contrary, at any time prior to the time the MSLO Stockholder Approval is obtained, the MSLO
Board (at the recommendation of the Special Committee) may, (x) effect an Adverse Recommendation Change if the MSLO Board determines
in good faith (after consultation with its outside counsel) that the failure to take such action would reasonably be expected
to result in a breach of the directors’ fiduciary duties under applicable Law, either in response to a Superior Proposal
or an Intervening Event or (y) solely in response to a Superior Proposal received after the date hereof that was unsolicited
and did not otherwise result from a breach of this Section 5.5, cause MSLO to enter into a binding Alternative Acquisition
Agreement with respect thereto and terminate this Agreement pursuant to Section 8.1(i); provided, however,
that the MSLO Board may only effect an Adverse Recommendation Change or terminate this Agreement pursuant to Section 8.1(i)
if (and in no other circumstances may the MSLO Board effect an Adverse Recommendation Change):
(i) MSLO
notifies Sequential in writing at least three Business Days in advance that it intends to effect an Adverse Recommendation Change
or terminate this Agreement pursuant to Section 8.1(i), which notice shall specify the basis for the Adverse Recommendation
Change or termination and, in the case of a Superior Proposal, specifies the terms and conditions of, and the identity of the
Person making, such Superior Proposal, and contemporaneously furnishes a copy (if any) of the proposed Alternative Acquisition
Agreement and any other relevant transaction documents (it being understood and agreed that any material amendment to the financial
terms or any other material term of such Superior Proposal or material change in the facts or circumstances relating to an Intervening
Event shall require a new written notice by MSLO and a new three Business Day period);
(ii) after
providing such notice and prior to effecting such Adverse Recommendation Change or terminating this Agreement pursuant to Section
8.1(i), if Sequential makes a proposal during such the three Business Day period to adjust the terms and conditions of this
Agreement, MSLO shall, and shall cause its financial and legal advisors to, negotiate with Sequential in good faith (to the extent
Sequential seeks to negotiate) to make any revisions to the terms of the transactions contemplated by this Agreement as would
permit the MSLO Board not to effect an Adverse Recommendation Change or terminate this Agreement pursuant to Section 8.1(i);
and
(iii) the
MSLO Board shall have considered in good faith any changes to this Agreement offered in writing by Sequential no later than 11:59
p.m., New York City time, on the third Business Day of such three Business Day period and shall have determined (x) in the event
the MSLO Board’s determination pursuant to subparagraph (c) above is in response to a Superior Proposal, that such Superior
Proposal would continue to constitute a Superior Proposal if such changes offered in writing by Sequential were to be given effect
or (y) in the event the MSLO Board’s determination pursuant to subparagraph (c) above is in response to an Intervening Event,
that such changes would not affect the MSLO Board’s determination of the need for an Adverse Recommendation Change in response
to such Intervening Event.
For the avoidance of doubt, the terms and
conditions of this Section 5.5(d) shall apply both prior to and following the No Shop Period Start Date, including with
respect to any Acquisition Proposal received from any Excluded Party.
(e) Following
the No Shop Period Start Date, MSLO promptly (and in any event within 48 hours of receipt) shall advise Sequential, orally or
in writing, in the event MSLO or any of its Subsidiaries or Representatives receives (i) any indication by any Person that
it is considering making an Acquisition Proposal (including any request by any Person to waive any standstill or similar provision
applicable to such Person), (ii) any inquiry or request for information, discussion or negotiation that is reasonably likely
to lead to or that contemplates an Acquisition Proposal, or (iii) any proposal or offer that is or is reasonably likely to
lead to an Acquisition Proposal, in each case together with a description of the material terms and conditions of and facts surrounding
any such indication, inquiry, request, proposal or offer, the identity of the Person making any such indication, inquiry, request,
proposal or offer, and a copy of any written proposal, offer or draft agreement provided by such Person. MSLO (or its outside
counsel) shall, orally or in writing, keep Sequential (or its outside counsel) reasonably informed on a timely basis (and in any
event within 48 hours) with respect to any change to price or other material terms of such Acquisition Proposal. MSLO (or its
outside counsel) shall, promptly upon receipt or delivery thereof (and in any event within 48 hours), provide Sequential (or its
outside counsel) with copies of material agreements comprising such Acquisition Proposal and any amendments thereto. Without limiting
any of the foregoing, MSLO shall promptly (and in any event within 48 hours) notify Sequential, orally or in writing, if
it determines to begin providing information or to engage in discussions or negotiations concerning an Acquisition Proposal pursuant
to this Section 5.5.
(f) MSLO
agrees that any material violation of the restrictions set forth in this Section 5.5 by any Representative of MSLO
or any of its Subsidiaries shall be deemed to be a material breach of this Agreement by MSLO.
(g) Nothing
contained in Section 5.5 shall prohibit MSLO, the MSLO Board or any other committee of the MSLO Board from (i) complying
with its disclosure obligations under U.S. federal or state Law with regard to an Acquisition Proposal, including taking and disclosing
to its stockholders a position contemplated by Rule 14e–2(a), Rule 14d–9 or Item 1012(a) of Regulation M–A
promulgated under the Exchange Act (or any similar communication to stockholders) or (ii) making any “stop-look-and listen”
communication to the stockholders of MSLO pursuant to Rule 14d-9(f) under the Exchange Act; provided, that neither the
MSLO Board nor any committee thereof shall effect an Adverse Recommendation Change unless the applicable requirements of Section
5.5 shall have been satisfied.
(h) For
purposes of this Agreement:
(i) “Acquisition
Proposal” means any proposal or offer with respect to any direct or indirect acquisition or purchase, in one transaction
or a series of transactions, and whether through any merger, reorganization, consolidation, tender offer, self-tender, exchange
offer, stock acquisition, asset acquisition, binding share exchange, business combination, recapitalization, liquidation, dissolution,
joint venture or otherwise, of (A) assets or businesses of MSLO and its Subsidiaries that generate 20% or more of the net
revenues or net income or that represent 20% or more of the total assets (based on fair market value) of MSLO and its Subsidiaries,
taken as a whole, immediately prior to such transaction, or (B) 20% or more of the combined voting power of the outstanding
MSLO Class A Common Stock and Class B Common Stock, including any tender offer or exchange offer that if consummated would result
in any Person beneficially owning twenty percent (20%) or more of the combined voting power of the outstanding MSLO Class A Common
Stock and Class B Common Stock, in each case other than the MSLO Merger and other transactions contemplated by this Agreement;
(ii) “Excluded
Party” means a Person or group of Persons from whom MSLO or any of its Representatives has received, after the execution
of this Agreement and prior to the No Shop Period Start Date, a bona fide written Acquisition Proposal that the Madeline Board
has determined in good faith constitutes a Superior Proposal or would reasonably be expected to result in a Superior Proposal;
(iii) “Intervening
Event” means a material event or circumstance that was not known to the MSLO Board prior to the execution of this Agreement
(or if known, the consequences of which were not known or reasonably foreseeable), which event or circumstance, or any material
consequence thereof, becomes known to the MSLO Board prior to the receipt of MSLO Stockholder Approval; provided, that in no event
shall the receipt, existence or terms of an Acquisition Proposal or any matter relating thereto or consequence thereof constitute
an Intervening Event; and
(iv) “Superior
Proposal” means any bona fide binding written Acquisition Proposal that the MSLO Board determines in good faith (after
consultation with outside counsel and its financial advisor), taking into account all legal, financial, regulatory and other aspects
of the proposal and the Person making the proposal, including the financing terms thereof, is (A) more favorable to the stockholders
of MSLO from a financial point of view than the MSLO Merger and the other transactions contemplated by this Agreement (including
any adjustment to the terms and conditions proposed by Sequential in response to such proposal) and (B) reasonably likely
to be completed on the terms proposed; provided, that, for purposes of this definition of “Superior Proposal,”
references in the term “Acquisition Proposal” to “20%” shall be deemed to be references to “50%”.
5.6 Directors. Prior
to the Effective Time, MSLO shall cause each member of the MSLO Board, other than any persons designated by Sequential at least
two Business Days prior to the Closing Date, to execute and deliver a letter effectuating his or her resignation as a director
of the MSLO Board effective as of the Effective Time.
5.7 Financing.
(a) Sequential
shall use its reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary,
proper or advisable to arrange and obtain the Financing on the terms and conditions described in the Financing Commitments (including
the exercise of “market flex” provisions in the related fee letter) as promptly as practicable following the date
hereof (taking into account the expected timing of the Closing). Sequential shall comply with its obligations, and enforce its
rights, under the Financing Commitments in a timely and diligent manner. In the event that all conditions to the Financing Commitments
set forth therein have been, or upon funding will be, satisfied, Sequential shall use its reasonable best efforts to cause the
lenders party thereto and the other Persons providing such Financing to comply with their obligations under the Financing Commitments
and the definitive financing agreements entered into in connection with the Financing and to fund the Financing required to consummate
the transactions contemplated by this Agreement and to pay related fees, costs and expenses on or prior to the Closing Date. Sequential
will keep MSLO reasonably informed of the status of its efforts to arrange the Financing and to satisfy the conditions thereof,
including (A) promptly notifying MSLO of (1) any material breach or default by any party to the Financing Commitments or any definitive
financing agreement entered into in connection with the Financing, if such breach or default would reasonably be expected to affect
the timely availability of, or the amount of, the Financing and (2) the receipt by any of Sequential or any of its Representatives
of any written notice or other written communication from any lender committing or providing the Financing or other Person with
respect to (x) any actual, threatened or alleged breach, default, termination or repudiation by any party to the Financing Commitments
or any definitive financing agreement entered into in connection with the Financing or any provision thereof (including any proposal
by any lender or other Person to withdraw or terminate or make any material change in the terms of the Financing Commitment that
would reasonably be expected to affect the timely availability of, or the amount of, the Financing) or (y) any material dispute
or disagreement between or among any parties to any Financing Commitment or any definitive financing agreement entered into in
connection with the Financing, if such dispute or disagreement would reasonably be expected to affect the timely availability
of, or amount of, the Financing and (B) upon MSLO’s reasonable request, advising and updating MSLO, in a reasonable level
of detail, with respect to status of the Financing. Sequential may replace or amend all or any portion of the Financing Commitments;
provided, that such replacement or amendment would not (i) reduce the aggregate cash amount of proceeds of the Financing (including
by changing the amount of fees to be paid or original issue discount of the Financing (except as set forth in any “market
flex” provisions existing on the date hereof in the related fee letter)), (ii) impose new or additional conditions, or otherwise
expand any conditions, to the receipt of the Financing from those set forth in the Financing Commitments on the date hereof, (iii)
reasonably be expected to prevent, or materially delay or impair, the availability of the full amount of the Financing or make
the funding of the Financing or the satisfaction of the conditions to obtaining the Financing less likely to occur, (iv) adversely
affect the ability of Sequential to enforce its rights against any lender or any other Person providing or committing to provide
the Financing or (v) adversely impact the ability of Sequential to cause TopCo to timely consummate the MSLO Merger and the other
transactions contemplated hereby. For purposes of this Agreement, references to “Financing” shall include the financing
contemplated by the Financing Commitments as replaced, amended or modified as permitted hereby, including, if applicable, pursuant
to an alternative financing that is in compliance herewith, and references to “Financing Commitments” shall include
such documents as replaced, amended or modified as permitted hereby, including, if applicable, pursuant to an alternative financing
in compliance herewith. Without limiting the generality of the foregoing and subject to replacements or amendments permitted hereby,
Sequential shall use its reasonable best efforts to (i) maintain in effect the Financing Commitments until the transactions
contemplated by this Agreement are consummated, (ii) satisfy on a timely basis (taking into account the expected timing of the
Closing) all conditions and covenants applicable to Sequential in the Financing Commitments and any definitive agreements entered
into in connection therewith at or prior to Closing and otherwise comply with its obligations thereunder, (iii) negotiate and
enter into definitive agreements with respect thereto on the terms and conditions consistent with those contemplated by the Financing
Commitments and (iv) consummate the Financing at or prior to the Closing. If, notwithstanding the use of reasonable best efforts
by Sequential to satisfy its obligations under this Section 5.7, any portion of the Financing or the Financing Commitments
(or any definitive financing agreement relating thereto) expire or are terminated or otherwise become unavailable prior to the
Closing, in whole or in part, for whatever reason, Sequential shall (i) promptly notify MSLO of such expiration, termination
or unavailability and the reason therefor and (ii) use its reasonable best efforts to promptly arrange and obtain alternative
financing from alternative sources, in an amount sufficient to consummate the transactions contemplated by this Agreement and
to pay related fees, costs and expenses as promptly as practicable following the occurrence of such event and which do not include
any conditions to the consummation of such alternative financing that are more onerous than the conditions set forth in the Financing
Commitments. True, complete and correct copies of each commitment letter and other agreement relating to the alternative financing
will be promptly provided to MSLO. Sequential acknowledges and agrees that the obtaining of the Financing is not a condition to
the Closing. For the avoidance of doubt, if the Financing has not been obtained, Sequential will continue to be obligated, subject
to the fulfillment or waiver of the conditions set forth in Sections 7.1 and 7.3, to complete the Mergers and consummate
the other transactions contemplated hereby.
(b) Prior
to the Closing, MSLO shall use reasonable best efforts to provide to Sequential, at Sequential’s sole expense, all cooperation
reasonably requested by Sequential in connection with the Financing, including by using reasonable best efforts in (i) furnishing
Sequential and its lenders any information and financial statements reasonably requested by such Persons as is customarily required
in connection with the execution of debt financings similar to the Financing (provided, that MSLO will have no obligation
to prepare pro forma financial information or post-closing financial information), (ii) participating, but only together
with the executive officers of Sequential and other members of senior management and representatives of Sequential, and at a time
and place acceptable to the executive officers of MSLO, in a reasonable number of meetings (including customary one-on-one meetings
with the parties acting as lead arrangers or agents for, and prospective lenders and purchasers of, the Financing and the executive
officers of MSLO and other members of senior management and representatives of MSLO), presentations, road shows, due diligence
sessions and sessions with rating agencies in connection with the Financing, as reasonably requested by Sequential, (iii) assisting
Sequential and its lenders in the preparation of customary bank information memoranda, rating agency presentations and lender
presentations relating to the Financing, (iv) cooperating with the marketing efforts of Sequential and its lenders for all
or any portion of the Financing, (v) providing information with respect to the assets of MSLO and its Subsidiaries that will
serve as collateral for the Financing as is reasonably requested by Sequential and, subject to Section 6.2, providing reasonable
access to Sequential and its lenders, during normal working hours and upon reasonable advance notice, to allow them to conduct
audit examinations and appraisals with respect to such collateral, (vi) seeking to cause its auditors to provide assistance to
Sequential consistent with their customary practice (including to provide and consent to the use of their audit reports relating
to the consolidated financial statements of MSLO and its Subsidiaries), in each case on customary terms and consistent with their
customary practice in connection with financings similar to the Financing, (vii) so long as such documents and other information
are reasonably requested by Sequential in writing at least ten Business Days prior to the Closing Date, providing all documentation
and other information required by regulatory authorities with respect to MSLO and its Subsidiaries under applicable “know
your customer” and anti-money laundering rules and regulations, including the USA PATRIOT Act of 2001, as amended, and (viii)
seeking to arrange for customary payoff letters, lien terminations and instruments of discharge to be delivered at Closing providing
for the payoff, discharge and termination on the Closing Date of all indebtedness contemplated by the Financing Commitment to
be paid off, discharged and terminated at Closing; provided, however, that, irrespective of the above, (A) such
requested cooperation shall not unreasonably interfere with the business or the ongoing operations of MSLO and its Subsidiaries,
(B) nothing in this Section 5.7(b) shall require cooperation to the extent that it would (x) cause any condition
to the Closing set forth in Sections 7.1 and 7.3 to not be satisfied or otherwise cause any breach of this Agreement
or (y) reasonably be expected to conflict with or violate MSLO’s or any its Subsidiaries’ organizational documents
or any applicable Law, (C) prior to the Closing, none of the directors or managers of MSLO or any of its Subsidiaries, acting
in such capacity, shall be required to execute, deliver or enter into or perform any agreement, certificate, document or instrument
with respect to the Financing or adopt any resolutions approving the agreements, documents and instruments pursuant to which the
Financing is obtained, and (D) none of MSLO’s or its Subsidiaries’ officers or employees shall be required to
execute, deliver or enter into, or perform any agreement, document or instrument with respect to the Financing that is not contingent
upon the Closing or that would be effective prior to the Effective Time.
(c) Notwithstanding
Section 5.7(b) above, none of MSLO or any of its Subsidiaries shall be required to bear any cost or expense or to pay any
commitment or other similar fee or make any other payment in connection or incur or assume any other liability or obligation with
the Financing prior to the Effective Time except in the case of expenses that are reimbursed as provided in Section 8.2(b).
Sequential shall, promptly upon request, reimburse MSLO for all reasonable and documented out-of-pocket costs and expenses (including
reasonable attorneys’ fees) incurred by MSLO or any of its Subsidiaries in connection with fulfilling its obligations pursuant
to Section 5.7(b). Sequential shall indemnify and hold harmless MSLO and its Subsidiaries (and their respective Representatives)
from and against any and all liabilities, losses, damages, claims, costs, expenses, interest, awards, judgments and penalties
suffered or incurred in connection with the arrangement of the Financing and any information utilized in connection therewith
(other than historical information relating to MSLO or its Subsidiaries provided by MSLO in writing specifically for use in the
Financing offering documents). MSLO hereby consents to the use of its and its Subsidiaries’ logos in connection with the
Financing; provided, that such logos are used solely in a manner that is not intended to nor reasonably likely to harm
or disparage MSLO or any of its Subsidiaries or the reputation or goodwill of MSLO or any of its Subsidiaries and its or their
marks.
5.8 Termination
of Certain Agreements. Except for any agreements or arrangements set forth in Section 5.8 of the Sequential Disclosure
Schedule which shall continue in accordance with their respective terms, at or prior to the MSLO Effective Time, MSLO shall take
all actions necessary to cause any and all arrangements and agreements to which it or any of its Subsidiaries is a party with
Martha Stewart to be terminated as of the MSLO Effective Time without any further liability or obligation on the part of MSLO
or any of its Subsidiaries, except in each case with respect to indemnification matters.
ARTICLE
VI
ADDITIONAL AGREEMENTS
6.1 Preparation
of the Form S-4 and the Proxy Statement; MSLO Stockholders Meeting.
(a) As
soon as practicable following the date of this Agreement, Sequential and MSLO shall prepare, and Sequential shall cause TopCo
to file with the SEC, the Form S-4, including the related Proxy Statement/Prospectus and Information Statement. Each of Sequential
and MSLO shall use reasonable best efforts to have the Form S-4 declared effective under the Securities Act as promptly as practicable
after such filing. Each of Sequential and MSLO shall furnish all information concerning such Person and its Affiliates to the
other, and provide such other assistance, as may be reasonably requested, in connection with the preparation, filing and distribution
of the Form S-4, Proxy Statement/Prospectus and Information Statement. The Form S-4 and Proxy Statement/Prospectus shall include
all information reasonably requested by such other party to be included therein. Each of Sequential and MSLO shall promptly notify
the other upon the receipt of any comments from the SEC or any request from the SEC for amendments or supplements to the Form
S-4 or Proxy Statement/Prospectus and shall provide the other with copies of all correspondence between it and its Representatives,
on one hand, and the SEC, on the other hand. Each of Sequential and MSLO shall use its reasonable best efforts to respond as promptly
as practicable to any comments from the SEC with respect to the Form S-4 or Proxy Statement/Prospectus. Notwithstanding the foregoing,
prior to filing the Form S-4 (or any amendment or supplement thereto) or mailing the Proxy Statement/Prospectus (or any amendment
or supplement thereto) or responding to any comments of the SEC with respect thereto, each of Sequential and MSLO (i) shall
provide the other an opportunity to review and comment on such document or response (including the proposed final version of such
document or response) and (ii) shall include in such document or response all comments reasonably proposed by the other. Each
of Sequential and MSLO shall advise the other, promptly after receipt of notice thereof, of the time of effectiveness of the Form
S-4, the issuance of any stop order relating thereto or the suspension of the qualification of shares of TopCo Common Stock for
offering or sale in any jurisdiction, and each of Sequential and MSLO shall use its reasonable best efforts to have any such stop
order or suspension lifted, reversed or otherwise terminated. Sequential shall also cause TopCo to take any other action required
to be taken under the Securities Act, the Exchange Act, any applicable foreign or state securities or “blue sky” laws
and the rules and regulations thereunder in connection with the Mergers, the issuance of the Merger Consideration and the issuance
of shares of TopCo Common Stock under the Sequential Benefit Plans. If at any time prior to the Effective Time any information
relating to Sequential, MSLO, TopCo, or any of their respective Affiliates, officers or directors, should be discovered by Sequential,
MSLO or TopCo that should be set forth in an amendment or supplement to any of the Form S-4 or the Proxy Statement/Prospectus,
so that any of such documents would not include any misstatement of a material fact or omit to state any material fact necessary
to make the statements therein, in light of the circumstances under which they were made, not misleading, the party which discovers
such information shall promptly notify the other parties hereto and an appropriate amendment or supplement describing such information
shall be promptly filed with the SEC and, to the extent required by law, disseminated to the stockholders of Sequential and MSLO.
(b) MSLO
shall use its reasonable best efforts to, as promptly as practicable after the Form S-4 is declared effective under the Securities
Act, duly give notice of, convene and hold a meeting of its stockholders (the “MSLO Stockholders Meeting”),
and shall within five Business Days of the effectiveness of the Form S-4 publicly announce the date of the MSLO Stockholders Meeting,
in accordance with the DGCL and MSLO’s certificate of incorporation and bylaws for the purpose of obtaining the MSLO Stockholder
Approval and shall, subject to the provisions of Section 5.5, through its Board of Directors, recommend to its stockholders
the adoption and approval of this Agreement. MSLO may only postpone or adjourn the MSLO Stockholders Meeting (i) to solicit additional
proxies for the purpose of obtaining the MSLO Stockholder Approval, (ii) for the absence of a quorum, (iii) with the consent
of Sequential or (iv) to allow reasonable additional time for the filing and/or mailing of any supplemental or amended disclosure
that MSLO has determined after consultation with outside legal counsel is reasonably likely to be required under applicable Law
and for such supplemental or amended disclosure to be disseminated and reviewed by stockholders of MSLO prior to the MSLO Stockholders
Meeting. MSLO shall use its reasonable best efforts to (i) cause the Proxy Statement/Prospectus to be mailed to MSLO’s stockholders
as promptly as practicable after the Form S-4 is declared effective under the Securities Act and to hold the MSLO Stockholders
Meeting as soon as practicable after the Form S-4 becomes effective and (ii) subject to the provisions of Section 5.5,
solicit the MSLO Stockholder Approval. MSLO shall, through the MSLO Board, recommend to its stockholders that they vote in favor
of the MSLO Merger and shall include such recommendation in the Proxy Statement/Prospectus, except to the extent that the MSLO
Board shall have made an Adverse Recommendation Change as permitted by Section 5.5. MSLO agrees, subject to Section
5.5, that its obligations pursuant to this Section 6.1 shall not be affected by the commencement, public proposal,
public disclosure or communication to MSLO of any Acquisition Proposal.
6.2 Access
to Information; Confidentiality. Upon reasonable notice and subject to applicable Law, each of Sequential and MSLO shall,
and shall cause each of its Subsidiaries to, afford to the other and its representatives reasonable access during normal business
hours during the period prior to the Closing Date to all of the properties, books, Contracts, commitments, personnel and records
and, during such period, each of Sequential and MSLO shall, and shall cause each of its Subsidiaries to, furnish promptly to the
other and its representatives such information concerning its business, properties and personnel as such other party may reasonably
request, other than to the extent such information is contemplated to be provided pursuant to Section 5.5, in which case,
the provisions of Section 5.5 shall apply to the sharing of such information. The foregoing notwithstanding, neither Sequential
nor MSLO shall be required to afford such access if and to the extent it would (w) unreasonably disrupt its operations or any
of its Subsidiaries, (x) violate any of its or its Subsidiaries’ obligations with respect to confidentiality, (y) cause
a risk of a loss of privilege or trade secret protection to it or any of its Subsidiaries or (z) constitute a violation of any
applicable Law; provided, however, that, in each case, Sequential or MSLO, as the case may be, uses commercially
reasonable efforts to minimize the effects of such restriction or to provide a reasonable alternative to such access. All information
furnished pursuant to this Section 6.2 shall be subject to the Confidentiality Agreement, dated as of April 27,
2015, between MSLO and Sequential (the “Confidentiality Agreement”). No investigation pursuant to this Section 6.2
or information provided to, made available to or delivered by either Sequential or MSLO pursuant to this Section 6.2
or otherwise shall affect any representations or warranties, conditions or rights of either Sequential or MSLO contained in
this Agreement.
6.3 Required
Actions.
(a) Subject
to the terms and conditions of this Agreement, each of the parties shall use its reasonable best efforts to take, or cause to
be taken, all actions, and do, or cause to be done, and assist and cooperate with the other parties in doing, all things necessary
to consummate and make effective, as soon as reasonably possible, the Mergers and the other transactions contemplated by this
Agreement in accordance with the terms hereof. Without limiting the generality of the foregoing, upon the terms and subject to
the conditions set forth in this Agreement, each of the parties agrees to use reasonable best efforts to take, or cause to be
taken, all actions that are necessary, proper or advisable to consummate and make effective, in the most expeditious manner practicable,
the Mergers and the other transactions contemplated by this Agreement, including using reasonable best efforts to accomplish the
following: (i) obtain all required consents, approvals or waivers from, or participation in other discussions or negotiations
with, third parties, including as required under any Contract, (ii) defend any lawsuits or other legal proceedings, whether judicial
or administrative, challenging this Agreement or the consummation of the Mergers and the other transactions contemplated by this
Agreement, (iii) obtain all necessary actions or nonactions, waivers, consents, approvals, orders and authorizations from Governmental
Entities and (iv) make all necessary registrations, declarations and filings with any Governmental Entity, including filings required
under the HSR Act with the United States Federal Trade Commission and the Antitrust Division of the United States Department of
Justice; provided that no party shall be required to pay (and MSLO and its Subsidiaries shall not pay or agree to pay without
the prior written consent of Sequential, which consent shall not be unreasonably withheld, conditioned or delayed) any fee, penalty
or other consideration to any third party for any consent or approval required for the consummation of the transactions contemplated
by this Agreement under any Contract. In furtherance and not in limitation of the foregoing, Sequential and MSLO each shall, no
later than ten Business Days following the execution and delivery of this Agreement, file a Notification and Report Form pursuant
to the HSR Act with respect to the transactions contemplated hereby and use its reasonable best efforts to take, or cause to be
taken, all other actions consistent with this Section 6.3 necessary to cause the expiration or termination of the applicable
waiting period under the HSR Act as soon as practicable. Sequential shall be responsible for any filing and other similar fees
payable in connection with the filing of the Notification and Report Form and any other submissions under the HSR Act.
(b) Sequential
shall give prompt notice to MSLO, and MSLO shall give prompt notice to Sequential, of (i) any representation or warranty
made by it contained in this Agreement that is qualified as to materiality becoming untrue or inaccurate in any respect or any
such representation or warranty that is not so qualified becoming untrue or inaccurate in any material respect or (ii) the
failure by it to comply with or satisfy in any material respect any covenant, condition or agreement to be complied with or satisfied
by it under this Agreement; provided, however, that no such notification shall affect the representations, warranties,
covenants or agreements of the parties or the conditions to the obligations of the parties under this Agreement.
6.4 Indemnification
and Insurance.
(a) From
and after the Effective Time, TopCo shall indemnify and hold harmless each individual who is as of the date of this Agreement,
or who becomes prior to the Effective Time, a director or officer of MSLO or Sequential or any of their respective Subsidiaries
or who is as of the date of this Agreement, or who thereafter commences prior to the Effective Time, serving at the request of
MSLO or Sequential, as applicable, or any of their respective Subsidiaries as a director or officer of another Person (including
such individual’s affiliates, the “Indemnified Parties”), against all claims, losses, liabilities, damages,
judgments, inquiries, fines and reasonable fees, costs and expenses, including attorneys’ fees and disbursements, incurred
in connection with any claim, action, suit or proceeding, whether civil, criminal, administrative or investigative (including
with respect to matters existing or occurring at or prior to the Effective Time (including this Agreement and the transactions
and actions contemplated hereby)), arising out of or pertaining to the fact that the Indemnified Party (or such Indemnified Party’s
affiliate) is or was an officer or director of MSLO or Sequential, as applicable, or any of their respective Subsidiaries is or
was serving at the request of MSLO or Sequential, as applicable, or any of their respective subsidiaries as a director or officer
of another person or in respect of any acts or omissions in their capacities as such directors or officers occurring prior to
the Effective Time, whether asserted or claimed prior to, at or after the Effective Time, to the fullest extent permitted by applicable
Law, and any indemnification agreements in existence as of the date of this Agreement. In the event of any such claim, action,
suit or proceeding, (i) each Indemnified Party will be entitled to advancement of expenses incurred in the defense of any such
claim, action, suit or proceeding from TopCo to the fullest extent permitted by applicable Law; provided, that any person
to whom expenses are advanced provides an undertaking, if and only to the extent required by the DGCL, to repay such advances
if it is ultimately determined that such person is not entitled to indemnification, and (ii) TopCo shall, and shall cause its
Subsidiaries to, cooperate in the defense of any such matter. In the event that TopCo, the Sequential Surviving Corporation or
the MSLO Surviving Corporation or any of their respective successors or assigns (i) consolidates with or merges into any other
person and is not the continuing or surviving corporation or entity of such consolidation or merger or (ii) transfers or conveys
all or substantially all of its properties and assets to any person, then, and in each such case, TopCo, the Sequential Surviving
Corporation and/or the MSLO Surviving Corporation, as applicable, shall cause proper provision to be made so that the successors
and assigns of TopCo, the Sequential Surviving Corporation and/or the MSLO Surviving Corporation, as applicable, assume the obligations
set forth in this Section 6.4(a).
(b) For
a period of six years from and after the Effective Time, TopCo shall either cause to be maintained in effect the current policies
of directors’ and officers’ liability insurance and fiduciary liability insurance maintained by MSLO or Sequential
or any of their Subsidiaries or provide substitute polices of not less than the existing coverage and have other terms not less
favorable to the insured persons with respect to claims arising from facts or events that occurred on or before the Effective
Time, except that in no event shall TopCo be required to pay with respect to such insurance policies (or substitute insurance
policies) (i) of MSLO in respect of any one policy year more than 300% of the annual premium payable by MSLO for such insurance
for the year ending December 31, 2014 (the “MSLO Maximum Amount”), and if TopCo is unable to obtain the insurance
required by this Section 6.4(b) it shall obtain as much comparable insurance as possible for the years within such six-year
period for an annual premium equal to the MSLO Maximum Amount, in respect of each policy year within such period; provided,
that in lieu of the foregoing, MSLO may obtain at or prior to the Effective Time a six-year “tail” policy under MSLO’s
existing directors and officers insurance policy providing equivalent coverage to that described in the preceding sentence if
and to the extent that the same may be obtained for an amount that, on an annual basis, does not exceed the MSLO Maximum Amount,
or (ii) of Sequential in respect of any one policy year more than 300% of the annual premium payable by Sequential for such insurance
for the year ending December 31, 2014 (the “Sequential Maximum Amount”), and if TopCo is unable to obtain the
insurance required by this Section 6.4(b), it shall obtain as much comparable insurance as possible for the years within
such six-year period for an annual premium equal to the Sequential Maximum Amount, in respect of each policy year within such
period; provided, that in lieu of the foregoing, Sequential may obtain at or prior to the Effective Time a six-year “tail”
policy under Sequential’s existing directors’ and officers’ insurance policy providing equivalent coverage to
that described in the preceding sentence if and to the extent that the same may be obtained for an amount that, on an annual basis,
does not exceed the Sequential Maximum Amount.
(c) The
provisions of this Section 6.4 (i) shall survive consummation of the Mergers, (ii) are intended to be for the benefit of,
and will be enforceable by, each indemnified or insured party (including the Indemnified Parties), his or her heirs and his or
her representatives, and (iii) are in addition to, and not in substitution for, any other rights to indemnification or contribution
that any such person may have by contract or otherwise.
6.5 Sequential
Stockholder Approval. Sequential shall take all lawful action to deliver, immediately following (and in any event within one
hour, and prior to any public announcement, of) the execution of this Agreement, to MSLO the written consents in the form attached
hereto as Exhibit B signed by the holders of shares of Sequential Common Stock specified thereon and in any event sufficient
to constitute the Sequential Stockholder Approval, in accordance with the DGCL and the certificate of incorporation and bylaws
of Sequential (the “Sequential Written Consent”). As promptly as practicable after the Form S-4 is declared
effective under the Securities Act, Sequential shall mail the Information Statement to the holders of Sequential Common Stock
in accordance with the DGCL and the applicable requirements of the SEC.
6.6 Public
Announcements. The initial press release with respect to this Agreement and the transactions contemplated hereby shall be
a joint release mutually agreed upon by MSLO and Sequential. Thereafter, Sequential, on the one hand, and MSLO, on the other hand,
shall consult with each other before issuing, and give each other a reasonable opportunity to review and comment upon, any press
release or other public statements with respect to this Agreement, the Mergers and the other transactions contemplated hereby
and shall not issue any such press release or make any public announcement prior to such consultation and review, except as may
be required by applicable Law, court process or by obligations pursuant to any listing agreement with any national securities
exchange or national securities quotation system; provided that (i) MSLO shall not be required to provide any such review or comment
to Sequential in connection with the receipt and existence of an Acquisition Proposal and matters related thereto or an Adverse
Recommendation Change (other than as required pursuant to Section 5.5) and (ii) each party hereto and their respective
Affiliates may make statements that are substantially similar to previous press releases, public disclosures or public statements
made by MSLO and Sequential in compliance with this Section 6.6.
6.7 Takeover
Laws. Neither Sequential nor MSLO shall (a) take any action to cause any “moratorium,” “fair price,”
“interested shareholder,” “business combination,” “control share acquisition” or similar provision
of any state anti-takeover Law (collectively, “Takeover Laws”) to become applicable to this Agreement, the
Mergers or any of the other transactions contemplated hereby and (b) if any Takeover Law is or becomes applicable to this
Agreement, the Mergers or any of the other transactions contemplated hereby, take all action necessary to ensure that the Mergers
and the other transactions contemplated hereby may be consummated as promptly as practicable on the terms contemplated by this
Agreement and otherwise to minimize the effect of such Takeover Law with respect to this Agreement, the Mergers and the other
transactions contemplated hereby.
6.8 Section
16 Matters. Prior to the Effective Time, each of TopCo, the Sequential Board and the MSLO Board shall take all such steps
as may be necessary or appropriate to cause the transactions contemplated by this Agreement, including any dispositions of shares
of MSLO Common Stock (including derivative securities with respect to such shares) and/or shares of Sequential Common Stock (including
derivative securities with respect to such shares) resulting from the transactions contemplated by this Agreement by each individual
who is or will be subject to the reporting requirements of Section 16(a) of the Exchange Act with respect to MSLO and/or
Sequential, as applicable, to be exempt under Rule 16b-3 promulgated under the Exchange Act.
6.9 Stockholder
Litigation. In the event that any stockholder litigation related to this Agreement, the Mergers or the other transactions
contemplated by this Agreement is brought, or, to the knowledge of Sequential or MSLO, threatened in writing, against a party
and/or the members of a party’s board of directors prior to the Effective Time, Sequential or MSLO, as applicable, shall
promptly notify the other of any such stockholder litigation brought, or, to the knowledge of the applicable party, threatened
in writing against such party and/or members of the party’s board of directors and shall keep the other reasonably informed
with respect to the status thereof. None of Sequential, MSLO or any of their Subsidiaries or Representatives shall compromise,
settle, come to an arrangement regarding, or agree to compromise, settle or come to an arrangement regarding, any such stockholder
litigation or consent to the same unless Sequential or MSLO, as applicable, shall have consented in writing in its reasonable
discretion.
6.10 Nasdaq
Listing. Sequential shall use reasonable best efforts to cause the TopCo Common Stock issuable under ARTICLE II to
be approved for listing on Nasdaq, subject to official notice of issuance, as promptly as practicable after the date hereof, and
in any event prior to the Closing Date.
6.11 Employees
and Employee Benefits.
(a) For
a period beginning on the Closing Date and continuing thereafter for 12 months, subject to any contractual obligations that may
apply, TopCo shall provide, or shall cause MSLO Surviving Corporation and its Subsidiaries to provide, employees of MSLO as of
the Closing who continue employment with TopCo or any of its Subsidiaries, including MSLO Surviving Corporation, following the
Closing (the “Continuing Employees”) with (i) wage or base salary levels (but not any short-term incentive
compensation opportunities or other bonus plans (other than the commission sales plan set forth in Section 6.11(a) of the MSLO
Disclosure Schedule)) that are not less than those in effect immediately prior to the Effective Time, and (ii) employee benefits
(excluding equity-based compensation) that are comparable in the aggregate to either those in effect for such Continuing Employees
immediately prior to the Effective Time or those provided to similarly-situated employees of Sequential from time-to-time, provided
that, (x) until December 31, 2015, Topco and the MSLO Surviving Corporation agree to keep in effect all employee benefits
(excluding equity-based compensation) that are applicable to employees of MSLO as of the date hereof and (y) notwithstanding the
immediately preceding clause (x), until the one year anniversary of the Closing Date, TopCo and the MSLO Surviving Corporation
agree to keep in effect all severance plans, practices and policies that are applicable to employees of MSLO as of the date hereof
and set forth on Section 6.11(a) of the MSLO Disclosure Schedule. Nothing herein shall be deemed to limit the right of TopCo or
any of their respective Affiliates to (A) terminate the employment of any Continuing Employee at any time, (B) change or modify
the terms or conditions of employment for any Continuing Employee, or (C) change or modify any Sequential Benefit Plan, MSLO Benefit
Plan or other employee benefit plan or arrangement in accordance with its terms.
(b) For
all purposes under the employee benefit plans, programs and arrangements established or maintained by TopCo and its respective
Affiliates in which Continuing Employees may be eligible to participate after the Closing (the “New Benefit Plans”),
each Continuing Employee shall be credited with the same amount of service as was credited by MSLO as of the Closing under similar
or comparable MSLO Benefit Plans in which such Continuing Employee participated immediately prior to the Closing (except (i) for
purposes of benefit accrual under defined benefit plans and retiree medical arrangements or (ii) to the extent such credit would
result in a duplication of benefits). In addition, and without limiting the generality of the foregoing, (i) with respect to any
New Benefit Plans in which the Continuing Employees may be eligible to participate following the Closing, each Continuing Employee
will immediately be eligible to participate in such New Benefit Plans, without any waiting time, to the extent coverage under
such New Benefit Plans replaces coverage under a similar or comparable MSLO Benefit Plan in which such Continuing Employee was
eligible to participate immediately before such commencement of participation and (ii) for purposes of each New Benefit Plan providing
medical, dental, pharmaceutical and/or vision benefits to any Continuing Employee, TopCo shall cause all preexisting condition
exclusions and actively-at-work requirements of such New Benefit Plan to be waived for such Continuing Employee and his or her
covered dependents, to the extent any such exclusions or requirements were waived or were inapplicable under any similar or comparable
MSLO Benefit Plan in which such Continuing Employee participated immediately prior to the Closing. TopCo shall use commercially
reasonable efforts to cause any eligible expenses incurred by such Continuing Employee and his or her covered dependents during
the portion of the plan year of the MSLO Benefit Plan ending on the date such Continuing Employee’s participation in the
corresponding New Benefit Plan begins to be taken into account under such New Benefit Plan for purposes of satisfying all deductible,
coinsurance and maximum out-of-pocket requirements applicable to such Continuing Employee and his or her covered dependents for
the applicable plan year as if such amounts had been paid in accordance with such New Benefit Plan.
(c) The
terms of this Section 6.11 are included for the sole benefit of the respective parties hereto and shall not confer any
rights or remedies upon any Continuing Employee or former employee of MSLO, any participant or beneficiary in any MSLO Benefit
Plan or any other Person or Governmental Entity (whether as a third party beneficiary or otherwise) other than the parties hereto.
Nothing contained in this Agreement shall (i) constitute or be deemed to constitute an amendment to any MSLO Benefit Plan or other
compensation or benefit plan, policy, program or arrangement of MSLO, Sequential or any other Person, (ii) obligate TopCo or any
of its Subsidiaries to (A) maintain any particular benefit plan or arrangement or (B) retain the employment of any particular
employee; or (iii) prevent the MSLO Surviving Corporation, TopCo or any of their Subsidiaries from amending or terminating any
benefit plan or arrangement.
ARTICLE
VII
CONDITIONS PRECEDENT
7.1 Conditions
to Each Party’s Obligation to Effect the Mergers. The respective obligations of the parties to effect the Mergers shall
be subject to the satisfaction, or waiver (except with respect to Section 7.1(a), which shall not be waivable) by each
of the parties, at or prior to the Closing of the following conditions:
(a) MSLO
Stockholder Approval. The MSLO Stockholder Approval shall have been obtained.
(b) Sequential
Stockholder Approval. The Sequential Stockholder Approval shall have been obtained.
(c) Listing.
The shares of TopCo issuable to the stockholders of MSLO and Sequential and as contemplated by ARTICLE II, shall have been
authorized for listing on Nasdaq, subject to official notice of issuance.
(d) HSR
Act. Any applicable waiting period (and any extension thereof) under the HSR Act relating to the transactions contemplated
by this Agreement shall have expired or been terminated.
(e) Form S-4.
The Form S-4 shall have been declared effective by the SEC under the Securities Act prior to the mailing of the Proxy Statement/Prospectus,
and no stop order suspending the effectiveness of the Form S-4 shall have been issued and no proceedings for that purpose
shall have been initiated or been threatened by the SEC.
(f) No
Injunctions or Restraints. No statute, rule, regulation, executive order, decree, temporary restraining order, preliminary
or permanent injunction or other order enacted, entered, promulgated, enforced or issued by any Governmental Entity, or other
legal restraint or prohibition, shall be in effect preventing the consummation of the Mergers and the transactions contemplated
by this Agreement.
7.2 Conditions
to Obligations of MSLO. The obligation of MSLO to consummate the transactions contemplated hereby is also subject to
the satisfaction, or waiver by MSLO, at or prior to the Closing of the following conditions:
(a) Representations
and Warranties. (i) The representations and warranties of Sequential set forth in Section 4.2, Section
4.3 and Section 4.22 of this Agreement shall be true and correct other than in de minimis respects on the date
of this Agreement and as of the Closing Date, as if made at and as of such date (except to the extent that any such representation
or warranty speaks as of an earlier date, in which case such representation or warranty shall be true and correct as of such earlier
date), and (ii) the other representations and warranties of Sequential set forth in this Agreement shall be true and correct
on the date of this Agreement and as of the Closing Date, as if made at and as of such date (except to the extent that any such
representation or warranty speaks as of an earlier date, in which case such representation or warranty shall be true and correct
as of such earlier date), except where the failure of such representations and warranties to be so true and correct (without giving
effect to any limitation as to “materiality” or “Sequential Material Adverse Effect” set forth therein,
except as set forth in Section 4.8(b)), individually or in the aggregate, has not had, and would not reasonably be expected
to have, a Sequential Material Adverse Effect.
(b) Performance
of Obligations of Sequential. Sequential shall have performed in all material respects all material obligations required to
be performed by it under this Agreement at or prior to the Closing Date.
(c) Absence
of Sequential Material Adverse Effect. Since the date of this Agreement, there shall not have occurred any change, state of
facts, circumstance, occurrence, development, event or effect that, individually or in the aggregate, has had or would reasonably
be expected to have a Sequential Material Adverse Effect.
(d) Officer’s
Certificate. MSLO shall have received a certificate signed by an executive officer of Sequential certifying as to the matters
set forth in Sections 7.2(a), 7.2(b) and 7.2(c).
(e) MSLO
Opinion. MSLO shall have received from Debevoise & Plimpton LLP, counsel to MSLO, a written opinion dated the Effective
Time to the effect that for U.S. federal income tax purposes the Mergers will constitute a transaction described in Section 351
of the Code. In rendering such opinion, counsel to MSLO shall be entitled to rely upon customary assumptions and representations
reasonably satisfactory to such counsel, including representations set forth in certificates of officers of MSLO and Sequential.
(f) FIRPTA
Certificate. TopCo shall have received a statement from MSLO meeting the requirements of Section 1.1445-2(c) and 1.897-2(h)
of the Treasury Regulations, certifying that the shares of MSLO Common Stock (and any other relevant equity interests in MSLO)
are not U.S. real property interests within the meaning of Section 897 of the Code.
7.3 Conditions
to Obligations of Sequential. The obligation of Sequential to consummate the transactions contemplated hereby is also subject
to the satisfaction, or waiver by Sequential, at or prior to the Effective Time, of the following conditions:
(a) Representations
and Warranties. (i) The representations and warranties of MSLO set forth in Sections 3.2, 3.3
and 3.21 of this Agreement shall be true and correct other than in de minimis respects on the date of this Agreement and
as of the Closing Date, as if made at and as of such date (except to the extent that any such representation or warranty speaks
as of an earlier date, in which case such representation or warranty shall be true and correct as of such earlier date), and (ii) the
other representations and warranties of MSLO set forth in this Agreement shall be true and correct on the date of this Agreement
and as of the Closing Date, as if made at and as of such date (except to the extent that any such representation or warranty speaks
as of an earlier date, in which case such representation or warranty shall be true and correct as of such earlier date), except
where the failure of such representations and warranties to be so true and correct (without giving effect to any limitation as
to “materiality” or “MSLO Material Adverse Effect” set forth therein, except as set forth in Section
3.8(b)), individually or in the aggregate, has not had, and would not reasonably be expected to have, a MSLO Material Adverse
Effect.
(b) Performance
of Obligations of MSLO. MSLO shall have performed in all material respects all material obligations required to be performed
by it under this Agreement at or prior to the Closing Date.
(c) Absence
of MSLO Material Adverse Effect. Since the date of this Agreement, there shall not have occurred any change, state of facts,
circumstance, occurrence, development, event or effect that, individually or in the aggregate, has had or would reasonably be
expected to have a MSLO Material Adverse Effect.
(d) Officer’s
Certificate. Sequential shall have received a certificate signed by an executive officer of MSLO certifying as to the matters
set forth in Sections 7.3(a), 7.3(b) and 7.3(c).
(e) Sequential
Opinion. Sequential shall have received from Gibson, Dunn & Crutcher LLP, counsel to Sequential, a written opinion dated
the Effective Time to the effect that for U.S. federal income tax purposes the Mergers will constitute a transaction described
in Section 351 of the Code. In rendering such opinion, counsel to Sequential shall be entitled to rely upon customary assumptions
and representations reasonably satisfactory to such counsel, including representations set forth in certificates of officers of
Sequential and MSLO.
(f) FIRPTA
Certificate. TopCo shall have received a statement from Sequential meeting the requirements of Section 1.1445-2(c) and 1.897-2(h)
of the Treasury Regulations, certifying that the shares of Sequential Common Stock (and any other relevant equity interests in
Sequential) are not U.S. real property interests within the meaning of Section 897 of the Code.
ARTICLE
VIII
TERMINATION AND AMENDMENT
8.1 Termination. This
Agreement may be terminated at any time prior to the Effective Time, by action taken or authorized by the board of directors of
the terminating party or parties:
(a) by
mutual written consent of MSLO and Sequential;
(b) by
either MSLO or Sequential, if any Governmental Entity of competent jurisdiction shall have issued a final and nonappealable Order
permanently enjoining or otherwise prohibiting the consummation of the transactions contemplated by this Agreement, except that
no party may terminate this Agreement pursuant to this Section 8.1(b) if such party’s breach of its obligations
under this Agreement proximately contributed to the occurrence of such Order;
(c) by
either MSLO or Sequential , if the Mergers shall not have been consummated on or before December 22, 2015, subject to extension
by the mutual agreement of MSLO and Sequential (the “End Date”); provided, however, that no party
may terminate this Agreement pursuant to this Section 8.1(c) if such party’s breach of its obligations under this
Agreement was the primary cause of the failure of the Closing to occur by the End Date;
(d) by
either MSLO or Sequential, if the MSLO Stockholder Approval shall not have been obtained by reason of the failure to obtain the
required vote at a MSLO Stockholders Meeting duly convened thereof or at any adjournment or postponement thereof.
(e) by
MSLO if the Sequential Written Consent shall not have been delivered to Sequential in accordance with Section 228 of the DGCL
and to MSLO within 24 hours after execution of this Agreement;
(f) by
MSLO, if there shall have been a breach of any of the covenants or agreements or any inaccuracy of any of the representations
or warranties set forth in this Agreement on the part of Sequential, which breach or inaccuracy, either individually or in the
aggregate, would result in, if occurring or continuing on the Closing Date, the failure of the conditions set forth in Section 7.2(a)
or (b), unless such failure is reasonably capable of being cured, and Sequential is continuing to use its reasonable
best efforts to cure such failure, by the End Date;
(g) by
Sequential, if there shall have been a breach of any of the covenants or agreements or any inaccuracy of any of the representations
or warranties set forth in this Agreement on the part of MSLO, which breach or inaccuracy, either individually or in the aggregate,
would result in, if occurring or continuing on the Closing Date, the failure of the conditions set forth in Section 7.3(a)
or (b), unless such failure is reasonably capable of being cured, and MSLO is continuing to use its reasonable best
efforts to cure such failure, by the End Date;
(h) by
Sequential if (A) an Adverse Recommendation Change shall have occurred, (B) prior to the MSLO Stockholders Meeting, following
the receipt by MSLO of an Acquisition Proposal or amendment thereto, the MSLO Board shall have failed to publicly reaffirm its
recommendation of the MSLO Merger within 10 Business Days after the date Sequential requests in writing that the MSLO Board so
reaffirm the recommendation, or (C) MSLO shall have intentionally and materially breached its obligations set forth in Section
5.5 or 6.1; or
(i) by
MSLO at any time prior to obtaining the MSLO Stockholder Approval, in order to accept a Superior Proposal in accordance with Section
5.5(d); provided, that MSLO shall have (A) simultaneously with such termination entered into the associated Alternative
Acquisition Agreement and (B) paid any amounts due pursuant to Section 8.2(c).
8.2 Effect
of Termination.
(a) In
the event of termination of this Agreement by either MSLO or Sequential in accordance with Section 8.1, this Agreement
shall forthwith become void and have no effect, and none of MSLO, Sequential, any of their respective Subsidiaries or Affiliates
or any of the officers or directors of any of the foregoing shall have any liability of any nature whatsoever under this Agreement,
or in connection with the transactions contemplated by this Agreement, except that Section 3.21, Section 4.22,
this Section 8.2 and ARTICLE IX shall survive any termination of this Agreement; provided, that, except as
otherwise provided in this Section 8.2, no party will be relieved or released from any liability or damages arising from
an intentional and material breach of any provision of this Agreement prior to such termination, and in each case the aggrieved
party will be entitled to all rights and remedies available at Law or in equity (which the parties acknowledge and agree will
not be limited to reimbursement of expenses or out-of-pocket costs). Without limiting the foregoing, MSLO acknowledges and agrees
that the payment of the Expense Reimbursement or Termination Fee pursuant to Section 8.2(b) or Section 8.2(c), respectively,
will not preclude Sequential, in the case of an intentional and material breach of this Agreement by MSLO or fraud, from seeking
additional damages from MSLO on account of such intentional and material breach or fraud (it being understood that the MSLO Board’s
failure to reaffirm its recommendation under the circumstances set forth in Section 8.1(h)(B) will not be deemed an intentional
and material breach of this Agreement if the MSLO Board has determined the failure to take such action would reasonably be expected
to result in a breach of its fiduciary duties under applicable Law). For purposes of this Agreement, “intentional and material
breach” means a material breach that is a consequence of an act (or failure to act) undertaken by the breaching party with
the knowledge (actual or constructive) that the taking of (or the failure to take) such act would, or would be reasonably expected
to, cause a breach of this Agreement. No termination of this Agreement shall affect the obligations of the parties contained in
the Confidentiality Agreement, all of which obligations shall survive termination of this Agreement in accordance with their terms.
(b) In
the event that Agreement is terminated pursuant to Section 8.1(d) or (g), MSLO shall promptly, and in any event
within two Business Days after termination of this Agreement, reimburse Sequential for any and all expenses incurred in connection
with this Agreement, the Financing Commitments and the transactions contemplated hereby and thereby in an amount not to exceed
$2,500,000 (the “Expense Reimbursement”).
(c) In
the event that:
(i) (A) after
the date of this Agreement but prior to the date of the MSLO Stockholders Meeting, any Person or group of Persons shall have publicly
made an Acquisition Proposal (whether or not conditional), (B) this Agreement is terminated by MSLO or Sequential pursuant
to Section 8.1(c) or (d) or by Sequential pursuant to Section 8.1(g) and (C) within 12 months
after the date of such termination, MSLO enters into an agreement in respect of any Acquisition Proposal, or recommends or submits
an Acquisition Proposal to its stockholders for adoption, and such Acquisition Proposal is later consummated, which, in each case,
need not be the same Acquisition Proposal that was made, disclosed or communicated prior to termination hereof, provided
that for purposes of this Section 8.2(c)(i) the references to “20%” in the definition of “Acquisition
Proposal” shall be deemed to be references to “50%”;
(ii) this
Agreement is terminated by Sequential pursuant to Section 8.1(h); or
(iii) this
Agreement is terminated by MSLO pursuant to Section 8.1(i);
then, in any such event, MSLO shall pay to
Sequential the applicable Termination Fee (less the amount of any Expense Reimbursement previously paid pursuant to Section 8.2(b)),
it being understood that in no event shall MSLO be required to pay the Termination Fee on more than one occasion. Payment of the
Termination Fee shall be made by wire transfer of immediately available funds to the accounts designated by Sequential (A) no
later than three Business Days after the date on which MSLO consummates such Acquisition Proposal in the case of a Termination
Fee payable pursuant to Section 8.2(c)(i), (B) as promptly as reasonably practicable after termination (and, in any event,
within three Business Days thereof) in the case of a Termination Fee payable pursuant to Section 8.2(c)(ii), and (C) simultaneously
with, and as a condition to the effectiveness of, termination, in the case of a Termination Fee payable pursuant to Section
8.2(c)(iii).
(d) Each
of the parties hereto acknowledges and agrees that (i) the agreements contained in this Section 8.2 are an integral part
of this Agreement and the transactions contemplated hereby and that, without these agreements, the parties would not enter into
this Agreement and (ii) the Termination Fee, in the circumstances in which such fee becomes payable, constitutes liquidated damages
and is not a penalty.
8.3 Amendment. Subject
to compliance with applicable Law, this Agreement may be amended by MSLO and Sequential, by action taken or authorized by their
respective boards of directors, at any time before or after the Sequential Stockholder Approval or the MSLO Stockholder Approval
is obtained; provided, however, that after the Sequential Stockholder Approval and/or MSLO Stockholder Approval
has been obtained, there may not be, without further approval of the stockholders of Sequential or stockholders of MSLO, as applicable,
any amendment of this Agreement which by applicable Law otherwise requires the further approval of such stockholders. This Agreement
may not be amended except by an instrument in writing signed on behalf of each of the parties. Notwithstanding anything to the
contrary contained herein, neither this Section 8.3 nor Section 9.8, Section 9.10, Section 9.12
or Section 9.13 (and any other provision of this Agreement to the extent an amendment, supplement, waiver or other
modification of such provision would modify the substance of such Sections) may be amended, supplemented, modified or waived in
a manner that is adverse to the interests of the lenders party to the Financing Commitment in any respect without the written
consent of such lenders.
8.4 Extension;
Waiver. At any time prior to the Effective Time, MSLO and Sequential may, to the extent legally allowed, (a) extend the
time for the performance of any of the obligations or other acts of the other party, (b) waive any inaccuracies in the representations
and warranties contained in this Agreement, and (c) waive compliance with any of the agreements or conditions contained in
this Agreement. Any agreement on the part of a party to any such extension or waiver will be valid only if set forth in a written
instrument signed by an authorized officer on behalf of such party, but such extension or waiver or failure to insist on strict
compliance with an obligation, covenant, agreement or condition will not operate as a waiver of, or estoppel with respect to,
any subsequent or other failure.
ARTICLE
IX
GENERAL PROVISIONS
9.1 Nonsurvival
of Representations and Warranties. None of the representations, warranties, covenants or agreements in this Agreement or in
any instrument delivered pursuant to this Agreement shall survive the Effective Time, other than those covenants or agreements
of the parties which by their terms apply, or are to be performed in whole or in part, after the Effective Time.
9.2 Fees
and Expenses. Except as set forth in this Section 9.2, in Section 6.3 and in Section 8.2, all fees and
expenses incurred in connection with the Mergers, this Agreement and the transactions contemplated by this Agreement shall be
paid by the party incurring such fees or expenses, whether or not the Merger is consummated, except that each of MSLO and Sequential
shall bear and pay one-half of the costs and expenses (other than the fees and expenses of each party’s attorneys and accountants,
which shall be borne by the party incurring such expenses) incurred by the parties hereto in connection with the filing, printing
and mailing of the Form S-4 and the Proxy Statement/Prospectus (including SEC filing fees).
9.3 Notices.
All notices and other communications hereunder shall be in writing and shall be deemed duly given (a) on the date of
delivery if delivered personally, or if by email, upon the date such email is sent, (b) on the first Business Day following
the date of dispatch if delivered utilizing a next-day service by a recognized next-day courier or (c) on the earlier of
confirmed receipt or the fifth Business Day following the date of mailing if delivered by registered or certified mail, return
receipt requested, postage prepaid. All notices hereunder shall be delivered to the addresses set forth below, or pursuant to
such other instructions as may be designated in writing by the party to receive such notice:
Martha Stewart Living Omnimedia, Inc.
601 W. 26th Street, 9th Floor
New York, NY 10001
Phone: (212) 827-8394
Email: ahoffman@marthastewart.com
Attention: Allison Hoffman
with a copy (which shall not constitute notice) to:
Debevoise & Plimpton LLP
919 Third Avenue
New York, NY 10022
Phone: (212) 909-6226
Email: rdbohm@debevoise.com
Attention: Richard D. Bohm
| (b) | if to Sequential, TopCo, Singer Merger Sub or Madeline
Merger Sub, to: |
Sequential Brands Group, Inc.
5 Bryant Park, 30th Floor
New York, NY 10018
Phone: (646) 564-2577
Email: yshmidman@sbg-ny.com
Attention: Yehuda Shmidman
with a copy (which shall not constitute notice) to:
Gibson, Dunn & Crutcher LLP
200 Park Avenue
New York, NY 10166-0193
Phone: (212) 351-4062
Email: bbecker@gibsondunn.com
Attention: Barbara L. Becker
9.4 Definitions.
Capitalized terms used in this Agreement shall have the respective meanings ascribed thereto in the sections of this Agreement
set forth next to such terms on Annex A hereto. For purposes of this Agreement:
“Adjusted Cash Conversion Number”
shall mean the Cash Conversion Number less the aggregate MSLO Cash Consideration payable pursuant to Section 2.4(b)(i).
“Affiliate” of any Person
means another Person that directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common
control with, such first Person.
“Business Day” means any
day other than (i) a Saturday or a Sunday or (ii) a day on which banking and savings and loan institutions are authorized
or required by Law to be closed in New York City.
“Contract” means any binding
written or oral contract (other than immaterial oral contracts), agreement, instrument, lease, license, understanding, undertaking,
commitment or obligation to which any Person is a party.
“Exchange Act” means the
Securities Exchange Act of 1934, as amended.
“GAAP” means United States
generally accepted accounting principles, consistently applied.
“Governmental Entity”
means any nation or government, any state, agency, commission, or other political subdivision thereof, any insurance regulatory
authority, any self-regulatory authority, or any entity (including a court) of competent jurisdiction properly exercising executive,
legislative, judicial or administrative functions of the government.
“Intellectual Property”
means all U.S. and non-U.S. (a) trademarks, service marks, logos, symbols, brand names, trade names, trade dress, domain names
and other indicia of origin, all registrations and applications for all of the foregoing, including all extensions, modifications
and renewals thereof, and all goodwill associated with the foregoing (collectively, “Marks”), (b) published
works of authorship (including software and computer programs), copyrights therein and thereto, and all registrations and applications
for all of the foregoing, including all renewals, extensions, restorations and reversions thereof (collectively, “Copyrights”),
(c) patents and patent applications, including divisionals, continuations, continuations-in-part, renewals, provisionals,
extensions, reexaminations and reissues thereof (collectively, “Patents”), (d) inventions, discoveries,
proprietary methods, processes, trade secrets, know-how, proprietary information, schematics, databases, formulae, drawings, prototypes,
models, designs and customer lists (collectively, “Trade Secrets”), and (e) all other similar intellectual
property or proprietary rights.
“knowledge of MSLO” or
“knowledge” when used in reference to MSLO means the actual knowledge of those individuals listed in Section
9.4 of the MSLO Disclosure Schedule, after due inquiry.
“knowledge of Sequential”
or “knowledge” when used in reference to Sequential means the actual knowledge of those individuals listed
in Section 9.4 of the Sequential Disclosure Schedule, after due inquiry.
“Law” means any statute,
law, ordinance, rule or regulation (domestic or foreign) issued, promulgated or entered into by or with any Governmental Entity.
“Lien” means any charge,
claim, limitation, condition, equitable interest, mortgage, lien, option, pledge, security interest, easement, encroachment, right
of first refusal, adverse claim or restriction of any kind, including any restriction on or transfer or other assignment, as security
or otherwise, of or relating to use, quiet enjoyment, voting, transfer, receipt of income or exercise of any other attribute of
ownership.
“MSLO Material Adverse Effect”
means any change, state of facts, circumstance, occurrence, development, event or effect that, individually or in the aggregate,
is materially adverse to (A) the financial condition, properties, assets, liabilities, businesses or results of operations
of MSLO and the MSLO Subsidiaries, taken as a whole, excluding any such change, state of facts, circumstance, event or effect
to the extent caused by or resulting from (i) the execution, delivery and announcement of this Agreement and the transactions
contemplated hereby, including litigation resulting therefrom or with respect thereto, and any adverse change in business relationships
resulting therefrom or with respect thereto, including as a result of the identity of the other party to the Mergers, (ii) changes
in economic, market, business, regulatory or political conditions generally or global financial markets, (iii) changes, circumstances
or events generally affecting the industries in which MSLO and the MSLO Subsidiaries operate, (iv) changes in any Law or
GAAP following the date hereof, (v) the mere failure of MSLO or any of its Subsidiaries to meet, with respect to any period or
periods, any internal or industry analyst projections, forecasts, estimates of earnings or revenues, or business plans (it being
agreed that the facts or circumstances giving rise to such failure that are not otherwise excluded from the definition of MSLO
Material Adverse Effect may be taken into account in determining whether a MSLO Material Adverse Effect has occurred), (vi) any
change, in and of itself, in the market price or trading volume of the MSLO Common Stock (it being agreed that the facts or circumstances
giving rise to such change that are not otherwise excluded from the definition of MSLO Material Adverse Effect may be taken into
account in determining whether a MSLO Material Adverse Effect has occurred), or (vii) the taking of any action expressly required
by this Agreement, except in the case of the foregoing clauses (ii), (iii) and (iv) to the extent those changes, state of
facts, circumstances, events, or effects have a materially disproportionate effect on MSLO and the MSLO Subsidiaries taken as
a whole relative to other companies operating in industries in which MSLO and the MSLO Subsidiaries operate, and/or (B) the
ability of MSLO to perform its obligations under this Agreement.
“MSLO Registered Intellectual Property”
means any Registered Intellectual Property owned by MSLO or any of its Subsidiaries.
“Order” means any order,
writ, injunction, decree, judgment or stipulation issued, promulgated or entered into by or with any Governmental Entity.
“Permitted Liens” means
(a) any Liens for Taxes or other governmental charges not yet due and payable or the amount of which is being contested in
good faith by appropriate proceedings and for which adequate accruals or reserves have been established in accordance with GAAP,
(b) carriers’, warehousemen’s, mechanics’, materialmen’s, repairmen’s, workmen’s, landlords’
or other similar Liens, (c) pledges or deposits in the ordinary course of business and on a basis consistent with past practice
in connection with workers’ compensation, unemployment insurance or other social security legislation, (d) non-monetary
Liens that do not, individually or in the aggregate, materially impair the continued or contemplated use or operation of the property
to which they relate, (e) statutory Liens arising by operation of Law with respect to a liability incurred in the ordinary
course of business on a basis consistent with past practice which is not yet due or payable or which is being contested in good
faith by appropriate proceedings and for which adequate accruals or reserves have been established in accordance with GAAP, (f) immaterial
easements, rights of way or other similar matters or restrictions or exclusions that would be shown by a current title report
or other similar report and that do not, individually or in the aggregate, materially impair the continued or contemplated use
or operation of the property to which they relate, (g) transfer restrictions imposed by applicable securities laws, (h) Liens
that are disclosed on the MSLO Balance Sheet or the Sequential Balance Sheet, as applicable and (i) Liens listed in Section 10.2
of the MSLO Disclosure Schedule or Section 10.2 of the Sequential Disclosure Schedule, as applicable.
“Person” means any natural
person, firm, corporation, partnership, company, limited liability company, trust, joint venture, association, Governmental Entity
or other entity.
“Registered” shall mean
issued, registered, renewed or the subject of a pending application.
“Related Party” has the
meaning set forth in Item 404 of Regulation S-K under the Exchange Act.
“Securities Act” means
the Securities Act of 1933, as amended.
“Sequential Material Adverse Effect”
means any change, state of facts, circumstance, occurrence, development, event or effect that, individually or in the aggregate,
is materially adverse to (A) the financial condition, properties, assets, liabilities, businesses or results of operations
of Sequential and the Sequential Subsidiaries, taken as a whole, excluding any such change, state of facts, circumstance, event
or effect to the extent caused by or resulting from (i) the execution, delivery and announcement of this Agreement and the
transactions contemplated hereby, including litigation resulting therefrom or with respect thereto, and any adverse change in
business relationships resulting therefrom or with respect thereto, including as a result of the identity of the other party to
the Mergers, (ii) changes in economic, market, business, regulatory or political conditions generally or global financial
markets, (iii) changes, circumstances or events generally affecting the industries in which Sequential and the Sequential
Subsidiaries operate, (iv) changes in any Law or GAAP following the date hereof, (v) the mere failure of Sequential or any
of its Subsidiaries to meet, with respect to any period or periods, any internal or industry analyst projections, forecasts, estimates
of earnings or revenues, or business plans (it being agreed that the facts or circumstances giving rise to such failure that are
not otherwise excluded from the definition of Sequential Material Adverse Effect may be taken into account in determining whether
a Sequential Material Adverse Effect has occurred), (vi) any change, in and of itself, in the market price or trading volume of
the Sequential Common Stock (it being agreed that the facts or circumstances giving rise to such change that are not otherwise
excluded from the definition of Sequential Material Adverse Effect may be taken into account in determining whether a Sequential
Material Adverse Effect has occurred), or (vii) the taking of any action expressly required by this Agreement, except in the case
of the foregoing clauses (ii), (iii), and (iv) to the extent those changes, state of facts, circumstances, events, or effects
have a materially disproportionate effect on Sequential and the Sequential Subsidiaries taken as a whole relative to other companies
operating in industries in which Sequential and the Sequential Subsidiaries operate, and/or (B) the ability of Sequential
to perform its obligations under this Agreement.
“Sequential Registered Intellectual
Property” means any Registered Intellectual Property owned by Sequential or any of its Subsidiaries.
“Subsidiary” means, with
respect to any Person, another Person in which such first Person owns, directly or indirectly, an amount of the voting securities,
other voting ownership or voting partnership interests which is sufficient to elect at least a majority of its board of directors
or other governing body (or, if there are no such voting interests, 50% or more of the equity interests of such Person).
“Tax” means all income,
gross receipts, franchise, sales, use, ad valorem, property, payroll, withholding, excise, severance, transfer, employment, estimated,
alternative or add-on minimum, value added, stamp, occupation, premium, environmental and windfall profits taxes, and other taxes,
charges, fees, levies, imposts, customs, duties, licenses or other assessments, together with any interest, additions to tax and
any penalties.
“Tax Return” means any
statement, report, return, information return or claim for refund relating to Taxes (including any elections, declarations, schedules
or attachments thereto and any amendment to any of the foregoing).
“Termination Fee” means
(a) if payable in connection with the termination of this Agreement on or prior to the 45th calendar day following the date of
this Agreement either (x) by MSLO pursuant to Section 8.1(i) in order to enter into an Alternative Acquisition Agreement
with an Excluded Party or (y) by Sequential pursuant to Section 8.1(h) and the event giving rise to such termination is
the submission of an Acquisition Proposal by an Excluded Party, then, in either case, an amount equal to $7,500,000 and (b) if
payable in any other circumstance, an amount equal to $12,800,000.
“Treasury Regulations”
means the regulations (including temporary regulations) of the United States Treasury Department pertaining to the Internal Revenue
Code.
9.5 Interpretation. When
a reference is made in this Agreement to a Section, Article or Exhibit, such reference shall be to a Section, Article or Exhibit
of this Agreement, unless otherwise indicated. The table of contents and headings contained in this Agreement or in any Exhibit
are for convenience of reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.
All words used in this Agreement will be construed to be of such gender or number as the circumstances require. Any capitalized
terms used in any Exhibit but not otherwise defined therein shall have the meaning set forth in this Agreement. All Exhibits annexed
hereto or referred to herein are hereby incorporated in and made a part of this Agreement as if set forth herein. The word “including”
and words of similar import when used in this Agreement will mean “including, without limitation,” unless otherwise
specified. All references to “dollars” or “$” or “US$” in this Agreement refer to the lawful
currency of the United States. The words “made available” shall include, without limitation, those documents or information
made available in an electronic dataroom or website or in a physical dataroom, in each case, to which the intended recipient or
its representatives had access, or such item was otherwise available on the SEC’s public website (www.sec.gov).
9.6 Severability. Whenever
possible, each provision or portion of any provision of this Agreement shall be interpreted in such manner as to be effective
and valid under applicable Law, but if any provision or portion of any provision of this Agreement is held to be invalid, illegal
or unenforceable in any respect under any applicable Law or rule in any jurisdiction, such invalidity, illegality or unenforceability
shall not affect any other provision or portion of any provision in such jurisdiction, and this Agreement shall be reformed, construed
and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision or portion of any provision had never
been contained herein.
9.7 Counterparts.
This Agreement may be executed in two or more counterparts, all of which shall be considered one and the same instrument and
shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other party.
This Agreement may be executed by facsimile or electronic transmission signature and a facsimile or electronic transmission signature
shall constitute an original for all purposes.
9.8 Entire
Agreement; No Third-Party Beneficiaries. This Agreement (including the Exhibits and Annexes hereto), taken together with
the Sequential Disclosure Schedule and the MSLO Disclosure Schedule, and the Confidentiality Agreement, (a) constitute the
entire agreement, and supersede all prior agreements (other than the Confidentiality Agreement) and understandings, both written
and oral, among the parties with respect to the Mergers and the other transactions contemplated by this Agreement and (b) are
not intended to confer upon any Person other than the parties any rights or remedies, except for (i) after the Effective Time,
the rights of the holders of MSLO Common Stock to receive the MSLO Merger Consideration and the holders of Sequential Common Stock
to receive the Sequential Merger Consideration in accordance with the terms and conditions of ARTICLE II and, after the
Effective Time, the right of the holders of MSLO Equity Awards, Sequential Equity Awards and Sequential Warrants to receive the
amounts set forth in ARTICLE II, (ii) Section 6.4 (which shall be for the benefit of the Persons set forth therein,
and any such Person will have the rights provided for therein), (iii) the rights granted to the lenders party to the Financing
Commitment and other Persons providing the Financing under this Section 9.8 and Section 8.3, Section 9.8,
Section 9.10, Section 9.12 and Section 9.13 (and each such Section shall expressly inure to the
benefit of such lenders and Persons and such lenders and Persons shall be entitled to rely on and enforce the provisions of such
Sections) and (iv) this ARTICLE IX in respect of the Sections set forth under the foregoing clauses (i), (ii) and (iii).
9.9 Governing
Law. This Agreement and all disputes or controversies arising out of or relating to this Agreement or the transactions contemplated
hereby shall be governed by, and construed in accordance with, the internal laws of the State of Delaware, without regard to the
laws of any other jurisdiction that might be applied because of the conflicts of laws principles of the State of Delaware.
9.10 Assignment;
Successors. Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned or
delegated, in whole or in part, by operation of law or otherwise, by any party without the prior written consent of the other
parties, and any such assignment without such prior written consent shall be null and void. Subject to the preceding sentence,
this Agreement will be binding upon, inure to the benefit of, and be enforceable by, the parties and their respective successors
and assigns.
9.11 Specific
Enforcement. The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise breached. Accordingly, each of the parties shall
be entitled to specific performance of the terms hereof, including an injunction or injunctions to prevent breaches of this Agreement
and to enforce specifically the terms and provisions of this Agreement in the Court of Chancery of the State of Delaware; provided,
that if jurisdiction is not then available in the Court of Chancery of the State of Delaware, then in any federal court located
in the State of Delaware, this being in addition to any other remedy to which such party is entitled at law or in equity. The
parties further agree not to assert that a remedy of specific enforcement is unenforceable, invalid, contrary to Law or inequitable
for any reason, nor to object to a remedy of specific performance on the basis that a remedy of monetary damages would provide
an adequate remedy for any such breach. Each party further agrees that no other party hereto or any other Person shall be required
to obtain, furnish or post any bond or similar instrument in connection with or as a condition to obtaining any remedy referred
to in this Section 9.11, and each party hereto irrevocably waives any right it may have to require the obtaining,
furnishing or posting of any such bond or similar instrument. The equitable remedies described in this Section 9.11 shall
be in addition to, and not in lieu of, any other remedies at law or in equity that the parties to this Agreement may elect to
pursue consistent with the terms of this Agreement.
9.12 Submission
to Jurisdiction. Each of the parties irrevocably agrees that any legal action or proceeding arising out of or relating
to this Agreement brought by any party or its Affiliates against any other party or its Affiliates shall be brought and determined
in the Court of Chancery of the State of Delaware; provided, that if jurisdiction is not then available in the Court of
Chancery of the State of Delaware, then any such legal action or proceeding may be brought in any federal court located in the
State of Delaware. Each of the parties hereby irrevocably submits to the jurisdiction of the aforesaid courts for itself and with
respect to its property, generally and unconditionally, with regard to any such action or proceeding arising out of or relating
to this Agreement and the transactions contemplated hereby. Each of the parties agrees not to commence any action, suit or proceeding
relating thereto except in the courts described above in Delaware, other than actions in any court of competent jurisdiction to
enforce any judgment, decree or award rendered by any such court in Delaware as described herein. Each of the parties further
agrees that notice as provided herein shall constitute sufficient service of process and the parties further waive any argument
that such service is insufficient. Each of the parties hereby irrevocably and unconditionally waives, and agrees not to assert,
by way of motion or as a defense, counterclaim or otherwise, in any action or proceeding arising out of or relating to this Agreement
or the transactions contemplated hereby, (a) any claim that it is not personally subject to the jurisdiction of the courts
in Delaware as described herein for any reason, (b) that it or its property is exempt or immune from jurisdiction of any
such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment,
attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) that (i) the suit, action or
proceeding in any such court is brought in an inconvenient forum, (ii) the venue of such suit, action or proceeding is improper
or (iii) this Agreement, or the subject matter hereof, may not be enforced in or by such courts. Notwithstanding the foregoing,
each party hereto hereby (v) agrees that it will not bring or support any action, clause of action, claim, cross-claim or third-party
claim of any kind or description, whether in law or equity, whether in contract or in tort or otherwise, against the lenders party
to the Financing Commitment and any other Person providing Financing in any way relating to this Agreement, the Financing Commitments
or any of the transactions contemplated hereby or thereby, including without limitation any dispute arising out of or relating
in any way to the Financing or the performance thereof or the transactions contemplated thereby, in any forum other than exclusively
in the Supreme Court of the State of New York, County of New York, or, if under applicable Law exclusive jurisdiction is vested
in the federal courts, the United States District Court for the Southern District of New York (and appellate courts thereof),
(w) submits for itself and its property with respect to any such action to the exclusive jurisdiction of such courts, (x) agrees
that service of process, summons, notice or document by registered mail addressed to it at its address provided in Section 9.3
shall be effective service of process against it for any such action brought in any such court, (y) waives and hereby irrevocably
waives, to the fullest extent permitted by Law, any objection which it may now or hereafter have to the laying of venue of, and
the defense of an inconvenient forum to the maintenance of, any such action in any such court and (z) agrees that a final judgment
in any such action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner
provided by Law.
9.13 Waiver
of Jury Trial. EACH OF THE PARTIES TO THIS AGREEMENT HEREBY IRREVOCABLY WAIVES ALL RIGHT TO A TRIAL BY JURY IN ANY ACTION,
PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE FINANCING COMMITMENTS OR THE TRANSACTIONS CONTEMPLATED
HEREBY OR THEREBY.
9.14 No
Presumption Against Drafting Party. Each of MSLO and Sequential acknowledges that each party to this Agreement has been represented
by counsel in connection with this Agreement and the transactions contemplated by this Agreement. Accordingly, any rule of law
or any legal decision that would require interpretation of any claimed ambiguities in this Agreement against the drafting party
has no application and is expressly waived.
[Remainder of page left intentionally
blank]
IN WITNESS WHEREOF, the parties hereto
have caused this Agreement to be executed by their respective officers thereunto duly authorized as of the date first above written.
|
MARTHA STEWART LIVING OMNIMEDIA, INC. |
|
|
|
By: |
/s/ Daniel W. Dienst |
|
Name: |
Daniel W. Dienst |
|
Title: |
Chief Executive Officer |
|
|
|
|
MADELINE MERGER SUB, INC. |
|
|
|
|
By: |
/s/ Yehuda Shmidman |
|
Name: |
Yehuda Shmidman |
|
Title: |
Chief Executive Officer |
|
|
|
|
SEQUENTIAL BRANDS GROUP, INC. |
|
|
|
|
By: |
/s/ Yehuda Shmidman |
|
Name: |
Yehuda Shmidman |
|
Title: |
Chief Executive Officer |
|
|
|
|
SINGER MERGER SUB, INC. |
|
|
|
|
By: |
/s/ Yehuda Shmidman |
|
Name: |
Yehuda Shmidman |
|
Title: |
Chief Executive Officer |
|
|
|
|
SINGER MADELINE HOLDINGS, INC. |
|
|
|
|
By: |
/s/ Yehuda Shmidman |
|
Name: |
Yehuda Shmidman |
|
Title: |
Chief Executive Officer |
Signature page to Merger Agreement
ANNEX A
DEFINED
TERMS
Defined Term |
|
Section
Number |
|
|
|
Acceptable Confidentiality Agreement |
|
5.5(b) |
Acquisition Proposal |
|
5.5(h)(i) |
Adjusted Cash Conversion Number |
|
9.4 |
Adverse Recommendation Change |
|
5.5(c)(i) |
Affiliate |
|
9.4 |
Agreement |
|
Preamble |
Alternative Acquisition Agreement |
|
5.5(c)(ii) |
Book-Entry Shares |
|
2.2(b) |
Business Day |
|
9.4 |
Cash Conversion Number |
|
2.4(a) |
Cash Election |
|
2.1(a)(i) |
Cash Election Share |
|
2.1(a)(i) |
Certificate |
|
2.2(b) |
Closing |
|
1.2 |
Closing Date |
|
1.2 |
Code |
|
Recitals |
Confidentiality Agreement |
|
6.2 |
Continuing Employees |
|
6.11(a) |
Contract |
|
9.4 |
Copyrights |
|
9.4 |
DGCL |
|
1.1(a) |
Dissenting Shares |
|
2.1(f) |
Effective Time |
|
1.3 |
Election |
|
2.3(a) |
Election Deadline |
|
2.3(d) |
End Date |
|
8.1(c) |
Environmental Laws |
|
3.15(b)(i) |
Environmental Permits |
|
3.15(b)(ii) |
ERISA |
|
3.13(a) |
Excess Shares |
|
2.2(e) |
Exchange Act |
|
9.4 |
Exchange Agent |
|
2.2(a) |
Exchange Fund |
|
2.2(a) |
Excluded Party |
|
5.5(h)(ii) |
Expense Reimbursement |
|
8.2(b) |
Financing |
|
4.18 |
Financing Commitments |
|
4.18 |
Form of Election |
|
2.3(b) |
Form S-4 |
|
3.4 |
GAAP |
|
9.4 |
Annex A
Governmental Entity |
|
9.4 |
Hazardous Materials |
|
3.15(b)(iii) |
HSR Act |
|
3.4 |
Indemnified Parties |
|
6.4(a) |
Information Statement |
|
3.4 |
Intellectual Property |
|
9.4 |
Intervening Event |
|
5.5(h)(iii) |
IRS |
|
3.13(a) |
IT Systems |
|
3.16(h) |
knowledge of MSLO |
|
9.4 |
knowledge of Sequential |
|
9.4 |
Law |
|
9.4 |
Lien |
|
9.4 |
Madeline Merger Sub |
|
Preamble |
Marks |
|
9.4 |
Measurement Date |
|
3.2(a) |
Merger Consideration |
|
2.1(b)(i) |
Merger Subs |
|
Preamble |
Mergers |
|
Recitals |
MSLO |
|
Preamble |
MSLO Balance Sheet |
|
3.6(j) |
MSLO Benefit Plan |
|
3.13(a) |
MSLO Board |
|
3.3 |
MSLO Book-Entry Shares |
|
2.2(b) |
MSLO Cash Consideration |
|
2.1(a)(i) |
MSLO Certificate |
|
2.2(b) |
MSLO Certificate of Merger |
|
1.3 |
MSLO Class A Common Stock |
|
Recitals |
MSLO Class B Common Stock |
|
Recitals |
MSLO Common Stock |
|
Recitals |
MSLO Disclosure Schedule |
|
Article III |
MSLO Effective Time |
|
1.3 |
MSLO Equity Awards |
|
2.1(d)(v) |
MSLO Holder |
|
2.3 |
MSLO Leased Real Properties |
|
3.11 |
MSLO Material Adverse Effect |
|
9.4 |
MSLO Material Contract |
|
3.17(a) |
MSLO Maximum Amount |
|
6.4(b) |
MSLO Merger |
|
Recitals |
MSLO Merger Consideration |
|
2.1(a)(i) |
MSLO Owned IP |
|
3.16(a) |
MSLO Performance RSU Award |
|
2.1(d)(iv) |
MSLO Performance Stock Option |
|
2.1(d)(ii) |
MSLO Preferred Stock |
|
3.2(a) |
MSLO Real Property Leases |
|
3.11 |
MSLO Registered Intellectual Property |
|
9.4 |
Annex A
MSLO RSU Award |
|
2.1(d)(iii) |
MSLO SEC Documents |
|
3.6(a) |
MSLO Stock Consideration |
|
2.1(a)(i) |
MSLO Stock Option |
|
2.1(d)(i) |
MSLO Stockholder Approval |
|
3.3 |
MSLO Stockholders Meeting |
|
6.1(b) |
MSLO Support Agreement |
|
Recitals |
MSLO Supporting Stockholders |
|
Recitals |
MSLO Surviving Corporation |
|
Recitals |
Nasdaq |
|
2.1(a)(iii) |
New Benefit Plans |
|
6.11(b) |
New Entity Organizational Documents |
|
4.23(a) |
No Shop Period Start Date |
|
5.5(a) |
Non-Election Share |
|
2.1(a)(i) |
NYSE |
|
3.4 |
Order |
|
9.4 |
Patents |
|
9.4 |
Permits |
|
3.9(b) |
Permitted Liens |
|
9.4 |
Person |
|
9.4 |
Proxy Statement/Prospectus |
|
3.4 |
Registered |
|
9.4 |
Related Party |
|
9.4 |
Representatives |
|
5.5(a) |
Sarbanes-Oxley Act |
|
3.6(a) |
SEC |
|
3.6(a) |
Securities Act |
|
9.4 |
Sequential |
|
Preamble |
Sequential Balance Sheet |
|
4.6(j) |
Sequential Benefit Plan |
|
4.13(a) |
Sequential Board |
|
4.3 |
Sequential Book-Entry Shares |
|
2.2(b) |
Sequential Certificate |
|
2.2(b) |
Sequential Certificate of Merger |
|
1.3 |
Sequential Common Stock |
|
Recitals |
Sequential Disclosure Schedule |
|
Article IV |
Sequential Effective Time |
|
1.3 |
Sequential Equity Awards |
|
2.1(e)(v) |
Sequential Exchange Ratio |
|
2.1(b)(i) |
Sequential Leased Real Properties |
|
4.11 |
Sequential Material Adverse Effect |
|
9.4 |
Sequential Material Contract |
|
4.17(a) |
Sequential Maximum Amount |
|
6.4(b) |
Sequential Merger |
|
Recitals |
Sequential Merger Consideration |
|
2.1(b)(i) |
Sequential Owned IP |
|
4.16(a) |
Annex A
Sequential Preferred Stock |
|
4.2(a)(i) |
Sequential Real Property Leases |
|
4.11 |
Sequential Registered Intellectual Property |
|
9.4 |
Sequential Restricted Stock Award |
|
2.1(e)(iii) |
Sequential RSU Award |
|
2.1(e)(ii) |
Sequential SEC Documents |
|
4.6(a) |
Sequential Stock Option |
|
2.1(e)(i) |
Sequential Stockholder Approval |
|
4.3 |
Sequential Surviving Corporation |
|
Recitals |
Sequential Trading Price |
|
2.1(a)(iii) |
Sequential Warrant |
|
2.1(e)(iv) |
Sequential Written Consent |
|
6.5 |
Shortfall Number |
|
2.4(b)(ii) |
Singer Merger Sub |
|
Preamble |
Special Committee |
|
Recitals |
Stock Election |
|
2.1(a)(i) |
Stock Election Share |
|
2.1(a)(i) |
Subsidiary |
|
9.4 |
Superior Proposal |
|
5.5(h)(iv) |
Takeover Laws |
|
6.7 |
Tax |
|
9.4 |
Tax Return |
|
9.4 |
Termination Fee |
|
9.4 |
TopCo |
|
Preamble |
TopCo Common Stock |
|
Recitals |
Total Cash Election Number |
|
2.4(b)(i) |
Trade Secrets |
|
9.4 |
Treasury Regulations |
|
9.4 |
Annex A
Exhibit 3.2
AMENDED AND RESTATED BYLAWS
OF
SEQUENTIAL BRANDS GROUP, INC.
ARTICLE
I
OFFICES
Section
1. Delaware Registered Office. The address of the registered
office of Sequential Brands Group, Inc. (f/k/a People’s Liberation, Inc., f/k/a Century Pacific Financial Corporation) (hereinafter
called the “Corporation”) in the State of Delaware and the name of the registered agent at such address shall be as
specified in the Certificate of Incorporation or, if subsequently changed, as specified in the most recent statement of change
filed pursuant to law. The address of the registered office may be changed from time to time by the board of directors of the Corporation
(the “Board of Directors”).
Section
2. Other Offices. The Corporation shall have its principal
office at 5 Bryant Park, 30th Floor, New York, New York 10018. The Corporation may also have other offices, both within
and without the State of Delaware, as the Board of Directors from time to time shall determine or the business of the Corporation
may require.
ARTICLE
II
MEETINGS OF THE STOCKHOLDERS
Section
1. Times and Places of Meetings. Meetings of stockholders
for any purpose may be held at such time and place, if any, either within or without the State of Delaware, as shall be stated
in the notice of the meeting or in a duly executed waiver of notice thereof.
Section
2. Annual Meetings. The annual meeting of the stockholders,
for the election of directors and for the transaction of such other business as may properly come before the meeting, shall be
held at such place, if any, on such date, and at such time as the Board of Directors shall fix each year.
Section
3. Special Meetings. Special meetings of stockholders,
for any purpose or purposes, may be called only by the chairperson of the Board of Directors, the president, the secretary or a
majority of the Board of Directors and shall be called by the chairperson of the Board of Directors, the president, secretary or
a majority of the Board of Directors upon the written demand of the holders of not less than 80% of all the votes entitled to be
cast on any issue proposed to be considered at the meeting. Any stockholder seeking to call a special meeting of stockholders by
written demand shall deliver a notice thereof in proper written form and in timely manner to the secretary of the Corporation.
To be in proper written form, such notice shall comply with the requirements of Section 16 of this Article II. The Board of Directors
shall promptly, but in all events within ten (10) days after the date such notice is received, adopt a resolution fixing the record
date for determining stockholders entitled to demand a special meeting. If not otherwise fixed by the Board of Directors, the record
date for determining stockholders entitled to demand a special meeting shall be at the close of business on the day the first stockholder
signs such demand. The Board of Directors may postpone or reschedule any special meeting previously scheduled by the chairperson
of the Board of Directors, the Board of Directors, chief executive officer or president.
Section
4. Notice of Meetings. A notice stating the place, if
any, date and hour of the meeting, and in the case of a special meeting, the purpose or purposes for which the meeting is called,
shall be given not less than ten (10) nor more than sixty (60) days before the date of the meeting or as otherwise provided by
law, including in the case of a meeting at which the stockholders are asked to consider a merger, consolidation, share exchange,
dissolution or sale, lease or exchange of assets, to each stockholder of record entitled to vote at such meeting. If mailed, such
notice shall be deemed to be delivered when deposited in the United States mail addressed to the stockholder at the stockholder’s
address as it appears on the records of the Corporation, with postage thereon prepaid.
Section
5. Adjournments. Only the chairperson of the meeting of
stockholders, annual or special, may adjourn such meeting from time to time to reconvene at a different time or place, if any,
and notice need not be given of the adjourned meeting if the time and place, if any, thereof, and the means of remote communications,
if any, by which stockholders and proxyholders may be deemed to be present in person and vote at such adjourned meeting are announced
at the meeting at which the adjournment is taken; provided, however, that if the date of any adjourned meeting is more than thirty
(30) days after the date for which the meeting was originally noticed, or if a new record date is fixed for the adjourned meeting,
notice of the place, if any, date, and time of the adjourned meeting and the means of remote communications, if any, by which stockholders
and proxyholders may be deemed to be present in person and vote at such adjourned meeting, shall be given in conformity herewith.
At any adjourned meeting, any business may be transacted which might have been transacted at the original meeting.
Section
6. Waiver of Notice. Whenever any notice whatsoever is
required to be given under the provisions of the General Corporation Law of the State of Delaware (the “DGCL”) or the
certificate of incorporation or these bylaws, a waiver thereof in writing signed by the person or persons entitled to such notice,
whether before or after the time stated therein, shall be deemed equivalent to the giving of such notice. Attendance at any meeting,
either annual or special, shall constitute waiver of notice thereof, unless the person objects to the holding of the meeting in
writing because proper notice was not given.
Section
7. Record Date. For the purpose of determining stockholders
entitled to notice of any meeting of stockholders, or stockholders entitled to receive payment of any dividend, or to make a determination
of stockholders for any other proper purpose (other than action by consent in writing without a meeting), the Board of Directors
may fix in advance a date as the record date for any such determination of stockholders, such date in any case to be not more than
sixty (60) days and, for a meeting of stockholders, not less than ten (10) days or in the case of a meeting at which the stockholders
are asked to consider a merger, consolidation, share exchange, dissolution or sale, lease or exchange of assets, not less than
twenty (20) days, immediately preceding such meeting or other action. If the Board of Directors so fixes a record date for determining
stockholders entitled to notice of any meeting, such date shall also be the record date for determining the stockholders entitled
to vote at such meeting unless the Board of Directors determines, at the time it fixes such record date, that a later date on or
before the date of the meeting shall be the date for making such determination. If no record date is fixed for the determination
of stockholders entitled to notice of or to vote at a meeting of stockholders, the close of business on the day next preceding
the date on which notice of the meeting is given (or, if notice is waived, at the close of business on the day next preceding the
day on which the meeting is held) shall be the record date for such determination of stockholders. The provisions of this Section
7 do not apply to the determination of the record date for stockholders entitled to consent to corporate action in writing without
a meeting.
Section
8. List of Stockholders. The officer or agent having charge
of the share ledger or transfer books for shares of the Corporation shall make, at least ten (10) days before every meeting of
stockholders, a complete list of the stockholders entitled to vote at such meeting, arranged in alphabetical order, with the address
of and the number of shares of each class of capital stock of the Corporation registered in the name of each stockholder; provided,
that if the record date for determining the stockholders entitled to vote is less than ten days before the date of the meeting,
the list shall reflect the stockholders entitled to vote as of the tenth day before the meeting date. Such list of stockholders,
for ten (10) days before such meeting, shall be kept on file at the principal place of business of the Corporation or on a reasonably
accessible electronic network (provided the information required to access such network is made available to stockholders) and
shall be subject to inspection by any stockholder, and to copying at the stockholder’s expense, at any time during usual
business hours. If the meeting is to be held at a place, such list shall also be produced and kept open at the time and place of
the meeting and shall be subject to the inspection by any stockholder during the whole time of the meeting. Except as provided
by applicable law, the original share ledger or transfer book, or a duplicate thereof kept in the State of Delaware, shall be the
only evidence as to who are the stockholders entitled to examine such list or share ledger or transfer book or to vote at any meeting
of stockholders.
Section
9. Quorum. A majority of the outstanding shares entitled
to vote on a matter, represented in person or by proxy, shall constitute a quorum for consideration of such matter at any meeting
of stockholders; provided, that if less than a majority of such outstanding shares are represented at the meeting, a majority of
the shares so represented may adjourn the meeting from time to time without further notice until a quorum shall attend. Where a
separate vote by a class or series is required, a majority of the shares of such class or series represented in person or by proxy
shall constitute a quorum to take the action with respect to that vote by that class or series on that matter. If a quorum is present,
the affirmative vote of the majority of such shares represented at the meeting and entitled to vote on a matter shall be the act
of the stockholders, unless the vote of a greater number or voting by classes is required by the DGCL, the certificate of incorporation
or these bylaws. If a quorum fails to attend the meeting, the chairperson of the meeting may adjourn the meeting to another place,
if any, date or time.
Section
10. Proxies. Each stockholder entitled to vote at a meeting
of stockholders or to express consent to corporate action in writing without a meeting may authorize another person or persons
to act for such stockholder by proxy, but no such proxy shall be voted or acted upon after eleven (11) months from its date, unless
the proxy provides for a longer period. A proxy shall be irrevocable if it states that it is irrevocable and if, and only as long
as, it is coupled with an interest sufficient in law to support an irrevocable power. A stockholder may revoke any proxy which
is not irrevocable by attending the meeting and voting in person or by delivering to the Secretary of the Corporation a revocation
of the proxy or a new proxy bearing a later date. Voting at meetings of stockholders need not be by written ballot.
Section
11. Voting of Shares. Except as otherwise provided by the certificate
of incorporation or by resolutions of the Board of Directors providing for the issue of any shares of preferred or special classes
in series, each outstanding share, regardless of class, shall be entitled to one vote on each matter submitted to a vote at a meeting
of stockholders.
Section
12. Voting of Shares by Certain Holders. Shares registered in
the name of another Corporation, domestic or foreign, may be voted by any officer, agent, proxy or other legal representative authorized
to vote such shares under the law of incorporation of such Corporation. The Corporation may treat the president or other person
holding the position of chief executive officer of such other Corporation as authorized to vote such shares, together with any
other person indicated and any other holder of an office indicated by the corporate stockholder to the Corporation as a person
or an office authorized to vote such shares. Such persons and offices indicated shall be registered by the Corporation on the transfer
books for shares and included in any voting list prepared in accordance with the DGCL and these bylaws. Shares registered in the
name of a deceased person, a minor ward or a person under legal disability may be voted by such person’s administrator, executor
or court-appointed guardian, either in person or by proxy, without a transfer of such shares into the name of such administrator,
executor or court-appointed guardian. Shares registered in the name of a trustee may be voted by such trustee, either in person
or by proxy. Shares registered in the name of a receiver may be voted by such receiver, and shares held by or under the control
of a receiver may be voted by such receiver without the transfer thereof into the receiver’s name if authority so to do is
contained in an appropriate order of the court by which such receiver was appointed. A stockholder whose shares are pledged may
vote such shares until the shares have been transferred into the name of the pledgee, and thereafter the pledgee shall be entitled
to vote the shares so transferred. Shares of the Corporation owned by the Corporation shall not be voted, directly or indirectly,
at any meeting and shall not be counted in determining the total number of outstanding shares entitled to vote at any given time,
but shares of the Corporation held by the Corporation in a fiduciary capacity may be voted and shall be counted in determining
the total number of outstanding shares entitled to vote at any given time.
Section
13. Inspectors at Meetings of Stockholders. The Board of Directors,
in advance of any meeting of stockholders, may appoint one or more inspectors, who may be employees of the Corporation, to act
at such meeting or any adjournment thereof and make a written report thereof. If inspectors of election are not so appointed, the
chairperson of the meeting may, or upon the request of any stockholder shall, appoint one or more persons as inspectors for such
meeting. Such inspectors shall ascertain and report the number of shares represented at the meeting, based upon their determination
of the validity and effect of proxies; count all votes and report the results; and do such other acts as are proper to conduct
the election and voting with impartiality and fairness to all the stockholders. Each report of an inspector shall be in writing
and signed by the inspector or by a majority of them if there is more than one inspector acting at such meeting. If there is more
than one inspector, the report of a majority shall be the report of the inspectors. The report of the inspector or inspectors on
the number of shares represented at the meeting and the results of the voting shall be prima facie evidence thereof. For the avoidance
of doubt, the provisions of this Section 13 do not apply to the inspection of consents in writing to take corporate action and/or
any revocation or revocations of such consents.
Section
14. Voting by Ballot. Voting on any question or in any election
may be by voice vote, unless the presiding officer shall order that voting be by ballot.
Section
15. Organization of Meetings. The Board of Directors of the
Corporation may adopt by resolution such rules and regulations for the conduct of the meeting of the stockholders as it shall deem
appropriate. At each meeting of stockholders, one of the following persons shall act as chairperson and shall preside thereat,
in the following order of precedence: the chairperson of the Board of Directors; the chief executive officer; president; any vice-president
acting in place of the president as provided by these bylaws; any person designated by the affirmative vote of the holders of a
majority of the shares represented at the meeting in person or by proxy and entitled to vote. Except to the extent inconsistent
with such rules and regulations as adopted by the Board of Directors, the chairperson of any meeting of the stockholders shall
have the right and authority to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of
such chairperson, are appropriate for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted
by the Board of Directors or prescribed by the chairperson of the meeting, may include, without limitation, the following: (a)
the establishment of an agenda or order of business for the meeting; (b) the determination of when the polls shall open and close
for any given matter to be voted on at the meeting; (c) rules and procedures for maintaining order at the meeting and the safety
of those present; (d) limitations on attendance at or participation in the meeting to stockholders of record of the Corporation,
their duly authorized and constituted proxies or such other persons as the chairperson of the meeting shall determine; (e) restrictions
on entry to the meeting after the time fixed for the commencement thereof; and (f) limitations on the time allotted to questions
or comments by participants.
Section
16. Notice of Stockholder Business and Nominations.
(A) Meetings
of Stockholders.
1) Nominations
of persons for election to the Board of Directors and the proposal of business to be considered by the stockholders may be made
at an annual meeting of stockholders (a) pursuant to the Corporation’s notice of meeting, (b) by or at the direction of the
Board of Directors, (c) as expressly provided in the Corporation’s certificate of incorporation, or (d) by any stockholder
of record of the Corporation at the relevant time, provided that holders of the common stock of the Corporation (the “Common
Stockholders”) comply with the notice procedures set forth in Sections 16(A)(2) and (3).
2) For
nominations or other business to be properly brought before an annual meeting by a Common Stockholder, such stockholder must have
given timely notice thereof in writing to the secretary of the Corporation and such other business must be a proper matter for
stockholder action. To be timely, the Common Stockholder’s notice shall be delivered to the secretary of the Corporation
at the principal offices of the Corporation not later than the close of business on the 90th day nor earlier than the close of
business on the 120th day before the first anniversary of the preceding year’s annual meeting; provided, however, that if
the date of the annual meeting is more than 30 days before or more than 60 days after such anniversary date, notice by the Common
Stockholder to be timely must be so delivered not earlier than the close of business on the 120th day before such annual meeting
and not later than the close of business on the later of the 90th day before such annual meeting or the 10th day following the
day on which public announcement of the date of such meeting is first made. In no event shall the public announcement of an adjournment
of a meeting of stockholders commence a new time period for the giving of a Common Stockholder’s notice as described above.
Such Common Stockholder’s notice shall set forth: (a) as to each person whom the Common Stockholder proposes to nominate
for election or reelection as a director, (i) the name, age, business and residence address of such person, (ii) the principal
occupation or employment of such person, (iii) the class and number of shares of the Corporation’s common stock that are
owned beneficially and of record by such person and (iv) any other information relating to such person that is required to be
disclosed in solicitations of proxies for election of directors in an election contest, or is otherwise required, in each case
pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 14a-11
thereunder (including such person’s written consent to being named in the proxy statement as a nominee and to serving as
a director if elected); (b) as to any other business that the stockholder proposes to bring before the meeting, (i) a brief description
of the business described to be brought before the meeting, the text of the proposal or business (including the text of any resolutions
proposed for consideration and, in the event that such business includes a proposal to amend the bylaws, the language of the proposed
amendment) and the reasons for conducting such business at the meeting and (ii) a description of all agreements, arrangements,
and understandings between such Common Stockholder and beneficial owners, if any, on whose behalf such business is brought or
proposal made, on the one hand, and any other person or persons (including their names), on the other hand, in connection with
the proposal of such business by such Common Stockholder; and (c) as to the Common Stockholder giving the notice and the beneficial
owner, if any, on whose behalf the nomination or proposal is made (i) the name and address of such Common Stockholder, as they
appear on the Corporation’s books, and of such beneficial owner, if any, on whose behalf the nomination or proposal is made,
(ii)(A) the class and number of shares of the Corporation which are owned beneficially and of record by such Common Stockholder
and such beneficial owner, if any, on whose behalf the nomination or proposal is made, (B) any option, warrant, convertible security,
stock appreciation right, or similar right with an exercise or conversion privilege or a settlement payment or mechanism at a
price related to any class of shares of the Corporation or with a value derived in whole or in part from the value of any class
of shares of the Corporation, whether or not such instrument or right shall be subject to settlement in the underlying class of
capital stock of the Corporation or otherwise (a “Derivative Instrument”) directly or indirectly owned beneficially
or of record by such stockholder and beneficial owner and any other direct or indirect opportunity to profit or share in any profit
derived from any increase or decrease in the value of shares of the Corporation, (C) any proxy, contract, arrangement, understanding,
or relationship pursuant to which such stockholder and beneficial owner has a right to vote any shares of any security of the
Corporation, (D) any short interest in any security of the Corporation (for purposes of this Section 1.3 a person shall be deemed
to have a short interest in a security if such person directly or indirectly, through any contract, arrangement, understanding,
relationship or otherwise, has the opportunity to profit or share in any profit derived from any decrease in the value of the
subject security), (E) any rights to dividends on the shares of the Corporation owned beneficially by such stockholder that are
separated or separable from the underlying shares of the Corporation, (F) any proportionate interest in shares of the Corporation
or Derivative Instruments held, directly or indirectly, by a general or limited partnership in which such stockholder is a general
partner or, directly or indirectly, beneficially owns an interest in a general partner and (G) any performance-related fees (other
than an asset-based fee) that such stockholder is entitled to based on any increase or decrease in the value of shares of the
Corporation or Derivative Instruments, if any, as of the date of such notice, including without limitation any such interests
held by members of such stockholder’s immediate family sharing the same household (which information shall be supplemented
by such stockholder and beneficial owner, if any, not later than 10 days after the record date for the meeting to disclose such
ownership as of the record date), (iii) any material interest of the record stockholder, or the beneficial owner, if any, on whose
behalf the nomination or proposal is made, in such business or proposal, (iv) a representation that the stockholder is a holder
of record of stock of the Corporation entitled to vote at such meeting and intends to appear in person or by proxy at the meeting
to propose such business or nomination, (v) a representation as to whether or not the record stockholder or the beneficial owner,
if any, intends or is part of a group that intends (x) to deliver a proxy statement and/or form of proxy to holders of at least
the percentage of the Corporation’s outstanding capital stock required to approve or adopt the proposal or elect the nominee
and/or (y) to solicit proxies from stockholders in support of such proposal or nomination, and (vi) any other information relating
to such stockholder and beneficial owner that would be required to be disclosed in a proxy statement or other filings required
to be made in connection with solicitation of proxies for, as applicable, the proposal and/or the election of directors in a contested
election pursuant to Regulation 14A under the Exchange Act. The Corporation may require any proposed nominee to furnish such other
information as it may reasonably require to determine the eligibility of such proposed nominee to serve as a director of the Corporation
including a questionnaire with respect to the background and qualification of such person to serve as a director and such person’s
independence. The foregoing notice requirements shall be deemed satisfied by a Common Stockholder if the Common Stockholder has
notified the Corporation of his or her intention to present a proposal at an annual meeting of stockholders in compliance with
Rule 14a-8 (or any successor thereof) under the Exchange Act and such Common Stockholder’s proposal has been included in
a proxy statement that has been prepared by the Corporation to solicit proxies for such annual meeting. The Corporation may require
any proposed nominee to furnish such other information as it may reasonably require to determine the eligibility of such proposed
nominee to serve as a director of the Corporation.
3) Notwithstanding
anything in the second sentence of Section 16(A)(2) to the contrary and except with respect to the first annual meeting of the
Corporation, if the number of directors to be elected to the Board of Directors is increased and there is no public announcement
naming the nominees for such new directors made by the Corporation at least 100 days before the first anniversary of the preceding
year’s annual meeting, a Common Stockholder’s notice required by this Section 16 shall also be considered timely, but
only with respect to nominees for any new positions for directors, if it is delivered to the secretary of the Corporation at the
principal executive offices of the Corporation not later than the close of business on the 10th day following the day on which
the Corporation makes such public announcement.
(B) Special
Meetings of Stockholders. Only such business shall be conducted and proposals considered at a special meeting of stockholders
as shall have been brought before the meeting pursuant to a notice of meeting given pursuant to Section 4 of this Article II. Nominations
of persons for election to the Board of Directors may be made at a special meeting of stockholders at which directors are to be
elected pursuant to the Corporation’s notice of meeting (1) by or at the direction of the Board of Directors or (2) by any
stockholder of the Corporation who is a stockholder of record at the time of giving of notice provided for in this Section 16,
who is entitled to vote at the meeting and who complies with the notice procedures set forth in this Section 16. If the Corporation
calls a special meeting of stockholders for the purpose of electing one or more directors to the Board of Directors, any such stockholder
may nominate a person or persons (as the case may be), for election to such position(s) as specified in the Corporation’s
notice of meeting, if the stockholder’s notice required by Section 16(A)(2) shall be delivered to the secretary of the Corporation
at the principal office of the Corporation not earlier than the close of business on the 120th day before such special meeting
and not later than the close of business on the later of the 90th day before such special meeting or the 10th day following the
day on which public announcement is first made of the date of the special meeting and of the nominees proposed by the Board of
Directors to be elected at such meeting. In no event shall the public announcement of an adjournment of a special meeting commence
a new time period for the giving of a stockholder’s notice as described above.
(C) General.
1) Only
such persons who are nominated in accordance with the procedures set forth in this Section 16 may be elected as directors and
only such business may be conducted at a meeting of stockholders as has been brought before the meeting in accordance with the
procedures set forth in this Section 16. Except as otherwise provided by applicable law, the certificate of incorporation of the
Corporation or these bylaws, the chairperson of the meeting shall have the power and duty to determine whether a nomination or
any business proposed to be brought before the meeting was made, or proposed, as the case may be, in accordance with the procedures
set forth in this Section 16 and, if any proposed nomination or business is not in compliance with this Section 16, to declare
that such defective proposal or nomination shall be disregarded.
2) For
purposes of this Section 16, “public announcement” shall mean disclosure in a press release reported by the Dow Jones
News Service, Associated Press or comparable national news service or in a document publicly filed by the Corporation with the
Securities and Exchange Commission (the “SEC”) under Section 13, 14 or 15(d) of the Exchange Act.
3) Notwithstanding
the foregoing provisions of this Section 16, a stockholder shall also comply with all applicable requirements of the Exchange Act
and the rules and regulations thereunder, if any, with respect to the matters set forth in this Section 16. Nothing in this Section
16 shall be deemed to affect any rights of (i) stockholders to request inclusion of proposals in the Corporation’s proxy
statement under Rule 14a-8 (or any successor thereof) under the Exchange Act or (ii) the holders of any series of preferred shares
of the Corporation to elect directors under specified circumstances.
Section
17. Stockholder Action Without Meetings.
(A) Action
by Written Consent. Except as provided in the certificate of incorporation and subject to the requirements set forth in Sections
17(B) and (C) hereafter, any action required to be taken, or any action which may be taken, at any annual or special meeting of
stockholders, may be taken without a meeting, without prior notice and without a vote, if a consent in writing, setting forth the
action so taken, shall be signed by the holders of the outstanding stock having not less than the minimum number of votes that
would be necessary to authorize or to take such action under the provisions of the DGCL or the certificate of incorporation at
a meeting at which all shares entitled to vote thereon were present and voted. Prompt notice of the taking of the corporate action
without a meeting by less than unanimous written consent shall be given to those stockholders who have not consented in writing.
(B) Record
Date. In order that the Corporation may determine the stockholders entitled to consent to corporate action in writing without
a meeting as provided for in Section 17(A), the Board of Directors may fix a record date, which record date shall not precede the
date upon which the resolution fixing the record date is adopted by the Board of Directors, and which date shall not be more than
ten (10) days after the date upon which the resolution fixing the record date is adopted by the Board of Directors. Any stockholder
of record of the Corporation seeking to have the stockholders authorize or take corporate action by a consent in writing shall,
by written notice to the secretary of the Corporation, request the Board of Directors to fix a record date. The Board of Directors
shall promptly, but in all events within ten (10) days after the date on which such a request is received, adopt a resolution fixing
the record date, unless a record date has previously been fixed by the Board of Directors pursuant to the first sentence of this
Section 17(B). If no record date has been fixed by the Board of Directors pursuant to the first sentence of this paragraph or otherwise
within ten (10) days of the date on which such a request is received, the record date for determining stockholders entitled to
consent to corporate action in writing without a meeting, when no prior action by the Board of Directors is required by applicable
law, shall be the first date on which a signed consent in writing setting forth the action taken or proposed to be taken is delivered
to the Corporation by delivery to its registered office in Delaware or its principal place of business. Delivery shall be by hand
or by certified or registered mail, return receipt requested. If no record date has been fixed by the Board of Directors pursuant
to the first sentence of this Section 17(B), the record date for determining stockholders entitled to consent to corporate action
in writing without a meeting if prior action by the Board of Directors is required by applicable law shall be at the close of business
on the date on which the Board of Directors adopts the resolution taking such prior action.
(C) Inspectors
of Consent in Writing. In the event of the delivery, in the manner provided by this Section 17 and applicable law, to the Corporation
of the requisite consent or consents in writing to take corporate action and/or any revocation or revocations thereof, the Corporation
shall engage independent inspectors of elections for the purpose of promptly performing a ministerial review of the validity of
the consents and revocations. No action by consent in writing without a meeting shall be effective until such date as either the
secretary of the Corporation or the independent inspectors certify to the Corporation that the valid and unrevoked consents delivered
to the Corporation in accordance with Sections 16(A) and (B) and applicable law represent at least the minimum number of votes
that would be necessary to take the corporate action under the provisions of the DGCL or the certificate of incorporation at a
meeting at which all shares entitled to vote thereon were present and voted. Nothing contained in this Section 17 shall in any
way be construed to suggest or imply that the Board of Directors or any stockholder shall not be entitled to contest the validity
of any consent or revocation thereof, whether before or after such certification by the secretary of the Corporation or independent
inspectors, or to take any other action, including, without limitation, the commencement, prosecution or defense of any litigation
with respect thereto, and the seeking of injunctive relief in such litigation.
(D) Validity
and Effectiveness of Written Consents. Every written consent shall bear the date of signature of each stockholder who signs
the consent and no written consent shall be effective to take the corporate action referred to therein unless, within sixty (60)
days after the earliest dated written consent received in accordance with this Section 17, a valid written consent or valid written
consents signed by a sufficient number of stockholders to take such action are delivered to the Corporation in the manner prescribed
in this Section 17 and applicable law, and not revoked.
ARTICLE
III
BOARD OF DIRECTORS
Section
1. General Powers. The business and affairs of the Corporation
shall be managed by or under the direction of its Board of Directors. The Board of Directors may adopt such rules and procedures,
not inconsistent with the Certificate of Incorporation, these by-laws or applicable law, as it may deem proper for the conduct
of its meetings and the management of the Corporation.
Section
2. Tenure and Qualifications. Each director shall hold
office until the next annual meeting of stockholders following such director’s election and until such director’s successor
shall have been duly elected and qualified or until such director’s earlier death, resignation or removal. A director need
not be a resident of the State of Delaware or a stockholder of the Corporation. A director may resign at any time by giving written
notice to the Board of Directors, or to the chairperson of the board, chief executive officer, president or secretary of the Corporation.
A resignation shall be effective when the notice is given, unless the notice specifies a future date. In addition to the directors
who the Corporation’s stockholders elect, the Board of Directors may also designate, by resolution of the Board of Directors,
one or more advisory directors who may attend all meetings of the Board of Directors, but may not vote on any matters before the
Board of Directors. Except as set forth in this Section 2, the advisory director shall have no rights as a director either under
these bylaws, the Corporation’s charter, Delaware law or any other agreement to which the Corporation is a party. Notwithstanding
the foregoing, an advisory director shall be entitled to receive compensation for services as a director in the same amount and
manner that such director would be entitled to receive compensation as an employee director or non-employee director, as the case
may be, if such director were elected by the stockholders of the Corporation.
Section
3. Place of Meetings. The Board of Directors may hold
meetings, both regular and special, either within or without the State of Delaware.
Section
4. Regular Meetings. A regular meeting of the Board of
Directors shall be held without other notice than this bylaw, immediately after, and at the same place as, the annual meeting of
stockholders. Other regular meetings of the Board of Directors may be held without notice at such time and at such place as shall
from time to time be determined by the Board of Directors.
Section
5. Special Meetings. Special meetings of the Board of
Directors may be called only by the chairperson of the Board of Directors or the lead director and shall be called by the chairperson
of the Board of Directors or the secretary upon the written request of any two directors.
Section
6. Notice. Notice of any special meeting shall be given:
(i) at least two business days (or 12 hours, including at least four hours between 8:00 a.m. Central time and 6:00 p.m. Central
time, if telephonic participation or participation by other electronic communication equipment is provided for with respect to
the special meeting) prior thereto if the notice is given personally or by an electronic transmission, (ii) at least two business
days (also if telephonic participation or participation by other electronic communication equipment is provided for with respect
to the special meeting) prior thereto if the notice is given by having it delivered by a third party entity that provides delivery
services in the ordinary course of business and guarantees delivery of the notice to the director no later than the following business
day, and (iii) at least seven business days prior thereto if the notice is given by mail. For this purpose, the term “electronic
transmission” may include a facsimile, email or other electronic means. Notice shall be delivered to the director’s
business address and/or telephone number and shall be deemed given upon electronic transmission, upon delivery to the third party
delivery service, or upon being deposited in the United States mail with postage thereon prepaid. Any director may waive notice
of any meeting by signing a written waiver of notice either before or after the meeting. Attendance of a director at any meeting
shall constitute a waiver of notice of such meeting, except when a director attends a meeting for the express purpose of objecting
to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted
at, nor the purpose of, any regular or special meeting of the Board of Directors need be specified in the notice or waiver of notice
of such meeting.
Section
7. Quorum, Vote Required, Actions Requiring Approval.
A majority of the directors then in office shall constitute a quorum for the transaction of business at any meeting of the Board
of Directors, and the act of a majority of the directors present at a meeting at which a quorum is present shall be the act of
the Board of Directors. If less than a majority of such number of directors is present at the meeting, a majority of the directors
present may adjourn the meeting from time to time without further notice.
Section
8. Action by Unanimous Consent of Directors. Unless otherwise
restricted by the certificate of incorporation or these bylaws, any action required or permitted to be taken at any meeting of
the Board of Directors, or of any committee thereof, may be taken without a meeting if all members of the Board of Directors or
such committee, as the case may be, consent thereto in writing or by electronic transmission and the writing or writings or electronic
transmissions are filed with the minutes of proceedings of the Board of Directors or committee in accordance with applicable law.
Section
9. Participation with Communications Equipment. Members
of the Board of Directors or of any committee of the Board of Directors may participate in and act at any meeting of such board
or committee through the use of a conference telephone or other communications equipment by means of which all persons participating
in the meeting can hear each other. Participation in such meeting shall constitute attendance and presence in person at the meeting
of the person or persons so participating.
Section
10. Compensation of Directors. The Board of Directors may fix
the compensation of directors by the affirmative vote of a majority of the directors then in office and irrespective of any personal
interest of any of its members. In addition, the directors may be paid their expenses, if any, of attendance at each meeting of
the Board of Directors. No such payment shall preclude any director from serving the Corporation in any other capacity and receiving
compensation therefor. The chairperson of the board, the lead director, and members of special or standing committees may be compensated
additionally for so serving.
Section
11. Chairperson of the Board. The chairperson of the Board of
Directors, or in such person’s absence, the chief executive officer, or in the absence of both such persons, the president,
shall preside at all meetings of the stockholders and the Board of Directors. The chairperson of the Board of Directors shall be
elected by the Board of Directors and shall hold the position until a successor is elected and qualified or until such chairperson’s
earlier resignation or removal. Any vacancy occurring in the position shall be filled by the Board of Directors for the unexpired
portion of the term. The chairperson of the board shall serve at the pleasure of the Board of Directors. Election of a chairperson
of the board shall not of itself create contract rights.
Section
12. Interim Vacancies. In the interim between annual meetings
of stockholders or of special meetings of stockholders called for the election of directors and/or for the removal of one or more
directors and for the filling of any vacancy in that connection, newly created directorships and any vacancies in the Board of
Directors, including unfilled vacancies resulting from the removal of directors for cause or without cause, resignation, death,
disqualification or other causes shall be filled only by the vote of a majority of the remaining directors then in office, although
less than a quorum, or by the sole remaining director.
ARTICLE
IV
COMMITTEES OF THE BOARD OF DIRECTORS
Section
1. Establishment of Committees. The Board of Directors
may create one or more committees and appoint members of the Board of Directors to serve on the committee or committees. Each committee
shall have two or more members, who serve at the pleasure of the Board of Directors. The Board of Directors may designate one or
more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of such
committee. Any vacancy in a committee may be filled by the Board of Directors. Each committee shall keep regular minutes of its
meetings and report the same to the Board of Directors as required.
Section
2. Manner of Acting. Unless the appointment by the Board
of Directors requires a greater number, a majority of any committee shall constitute a quorum and a majority of a quorum shall
be necessary for action by any committee. A committee may act by unanimous consent in writing without a meeting. Each committee,
by majority vote of its members, shall determine the time and place of meetings and the notice required therefor.
Section
3. Authority of Committees. To the extent specified by
resolution of the Board of Directors and these bylaws, each committee may exercise the authority of the Board of Directors, provided,
however, a committee may not:
(A) authorize
distributions, except for dividends to be paid with respect to shares of any preferred or special classes or any series thereof;
(B) approve
or recommend to stockholders any act requiring the approval of stockholders under applicable law;
(C) fill
vacancies on the Board of Directors or any committee;
(D) elect
or remove officers or fix the compensation of any member of the committee;
(E) adopt,
amend or repeal these bylaws;
(F) approve
a plan of merger not requiring stockholder approval;
(G) authorize
or approve reacquisition of shares, except according to a general formula or method prescribed by the Board of Directors;
(H) authorize
or approve the issuance or sale, or contract for sale, of shares, or determine the designation and relative rights, preferences,
and limitations of a series of shares, except the Board of Directors may direct that a committee may fix the specific terms of
the issuance or sale or contract for sale, or the number of shares to be allocated to particular employees under an employee benefit
plan; or
(I) amend,
alter, repeal, or take action inconsistent with any resolution or action of the Board of Directors when the resolution or action
of the Board of Directors provides by its terms that it shall not be amended, altered or repealed by action of a committee.
ARTICLE
V
OFFICERS
Section
1. Positions and Election. The officers of the Corporation
shall be elected by the Board of Directors and shall include a president, a treasurer and a secretary. Any individual may be elected
to, and may hold, more than one office of the Corporation.
Section
2. Additional Officers and Agents. The Board of Directors
may appoint such other officers and agents as it deems necessary, including, without limitation, one or more vice presidents, one
or more assistant secretaries, one or more assistant treasurers and a controller, who shall exercise such powers and perform such
duties as shall be determined from time to time by the Board of Directors.
Section
3. Compensation of Officers. The compensation of all officers
of the Corporation shall be fixed by or under the direction of the Board of Directors. No officer shall be prevented from receiving
such compensation because such officer is also a director of the Corporation.
Section
4. Term of Office and Vacancy. Each elected officer shall
hold office until a successor is elected and qualified or until such officer’s earlier resignation or removal. Any vacancy
occurring in any office of the Corporation shall be filled by the Board of Directors for the unexpired portion of the term. Each
appointed officer shall serve at the pleasure of the Board of Directors. Election or appointment of an officer or agent shall not
of itself create contract rights.
Section
5. Removal. Any officer or agent may be removed by the
Board of Directors, with or without cause, whenever in its judgment the best interests of the Corporation will be served thereby,
but such removal shall be without prejudice to the contract rights, if any, of the person so removed. Election or appointment of
an officer or agent shall not of itself create contract rights.
Section
6. Chief Executive Officer. The chairperson of the Board
of Directors may, but need not, be the chief executive officer of the Corporation. The chief executive officer shall (a) determine
and administer the policies of the Corporation, subject to the instructions of the Board of Directors; (b) be authorized to execute
all documents in the name and on behalf of the Corporation; and (c) perform all duties incident to the office of chief executive
officer and such other duties as the Board of Directors or bylaws may from time to time prescribe.
Section
7. President. The president shall (a) be the chief operating
officer of the Corporation, and shall in general be in charge of the operations of the Corporation, subject to the control of the
Board of Directors; (b) be authorized to execute all documents in the name and on behalf of the Corporation; and (c) perform all
duties incident to the office of president and such other duties as the Board of Directors may from time to time prescribe.
Section
8. Vice Presidents. In the absence of the president or
in the event of the inability or refusal of the president to act, the vice president (or if there is more than one vice president,
the vice presidents in the order of seniority of title, or in the event of equal seniority, then in the order designated, or in
the absence of any designation, then in the order named in the most recent resolution providing for the annual election of officers)
shall perform the duties of the president, and when so acting, shall have all the powers of and be subject to all the restrictions
upon the president. Any vice president shall perform such other duties and have such other powers as the Board of Directors or
the chief executive officer or president may from time to time prescribe.
Section
9. Secretary. The secretary shall (a) attend meetings
of the Board of Directors and meetings of the stockholders and record minutes of the proceedings of the meetings of the stockholders
and of the Board of Directors, and when required, shall perform like duties for the committees of the Board of Directors; (b) assure
that all notices are duly given in accordance with the provisions of these bylaws or as required by law; (c) maintain custody of
the corporate records of the Corporation; (d) keep or cause to be kept a register of the post office address of each stockholder
as furnished to the secretary by such stockholder; (e) sign with the chief executive officer, president or a vice president certificates
for shares of the Corporation, the issuance of which shall have been authorized by resolution of the Board of Directors; (f) have
charge of the stock transfer books of the Corporation and authority over a stock transfer agent, if any; (g) certify copies of
the bylaws, resolutions of the stockholders and Board of Directors and committees thereof and other documents of the Corporation
as true and correct copies thereof; and (h) perform all duties incident to the office of secretary and such other duties as the
Board of Directors or the chief executive officer or president may from time to time prescribe.
Section
10. Assistant Secretaries. The assistant secretary, or if there
is more than one, the assistant secretaries, respectively, as authorized by the Board of Directors, may sign with the president
or a vice president certificates for shares of the Corporation, the issuance of which shall have been authorized by resolution
of the Board of Directors, and shall, in the absence of the secretary or in the event of the inability or refusal of the secretary
to act, perform the duties and exercise the powers of the secretary, and shall perform such other duties as the Board of Directors,
chief executive officer, president or secretary may from time to time prescribe.
Section
11. Treasurer. The treasurer shall (a) have custody of the funds
and securities of the Corporation; (b) deposit all moneys and other valuable effects in the name and to the credit of the Corporation
in such depositories as may be designated by the Board of Directors; (c) maintain adequate accounts of the Corporation; (d) disburse
the funds of the Corporation as may be ordered by the Board of Directors; (e) submit financial statements to the president and
the Board of Directors; and (f) perform all duties incident to the office of treasurer and such other duties as the Board of Directors
or the chief executive officer or president may from time to time prescribe.
Section
12. Assistant Treasurers. The assistant treasurer, or if there
is more than one, the assistant treasurers, respectively, as authorized by the Board of Directors, shall, in the absence of the
treasurer or in the event of the inability or refusal of the treasurer to act, perform the duties and exercise the power of the
treasurer and shall perform such other duties and have such other power as the Board of Directors, the chief executive officer,
president or treasurer may from time to time prescribe.
Section
13. Controller. The controller shall conduct the accounting
activities of the Corporation, including the maintenance of the Corporation’s general and supporting ledgers and books of
account, operating budgets, and the preparation and consolidation of financial statements.
Section
14. General Powers of Officers. The chief executive officer,
president, any executive vice president, senior vice president or any vice president, may sign without countersignature or attestation
any deeds, mortgages, bonds, contracts, reports to public agencies, or other instruments whether or not the Board of Directors
has expressly authorized execution of such instruments, except in cases where the signing and execution thereof shall be expressly
delegated by the Board of Directors or by these bylaws solely to some other officer or agent of the Corporation, or shall be required
by law to be otherwise signed or executed. Any other officer of this Corporation may sign contracts, reports to public agencies,
or other instruments which are in the regular course of business and within the scope of such officer’s authority, except
where the signing and execution thereof shall be expressly delegated by the Board of Directors or by these bylaws to some other
officer or agent of the Corporation, or shall be required by law to be otherwise signed or executed.
Section 15. Delegation
of Authority. The Board of Directors may from time to time delegate the powers or duties of any officer to any other officers
or agents, notwithstanding any provision hereof.
ARTICLE
VI
CONTRACTS, CHECKS AND DEPOSITS
Section
1. Contracts. The Board of Directors may authorize any
officer or officers, or agent or agents, to enter into any contract and execute and deliver any instrument in the name of and on
behalf of the Corporation, and such authority may be general or confined to specific instances.
Section
2. Checks, Drafts, Notes. All checks, drafts or other
orders for the payment of money, notes and other evidences of indebtedness, issued in the name of the Corporation, shall be signed
by such officer or officers, or agent or agents, of the Corporation and in such manner as shall from time to time be determined
by resolution of the Board of Directors.
Section
3. Deposits. All funds of the Corporation other than petty
cash shall be deposited to the credit of the Corporation in such banks, trust companies or other depositories as the Board of Directors
may select.
Section
4. Facsimile Signatures. In addition to the provisions
for use of facsimile signatures elsewhere specifically authorized in these bylaws, facsimile signatures of any officer or officers
of the Corporation may be used whenever and as authorized by the Board of Directors or a committee thereof.
Section
5. Reliance upon Books, Reports and Records. Each director,
each member of any committee designated by the Board of Directors, and each officer of the Corporation shall, in the performance
of such person’s duties, be fully protected in relying in good faith upon the books of account or other records of the Corporation
and upon such information, opinions, reports or statements presented to the Corporation by any of its officers or employees, or
committees of the Board of Directors so designated, or by any other person as to matters which such director or committee member
reasonably believes are within such other person’s professional or expert competence and who has been selected with reasonable
care by or on behalf of the Corporation.
ARTICLE
VII
SHARES
Section
1. Issued Shares. The issued shares of the Corporation
may be represented by certificates, or may be uncertificated shares, in either case in whole or in part, as determined and authorized
by the Board of Directors.
Section
2. Certificates for Shares. Certificates representing
shares of the Corporation shall be in such form as may be determined by the Board of Directors. Such certificates shall be signed
by the president or vice president and by the secretary or an assistant secretary. Any signatures or countersignature on the certificate
may be facsimiles. If any officer of the Corporation, or any officer or employee of the transfer agent or registrar, who has signed
or whose facsimile signature has been placed upon such certificate ceases to be an officer of the Corporation, or an officer or
employee of the transfer agent or registrar, before such certificate is issued, the certificate may be issued by the Corporation
with the same effect as if the officer of the Corporation, or the officer or employee of the transfer agent or registrar, had not
ceased to be such at the date of its issue. Certificates for shares shall be individually numbered or otherwise individually identified.
Each certificate for shares shall state the name of the registered owner of the shares in the stock ledger, the number and the
class and series, if any, of such shares, and the date of issuance of the certificate. If the Corporation is authorized to issue
more than one class of stock, a full summary or statement of all of the designations, preferences, qualifications, limitations,
restrictions, and special or relative rights of each class authorized to be issued, and, if the Corporation is authorized to issue
any preferred or special class in series, the variations in the relative rights and preferences among such series, shall be set
forth upon the face or back of the certificate. Such statement may be omitted if it shall be set forth upon the face or back of
the certificate that such statement, in full, will be furnished by the Corporation to any stockholder upon request and without
charge.
Section
3. Uncertificated Shares. The Board of Directors may provide
by resolution that some or all of any or all classes and series of its shares shall be uncertificated shares, and may provide an
election by individual stockholders to receive certificates or uncertificated shares and the conditions of such election, provided
that such resolution shall not apply to shares represented by a certificate until such certificate is surrendered to the Corporation.
Within a reasonable time after the registration of issuance or transfer of uncertificated shares, the Corporation shall send to
the registered owner thereof a written notice containing the information required to be set forth or stated on certificates pursuant
to the DGCL or these bylaws. Except as otherwise expressly provided by law, the rights and obligations of the holders of uncertificated
shares and rights and obligations of the holders of certificates representing shares of the same class and series shall be identical.
Section
4. Registration of Transfers of Shares. Transfers of shares
shall be registered in the records of the Corporation upon request by the registered owner thereof in person or by a duly authorized
attorney, upon presentation to the Corporation or to its transfer agent (if any) of a duly executed assignment and other evidence
of authority to transfer, or proper evidence of succession, and, if the shares are represented by a certificate, a duly endorsed
certificate or certificates for shares surrendered for cancellation, and with such proof of the authenticity of the signatures
as the Corporation or its transfer agent may reasonably require. The Person in whose name shares are registered in the stock ledger
of the Corporation shall be deemed the owner thereof for all purposes as regards to the Corporation.
Section
5. Lost Certificates. The Corporation may issue a new
share certificate in the place of any certificate theretofore issued by it, alleged to have been lost, stolen, or destroyed, upon
the making of an affidavit of that fact, by the person claiming the share certificate to be lost, stolen or destroyed. When authorizing
such issuance of a new certificate or certificates the Board of Directors may, in its discretion and as a condition precedent to
the issuance thereof, require the owner of such lost, stolen or destroyed certificate or certificates, or the owner’s legal
representative, to advertise the same in such manner as it shall require or to give the Corporation a bond in such sum as it may
direct as indemnity against any claim that may be made against the Corporation with respect to the certificate or certificates
alleged to have been lost, stolen or destroyed.
ARTICLE
VIII
OTHER PROVISIONS
Section
1. Distributions. The Board of Directors may
authorize, and the Corporation may make, distributions to its stockholders, subject to any restriction in the certificate of
incorporation and subject to any limitations provided by applicable law.
Section
2. Fiscal Year. The fiscal year of the Corporation shall
be fixed, and shall be subject to change, by the Board of Directors.
Section
3. Seal. The Board of Directors may, but shall not be
required to, provide by resolution for a corporate seal, which may be used by causing it, or a facsimile thereof, to be impressed
or affixed or in any other manner reproduced.
Section
4. Severability. A determination that any provision of
these bylaws is for any reason inapplicable, invalid, illegal or otherwise ineffective shall not affect or invalidate any other
provision of these bylaws.
Section
5. Exclusive Forum. Unless the Corporation consents in
writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if the Court of Chancery
does not have jurisdiction, the federal district court for the District of Delaware) shall be the sole and exclusive forum for
any (i) derivative action or proceeding brought on behalf of the Corporation, (ii) action asserting a claim for breach of a fiduciary
duty owed by any director, officer, employee or agent of the Corporation to the Corporation or the Corporation’s shareholders,
(iii) action asserting a claim arising pursuant to any provision of the DGCL or the certificate of incorporation or these bylaws
(as either may be amended from time to time) of the Corporation, or (iv) any action asserting a claim governed by the internal
affairs doctrine. If any action the subject matter of which is within the scope of the preceding sentence is filed in a court other
than a court located within the State of Delaware (a “Foreign Action”) in the name of any stockholder, such stockholder
shall be deemed to have consented to (a) the personal jurisdiction of the state and federal courts located within the State of
Delaware in connection with any action brought in any such court to enforce the preceding sentence and (b) having service of process
made upon such stockholder in any such action by service upon such stockholder’s counsel in the Foreign Action as agent for
such stockholder. Any person or entity purchasing or otherwise acquiring any interest in shares of stock of the Corporation shall
be deemed to have notice of and consented to the provisions of this Article VIII, Section 5.
ARTICLE
IX
AMENDMENTS
Subject to the provisions of the certificate
of incorporation, these bylaws may be altered, amended or repealed, and new bylaws may be adopted, by a majority of the Board of
Directors, which shall include the affirmative vote of at least one director of each class of the Board of Directors if the Board
shall then be divided into classes, without any action on the part of stockholders. Subject to the provisions of the certificate
of incorporation, these bylaws may also be altered, amended or repealed by the stockholders of the Corporation representing at
least 80% of the shares of the Corporation entitled to vote in the election of directors, voting as one class.
ARTICLE
X
INDEMNIFICATION
Section
1. Indemnification. The Corporation shall have the power
to indemnify, to the fullest extent not prohibited by law, any current or former director, officer, employee or agent of the Corporation
who was, or is threatened to be, made a party to any threatened, pending or completed action, suit or proceeding, whether civil,
criminal, administrative or investigative by reason of the fact that he is or was a director, officer, employee or agent of the
Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another company,
partnership, joint venture, trust or other enterprise, against expenses (including attorneys' fees), judgments, fines and amounts
paid in settlement actually and reasonably incurred by him in connection with such action, suit or proceeding, to the extent and
under the circumstances permitted by the DGCL. Such indemnification (unless ordered by a court) shall be made as authorized in
a specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the circumstances
because he has met the applicable standards of conduct set forth in the DGCL. Such determination shall be made (1) by a majority
vote of the directors who are not parties to such action, suit or proceeding, even though less than a quorum, (2) by a committee
of such directors designated by majority vote of such directors, even though less than a quorum, (3) if such quorum is not obtainable,
or even if obtainable a quorum of disinterested directors so directs, by independent legal counsel in a written opinion, or (4)
by the stockholders. The foregoing right of indemnification shall not be deemed exclusive of any other rights to which those seeking
indemnification may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise and shall
continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs,
executors and administrators of such a person.
Expenses incurred by a director, executive
officer, employee or agent in defending or testifying in a civil, criminal, administrative or investigative action, suit or proceeding
shall (in the case of a director or executive officer of the Corporation) and may (in the case of an employee or agent of the Corporation
who is not a director or executive officer of the Corporation) be paid by the Corporation in advance of the final disposition of
such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director, executive officer, employee or
agent to repay such amount if it shall ultimately be determined that such person is not entitled to be indemnified by the Corporation
against such expenses as authorized by this Article X, and the Corporation may enter into agreements with such persons for the
purpose of providing for such advances.
Section
2. Insurance. The Board of Directors shall have the power
to authorize to the extent permitted by the DGCL the purchase and maintenance of insurance on behalf of any person who is or was
a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director,
officer, employee or agent of another company, partnership, joint venture, trust or other enterprise against any liability asserted
against him or incurred by him in such capacity or arising out of his status as such whether or not the Corporation would have
the power to indemnify him against such liability under the provisions of the DGCL.
Exhibit 10.1
EXECUTION VERSION
VOTING AND SUPPORT AGREEMENT
VOTING AND SUPPORT AGREEMENT, dated as of
June 22, 2015 (this “Agreement”), by and among Sequential Brands Group, Inc., a Delaware corporation (“Sequential”),
Singer Madeline Holdings, Inc., a Delaware corporation (“TopCo”) and certain stockholders of Martha Stewart
Living Omnimedia, Inc., a Delaware corporation (“MSLO”), listed on Schedule A hereto (each, a “Stockholder”
and collectively, the “Stockholders”).
WITNESSETH:
WHEREAS, MSLO, Madeline
Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of TopCo (“Madeline Merger Sub”), Sequential,
Singer Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of TopCo (“Singer Merger Sub”),
and TopCo, are concurrently herewith entering into an Agreement and Plan of Merger (as in effect on the date hereof or as may be
amended, supplemented or otherwise modified from time to time, but solely as consented to by such Stockholder, in its discretion,
in the case of a Fundamental Amendment, the “Merger Agreement”), pursuant to which, among other things, at the
effective time under the Merger Agreement (the “Effective Time”), Madeline Merger Sub will merge with and into
MSLO, with MSLO continuing as the surviving corporation and a wholly owned subsidiary of TopCo (the “MSLO Merger”),
and Singer Merger Sub will merge with and into Sequential, with Sequential continuing as the surviving corporation and a wholly
owned subsidiary of TopCo (the “Sequential Merger” and, together with the MSLO Merger, the “Mergers”);
WHEREAS, each Stockholder
is the record and/or beneficial owner of the Existing Shares (as defined below);
WHEREAS, as a condition
and material inducement to Sequential’s willingness to enter into the Merger Agreement and to consummate the transactions
contemplated thereby, including the Sequential Merger, each Stockholder has agreed to enter into this Agreement, pursuant to which
such Stockholder is agreeing, among other things, to vote all of its Covered Shares (as defined below) in accordance with the terms
of this Agreement; and
WHEREAS, TopCo, Sequential
and the Stockholders wish to agree to certain matters as set forth herein.
NOW, THEREFORE, in consideration of the
foregoing and the mutual representations, warranties, covenants and agreements contained herein, and intending to be legally bound
hereby, the parties hereto hereby agree as follows:
Article
I
GENERAL
Section 1.1 Defined
Terms. The following capitalized terms, as used in this Agreement, shall have the meanings set forth below. Capitalized terms
used but not otherwise defined herein shall have the meanings ascribed thereto in the Merger Agreement.
(a) “Beneficial
Ownership” has the meaning ascribed to such term in Rule 13d-3 under the Securities Exchange Act of 1934, as amended.
The terms “Beneficially Own”, “Beneficially Owned” and “Beneficial Owner”
shall each have a correlative meaning.
(b) “Covered
Shares” means, with respect to each Stockholder, such Stockholder’s Existing Shares, together with any shares of
MSLO Common Stock and any shares of MSLO Common Stock issuable upon the conversion, exercise or exchange of securities that are
convertible into or exercisable or exchangeable for shares of MSLO Common Stock, in each case that such specified Stockholder has
or acquires Beneficial Ownership of on or after the date hereof.
(c) “DGCL”
means the General Corporation Law of the State of Delaware.
(d) “Encumbrance”
means any security interest, pledge, mortgage, lien (statutory or other), charge, option to purchase, lease or other right to acquire
any interest or any claim, restriction, covenant, title defect, hypothecation, assignment, deposit arrangement or other encumbrance
of any kind or any preference, priority or other security agreement or preferential arrangement of any kind or nature whatsoever
(including any conditional sale or other title retention agreement), excluding restrictions under securities laws.
(e) “Existing
Shares” means, with respect to each Stockholder, the number of shares of MSLO Common Stock Beneficially Owned by such
Stockholder, as of the date hereof, as set forth in Schedule A hereto.
(f) “Expiration
Date” means any date upon which the Merger Agreement is validly terminated in accordance with its terms.
(g) “Governmental
Entity” means any nation or government, any state, agency, commission, or other political subdivision thereof, any insurance
regulatory authority, any self-regulatory authority, or any entity (including a court) of competent jurisdiction properly exercising
executive, legislative, judicial or administrative functions of the government.
(h) “Law”
means any statute, law ordinance, rule or regulation (domestic or foreign) issued, promulgated or entered into by or with any Governmental
Entity.
(i) “Permitted
Transfer” means (i) a Transfer of Covered Shares by a Stockholder by will or by operation of law or other Transfers to
an Affiliate, immediate family members, trusts for the benefit of such Stockholder, any immediate family member of such Stockholder,
charity or other Transfers for estate planning purposes, or upon the death of such Stockholder, provided, that prior to
the effectiveness of such Transfer, such transferee executes and delivers to TopCo and Sequential a written agreement, in form
and substance reasonably acceptable to TopCo and Sequential, to assume all of such Stockholder’s obligations hereunder in
respect of the securities subject to such Transfer and to be bound by the terms of this Agreement, with respect to the securities
subject to such Transfer, to the same extent as such Stockholder is bound hereunder and to make each of the representations and
warranties hereunder in respect of the securities transferred as such Stockholder shall have made hereunder; (ii) a Transfer of
Covered Shares by a Stockholder to another Stockholder; or (iii) with respect to a Stockholder’s MSLO Stock Options and/or
MSLO Performance Stock Option which expire by their terms or would otherwise be terminated on or prior to the Expiration Date and
MSLO RSU Awards and/or MSLO Performance RSU Awards that vest and/or are settled on or prior to the Expiration Date, Transfers of
MSLO Common Stock to MSLO or into the public market (but not through the tender of any such shares into a tender or exchange offer)
(A) in order to pay the exercise price due in respect of any such expiring MSLO Stock Options and/or MSLO Performance Stock Options,
and/or (B) in order to satisfy required withholding and other payroll taxes due upon the exercise of any such expiring MSLO Stock
Options and MSLO Performance Stock Options and/or upon the vesting and/or settlement of any such MSLO RSU Awards and/or MSLO Performance
RSU Awards.
(j) “Transfer”
means, directly or indirectly, to sell, transfer, assign, pledge, encumber, hypothecate or similarly dispose of (by merger (including
by conversion into securities or other consideration), by tendering into any tender or exchange offer, by operation of law or otherwise),
either voluntarily or involuntarily, or to enter into any contract, option or other arrangement or understanding with respect to
the voting of or sale, transfer, assignment, pledge, encumbrance, hypothecation or similar disposition of (by merger, by tendering
into any tender or exchange offer, by testamentary disposition, by operation of law or otherwise).
Article
II
VOTING
Section 2.1 Agreement
to Vote.
(a) Each
of the Stockholders hereby irrevocably and unconditionally agrees, as to itself only, that during the period beginning on the date
hereof and ending on the earliest of (x) the Closing Date, (y) the Expiration Date or (z) the termination of this Agreement in
accordance with its terms, at any meeting of the stockholders of MSLO, however called, including any adjournment or postponement
thereof, and in connection with any action proposed to be taken by written consent of the stockholders of MSLO, the Stockholders
shall, in each case, to the fullest extent that such matters are submitted for the vote or written consent of the Stockholders
and that the Covered Shares are entitled to vote thereon or consent thereto:
(i) appear
at each such meeting or otherwise cause the Covered Shares as to which the Stockholders control the right to vote to be counted
as present thereat for purposes of calculating a quorum; and
(ii) vote
(or cause to be voted), in person or by proxy, or deliver (or cause to be delivered) a written consent covering, all of the Covered
Shares as to which the Stockholders control the right to vote (A) in favor of the adoption of the Merger Agreement and any related
proposal in furtherance thereof, as reasonably requested by Sequential and contemplated by the Merger Agreement, submitted for
the vote or written consent of stockholders, including, without limiting any of the foregoing obligations, in each case to the
extent MSLO is permitted pursuant to the Merger Agreement to take such actions, in favor of any proposal to adjourn or postpone
to a later date any meeting of the stockholders of MSLO at which any of the foregoing matters are submitted for consideration and
vote of the stockholders of MSLO (B) against any action or agreement submitted for the vote or written consent of stockholders
that is in opposition to the Merger or that would result in a breach of any covenant, representation or warranty or any other obligation
or agreement of MSLO contained in the Merger Agreement, or of the Stockholders contained in this Agreement, and (C) against any
Acquisition Proposal or other action, agreement or transaction submitted for the vote or written consent of stockholders that would
reasonably be expected to impede, delay, postpone, frustrate the purposes of, adversely affect or prevent the consummation of the
Mergers or the other transactions contemplated by the Merger Agreement or the performance by MSLO of its obligations under the
Merger Agreement or by the Stockholders of their obligations under this Agreement.
(b) Any
vote required to be cast or consent required to be executed pursuant to this Section 2.1 shall be cast (or consent shall be given)
by the Stockholders in accordance with such procedures relating thereto so as to ensure that it is duly counted, including for
purposes of determining whether a quorum is present.
(c) A
Stockholder shall not be bound to take the actions described in this Section 2.1 in the event of a Fundamental Amendment of the
Merger Agreement, unless such Stockholder, in its sole discretion, has consented thereto prior to the date of such Fundamental
Amendment.
(d) Nothing
in this Agreement, including this Section 2.1, shall limit or restrict any affiliate or designee of the Stockholder who serves
as a member of MSLO Board in acting in his or her capacity as a director or officer of MSLO and exercising his or her fiduciary
duties and responsibilities, it being understood that this Agreement shall apply to the Stockholders solely in their capacity as
stockholders of MSLO and shall not apply to any such affiliate or designee’s actions, judgments or decisions as a director
or officer of MSLO.
Section 2.2 No
Inconsistent Agreements. Each of the Stockholders hereby covenants and agrees, as to itself only, that, except for this Agreement
or as set forth on Schedule A, and except as may be permitted by Section 4.3(b), it (a) has not entered into, and shall not enter
into at any time while this Agreement remains in effect, any voting agreement or voting trust with respect to the Covered Shares
with respect to any of the matters described in Section 2.1(a)(ii) (the “Section 2.1(a) Matters”), (b)
has not granted, and shall not grant at any time while this Agreement remains in effect (except to the extent permitted by Section
2.1(c)), a proxy, consent or power of attorney with respect to the Covered Shares with respect to any of the Section 2.1(a) Matters
and (c) has not taken and shall not take any action that would have the effect of preventing or disabling such Stockholder from
performing any of its obligations under this Agreement. Each of the Stockholders, as to itself only, hereby represents that all
proxies or powers of attorney given by such Stockholder prior to the execution of this Agreement in respect of the voting of each
such Stockholder’s Covered Shares with respect to the Section 2.1(a) Matters, if any, are not irrevocable and each Stockholder
hereby revokes (and shall cause to be revoked) any and all previous proxies or powers of attorney with respect to each such Stockholder’s
Covered Shares with respect to the Section 2.1(a) Matters.
Article
III
REPRESENTATIONS AND WARRANTIES
Section 3.1 Representations
and Warranties of the Stockholders. Each Stockholder, as to itself only, hereby represents and warrants to Sequential as follows:
(a) Authorization.
The Stockholder has the legal capacity, full power and authority to execute and deliver this Agreement, to perform its obligations
hereunder and to consummate the transactions contemplated hereby. The execution and delivery by the Stockholder of this Agreement,
the performance by it of its obligations hereunder and the consummation by it of the transactions contemplated hereby have been
duly and validly authorized by the Stockholder and no other actions or proceedings on the part of the Stockholder or any manager
or partner thereof are necessary to authorize the execution and delivery by it of this Agreement, the performance by it of its
obligations hereunder or the consummation by it of the transactions contemplated hereby. This Agreement has been duly executed
and delivered by the Stockholder and, assuming this Agreement constitutes a valid and binding obligation of the other parties hereto,
constitutes a legal, valid and binding obligation of the Stockholder, enforceable against it in accordance with its terms (except
to the extent that enforceability may be limited by applicable bankruptcy, insolvency, moratorium, reorganization or similar Laws
affecting the enforcement of creditors’ rights generally or by general principles of equity).
(b) Ownership.
The Stockholder’s Existing Shares are, and all of the Covered Shares owned by the Stockholder from the date hereof through
the date of the MSLO Stockholder Meeting (including any permitted postponement or adjournment thereof, the “Meeting Date”)
will be, Beneficially Owned by the Stockholder, in each case as reflected on Schedule A hereto. As of the date hereof, the Stockholder’s
Existing Shares constitute all of the shares of MSLO Common Stock Beneficially Owned by the Stockholder. Except for the rights
granted to TopCo and Sequential hereby and except as set forth on Schedule A, the Stockholder has and will have at all times through
the Meeting Date sole (or shared with another Stockholder) voting power to control the vote and consent as contemplated herein,
sole (or shared with another Stockholder) power of disposition, sole (or shared with another Stockholder) power to issue instructions
with respect to the matters set forth in Article II, and sole (or shared with another Stockholder) power to agree to all of the
matters set forth in this Agreement, in each case, with respect to all of the Stockholder’s Existing Shares and with respect
to all of the Covered Shares owned by the Stockholder at all times through the Meeting Date.
(c) No
Violation. The execution, delivery and performance of this Agreement by the Stockholder does not and will not (whether with
or without notice or lapse of time, or both) (i) violate any provision of the certificate of formation or other comparable governing
documents, as applicable, of the Stockholder, (ii) violate, conflict with or result in the breach of any of the terms or conditions
of, result in any (or the right to make any) modification of or the cancellation or loss of a benefit under, require any notice,
consent or action under, or otherwise give any Person the right to terminate, accelerate obligations under or receive payment or
additional rights under, or constitute a default under, any Contract to which the Stockholder is a party or by which it is bound
or (iii) violate any Law applicable to the Stockholder or by which any of the Stockholder’s assets or properties is bound,
except for any of the foregoing as would not, either individually or in the aggregate, impair the ability of the Stockholder to
perform its obligations hereunder or to consummate the transactions contemplated hereby on a timely basis.
(d) Consents
and Approvals. The execution and delivery of this Agreement by the Stockholder does not, and the performance by each Stockholder
of its obligations under this Agreement and the consummation by it of the transactions contemplated hereby will not, require such
Stockholder to obtain any consent, approval, authorization or permit of, or to make any filing with or notification to, any Governmental
Entity, other than the filings of any reports with the SEC and except where the failure to obtain such consents, approvals, authorizations
or permits, or to make such filings and notifications, would not, either individually or in the aggregate, prevent or delay the
performance by the Stockholder of any of its obligations hereunder.
(e) Absence
of Litigation. As of the date hereof, there is no Action pending or, to the knowledge of the Stockholder, threatened against
or affecting the Stockholder or any of its Affiliates before or by any Governmental Entity that would reasonably be expected to
impair the ability of the Stockholder to perform its obligations hereunder or to consummate the transactions contemplated hereby
on a timely basis.
(f) Finder’s
Fees. Except as disclosed pursuant to the Merger Agreement, no investment banker, broker, finder or other intermediary is entitled
to a fee or commission from Sequential, Singer Merger Sub, MSLO, Madeline Merger Sub or TopCo in respect of this Agreement based
upon any arrangement or agreement made by the Stockholder (in such Stockholder’s capacity as a stockholder of MSLO).
(g) Reliance
by Sequential. The Stockholder understands and acknowledges that Sequential is entering into the Merger Agreement in reliance
upon the Stockholder’s execution and delivery of this Agreement and the representations and warranties of the Stockholder
contained herein.
Section 3.2 Representations
and Warranties of Sequential.
(a) Authorization.
Sequential has the power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate
the transactions contemplated hereby. The execution and delivery by Sequential of this Agreement, the performance by it of its
obligations hereunder and the consummation by it of the transactions contemplated hereby have been duly and validly authorized
by Sequential and no other actions or proceedings on the part of Sequential are necessary to authorize the execution and delivery
by it of this Agreement, the performance by it of its obligations hereunder or the consummation by it of the transactions contemplated
hereby. This Agreement has been duly executed and delivered by Sequential and, assuming this Agreement constitutes a valid and
binding obligation of the other parties hereto, constitutes a legal, valid and binding obligation of Sequential, enforceable against
it in accordance with its terms (except to the extent that enforceability may be limited by applicable bankruptcy, insolvency,
moratorium, reorganization or similar Laws affecting the enforcement of creditors’ rights generally or by general principles
of equity).
(b) No
Beneficial Ownership. Sequential hereby represents and warrants to the Stockholders that nothing contained in this Agreement
has caused or shall cause Sequential to acquire Beneficial Ownership of the Covered Shares.
Article
IV
OTHER COVENANTS
Section 4.1 Prohibition
on Transfers, Other Actions. From the date hereof through the Meeting Date, each Stockholder hereby agrees not to (i) Transfer
any of the Covered Shares, Beneficial Ownership thereof or any other interest therein (including by tendering into a tender or
exchange offer), unless such Transfer is a Permitted Transfer, (ii) enter into any agreement, arrangement or understanding with
any Person (other than TopCo and Sequential), or take any other action, that violates or conflicts with the Stockholder’s
representations, warranties, covenants and obligations under this Agreement, or (iii) take any action that would reasonably be
expected to restrict or otherwise adversely affect the Stockholder’s legal power, authority and right to comply with and
perform its covenants and obligations under this Agreement. Any Transfer in violation of this provision shall be void ab initio.
Section 4.2 Stock
Dividends, etc. In the event of a stock split, stock dividend or distribution, or any change in the shares of MSLO Common Stock
by reason of any split-up, reverse stock split, recapitalization, combination, reclassification, reincorporation, exchange of shares
or the like, the terms “Existing Shares” and “Covered Shares” shall be deemed to refer to and include such
shares as well as all such stock dividends and distributions and any securities into which or for which any or all of such shares
may be changed or exchanged or which are received in such transaction.
Section 4.3 No
Solicitation.
(a) Each
Stockholder hereby acknowledges that it has reviewed and understands the obligations of a Representative as set forth in Section
5.5 of the Merger Agreement. Each Stockholder hereby agrees that it shall, and shall direct its Representatives to, immediately
cease and cause to be terminated all existing discussions and negotiations with any Person conducted heretofore with respect to
any Acquisition Proposal.
(b) Notwithstanding
anything to the contrary in this Agreement, solely to the extent MSLO is permitted to take the actions set forth in Section 5.5(a)
or 5.5(b) of the Merger Agreement with respect to an Acquisition Proposal, each Stockholder and its Affiliates and Representatives
will be free to participate in any discussions or negotiations regarding such Acquisition Proposal with the Person making such
Acquisition Proposal, provided such action by such Stockholder and its Affiliates and Representatives would be permitted to be
taken by MSLO pursuant to Section 5.5(a) or 5.5(b) of the Merger Agreement.
(c) For
the avoidance of doubt, nothing in this Section 4.3 shall affect in any way the obligations of any Person (including MSLO) under
Section 5.5 of the Merger Agreement.
Section 4.4 Notice
of Acquisitions. Each Stockholder hereby agrees to notify Sequential in writing as promptly as practicable (and in any event
within 48 hours following such acquisition by the Stockholder) of the number of any additional shares of MSLO Common Stock or other
securities of MSLO of which the Stockholder acquires Beneficial Ownership on or after the date hereof.
Section 4.5 Waiver
of Appraisal Rights. Each Stockholder agrees not to exercise any rights of appraisal or any dissenters’ rights (including
under Section 262 of the DGCL) that the Stockholder may have (whether under applicable Law or otherwise) or could potentially have
or acquire in connection with the Mergers.
Section 4.6 Disclosure.
Subject to reasonable prior notice and approval (not to be unreasonably withheld, conditioned or delayed) of the Stockholders,
each Stockholder hereby authorizes MSLO and Sequential to publish and disclose in any announcement or disclosure required by the
SEC, including in the Proxy Statement/Prospectus the Stockholder’s identity and ownership of such Stockholder’s Covered
Shares and the nature of the Stockholder’s obligations under this Agreement.
Section 4.7 Notices
under the Merger Agreement. Sequential shall use commercially reasonable efforts to cause a copy of all notices delivered to
MSLO pursuant to the Merger Agreement to be delivered to the Stockholders within two Business Days of delivery to MSLO.
Section 4.8 Public
Announcement and S-4. TopCo and Sequential shall provide Martha Stewart and her counsel a reasonable opportunity to review
and comment upon, (i) any press release or other widely-disseminated public statements with respect to the Merger Agreement, this
Agreement or the other agreements to be entered in connection with the transactions contemplated by the Merger Agreement to which
any Stockholder is a party and (ii) the S-4 and Proxy Statement/Prospectus and any response to material SEC comments in connection
therewith, except as may be required by applicable Law, court process or by obligations pursuant to any listing agreement with
any national securities exchange or national securities quotation system; and provided that TopCo, Sequential and their
respective Affiliates may make statements that are substantially similar to previous press releases, public disclosures or public
statements made in compliance with the Merger Agreement and this Agreement.
Section 4.9 Expenses.
At Closing, TopCo and Sequential hereby consent to the reimbursement by MSLO prior to Closing to each Stockholder for the fees
and out-of-pocket expenses, including fees of attorneys and financial advisors, incurred by such Stockholder in connection with
the negotiation, execution and delivery of this Agreement, the Merger Agreement, or the other agreements to be entered into in
connection with the transactions contemplated by the Merger Agreement to which such Stockholder is a party, which amount will be
notified in writing to TopCo and Sequential at least two Business Days prior to the Closing; provided that the aggregate
amount of such fees and expenses required shall not exceed $4,000,000; provided, further that, if MSLO does not reimburse the Stockholders
for such expenses at or prior to the Effective Time, Sequential and TopCo hereby agree to reimburse, or cause MSLO to reimburse,
the Stockholders for such expenses promptly following the Effective Time.
Section 4.10 Indemnification.
From and after closing, TopCo shall indemnify and hold harmless each trust or similar entity affiliated with a Stockholder and
which is not a party to this agreement and such trust or similar entity’s officers, directors and trustees (the “Indemnified
Parties”), against all claims, losses, liabilities, damages, judgments, inquiries, fines and reasonable fees, costs
and expenses, including attorneys’ fees and disbursements, incurred in connection with any claim, action, suit or proceeding,
whether civil, criminal, administrative or investigative, arising out of or pertaining to the Merger Agreement and this Agreement,
and the transactions contemplated thereby and hereby, to the fullest extent permitted by applicable Law. In
the event of any such claim, action, suit or proceeding, (i) each Stockholder will be entitled to advancement of expenses incurred
in the defense of any such claim, action, suit or proceeding from TopCo to the fullest extent permitted by applicable Law; provided,
that any person to whom expenses are advanced provides an undertaking, if and only to the extent required by the DGCL, to repay
such advances if it is ultimately determined that such person is not entitled to indemnification, and (ii) TopCo shall, and shall
cause its subsidiaries to, cooperate in the defense of any such matter.
Article
V
MISCELLANEOUS
Section 5.1 Termination.
This Agreement shall remain in effect until the earliest to occur of (i) the Expiration Date, (ii) the Closing Date, (iii) an Adverse
Recommendation Change, (iv) the MSLO Stockholder Approval has been obtained, (v) the delivery of written notice by Sequential to
the Stockholders of termination of this Agreement, and (vi) the delivery of written notice of termination by the Stockholders to
Sequential following any Fundamental Amendment effected without the prior consent of the Stockholder, and upon the occurrence of
the earliest of such events this Agreement shall terminate and be of no further force; provided, however, that the
provisions of Section 4.10, this Section 5.1, Section 5.2 and Sections 5.4 through 5.13 shall survive any termination of this Agreement
indefinitely and (ii) Sections 4.6, 4.7 and 4.8 shall remain in effect until the Expiration Date. Nothing in this Section 5.1 and
no termination of this Agreement shall relieve or otherwise limit any party of liability for willful and material breach of this
Agreement. For the avoidance of doubt, in the event the Merger Agreement is validly terminated prior to the Effective Time, this
Agreement and any consent executed pursuant hereto shall be deemed null and void and shall have no further effect. “Fundamental
Amendment” means the execution by MSLO, Madeline Merger Sub, Sequential, Singer Merger Sub and TopCo of a written amendment
to, or written waiver by MSLO, Madeline Merger Sub, Sequential, Singer Merger Sub and TopCo of any provision of, the Merger Agreement
that reduces the amount of the Merger Consideration or changes the form of the Merger Consideration to include or substitute therefor
a form other than cash and shares of TopCo Common Stock in the proportion reflected in the Merger Agreement, amends the conditions
precedent set forth in Section 7.1 or 7.3 of the Merger Agreement (except in the case of a waiver of a condition by Sequential
or TopCo) or would result in additional monetary liability to such Stockholder.
Section 5.2 Stop
Transfer Order. In furtherance of this Agreement, each Stockholder hereby authorizes and instructs MSLO to instruct its transfer
agent to enter a stop transfer order with respect to all of the Covered Shares held of record by such Stockholder and (i) if
this Agreement is terminated in accordance with Section 5.1, then, promptly following the termination of this Agreement, or (ii)
immediately following the Closing (and in any event within such time as would not delay receipt by the Stockholder of the Merger
Consideration), to cause any stop transfer instructions imposed pursuant to this Section 5.2 to be lifted.
Section 5.3 No
Ownership Interest. Nothing contained in this Agreement shall be deemed to vest in Sequential any direct or indirect ownership
or incidence of ownership (whether beneficial ownership or otherwise) of or with respect to any Covered Shares, except as otherwise
provided herein. All rights, ownership and economic benefits of and relating to the Covered Shares shall remain vested in and belong
to the applicable Stockholder, and Sequential shall have no authority to direct the Stockholders in the voting or disposition of
any of the Covered Shares, except as otherwise provided herein.
Section 5.4 Notices.
All notices and other communications hereunder shall be in writing and shall be deemed duly given (a) on the date of delivery
if delivered personally, or if by e-mail, upon written confirmation of receipt by e-mail or otherwise, (b) on the first Business
Day following the date of dispatch if delivered utilizing a next-day service by a recognized next-day courier or (c) on the
earlier of confirmed receipt or the fifth Business Day following the date of mailing if delivered by registered or certified mail,
return receipt requested, postage prepaid. All notices hereunder shall be delivered to the addresses set forth below, or pursuant
to such other instructions as may be designated in writing by the party to receive such notice:
(a) if
to Sequential to:
Sequential Brands Group, Inc.
5 Bryant Park, 30th Floor
New York, NY 10018
Attention: Yehuda Shmidman
E-mail: yshmidman@sbg-ny.com
with a copy (which shall not constitute notice) to:
Gibson, Dunn & Crutcher LLP
200 Park Avenue
New York, NY 10166-0193
Attention: Barbara L. Becker
E-mail: bbecker@gibsondunn.com
(b) if
to a Stockholder, to the address set forth opposite such Stockholder’s name in Schedule A hereto, with a copies (which
shall not constitute notice) to:
Wachtell, Lipton, Rosen & Katz
51 West 52nd Street
New York, NY 10019
Attention: Andrew J. Nussbaum
Email: AJNussbaum@wlrk.com
and
Grubman Shire & Meiselas, P.C.
152 West 57th Street
New York, NY 10019
Attention: Allen J. Grubman; Lawrence
Shire; Eric Sacks
Email: AGrubman@gispc.com; lshire@gispc.com;
esacks@gispc.com
Section 5.5 Interpretation.
When a reference is made in this Agreement to a Section, Article, Exhibit or Schedule such reference shall be to a Section, Article,
Exhibit or Schedule of this Agreement unless otherwise indicated. The headings contained in this Agreement or in any Exhibit or
Schedule are for convenience of reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.
All words used in this Agreement will be construed to be of such gender or number as the circumstances require. Any capitalized
terms used in any Exhibit or Schedule but not otherwise defined therein shall have the meaning as defined in this Agreement. All
Exhibits and Schedules annexed hereto or referred to herein are hereby incorporated in and made a part of this Agreement as if
set forth herein. The word “including” and words of similar import when used in this Agreement will mean “including,
without limitation,” unless otherwise specified. The words “hereof,” “herein” and “hereunder”
and words of similar import when used in this Agreement shall refer to the Agreement as a whole and not to any particular provision
in this Agreement. The term “or” is not exclusive. The word “will” shall be construed to have the same
meaning and effect as the word “shall.” References to days mean calendar days unless otherwise specified.
Section 5.6 Counterparts;
Facsimile or .pdf Signatures. This Agreement may be executed in two or more counterparts, all of which shall be considered
one and the same instrument and shall become effective when one or more counterparts have been signed by each of the parties and
delivered to the other party. This Agreement may be executed by facsimile or .pdf signature and a facsimile or .pdf signature shall
constitute an original for all purposes.
Section 5.7 Entire
Agreement. This Agreement and, to the extent referenced herein, the Merger Agreement, together with the several agreements
and other documents and instruments referred to herein or therein or annexed hereto or thereto, constitute the entire agreement,
and supersede all prior written agreements, arrangements, communications and understandings and all prior and contemporaneous oral
agreements, arrangements, communications and understandings among the parties with respect to the subject matter hereof and thereof.
Section 5.8 Governing
Law; Submission to Jurisdiction; Waiver of Jury Trial.
(a) This
Agreement and all disputes or controversies arising out of or relating to this Agreement or the transactions contemplated hereby
shall be governed by, and construed in accordance with, the internal laws of the State of Delaware, without regard to the laws
of any other jurisdiction that might be applied because of the conflicts of laws principles of the State of Delaware.
(b) Each
of the parties irrevocably agrees that any legal action or proceeding arising out of or relating to this Agreement brought by any
party or its Affiliates against any other party or its Affiliates shall be brought and determined in the Court of Chancery of the
State of Delaware; provided, that if jurisdiction is not then available in the Court of Chancery of the State of Delaware,
then any such legal action or proceeding may be brought in any federal court located in the State of Delaware or any other Delaware
state court. Each of the parties hereby irrevocably submits to the jurisdiction of the aforesaid courts for itself and with respect
to its property, generally and unconditionally, with regard to any such action or proceeding arising out of or relating to this
Agreement and the transactions contemplated hereby. Each of the parties agrees not to commence any action, suit or proceeding relating
thereto except in the courts described above in Delaware, other than actions in any court of competent jurisdiction to enforce
any judgment, decree or award rendered by any such court in Delaware as described herein. Each of the parties further agrees that
notice as provided herein shall constitute sufficient service of process and the parties further waive any argument that such service
is insufficient. Each of the parties hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion
or as a defense, counterclaim or otherwise, in any action or proceeding arising out of or relating to this Agreement or the transactions
contemplated hereby, (a) any claim that it is not personally subject to the jurisdiction of the courts in Delaware as described
herein for any reason, (b) that it or its property is exempt or immune from jurisdiction of any such court or from any legal
process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution
of judgment, execution of judgment or otherwise) and (c) that (i) the suit, action or proceeding in any such court is
brought in an inconvenient forum, (ii) the venue of such suit, action or proceeding is improper or (iii) this Agreement,
or the subject matter hereof, may not be enforced in or by such courts.
(c) EACH
OF THE PARTIES TO THIS AGREEMENT HEREBY IRREVOCABLY WAIVES ALL RIGHT TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM
ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.
Section 5.9 Specific
Performance. Each of the parties to this Agreement hereby acknowledge and agree that irreparable damage would occur in the
event that any of the provisions of this Agreement were not performed in accordance with its specific terms or if the Agreement
was otherwise breached and that money damages, even if available, would not be an adequate remedy therefor. Accordingly, each party
agrees that the other parties shall be entitled to specific performance, an injunction, restraining order and/or such other equitable
relief, in addition to any other rights and remedies existing in its favor at law or in equity, as a court of competent jurisdiction
may deem necessary or appropriate to enforce its rights and each of the obligations hereunder (without posting of bond or other
security). Anything in this Agreement to the contrary notwithstanding, each party hereby agrees that specific performance or injunctive
relief pursuant to this Section 5.9 shall be its sole and exclusive remedy with respect to breaches or threatened breaches by any
other party to this Agreement, and no such party shall pursue any other form of relief (including monetary damages) that may be
available for a breach of this Agreement.
Section 5.10 Amendment;
Waiver. This Agreement may be amended, modified or supplemented by a writing executed by each of the parties hereto. This Agreement
may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise, except by an instrument
in writing specifically designated as an amendment hereto, signed on behalf of each of the parties in interest at the time of the
amendment.
Section 5.11 Severability.
Whenever possible, each provision or portion of any provision of this Agreement shall be interpreted in such manner as to be effective
and valid under applicable Law, but if any provision or portion of any provision of this Agreement is held to be invalid, illegal
or unenforceable in any respect under any applicable Law or rule in any jurisdiction, such invalidity, illegality or unenforceability
shall not affect any other provision or portion of any provision in such jurisdiction, and this Agreement shall be reformed, construed
and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision or portion of any provision had never
been contained herein.
Section 5.12 Assignment;
Successors; No Third Party Beneficiaries. Neither this Agreement nor any of the rights, interests or obligations under this
Agreement may be assigned or delegated, in whole or in part, by operation of law or otherwise, by any party without the prior written
consent of the other parties, and any such assignment without such prior written consent shall be null and void. Subject to the
preceding sentence, this Agreement will be binding upon, inure to the benefit of, and be enforceable by, the parties and their
respective successors and assigns. Nothing in this Agreement, express or implied, is intended to or shall confer upon any Person
other than the parties and their respective successors and permitted assigns any legal or equitable right, benefit or remedy of
any nature under or by reason of this Agreement; provided, however, that MSLO is hereby made a third party beneficiary of Article
II herein only for the purpose of seeking specific performance of each Stockholder’s obligations thereunder; and provided,
further, however, that the Indemnified Parties shall be third party beneficiaries of Section 4.10.
Section 5.13 Stockholder
Capacity. The restrictions and covenants of each Stockholder hereunder shall not be binding, and shall have no effect, in any
way with respect to any director or officer of MSLO or any of its Subsidiaries in such Person’s capacity as such a director
or officer, nor shall any action taken by any such director or officer in his or her capacity as such be deemed a breach by a Stockholder
of this Agreement.
[The remainder of this page is intentionally
left blank]
IN WITNESS WHEREOF, Sequential, TopCo and
the Stockholders have caused to be executed or executed this Agreement as of the date first written above.
|
SEQUENTIAL BRANDS GROUP, INC., |
|
|
|
|
By: |
/s/ Yehuda Shmidman |
|
Name: |
Yehuda Shmidman |
|
Title: |
Chief Executive Officer |
|
|
|
|
SINGER MADELINE HOLDINGS, INC. |
|
|
|
|
By: |
/s/ Yehuda Shmidman |
|
Name: |
Yehuda Shmidman |
|
Title: |
Chief Executive Officer |
Signature
Page to Voting and Support Agreement |
|
STOCKHOLDERS: |
|
|
|
/s/ Martha Stewart |
|
MARTHA STEWART |
Signature
Page to Voting and Support Agreement |
|
MARTHA STEWART FAMILY LIMITED PARTNERSHIP |
|
|
|
|
By: |
/s/ Martha Stewart |
|
Name: |
Martha Stewart |
|
Title: |
General Partner, in her capacity as trustee of the Martha Stewart 2012 Revocable Trust |
Signature
Page to Voting and Support Agreement |
SCHEDULE A
Stockholder | |
Address | |
Class A Common Stock | | |
Class B Common Stock | |
Martha Stewart | |
48 Girdle Ridge Road Katonah, NY 10536 | |
| 27,087,571 | (1) | |
| 24,984,625 | |
Martha Stewart Family Limited Partnership | |
48 Girdle Ridge Road Katonah, NY 10536 | |
| 24,984,625 | (2) | |
| 24,984,625 | |
(1) Includes
(i) 14,748 shares of the Class A Common Stock held by Martha Stewart, (ii) 1,300,000 shares of the Class A Common Stock that are
subject to exercisable options and (iii) 29,816 shares of Class A Common Stock held by the Martha Stewart 1999 Family Trust, of
which Martha Stewart is a co-trustee and as to which she shares voting and dispositive power. These shares also include (a) 24,984,625
shares of Class B Common Stock held by the Martha Stewart Family Limited Partnership (“MSFLP”), of which Martha Stewart,
as the sole trustee of the Martha Stewart 2012 Revocable Trust, is the sole general partner, each of which is convertible at the
option of the holder into one share of the Class A Common Stock and (b) 37,270 shares of Class A Common Stock held by the Martha
Stewart 2000 Family Trust, of which Martha Stewart is a co-trustee. In addition, Martha Stewart may be deemed to beneficially own
721,112 shares of Class A Common Stock held by the Martha and Alexis Stewart Charitable Foundation, for which Martha Stewart is
a co-trustee and as to which she shares voting and dispositive power. Martha Stewart executed a revocable proxy, dated as of October
6, 2004, whereby Martha Stewart appointed Alexis Stewart as her true and lawful proxy, attorney-in-fact and agent with respect
to all of the securities of the Company that are owned by Martha Stewart from time to time. This proxy is hereby revoked.
(2) Consists
of 24,984,625 shares of the Class B Common Stock, each of which is convertible at the option of the holder into one share of the
Class A Common Stock, all of which are owned by MSFLP and indirectly owned by Martha Stewart as the sole general partner of MSFLP
in her capacity as the sole trustee of the Martha Stewart 2012 Revocable Trust and as to which MSFLP is deemed to share voting
and dispositive power. Pursuant to a power of attorney, dated as of October 6, 2004, MSFLP appointed Alexis Stewart as its true
and lawful proxy, attorney-in-fact and agent with respect to all of the securities of the Company that are owned by MSFLP from
time to time. This power of attorney is hereby revoked.
Exhibit 99.1
EXECUTION VERSION
EMPLOYMENT AGREEMENT
BETWEEN
SINGER MADELINE HOLDINGS, INC.
AND
MARTHA STEWART
DATED AS OF JUNE 22, 2015
AGREEMENT, dated as of June 22, 2015
(the “Effective Date”), by and between Singer Madeline Holdings, Inc. (the “Company”), and
Martha Stewart (the “Founder”).
WHEREAS, the Founder is a party to
an employment agreement, dated April 1, 2009, as amended, with Martha Stewart Living Omnimedia, Inc., a Delaware corporation (“Martha
Stewart Living”) (the “Prior Employment Agreement); and
WHEREAS, pursuant to that Agreement
and Plan of Merger by and among Martha Stewart Living, Madeline Merger Sub, Inc., Sequential Brands Group, Inc., Singer Merger
Sub, Inc. and the Company, dated as of June 22, 2015 (the “Merger Agreement”), Martha Stewart Living will become
a wholly-owned subsidiary of the Company;
WHEREAS, the Company recognizes that
the Founder’s talents and abilities are unique and have been integral to the success of Martha Stewart Living;
WHEREAS, the Company wishes to secure
the ongoing services of the Founder pursuant to the terms and conditions set forth herein, and therefore the Founder and the Company
intend hereby to enter into a new amended and restated employment agreement as set forth herein;
NOW, THEREFORE, in consideration
of the premises and the mutual covenants set forth below, the parties hereby agree as follows:
1. Employment.
From and after the Closing Date (as defined in the Merger Agreement) (the “Closing Date”), the Company hereby
agrees to employ the Founder as Founder and Chief Creative Officer of the Company, and the Founder hereby accepts such employment,
on the terms and conditions set forth below. In addition, effective as of the Closing Date, Employee shall receive an interim appointment
to serve as a member of the Company’s board of directors (the “Board”) and shall continue to be nominated
to serve as a member of the Board during (i) the Employment Period (and, as applicable, the Consulting Period), and (ii) during
any period in which the Founder (whether through affiliates or otherwise) beneficially own at least (a) six percent (6%) of the
total outstanding equity in the Company, or (b) two-thirds (2/3) of the total shares of the Company which are beneficially owned
by the Founder (whether through affiliates or otherwise) on the Closing Date. This Agreement is contingent upon the occurrence
of the Closing (as defined in the Merger Agreement) and shall be null and void if the Closing does not occur.
2. Term.
The Founder’s employment by the Company hereunder shall begin on the Closing Date and shall end on December 31, 2020 (the
“Initial Employment Period”), but subject to earlier termination as provided herein; provided that the
Initial Employment Period shall be automatically renewed for five additional calendar years ending December 31, 2025 (subject to
earlier termination as provided herein) if either the aggregate Gross Licensing Revenues (as defined below) for calendar years
2018 through 2020 exceed $195 million or the Gross Licensing Revenues for calendar year 2020 equal or exceed $65 million (the “Extended
Employment Period”). For purposes hereof, the “Employment Period” shall mean the Initial Employment
Period, and upon the occurrence of an Extended Employment Period, both the Initial Employment Period and the Extended Employment
Period. If the Employment Period is not extended past the Initial Employment Period pursuant to the first sentence of this Section
2, the Founder shall become a part-time consultant/brand ambassador for the Company for five (5) calendar years following the end
of the Initial Employment Period (the “Consulting Period”) on terms reasonably acceptable to the Founder and
the Company, and will receive only the compensation for such service specified in Section 8(d) (which compensation, for the avoidance
of doubt, shall be due and payable to the Founder regardless of whether an agreement regarding the Founder’s part-time consulting/brand
ambassadorship is entered into on terms reasonably acceptable to the Founder and the Company).
3. Position
and Duties. During the Employment Period, the Founder shall serve as Founder and Chief Creative Officer of the Company.
The Founder will have the power, responsibility, duties and authority customary for a Chief Creative Officer of corporations of
the size, type and nature of the Company and which are substantially consistent with her creative duties and authority with respect
to her current services with Martha Stewart Living (including those duties and authority with respect to the Company’s business
not involving Martha Stewart Living as are reasonable, to be mutually agreed upon between the Founder and the CEO of the Company
(the “CEO”) from time to time).
The Founder shall report directly to the
CEO. Unless otherwise authorized by the CEO, during the Employment Period, the Founder shall devote substantially all of her working
time, attention and energies during normal business hours (other than absences due to illness or vacation) to the performance of
her duties for the Company and Martha Stewart Living. Without limitation, during the Employment Period, the Founder will make herself
reasonably available, subject to her prior personal and professional commitments, for all appearances, events and related activities
specified or agreed to under the Company’s and Martha Stewart Living’s licensing agreements in effect as of the Closing
Date (but, for the avoidance, any extensions or modifications of such licensing agreements which provide for additional appearances,
events or similar activities shall require the consent of the Founder). During the Employment Period, subject at all times to her
prior personal and professional commitments, the Founder shall be reasonably available for promotional activities and shall also
provide endorsement services to promote the Company’s products and services from time-to-time during the Employment Period
consistent with her past practices with Martha Stewart Living (collectively, “Promotional Services”).
Notwithstanding the above, the Founder shall
be permitted, to the extent such activities do not violate, or substantially interfere with her performance of her duties and responsibilities
under this Agreement during the Employment Period, or any other agreement to which she and the Company are parties, in all cases
except for (iii), as determined by the CEO and the Board, to (i) engage in motion picture, television, public speaking and publishing
activities, (ii) appear from time to time in commercials and/or advertisements that do not present a conflict with the Company’s
or Martha Stewart Living’s interests with respect to its products or significant business relationships, in all cases subject
to the approval of the Board, (iii) manage her personal, financial and legal affairs (including writing her autobiography), (iv)
serve on civic or charitable boards or committees (it being expressly understood and agreed that the Founder’s continuing
to serve on any such board and/or committees on which she is serving, or with which she is otherwise associated, as of the Closing
Date, shall be deemed not to interfere with her performance of her duties and responsibilities under this Agreement), (v) serve
on boards of other companies and (vi) make personal appearances and lectures, and the Founder shall be entitled to receive and
retain all remuneration received by her from the items listed in clauses (i) through (vi) of this paragraph (including, without
limitation, appearance and speaking fees, book advances, royalties, residuals and other fees and compensation (including guild
and union payments) payable therewith) outside the performance of her duties hereunder. In addition, the Founder is entitled to
engage in motion picture and television activities on behalf of third parties and to receive and retain all remuneration therefrom,
so long as such activities do not substantially interfere with the performance of her duties and responsibilities hereunder. The
Founder and the Company agree that, to the extent that any such third party production would require the Founder to provide recurring
services, she may provide such services so long as the Company receives one-third of any talent fee that would be payable in respect
of her services as a performer. The Founder will be entitled to retain the remainder of such talent fees. For the avoidance of
doubt, where the Founder’s services do not require recurring services that could interfere with her duties and responsibilities
hereunder, she shall continue to have the right to receive and retain all of the fees payable.
4. Place
of Performance. During the Employment Period, the locations of employment of the Founder shall be in New York City, New
York (which office location shall remain the headquarters of Martha Stewart Living) and Bedford, New York, in the Founder’s
reasonable discretion, and the Founder shall not be required to relocate her employment to any other location. During the Employment
Period (and during any period the Founder is entitled to the Existing Expense Reimbursements pursuant to Section 8), the Company
shall not terminate, other than for “cause” (as such term is defined in the Company’s severance plan applicable
to all of its employees), any of the employees (or replacements of such employees) listed on Exhibit A attached hereto and such
individuals shall continue to receive no less than their current compensation and level of benefits as provided for on the date
hereof; provided that the Company shall not be required to pay compensation or benefits to any such person in excess of such individual’s
compensation and benefits on the date hereof. In addition, the Company shall provide the Founder with the same offices in New York,
New York that were provided by Martha Stewart Living through at least the expiration of the current lease on January 31, 2018.
5. Compensation
and Related Matters.
(a) Base
Compensation. In consideration of her performance of her duties hereunder, during the Employment Period the Company shall pay
the Founder base compensation at the rate of Five Hundred Thousand Dollars ($500,000) per year (the “Base Compensation”).
The Base Compensation shall be paid in approximately equal installments in accordance with the Company’s customary payroll
practices and subject to all applicable income and employment tax withholdings. The Base Compensation may be increased by the Board
in its sole discretion. If the Base Compensation is increased by the Board, such increased Base Compensation shall then constitute
the Base Compensation for all purposes under this Agreement.
(b) Annual
Bonus. For each year during the Employment Period, to the extent that the Company pays bonuses to other senior executives in
addition to contractually-committed amounts, the CEO and the Board will consider an appropriate discretionary bonus for the Founder.
(c) Guaranteed
Payment. In addition, for each calendar year during the Employment Period commencing with 2015, the Founder shall receive a
guaranteed annual payment of One Million Three Hundred Thousand Dollars ($1,300,000) (the “Guaranteed Payment”), pro
rated for partial years of employment during the Employment Period. The Guaranteed Payment shall be paid at the same time as Base
Compensation is paid and shall be subject to all applicable income and employment tax withholding.
(d) Incentive
Payments. For each calendar year during the Employment Period commencing on or after January 1, 2016, the Company shall pay
the Founder an amount equal to ten percent (10%) of Gross Licensing Revenues earned by the Company during such calendar year in
excess of Forty Six Million Dollars ($46,000,000). Any such amount shall be paid no later than March 15 of the year following the
calendar year to which it relates. For purposes hereof, “Gross Licensing Revenues” means total revenues (including,
without limitation, licensing royalties (and, for the avoidance of doubt minimum royalties, and other measurable consideration
which can be reduced to monetary value)) earned and received by the Company from the licensing of the Martha Stewart brand (including,
all associated and related marks, but excluding publishing and media).
(e) Vacation.
During the Employment Period, the Founder shall be entitled to six weeks of vacation per year. Vacation not taken during the applicable
fiscal year (but not in excess of three weeks) shall be carried over to the next following fiscal year.
(f) Welfare,
Pension and Incentive Benefit Plans. During the Employment Period, the Founder (and her eligible spouse and dependents) shall
be entitled to participate in all welfare benefit plans and programs maintained by the Company from time to time for the benefit
of its senior executives, including, without limitation, all medical, hospitalization, dental, disability, accidental death and
dismemberment, travel accident and life insurance plans, programs and arrangements. In addition, during the Employment Period,
the Founder shall be eligible to participate in all pension, retirement, savings and other employee benefit plans and programs
maintained from time to time by the Company for the benefit of its senior executives, other than any equity-based incentive plans,
severance plans, retention plans and any annual cash incentive plan.
(g) Equity
Awards. The Founder shall participate in any equity incentive program approved by the Compensation Committee of the Board on
the same basis as senior executives of the Company.
(h) Expenses.
The Company shall directly pay or reimburse the Founder for customary and reasonable expenses incurred in connection with her performance
of duties for the Company in accordance with the Company’s expense reimbursement policy for its senior executives and for
other reasonable and customary expenses (not to exceed $100,000 per year) as are approved in advance by the CEO. In addition, the
Company shall directly pay or reimburse the Founder for all reasonable expenses she incurs in connection with any service days
spent providing Promotional Services (including first class travel, hotel accommodations, and hair and make-up services); for the
avoidance of doubt, such payments shall not be subject to or taken into account with respect to the $100,000 cap referred to in
the immediately-preceding sentence. In addition, the Company will continue to pay for and reimburse the Founder for her expenses
in accordance with the Prior Employment Agreement and the expense policy in place for Martha Stewart Living on the Effective Date
as specified in Exhibit B, provided that in no event shall the aggregate budget for years after 2015 be increased or decreased
except by mutual agreement of the CEO and the Founder (the “Existing Expense Reimbursements”).
(i) Legacy
Payments. Beginning with calendar years commencing on or after January 1, 2026, the Company shall pay the Founder three and
one-half percent (3.5%) of Gross Licensing Revenues for each such calendar year for the remainder of the Founder’s life (with
a minimum of five (5) years of payments, to be made to the Founder’s estate for the period from January 1, 2026 (or, if later,
the Founder’s death) through December 31, 2030 if the Founder dies before December 31, 2030) (the “Legacy Payments”
and, the period with respect to which the Legacy Payments are made, the “Legacy Payment Period”). The Legacy
Payments shall be paid on a calender quarter basis and shall be accompanied by a detailed statement setting forth each licensee,
the gross sales by each such licensee and the revenues received from each such licensee. The Legacy Payments described in this
Section 5(i) shall be made regardless of the time or reason for the Founder’s termination of employment.
(j) Audit.
The Founder’s representatives may, during regular business hours and upon reasonable advance notice to the Company, during
the period for which the Founder (or her estate) is entitled to any payments hereunder and for one year thereafter, audit the Company’s
books of account and records and examine and copy all documents and materials relating to the this Agreement and activities hereunder,
including the books of account and records, invoices, credits and shipping documents and all information related to the determination
of Gross Licensing Revenues. If any such audit finds that any of the Company’s payments hereunder were less than the amount
that should have been paid and the Company agrees with such finding, the payment required to be made to eliminate the discrepancy,
plus interest at the rate of five percent (5%) per annum, shall be made promptly, and, if the discrepancy is ten percent (10%)
or more of the amount actually paid for the subject period, the Company promptly shall reimburse the Founder for the actual cost
and expenses of the audit.
6. Termination.
The Founder’s employment hereunder may be terminated during the Employment Period under the following circumstances:
(a) Death.
The Founder’s employment hereunder shall terminate upon her death.
(b) Disability.
The Company shall have the right to terminate the Founder’s employment as a result of the Founder’s Disability (as
defined below) as determined by a physician selected by the Founder, and reasonably acceptable to the Company. “Disability”
shall mean (i) the Founder’s inability to engage in any substantial gainful activity by reason of any medically determinable
physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not
less than twelve (12) months; (ii) the Founder is, by reason of any medically determinable physical or mental impairment that can
be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, receiving
income replacement benefits for a period of not less than three (3) months under an accident and health plan covering the Founder;
or (iii) the Founder is determined to be totally disabled by the Social Security Administration.
(c) Cause.
The Company shall have the right to terminate the Founder’s employment for “Cause.” For purposes of this Agreement,
the Company shall have “Cause” to terminate the Founder’s employment only upon the Founder’s:
(i) willful
gross misconduct or conviction of a felony after the Effective Date that, in either case, results in material and demonstrable
damage to the business or reputation of the Company; or
(ii) willful
and continued failure to perform her duties hereunder (other than such failure resulting from legal necessity or after the issuance
of a Notice of Termination by the Founder for Good Reason) within ten business days after the Company delivers to her a written
demand for performance that specifically identifies the actions to be performed.
For purposes of this Section 6(c), no act
or failure to act by the Founder shall be considered “willful” if such act is done by the Founder in the good faith
belief that such act is or was to be beneficial to the Company or one or more of its businesses, or such failure to act is due
to the Founder’s good faith belief that such action would be materially harmful to the Company or one of its businesses.
Cause shall not exist unless and until the Company has delivered to the Founder a copy of a resolution duly adopted by a majority
of the Board (excluding the Founder for purposes of determining such majority) at a meeting of the Board called and held for such
purpose after reasonable (but in no event less than thirty days’) notice to the Founder and an opportunity for the Founder,
together with her counsel, to be heard before the Board, finding that in the good faith opinion of the Board that “Cause”
exists, and specifying the particulars thereof in detail. This Section 6(c) shall not prevent the Founder from challenging in any
court of competent jurisdiction the Board’s determination that Cause exists or that the Founder has failed to cure any act
(or failure to act) that purportedly formed the basis for the Board’s determination.
(d) Good
Reason. The Founder may terminate her employment for “Good Reason” after giving the Company detailed written
notice thereof, if the Company shall have failed to cure the event or circumstance constituting “Good Reason” within
ten business days after receiving such notice. Good Reason shall mean the occurrence of any of the following without the written
consent of the Founder:
(i) the
assignment to the Founder of duties materially inconsistent with this Agreement or a material adverse change in her titles or responsibilities
(and, for the avoidance of doubt, Employee no longer serving as a member of the Board shall not constitute Good Reason unless the
Company has not nominated the Founder for the Board);
(ii) the
Company’s failure to nominate the Founder for the Board in accordance with the provisions of Section 1;
(iii) any
failure by the Company to comply with Section 5 hereof in any material way;
(iv) the
requirement by the Company that the Founder relocate her primary offices outside of New York, New York;
(v) the
failure of the Company to comply with and satisfy Section 12(a) of this Agreement; or
(vi) any
material breach of this Agreement by the Company.
The Founder’s continued employment
shall not constitute consent to, or a waiver of rights with respect to, any act or failure to act constituting Good Reason hereunder.
(e) Without
Cause. The Company shall have the right to terminate the Founder’s employment hereunder without Cause by providing the
Founder with a Notice of Termination.
(f) Without
Good Reason. The Founder shall have the right to terminate her employment hereunder without Good Reason by providing the Company
with a Notice of Termination.
7. Termination
Procedure.
(a) Notice
of Termination. Any termination of the Founder’s employment by the Company or by the Founder during the Employment Period
(other than pursuant to Section 6(a)) shall be communicated by written Notice of Termination to the other party. For purposes of
this Agreement, a “Notice of Termination” shall mean a notice indicating the specific termination provision
in this Agreement relied upon and setting forth in reasonable detail the facts and circumstances claimed to provide a basis for
termination of the Founder’s employment under that provision.
(b) Date
of Termination. “Date of Termination” shall mean (i) if the Founder’s employment is terminated by
her death, the date of her death, (ii) if the Founder’s employment is terminated pursuant to Section 6(b), thirty (30) days
after the date of receipt of the Notice of Termination (provided that the Founder does not return to the substantial performance
of her duties on a full-time basis during such thirty (30) day period), and (iii) if the Founder’s employment is terminated
for any other reason, the date on which a Notice of Termination is given or any later date (within thirty (30) days after the giving
of such notice) set forth in such Notice of Termination.
8. Compensation
upon Termination or During Disability. In the event the Founder is disabled or her employment terminates during the Employment
Period, the Company shall provide the Founder with the payments and benefits set forth below. The Founder acknowledges and agrees
that the payments set forth in this Section 8 constitute liquidated damages for termination of her employment during the Employment
Period. For the avoidance of doubt, the termination of the Founder’s employment for any reason after the Employment Period
ends shall not entitle the Founder to any payments pursuant to this Section 8 (other than the Accrued Obligations to the extent
provided below).
(a) Termination
by Company without Cause or by the Founder for Good Reason. If the Founder’s employment is terminated by the Company
without Cause (other than Disability) or by the Founder for Good Reason, subject in all respects to the application of Section
21(b) below, and (except with respect to the payments to be provided pursuant to section 8(a)(i)) subject to the Founder executing
(and not revoking) a release of claims in the form attached hereto as Exhibit C (the “Release”) within twenty-one (21)
days following the Date of Termination:
(i) the
Company shall pay to the Founder (A) a lump sum payment equal to the sum of accrued Base Compensation and accrued vacation pay
through the Date of Termination, (B) the Guaranteed Payment, payable for each year remaining in the then-current Employment Period
(as if no Date of Termination had occurred) at the time(s) payable pursuant to Section 5(c), (C) the Legacy Payments, payable at
the time(s) payable during the Legacy Payment Period pursuant to Section 5(i) and (D) accrued expenses incurred before the Date
of Termination and payable pursuant to Section 5(h);
(ii) in
addition to the amounts set forth in clause (i) above, if the Date of Termination occurs during the Initial Employment Period,
the Company shall continue to pay the Base Compensation and the Existing Expense Reimbursements and make the payments specified
in Section 5(d) through the end of the Initial Employment Period (in each such case as if no Date of Termination had occurred during
such period), and, unless the Founder becomes entitled to continue to receive the payments set forth in clause (iii)(B)
below, the Founder also will receive the payments pursuant to Section 8(d) below, in accordance with and during the five-year period
set forth therein;
(iii) in
addition to the amounts set forth in clause (i) above, if (A) the Date of Termination occurs during the Extended Employment Period,
or (B) the Date of Termination occurs during the Initial Employment Period but the Employment Period would have been extended for
another five years pursuant to Section 2 (based on achievement of the criteria specified therein) had the Founder otherwise remained
employed through the end of the Initial Employment Period, the Company shall continue to pay the Base Compensation, the Guaranteed
Payment, the Existing Expense Reimbursements and the payments specified in Section 5(d), in each case through the end of the Extended
Employment Period as if no Date of Termination had occurred during such period (without duplication of any amount payable pursuant
to clause (ii) immediately above);
(iv) the
Company shall continue to provide the Founder and her eligible spouse and dependents for a period equal to the greater of (A) the
remaining term of the Employment Period (as if no Date of Termination had occurred), or (B) three years following the Date of Termination,
the medical, hospitalization, dental and life insurance programs provided for in Section 5(f), as if she had remained employed;
provided, that if the Founder, her spouse or her eligible dependents cannot continue to participate in the Company programs providing
such benefits, the Company shall arrange to provide the Founder and her spouse and dependents with the economic equivalent of the
benefits they otherwise would have been entitled to receive under such plans and programs; and provided, further, that such benefits
shall terminate on the date or dates the Founder becomes eligible to receive equivalent coverage and benefits under the plans and
programs of a subsequent employer at an equivalent cost to the Founder (such coverage and benefits to be determined on a coverage-by-coverage,
or benefit-by-benefit, basis);
(v) until
the third anniversary of the Date of Termination, the Company shall continue to provide the Founder with an office and an assistant
(of the Founder’s choice) in New York, New York and Bedford, NY; and
(vi) the
Founder shall be entitled to any other rights, compensation and/or benefits as may be due to the Founder in accordance with the
terms and provisions of any agreements, plans or programs of the Company (other than any severance-based plan or program).
The payments and benefits provided for in
clause (i) above are hereinafter referred to as the “Accrued Obligations.” To the extent any of the benefits
provided for in clauses (ii) – (vi) above are taxable to the Founder, and except as permitted by Section 409A (as defined
in Section 21(a) below), any right to reimbursement or in-kind benefits will not be subject to liquidation or exchange for another
benefit, the amount of expenses eligible for reimbursement, or in-kind benefits, provided during any taxable year it will not affect
the expenses eligible for reimbursement in a later taxable year, and any payments for reimbursements will be paid on or before
the last day of the taxable year following the taxable year in which the expense was incurred.
(b) Cause
or by Founder without Good Reason. If the Founder’s employment is terminated by the Company for Cause or by the Founder
other than for Good Reason, then the Company shall provide the Founder with her Accrued Obligations. The Company shall have no
further obligation to the Founder hereunder (other than, for the avoidance of doubt, the Legacy Payments).
(c) Death
or Disability. Upon the Founder’s death or Disability (including, death or Disability which occurs prior to Closing)
(i) on or before the end of the Initial Employment Period, the Company will continue to pay the Base Compensation, the Guaranteed
Payment, and the payments described in Section 5(d) through December 31, 2020 and, for calendar years 2021 through 2025, the Company
will pay the Founder (or, as applicable, her estate) four percent (4%) of Gross Licensing Revenues for each such year; or (ii)
after the fifth year following Closing, the Company will pay the Founder (or, as applicable, her estate) four percent (4%) of Gross
Licensing Revenues for each year commencing with the year in which such death or Disability occurs through December 31, 2025. For
the avoidance of doubt, the Legacy Payments shall also be paid at the time(s) payable during the Legacy Payment Period pursuant
to Section 5(i).
(d) Non-Extension
of Employment Period. If the Employment Period is not extended pursuant to the last sentence of Section 2, the Founder shall
be entitled to (i) the Accrued Obligations and (ii) the following amounts for each of the five (5) calendar years in the Consulting
Period: (A) if both Gross Licensing Revenues are less than $51 million for calendar year 2020 and aggregate Gross Licensing Revenues
for calendar years 2018 through 2020 are less than $153 million, $1,500,000 per year; (B) if Gross Licensing Revenues are between
$51 million and $55,999,999 for calendar year 2020 and aggregate Gross Licensing Revenues for calendar years 2018 through 2020
were equal to or greater than $153 million (but were less than $168 million), $3 million per year; or (C) if Gross Licensing Revenues
equal or exceed $56 million for calendar 2020 (but are less than $61 million) or Gross Licensing Revenues for calendar years 2018
through 2020 equaled or exceeded $168 million (but were less than $183 million), $4.5 million per year. Such amounts shall be paid
quarterly and in no event no later than March 15 of the calendar year following the calendar year to which they relate. For the
avoidance of doubt, the Legacy Payments shall also be paid at the time(s) payable during the Legacy Payment Period pursuant to
Section 5(i).
(e) Mitigation.
The Founder shall not be required to mitigate damages with respect to the termination of her employment under this Agreement by
seeking other employment or otherwise and there shall be no offset against amounts due the Founder under this Agreement on account
of subsequent employment except as specifically provided in this Section 8. Additionally, amounts owed to the Founder under this
Agreement shall not be offset by any claims the Company may have against the Founder, and the Company’s obligation to make
the payments provided for in this Agreement, and otherwise to perform its obligations hereunder, shall not be affected by any other
circumstances, including, without limitation, any counterclaim, recoupment, defense or other right which the Company may have against
the Founder or others.
9. Confidential
Information; Noncompetition; Nonsolicitation; Nondisparagement.
(a) Confidential
Information. Except as may be required or appropriate in connection with her carrying out her duties under this Agreement,
the Founder shall not, without the prior written consent of the Company or as may otherwise be required by law or any legal process,
or as is necessary in connection with any adversarial proceeding against the Company (in which case the Founder shall cooperate
with the Company in obtaining a protective order at the Company’s expense against disclosure by a court of competent jurisdiction),
communicate, to anyone other than the Company and those designated by the Company or on behalf of the Company in the furtherance
of its business or to perform her duties hereunder, any trade secrets, confidential information, knowledge or data relating to
the Company, its affiliates or any businesses or investments of the Company or its affiliates, obtained by the Founder during the
Founder’s employment by the Company and MSLO LLC that is not generally available public knowledge (other than by acts by
the Founder in violation of this Agreement.)
(b) Noncompetition.
During the Employment Period and until the 12-month anniversary of the Founder’s Date of Termination if the Founder’s
employment is terminated by the Company for Cause or the Founder terminates employment without Good Reason, the Founder shall not
engage in or become associated with any Competitive Activity. For purposes of this Section 9(b), a “Competitive Activity”
shall mean any business or other endeavor that engages in any country in which the Company has significant business operations
to a significant degree in a business that directly competes with all or any substantial part of any of the Company’s businesses
of (i) producing television and other video programs, (ii) designing, developing, licensing, promoting and selling merchandise
through catalogs, direct marketing, Internet commerce and retail stores of the product categories in which the Company so participates
using the Founder’s name, likeness, image, or voice to promote or market any such product or service, (iii) the creation,
publication or distribution of regular or special issues of magazines, and (iv) any other business in which the Company or Martha
Stewart Living is engaged during the last twelve (12) months of the Employment Period (the activities described in clauses (i)
through (iv), in each case determined as of the date of the action alleged to be Competitive Activity, (the “Businesses”);
provided, that, a Competitive Activity shall not include (i) any speaking engagement to the extent such speaking engagement does
not promote or endorse a product or service which is competitive with any product or service of the Company, (ii) the writing of
any book or article relating to subjects other than the Businesses (e.g., nonfiction relating to the Founder’s career or
general business advice) or (iii) the television, video or music business so long as such activity does not relate to the Businesses.
The Founder shall be considered to have become “associated with a Competitive Activity” if she becomes involved
as an owner, employee, officer, director, independent contractor, agent, partner, advisor, or in any other capacity calling for
the rendition of the Founder’s personal services, with any individual, partnership, corporation or other organization that
is engaged in a Competitive Activity and her involvement relates to a significant extent to the Competitive Activity of such entity;
provided, however, that the Founder shall not be prohibited from (a) owning less than one percent (1%) of any publicly traded corporation,
whether or not such corporation is in competition with the Company, or investing in any mutual fund or other investment fund over
which the Founder has no investment discretion or (b) serving as a director of a corporation or other entity the primary business
of which is not a Competitive Activity. If, at any time, the provisions of this Section 9(b) shall be determined to be invalid
or unenforceable, by reason of being vague or unreasonable as to area, duration or scope of activity, this Section 9(b) shall be
considered divisible and shall become and be immediately amended to only such area, duration and scope of activity as shall be
determined to be reasonable and enforceable by the court or other body having jurisdiction over the matter; and the Founder agrees
that this Section 9(b) as so amended shall be valid and binding as though any invalid or unenforceable provision had not been included
herein.
(c) Nonsolicitation.
During the Employment Period, and for 12 months after the Founder’s Date of Termination if the Founder’s employment
is terminated by the Company for Cause or the Founder terminates employment without Good Reason, the Founder will not, directly
or indirectly, (1) solicit for employment by other than the Company any person (other than any personal secretary or assistant
hired to work directly for the Founder) employed by the Company or its affiliated companies as of the Date of Termination, (2)
solicit for employment by other than the Company any person known by the Founder (after reasonable inquiry) to be employed at the
time by the Company or its affiliated companies as of the date of the solicitation or (3) solicit any customer or other person
with a business relationship with the Company or any of its affiliated companies to terminate, curtail or otherwise limit such
business relationship.
(d) Non-disparagement.
During the Employment Period and for two (2) years thereafter, (i) neither the Founder, nor anyone acting on behalf of the Founder,
shall make or publish any disparaging or derogatory statement (whether written or oral) regarding the Company or any of its affiliated
companies or businesses that are known to the Founder to be so affiliated, the individuals who serve as members of the Board during
such period or those individuals who serve in positions of executive vice president or more senior positions at the Company during
the Employment Period and, during the two-year period thereafter, only such individuals whose titles are publicly available, based
on the Company’s website, in each such case in any public communication, or in any non-public communication with any member
of the media or with any other person which may be reasonably expected to be publicly disseminated to the press or the media, and
(ii) neither the Company nor any of its affiliated companies or businesses or their affiliates, individuals who serve as members
of the Board during such period, or those individuals who serve in positions of executive vice president or more senior positions
at the Company , nor anyone authorized by the Company to speak on behalf of the Company, shall make or publish any disparaging
or derogatory statement (whether written or oral) regarding the Founder in any public communication, or in any non-public communication
with any member of the media or with any other person which may be reasonably expected to be publicly disseminated to the press
or the media.
(e) Injunctive
Relief. In the event of a breach or threatened breach of this Section 9, the Founder agrees that the Company shall be entitled
to injunctive relief in a court of appropriate jurisdiction to remedy any such breach or threatened breach, the Founder acknowledging
that damages would be inadequate and insufficient.
10. Indemnification.
(a) General.
The Company agrees that if the Founder is made a party or is threatened to be made a party to any audit, action, suit or proceeding,
whether civil, criminal, regulatory, administrative or investigative (a “Proceeding”), by reason of the fact
that the Founder is or was a trustee, director, officer or employee of the Company, MSLO LLC, or any predecessor to MSLO LLC (including
any sole proprietorship owned by the Founder) or any of their affiliates or is or was serving at the request of the Company, MSLO
LLC, any predecessor to MSLO LLC (including any proprietorship owned by the Founder), or any of their affiliates as a trustee,
director, officer, member, employee or agent of another corporation or a partnership, joint venture, limited liability company,
trust or other enterprise, including, without limitation, service with respect to employee benefit plans, whether or not the basis
of such Proceeding is alleged action in an official capacity as a trustee, director, officer, member, employee or agent while serving
as a trustee, director, officer, member, employee or agent, the Founder shall be indemnified and held harmless by the Company to
the fullest extent authorized by Delaware law, as the same exists or may hereafter be amended, against all Expenses incurred or
suffered by the Founder in connection therewith. Such indemnification and this Section 10(a) shall continue as to the Founder even
if the Founder has ceased to be an officer, director, trustee or agent, or is no longer employed by the Company and shall inure
to the benefit of her heirs (including trusts and trustees), executors and administrators or upon any termination of this Agreement.
In addition, the Company shall indemnify and hold harmless the Founder in connection with any claim for indemnification under clause
(bb) of paragraph 11(a) of the Production Agreement (as defined in the Prior Employment Agreement).
(b) Expenses.
As used in this Agreement, the term “Expenses” shall include, without limitation, damages (whether punitive
or otherwise), losses, judgments, liabilities, fines, penalties, excise and other penalty taxes, compensation and benefits payable
to employees, consultants and independent contractors, settlements, and costs (including out-of-pocket expenses), attorneys’
fees, accountants’ fees, and disbursements and costs of attachment or similar bonds, investigations, and any expenses of
establishing a defense in any Proceeding and any right to indemnification under this Agreement.
(c) Enforcement.
If a claim or request under this Section 10 is not paid by the Company or on its behalf, within thirty (30) days after a written
claim or request has been received by the Company, the Founder may at any time thereafter bring suit against the Company to recover
the unpaid amount of the claim or request and if successful in whole or in part, the Founder shall be entitled to be paid also
the expenses of prosecuting such suit. All obligations for indemnification hereunder shall be subject to, and paid in accordance
with, applicable Delaware law.
(d) Partial
Indemnification. If the Founder is entitled under any provision of this Agreement to indemnification by the Company for some
or a portion of any Expenses, but not, however, for the total amount thereof, the Company shall nevertheless indemnify the Founder
for the portion of such Expenses to which the Founder is entitled.
(e) Advance
of Expenses. Expenses incurred by the Founder in connection with any Proceeding shall be paid by the Company in advance upon
request of the Founder that the Company pay such Expenses, but only in the event that the Founder shall have delivered in writing
to the Company (i) an undertaking to reimburse the Company for Expenses with respect to which the Founder is not entitled to indemnification
and (ii) a statement of her good faith belief that the standard of conduct necessary for indemnification by the Company has been
met.
(f) Notice
of Claim. The Founder shall give to the Company notice of any claim made against her for which indemnification will or could
be sought under this Agreement. In addition, the Founder shall give the Company such information and cooperation as it may reasonably
require and as shall be within the Founder’s power and at such times and places as are convenient for the Founder.
(g) Defense
of Claim. With respect to any Proceeding as to which the Founder notifies the Company of the commencement thereof:
(i) The
Company will be entitled to participate therein at its own expense;
(ii) Except
as otherwise provided below, to the extent that it may wish, the Company will be entitled to assume the defense thereof, with counsel
reasonably satisfactory to the Founder, which in the Company’s sole discretion may be regular counsel to the Company and
may be counsel to other officers and directors of the Company or any subsidiary. The Founder also shall have the right to employ
her own counsel in such action, suit or proceeding if she reasonably concludes that failure to do so would involve a conflict of
interest between the Company and the Founder, and under such circumstances the fees and expenses of such counsel shall be at the
expense of the Company.
(iii) The
Company shall not be liable to indemnify the Founder under this Agreement for any amounts paid in settlement of any action or claim
effected without its written consent. The Company shall not settle any action or claim in any manner which would impose any penalty
that would not be paid directly or indirectly by the Company or limitation on the Founder without the Founder’s written consent.
Neither the Company nor the Founder will unreasonably withhold or delay their consent to any proposed settlement.
(h) Non-Exclusivity.
The right to indemnification and the payment of expenses incurred in defending a Proceeding in advance of its final disposition
conferred in this Section 10 shall not be exclusive of any other right which the Founder may have or hereafter may acquire under
any statute or certificate of incorporation or by-laws of the Company or any subsidiary, agreement, vote of shareholders or disinterested
directors or trustees or otherwise.
(i) Timing
of Reimbursements or Expenses. To the extent required under Section 409A (as defined in Section 21(a) below), any reimbursements
or expenses provided under this Section 10 shall be subject to the limitations on payment and reimbursement of taxable expenses
set forth in Section 8(a).
11. Legal
Fees and Expenses. If any contest or dispute shall arise between the Company and the Founder regarding any provision of
this Agreement, the Company shall reimburse the Founder for all legal fees and expenses reasonably incurred by the Founder in connection
with such contest or dispute, but only if the Founder prevails to a substantial extent with respect to the Founder’s claims
brought and pursued in connection with such contest or dispute. Such reimbursement shall be made as soon as practicable following
the resolution of such contest or dispute (whether or not appealed) to the extent the Company receives written evidence of such
fees and expenses. In addition to the foregoing, the Company shall reimburse the Founder for all legal and other advisor fees incurred
by her in connection with the negotiation and execution of this Agreement and the agreements relating to the Merger Agreement,
up to a maximum reimbursement of Four Million Dollars ($4,000,000). To the extent required under Section 409A (as defined in Section
21(a) below), any reimbursements or expenses provided under this Section 11 shall be subject to the limitations on payment and
reimbursement of taxable expenses set forth in Section 8(a).
12. Successors;
Binding Agreement.
(a) Company’s
Successors. No rights or obligations of the Company under this Agreement may be assigned or transferred, except that the Company
shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially
all of the business and/or assets of the Company to expressly assume and agree to perform this Agreement in the same manner and
to the same extent that the Company would be required to perform it if no such succession had taken place. As used in this Agreement,
“Company” shall include any successor to its business and/or assets (by merger, purchase or otherwise) which
executes and delivers the agreement provided for in this Section 12 or which otherwise becomes bound by all the terms and provisions
of this Agreement by operation of law.
(b) Founder’s
Successors. No rights or obligations of the Founder under this Agreement may be assigned or transferred by the Founder other
than her rights to payments or benefits hereunder, which may be transferred only by will or the laws of descent and distribution.
Upon the Founder’s death, this Agreement and all rights of the Founder hereunder shall inure to the benefit of and be enforceable
by the Founder’s beneficiary or beneficiaries, personal or legal representatives, or estate, to the extent any such person
succeeds to the Founder’s interests under this Agreement. If the Founder should die following her Date of Termination while
any amounts would still be payable to her hereunder if she had continued to live, all such amounts unless otherwise provided herein
shall be paid in accordance with the terms of this Agreement to such person or persons so appointed in writing by the Founder,
or otherwise to her legal representatives or estate.
13. Notice.
For the purposes of this Agreement, notices, demands and all other communications provided for in this Agreement shall be in writing
and shall be deemed to have been duly given when delivered either personally or by United States certified or registered mail,
return receipt requested, postage prepaid, addressed as follows:
If to the Founder:
At her residence address most recently filed with
the Company.
with a copy (which shall not constitute notice) to:
Grubman Shire & Meiselas, P.C.
152 West 57th Street
New York, NY 10019
Attention: Allen J. Grubman; Lawrence Shire; Eric
Sacks
Email: AGrubman@gispc.com; lshire@gispc.com; esacks@gispc.com
If to the Company:
Martha Stewart Living Omnimedia, Inc.
601 West 26th Street
New York, New York 10001
Attention: General Counsel
or to such other address as any party may have furnished to
the others in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt.
14. Miscellaneous.
No provisions of this Agreement may be amended, modified, or waived unless such amendment or modification is agreed to in writing
signed by the Founder and by a duly authorized officer of the Company, and such waiver is set forth in writing and signed by the
party to be charged. No waiver by either party hereto at any time of any breach by the other party hereto of any condition or provision
of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions
at the same or at any prior or subsequent time. No agreements or representations, oral or otherwise, express or implied, with respect
to the subject matter hereof have been made by either party which are not set forth expressly in this Agreement. The respective
rights and obligations of the parties hereunder of this Agreement (including, without limitation, the Founder’s right to
be nominated for a Board seat under Section 1 above) shall survive the Founder’s termination of employment and the termination
of this Agreement to the extent necessary for the intended preservation of such rights and obligations. Except as otherwise provided
in Section 10 hereof with respect to indemnification under Delaware law, the validity, interpretation, construction and performance
of this Agreement shall be governed by the laws of the State of New York without regard to its conflicts of law principles.
15. Key
Person Insurance. The Company may, at its discretion and expense, apply for and procure in its own name and for its own
benefit “key person” or other life insurance and/or disability insurance on the Founder in any amount or amounts considered
advisable. The Founder agrees to submit to any reasonably requested physical examination in connection with the Company’s
purchase of such insurance. The results of any such physical examination will be kept confidential by the Company and will only
be disclosed to the extent required to obtain such insurance. The Founder agrees to cooperate fully and supply any information
and execute and deliver any applications or other instruments in writing as may be reasonably necessary in connection with the
underwriting, purchase and/or retention of any insurance policy by the Company.
16. Validity.
The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability
of any other provision of this Agreement, which shall remain in full force and effect.
17. Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together
will constitute one and the same instrument.
18. Entire
Agreement. This Agreement and the Amended and Restated Intellectual Property License and Preservation Agreement of even
date herewith, and the Amended and Restated Intangible Asset License Agreement of even date herewith set forth the entire agreement
of the parties hereto in respect of the subject matter contained herein and, upon the commencement of the Employment Period, supersede
all prior agreements, promises, covenants, arrangements, communications, representations or warranties, whether oral or written,
by any officer, employee or representative of any party hereto in respect of such subject matter including, without limitation,
the Prior Employment Agreement. The parties agree that the Prior Employment Agreement will terminate effective as of 11.59 PM on
the day immediately preceding the Closing Date.
19. Withholding.
All payments hereunder shall be subject to any required withholding of Federal, state and local taxes pursuant to any applicable
law or regulation.
20. Section
Headings. The section headings in this Employment Agreement are for convenience of reference only, and they form no part
of this Agreement and shall not affect its interpretation.
21. Section
409A.
(a) The
intent of the parties is that payments and benefits under this Agreement comply with Section 409A of the Internal Revenue Code
of 1986, as amended, and the guidance issued thereunder (“Section 409A”) and, accordingly, to the maximum extent
permitted, all provisions of this Agreement shall be construed in a manner consistent with the requirements for avoiding taxes
or penalties under Section 409A. Founder is hereby advised to seek independent advice from her tax advisor(s) with respect to any
payments or benefits under this Agreement. Notwithstanding the foregoing, the Company does not guarantee the tax treatment of any
payments or benefits provided under this Agreement, whether pursuant to the Code, federal, state, local or foreign tax laws and
regulations.
(b) If
the Founder is deemed on the date of termination of her “separation from service” with the Company to be a “specified
employee”, each within the meaning of Section 409A(a)(2)(B) of the Code, then with regard to any payment or the providing
of any benefit under this Agreement, and any other payment or the provision of any other benefit, in any such case that is required
to be delayed in compliance with Section 409A(a)(2)(B) of the Code, such payment or benefit shall not be made or provided prior
to the earlier of (i) the expiration of the six-month period measured from the date of the Founder’s separation from service,
or (ii) the date of the Founder’s death, if and to the extent such six-month delay is required to comply with Section 409A(a)(2)(B)
of the Code. In such event, on or promptly after the first business day following the six-month-delay period, all payments delayed
pursuant to this Section 21 (whether they would have otherwise been payable in a single sum or in installments in the absence of
such delay) shall be paid or reimbursed to the Founder in a lump sum, and any remaining payments and benefits due under this Agreement
shall be paid or provided in accordance with the normal payment dates specified for them herein. To the extent applicable, if payment
of an amount under this Agreement could be paid in one of two calendar years subject to the delivery of the Release in accordance
with Section 8(a), and it is determined that payment of such amount in the earlier of such two years could constitute noncompliance
with Section 409A, then such amount shall be paid in the later of such two years and otherwise in accordance with the applicable
payment schedule provided for under this Agreement (subject to earlier payment upon the Founder’s death in accordance with
the first sentence of this Section 21(b)).
(c) If
under this Agreement, an amount is to be paid in installments, each installment shall be treated as a separate payment for purposes
of Treasury Regulation Section 1.409A-2(b)(2)(iii).
[Signature Page Follows]
IN WITNESS WHEREOF, the parties hereto
have executed this Agreement on this 22 day of June, 2015.
|
SINGER MADELINE HOLDINGS, INC. |
|
|
|
|
|
|
By: |
/s/ Yehuda Shmidman |
|
|
Name: |
Yehuda Shmidman |
|
|
Title: |
Chief Executive Officer |
|
|
|
|
|
|
/s/ Martha Stewart |
|
|
Martha Stewart |
|
Signature Page to Martha Stewart Employment Agreement |
Martha Stewart (NYSE:MSO)
Historical Stock Chart
From Jan 2025 to Feb 2025
Martha Stewart (NYSE:MSO)
Historical Stock Chart
From Feb 2024 to Feb 2025